IGNORE,USUBJID,COMPOUND,STUDY,STUDYDES,PART,EXTENS,CENTER,SUBJECT,INDNAME,TRTNAME,TRTNAMER,VISIT,VISNAME,BASE,SCREEN,DATEDAY,DATETIME,DURATION,NT,TIME,TIMEUNIT,TYPENAME,NAME,VALUE,VALUETXT,UNIT,ULOQ,LLOQ,ROUTE,II,ADDL,COMMENT,FOOD,AST0,BMI0,EVID
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-מאי-81,07:00,0,-14,-24.97916667,Days,Demographics,Age,72,.,Years,.,.,.,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-מאי-81,07:00,0,-14,-24.97916667,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-מאי-81,07:00,0,-14,-24.97916667,Days,Demographics,Weight,101,.,kg,.,.,.,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,16-מאי-81,12:38,0,0,-12.74444444,Days,PD,Efficacy marker,44.504,.,mm,.,50,.,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,17-מאי-81,07:00,0,0,-11.97916667,Days,Demographics,Weight,102,.,kg,.,.,.,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-מאי-81,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,06:19,0,0,-0.007638889,Days,PK,Plasma concentration Z,0,.,ug/ml,.,200,.,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,06:30,0.083333333,0,0,Days,Dose,Dose X,1530,.,mg,.,.,iv,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,08:50,0,0.0833,0.0833,Days,PK,Plasma concentration Z,2019.999,.,ug/ml,.,200,.,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,30-מאי-81,06:30,0,1,1,Days,PK,Plasma concentration Z,1476,.,ug/ml,.,200,.,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,05-יונ-81,06:30,0,7,7,Days,PK,Plasma concentration Z,422.001,.,ug/ml,.,200,.,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,12-יונ-81,09:04,0,14,14,Days,PD,Efficacy marker,45.678,.,mm,.,50,.,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,12-יונ-81,06:30,0,14,14,Days,PK,Plasma concentration Z,294,.,ug/ml,.,200,.,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-מאי-81,07:00,0,12,14.70196997,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,19-יונ-81,06:30,0,21,21,Days,PK,Plasma concentration Z,213.999,.,ug/ml,.,200,.,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,26-יונ-81,06:30,0,28,28,Days,PK,Plasma concentration Z,157.401,.,ug/ml,.,200,.,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,26-יונ-81,10:30,0,28,28.16666667,Days,PD,Efficacy marker,46.038,.,mm,.,50,.,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,10-יול-81,06:30,0,42,42,Days,PK,Plasma concentration Z,93.6,.,ug/ml,.,200,.,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,24-יול-81,06:30,0,56,56,Days,PK,Plasma concentration Z,53.001,.,ug/ml,.,200,.,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,07-אוג-81,06:30,0,70,70,Days,PK,Plasma concentration Z,27.399,.,ug/ml,.,200,.,.,.,.,0,1107,369,999
.,ZY100101107,Z,Y1,FIH HV Study ,1,0,1,1107,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,12,VISIT 12,0,0,21-אוג-81,06:30,0,84,84,Days,PK,Plasma concentration Z,16.521,.,ug/ml,.,200,.,.,.,.,0,1107,369,999
.,ZY100101108,Z,Y1,FIH HV Study ,1,0,1,1108,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,04-מאי-81,07:00,0,-14,-25,Days,Demographics,Age,78,.,Years,.,.,.,.,.,.,0,1108,369.3333333,999
.,ZY100101108,Z,Y1,FIH HV Study ,1,0,1,1108,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,04-מאי-81,07:00,0,-14,-25,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,0,1108,369.3333333,999
.,ZY100101108,Z,Y1,FIH HV Study ,1,0,1,1108,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,04-מאי-81,07:00,0,-14,-25,Days,Demographics,Weight,60.9,.,kg,.,.,.,.,.,.,0,1108,369.3333333,999
.,ZY100101108,Z,Y1,FIH HV Study ,1,0,1,1108,Healthy volunteers,SD IV Placebo,SD IV Placebo,2,Baseline,1,0,20-מאי-81,07:00,0,0,-9,Days,Demographics,Weight,59.8,.,kg,.,.,.,.,.,.,0,1108,369.3333333,999
.,ZY100101108,Z,Y1,FIH HV Study ,1,0,1,1108,Healthy volunteers,SD IV Placebo,SD IV Placebo,2,Baseline,1,0,23-מאי-81,15:53,0,0,-5.629861111,Days,PD,Efficacy marker,37.927,.,mm,.,.,.,.,.,.,0,1108,369.3333333,999
.,ZY100101108,Z,Y1,FIH HV Study ,1,0,1,1108,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,04-מאי-81,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,0,1108,369.3333333,999
.,ZY100101108,Z,Y1,FIH HV Study ,1,0,1,1108,Healthy volunteers,SD IV Placebo,SD IV Placebo,3,VISIT 03,1,0,29-מאי-81,07:00,0.083333333,0,0,Days,Dose,Dose X,0,.,mg,.,.,iv,.,.,.,0,1108,369.3333333,999
.,ZY100101108,Z,Y1,FIH HV Study ,1,0,1,1108,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,04-מאי-81,07:00,0,12,13.24352653,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,0,1108,369.3333333,999
.,ZY100101108,Z,Y1,FIH HV Study ,1,0,1,1108,Healthy volunteers,SD IV Placebo,SD IV Placebo,6,VISIT 06,0,0,12-יונ-81,09:50,0,14,14.11805556,Days,PD,Efficacy marker,36.851,.,mm,.,.,.,.,.,.,0,1108,369.3333333,999
.,ZY100101108,Z,Y1,FIH HV Study ,1,0,1,1108,Healthy volunteers,SD IV Placebo,SD IV Placebo,8,VISIT 08,0,0,27-יונ-81,09:09,0,28,29.08958333,Days,PD,Efficacy marker,37.873,.,mm,.,.,.,.,.,.,0,1108,369.3333333,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,03-מאי-81,07:00,0,-14,-26.02152778,Days,Demographics,Age,72,.,Years,.,.,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,03-מאי-81,07:00,0,-14,-26.02152778,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,03-מאי-81,07:00,0,-14,-26.02152778,Days,Demographics,Weight,67.3,.,kg,.,.,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,20-מאי-81,07:00,0,0,-9.021527778,Days,Demographics,Weight,68.2,.,kg,.,.,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,23-מאי-81,17:04,0,0,-5.602083333,Days,PD,Efficacy marker,25.447,.,mm,.,.,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,03-מאי-81,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,07:15,0,0,-0.011111111,Days,PK,Plasma concentration Z,0,.,ug/ml,.,200,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,07:31,0.083333333,0,0,Days,Dose,Dose X,1023,.,mg,.,.,iv,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,10:01,0,0.166,0.104166667,Days,PK,Plasma concentration Z,1850.001,.,ug/ml,.,200,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,11:30,0,0.166,0.165972222,Days,PK,Plasma concentration Z,NA,.,ug/ml,.,200,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,30-מאי-81,07:30,0,1,0.999305556,Days,PK,Plasma concentration Z,1362,.,ug/ml,.,200,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,05-יונ-81,07:30,0,7,6.999305556,Days,PK,Plasma concentration Z,410.001,.,ug/ml,.,200,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,03-מאי-81,07:00,0,12,13.27938863,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,12-יונ-81,07:30,0,14,13.99930556,Days,PK,Plasma concentration Z,272.001,.,ug/ml,.,200,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,12-יונ-81,10:13,0,14,14.1125,Days,PD,Efficacy marker,26.451,.,mm,.,.,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,19-יונ-81,07:55,0,21,21.01666667,Days,PK,Plasma concentration Z,194.799,.,ug/ml,.,200,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,26-יונ-81,08:02,0,28,28.02152778,Days,PK,Plasma concentration Z,169.8,.,ug/ml,.,200,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,28-יונ-81,13:11,0,28,30.23611111,Days,PD,Efficacy marker,NA,.,mm,.,.,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,10-יול-81,07:42,0,42,42.00763889,Days,PK,Plasma concentration Z,99.6,.,ug/ml,.,200,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,24-יול-81,08:00,0,56,56.02013889,Days,PK,Plasma concentration Z,63.399,.,ug/ml,.,200,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,08-אוג-81,08:23,0,70,71.03611111,Days,PK,Plasma concentration Z,40.401,.,ug/ml,.,200,.,.,.,.,0,1109,369.6666667,999
.,ZY100101109,Z,Y1,FIH HV Study ,1,0,1,1109,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,12,VISIT 12,0,0,21-אוג-81,07:30,0,84,83.99930556,Days,PK,Plasma concentration Z,20.4,.,ug/ml,.,200,.,.,.,.,0,1109,369.6666667,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,07-מאי-81,07:00,0,-14,-22.02777778,Days,Demographics,Age,71,.,Years,.,.,.,.,.,.,0,1110,370,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,07-מאי-81,07:00,0,-14,-22.02777778,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,0,1110,370,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,07-מאי-81,07:00,0,-14,-22.02777778,Days,Demographics,Weight,85,.,kg,.,.,.,.,.,.,0,1110,370,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,16-מאי-81,11:53,0,0,-12.82430556,Days,PD,Efficacy marker,29.153,.,mm,.,.,.,.,.,.,0,1110,370,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,17-מאי-81,07:00,0,0,-12.02777778,Days,Demographics,Weight,87,.,kg,.,.,.,.,.,.,0,1110,370,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,07-מאי-81,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,0,1110,370,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,07:25,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,200,.,.,.,.,0,1110,370,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,07:40,0.083333333,0,0,Days,Dose,Dose X,1305,.,mg,.,.,iv,.,.,.,0,1110,370,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,09:53,0,0.0833,0.092361111,Days,PK,Plasma concentration Z,1982.001,.,ug/ml,.,200,.,.,.,.,0,1110,370,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,11:40,0,0.166,0.166666667,Days,PK,Plasma concentration Z,2379.999,.,ug/ml,.,200,.,.,.,.,0,1110,370,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,30-מאי-81,07:40,0,1,1,Days,PK,Plasma concentration Z,1634.001,.,ug/ml,.,200,.,.,.,.,0,1110,370,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,05-יונ-81,07:40,0,7,7,Days,PK,Plasma concentration Z,507.999,.,ug/ml,.,200,.,.,.,.,0,1110,370,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,07-מאי-81,07:00,0,12,13.31336038,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,0,1110,370,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,12-יונ-81,07:40,0,14,14,Days,PK,Plasma concentration Z,330,.,ug/ml,.,200,.,.,.,.,0,1110,370,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,13-יונ-81,13:05,0,14,15.22569444,Days,PD,Efficacy marker,30.688,.,mm,.,.,.,.,.,.,0,1110,370,999
Ignore example 1,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,19-יונ-81,07:44,0,21,21.00277778,Days,PK,Plasma concentration Z,248.001,.,ug/ml,.,200,.,.,.,.,0,1110,370,999
Ignore example 2,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,26-יונ-81,07:40,0,28,28,Days,PK,Plasma concentration Z,193.401,.,ug/ml,.,200,.,.,.,.,0,1110,370,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,27-יונ-81,10:22,0,28,29.1125,Days,PD,Efficacy marker,30.817,.,mm,.,.,.,.,.,.,0,1110,370,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,10-יול-81,07:40,0,42,42,Days,PK,Plasma concentration Z,88.599,.,ug/ml,.,200,.,.,.,.,0,1110,370,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,24-יול-81,07:40,0,56,56,Days,PK,Plasma concentration Z,60.999,.,ug/ml,.,200,.,.,.,.,0,1110,370,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,07-אוג-81,07:47,0,70,70.00486111,Days,PK,Plasma concentration Z,27.6,.,ug/ml,.,200,.,.,.,.,0,1110,370,999
.,ZY100101110,Z,Y1,FIH HV Study ,1,0,1,1110,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,12,VISIT 12,0,0,21-אוג-81,07:44,0,84,84.00277778,Days,PK,Plasma concentration Z,13.539,.,ug/ml,.,200,.,.,.,.,0,1110,370,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,08-מאי-81,07:00,0,-14,-21.03472222,Days,Demographics,Age,77,.,Years,.,.,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,08-מאי-81,07:00,0,-14,-21.03472222,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,08-מאי-81,07:00,0,-14,-21.03472222,Days,Demographics,Weight,56.8,.,kg,.,.,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,20-מאי-81,07:00,0,0,-9.034722222,Days,Demographics,Weight,55,.,kg,.,.,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,20-מאי-81,07:18,0,0,-9.022222222,Days,PD,Efficacy marker,22.126,.,mm,.,.,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,08-מאי-81,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,07:35,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,07:50,0.083333333,0,0,Days,Dose,Dose X,825,.,mg,.,.,iv,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,10:05,0,0.0833,0.09375,Days,PK,Plasma concentration Z,1332,.,ug/ml,.,0.8,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,11:50,0,0.166,0.166666667,Days,PK,Plasma concentration Z,1416,.,ug/ml,.,0.8,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,30-מאי-81,07:50,0,1,1,Days,PK,Plasma concentration Z,945.999,.,ug/ml,.,0.8,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,05-יונ-81,07:50,0,7,7,Days,PK,Plasma concentration Z,276,.,ug/ml,.,0.8,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,08-מאי-81,07:00,0,12,13.62938961,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,12-יונ-81,07:50,0,14,14,Days,PK,Plasma concentration Z,170.199,.,ug/ml,.,0.8,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,13-יונ-81,07:22,0,14,14.98055556,Days,PD,Efficacy marker,23.604,.,mm,.,.,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,19-יונ-81,07:50,0,21,21,Days,PK,Plasma concentration Z,130.599,.,ug/ml,.,0.8,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,26-יונ-81,07:58,0,28,28.00555556,Days,PK,Plasma concentration Z,102.201,.,ug/ml,.,0.8,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,27-יונ-81,09:38,0,28,29.075,Days,PD,Efficacy marker,24.234,.,mm,.,.,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,10-יול-81,07:57,0,42,42.00486111,Days,PK,Plasma concentration Z,64.599,.,ug/ml,.,0.8,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,24-יול-81,07:50,0,56,56,Days,PK,Plasma concentration Z,33.201,.,ug/ml,.,0.8,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,07-אוג-81,07:36,0,70,69.99027778,Days,PK,Plasma concentration Z,16.719,.,ug/ml,.,0.8,.,.,.,.,0,1111,370.3333333,999
.,ZY100101111,Z,Y1,FIH HV Study ,1,0,1,1111,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,12,VISIT 12,0,0,21-אוג-81,07:51,0,84,84.00069444,Days,PK,Plasma concentration Z,8.4,.,ug/ml,.,0.8,.,.,.,.,0,1111,370.3333333,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,08-מאי-81,07:00,0,-14,-21.05555556,Days,Demographics,Age,73,.,Years,.,.,.,.,.,.,0,1112,370.6666667,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,08-מאי-81,07:00,0,-14,-21.05555556,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,0,1112,370.6666667,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,16-מאי-81,10:24,0,0,-12.91388889,Days,PD,Efficacy marker,25.198,.,mm,.,.,.,.,.,.,0,1112,370.6666667,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,08-מאי-81,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,0,1112,370.6666667,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,08:14,0,0,-0.004166667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1112,370.6666667,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,08:20,0.083333333,0,0,Days,Dose,Dose X,1111.5,.,mg,.,.,iv,.,.,.,0,1112,370.6666667,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,10:30,0,0.0833,0.090277778,Days,PK,Plasma concentration Z,1958.001,.,ug/ml,.,0.8,.,.,.,.,0,1112,370.6666667,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,12:20,0,0.166,0.166666667,Days,PK,Plasma concentration Z,1983.999,.,ug/ml,.,0.8,.,.,.,.,0,1112,370.6666667,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,30-מאי-81,08:22,0,1,1.001388889,Days,PK,Plasma concentration Z,1172.001,.,ug/ml,.,0.8,.,.,.,.,0,1112,370.6666667,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,05-יונ-81,08:21,0,7,7.000694444,Days,PK,Plasma concentration Z,438,.,ug/ml,.,0.8,.,.,.,.,0,1112,370.6666667,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,08-מאי-81,07:00,0,12,13.72698069,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,0,1112,370.6666667,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,12-יונ-81,08:21,0,14,14.00069444,Days,PK,Plasma concentration Z,284.001,.,ug/ml,.,0.8,.,.,.,.,0,1112,370.6666667,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,13-יונ-81,12:22,0,14,15.16805556,Days,PD,Efficacy marker,26.852,.,mm,.,.,.,.,.,.,0,1112,370.6666667,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,19-יונ-81,08:20,0,21,21,Days,PK,Plasma concentration Z,213.999,.,ug/ml,.,0.8,.,.,.,.,0,1112,370.6666667,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,26-יונ-81,08:22,0,28,28.00138889,Days,PK,Plasma concentration Z,162.399,.,ug/ml,.,0.8,.,.,.,.,0,1112,370.6666667,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,27-יונ-81,11:09,0,28,29.11736111,Days,PD,Efficacy marker,26.289,.,mm,.,.,.,.,.,.,0,1112,370.6666667,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,10-יול-81,08:20,0,42,42,Days,PK,Plasma concentration Z,99.6,.,ug/ml,.,0.8,.,.,.,.,0,1112,370.6666667,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,24-יול-81,08:22,0,56,56.00138889,Days,PK,Plasma concentration Z,66.399,.,ug/ml,.,0.8,.,.,.,.,0,1112,370.6666667,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,07-אוג-81,08:20,0,70,70,Days,PK,Plasma concentration Z,43.8,.,ug/ml,.,0.8,.,.,.,.,0,1112,370.6666667,999
.,ZY100101112,Z,Y1,FIH HV Study ,1,0,1,1112,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,12,VISIT 12,0,0,21-אוג-81,08:35,0,84,84.01041667,Days,PK,Plasma concentration Z,21.201,.,ug/ml,.,0.8,.,.,.,.,0,1112,370.6666667,999
.,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,16-מאי-81,11:17,0,0,-12.91527778,Days,PD,Efficacy marker,30.764,.,mm,.,.,.,.,.,.,0,1113,371,999
.,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,16-מאי-81,11:17,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,0,1113,371,999
.,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,09:00,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1113,371,999
.,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,09:15,0.083333333,0,0,Days,Dose,Dose X,1050,.,mg,.,.,iv,.,.,.,0,1113,371,999
.,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,11:28,0,0.0833,0.092361111,Days,PK,Plasma concentration Z,1755.999,.,ug/ml,.,0.8,.,.,.,.,0,1113,371,999
.,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,13:15,0,0.166,0.166666667,Days,PK,Plasma concentration Z,1761.999,.,ug/ml,.,0.8,.,.,.,.,0,1113,371,999
.,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,30-מאי-81,09:15,0,1,1,Days,PK,Plasma concentration Z,1272,.,ug/ml,.,0.8,.,.,.,.,0,1113,371,999
.,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,05-יונ-81,09:15,0,7,7,Days,PK,Plasma concentration Z,315.999,.,ug/ml,.,0.8,.,.,.,.,0,1113,371,999
.,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,12-יונ-81,09:15,0,14,14,Days,PK,Plasma concentration Z,204,.,ug/ml,.,0.8,.,.,.,.,0,1113,371,999
.,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-מאי-81,09:00,0,12,14.66101271,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,0,1113,371,999
.,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,13-יונ-81,13:51,0,14,15.19166667,Days,PD,Efficacy marker,32.17,.,mm,.,.,.,.,.,.,0,1113,371,999
.,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,19-יונ-81,09:17,0,21,21.00138889,Days,PK,Plasma concentration Z,151.401,.,ug/ml,.,0.8,.,.,.,.,0,1113,371,999
.,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,26-יונ-81,09:15,0,28,28,Days,PK,Plasma concentration Z,115.401,.,ug/ml,.,0.8,.,.,.,.,0,1113,371,999
.,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,27-יונ-81,13:33,0,28,29.17916667,Days,PD,Efficacy marker,33.057,.,mm,.,.,.,.,.,.,0,1113,371,999
.,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,10-יול-81,09:15,0,42,42,Days,PK,Plasma concentration Z,61.2,.,ug/ml,.,0.8,.,.,.,.,0,1113,371,999
.,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,24-יול-81,09:15,0,56,56,Days,PK,Plasma concentration Z,36.999,.,ug/ml,.,0.8,.,.,.,.,0,1113,371,999
.,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,07-אוג-81,08:34,0,70,69.97152778,Days,PK,Plasma concentration Z,16.38,.,ug/ml,.,0.8,.,.,.,.,0,1113,371,999
.,ZY100101113,Z,Y1,FIH HV Study ,1,0,1,1113,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,12,VISIT 12,0,0,21-אוג-81,09:15,0,84,84,Days,PK,Plasma concentration Z,6.54,.,ug/ml,.,0.8,.,.,.,.,0,1113,371,999
.,ZY100101114,Z,Y1,FIH HV Study ,1,0,1,1114,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,14-מאי-81,07:00,0,-14,-15.12152778,Days,Demographics,Weight,60.4,.,kg,.,.,.,.,.,.,0,1114,371.3333333,999
.,ZY100101114,Z,Y1,FIH HV Study ,1,0,1,1114,Healthy volunteers,SD IV Placebo,SD IV Placebo,2,Baseline,1,0,24-מאי-81,07:00,0,0,-5.121527778,Days,Demographics,Weight,59.8,.,kg,.,.,.,.,.,.,0,1114,371.3333333,999
.,ZY100101114,Z,Y1,FIH HV Study ,1,0,1,1114,Healthy volunteers,SD IV Placebo,SD IV Placebo,2,Baseline,1,0,24-מאי-81,08:11,0,0,-5.072222222,Days,PD,Efficacy marker,27.949,.,mm,.,.,.,.,.,.,0,1114,371.3333333,999
.,ZY100101114,Z,Y1,FIH HV Study ,1,0,1,1114,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,14-מאי-81,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,0,1114,371.3333333,999
.,ZY100101114,Z,Y1,FIH HV Study ,1,0,1,1114,Healthy volunteers,SD IV Placebo,SD IV Placebo,3,VISIT 03,1,0,29-מאי-81,09:55,0.083333333,0,0,Days,Dose,Dose X,0,.,mg,.,.,iv,.,.,.,0,1114,371.3333333,999
.,ZY100101114,Z,Y1,FIH HV Study ,1,0,1,1114,Healthy volunteers,SD IV Placebo,SD IV Placebo,2,Baseline,1,0,24-מאי-81,07:00,0,12,13.68249274,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,0,1114,371.3333333,999
.,ZY100101114,Z,Y1,FIH HV Study ,1,0,1,1114,Healthy volunteers,SD IV Placebo,SD IV Placebo,6,VISIT 06,0,0,13-יונ-81,06:22,0,14,14.85208333,Days,PD,Efficacy marker,28.196,.,mm,.,.,.,.,.,.,0,1114,371.3333333,999
.,ZY100101114,Z,Y1,FIH HV Study ,1,0,1,1114,Healthy volunteers,SD IV Placebo,SD IV Placebo,8,VISIT 08,0,0,26-יונ-81,12:42,0,28,28.11597222,Days,PD,Efficacy marker,28.466,.,mm,.,.,.,.,.,.,0,1114,371.3333333,999
.,ZY100101115,Z,Y1,FIH HV Study ,1,0,1,1115,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,17-יונ-81,07:00,0,-14,-21.97569444,Days,Demographics,Age,76,.,Years,.,.,.,.,.,.,0,1115,371.6666667,999
.,ZY100101115,Z,Y1,FIH HV Study ,1,0,1,1115,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,17-יונ-81,07:00,0,-14,-21.97569444,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,0,1115,371.6666667,999
.,ZY100101115,Z,Y1,FIH HV Study ,1,0,1,1115,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,17-יונ-81,07:00,0,-14,-21.97569444,Days,Demographics,Weight,65.9,.,kg,.,.,.,.,.,.,0,1115,371.6666667,999
.,ZY100101115,Z,Y1,FIH HV Study ,1,0,1,1115,Healthy volunteers,SD IV Placebo,SD IV Placebo,2,Baseline,1,0,01-יול-81,07:00,0,0,-7.975694444,Days,Demographics,Weight,61.7,.,kg,.,.,.,.,.,.,0,1115,371.6666667,999
.,ZY100101115,Z,Y1,FIH HV Study ,1,0,1,1115,Healthy volunteers,SD IV Placebo,SD IV Placebo,2,Baseline,1,0,01-יול-81,13:42,0,0,-7.696527778,Days,PD,Efficacy marker,28.216,.,mm,.,.,.,.,.,.,0,1115,371.6666667,999
.,ZY100101115,Z,Y1,FIH HV Study ,1,0,1,1115,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,17-יונ-81,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,0,1115,371.6666667,999
.,ZY100101115,Z,Y1,FIH HV Study ,1,0,1,1115,Healthy volunteers,SD IV Placebo,SD IV Placebo,3,VISIT 03,1,0,09-יול-81,06:25,0.083333333,0,0,Days,Dose,Dose X,0,.,mg,.,.,iv,.,.,.,0,1115,371.6666667,999
.,ZY100101115,Z,Y1,FIH HV Study ,1,0,1,1115,Healthy volunteers,SD IV Placebo,SD IV Placebo,6,VISIT 06,0,0,23-יול-81,08:47,0,14,14.09861111,Days,PD,Efficacy marker,27.762,.,mm,.,.,.,.,.,.,0,1115,371.6666667,999
.,ZY100101115,Z,Y1,FIH HV Study ,1,0,1,1115,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,17-יונ-81,07:00,0,12,14.55436828,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,0,1115,371.6666667,999
.,ZY100101115,Z,Y1,FIH HV Study ,1,0,1,1115,Healthy volunteers,SD IV Placebo,SD IV Placebo,8,VISIT 08,0,0,07-אוג-81,13:07,0,28,29.27916667,Days,PD,Efficacy marker,27.585,.,mm,.,.,.,.,.,.,0,1115,371.6666667,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,26-יונ-81,07:00,0,-14,-12.99652778,Days,Demographics,Age,76,.,Years,.,.,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,26-יונ-81,07:00,0,-14,-12.99652778,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,26-יונ-81,07:00,0,-14,-12.99652778,Days,Demographics,Weight,57.1,.,kg,.,.,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,02-יול-81,07:00,0,0,-6.996527778,Days,Demographics,Weight,56.8,.,kg,.,.,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,03-יול-81,13:47,0,0,-5.713888889,Days,PD,Efficacy marker,19.381,.,mm,.,.,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,26-יונ-81,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,06:40,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,06:55,0.083333333,0,0,Days,Dose,Dose X,85.2,.,mg,.,.,iv,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,09:13,0,0.0833,0.095833333,Days,PK,Plasma concentration Z,130.599,.,ug/ml,.,0.8,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,10:57,0,0.166,0.168055556,Days,PK,Plasma concentration Z,158.001,.,ug/ml,.,0.8,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,4,VISIT 04,1,0,10-יול-81,06:55,0,1,1,Days,PK,Plasma concentration Z,107.601,.,ug/ml,.,0.8,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,5,VISIT 05,0,0,16-יול-81,06:55,0,7,7,Days,PK,Plasma concentration Z,30.201,.,ug/ml,.,0.8,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,26-יונ-81,07:00,0,12,13.01423527,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,23-יול-81,06:55,0,14,14,Days,PK,Plasma concentration Z,13.839,.,ug/ml,.,0.8,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,23-יול-81,09:52,0,14,14.12291667,Days,PD,Efficacy marker,19.754,.,mm,.,.,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,7,VISIT 07,0,0,30-יול-81,06:55,0,21,21,Days,PK,Plasma concentration Z,6.321,.,ug/ml,.,0.8,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,06-אוג-81,06:55,0,28,28,Days,PK,Plasma concentration Z,2.301,.,ug/ml,.,0.8,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,07-אוג-81,12:32,0,28,29.23402778,Days,PD,Efficacy marker,20.87,.,mm,.,.,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,9,VISIT 09,0,0,20-אוג-81,06:55,0,42,42,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,10,VISIT 10,0,0,03-ספט-81,07:47,0,56,56.03611111,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,11,VISIT 11,0,0,17-ספט-81,06:55,0,70,70,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1116,372,999
.,ZY100101116,Z,Y1,FIH HV Study ,1,0,1,1116,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,12,VISIT 12,0,0,01-אוק-81,06:55,0,84,84,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1116,372,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,24-יונ-81,07:00,0,-14,-15.01736111,Days,Demographics,Age,83,.,Years,.,.,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,24-יונ-81,07:00,0,-14,-15.01736111,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,24-יונ-81,07:00,0,-14,-15.01736111,Days,Demographics,Weight,54.9,.,kg,.,.,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,02-יול-81,07:00,0,0,-7.017361111,Days,Demographics,Weight,54.6,.,kg,.,.,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,03-יול-81,13:11,0,0,-5.759722222,Days,PD,Efficacy marker,18.829,.,mm,.,.,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,24-יונ-81,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,07:11,0,0,-0.009722222,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,07:25,0.083333333,0,0,Days,Dose,Dose X,81.9,.,mg,.,.,iv,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,09:40,0,0.0833,0.09375,Days,PK,Plasma concentration Z,182.001,.,ug/ml,.,0.8,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,11:25,0,0.166,0.166666667,Days,PK,Plasma concentration Z,197.199,.,ug/ml,.,0.8,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,4,VISIT 04,1,0,10-יול-81,07:25,0,1,1,Days,PK,Plasma concentration Z,122.601,.,ug/ml,.,0.8,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,5,VISIT 05,0,0,16-יול-81,07:25,0,7,7,Days,PK,Plasma concentration Z,25.8,.,ug/ml,.,0.8,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,23-יול-81,07:25,0,14,14,Days,PK,Plasma concentration Z,12.519,.,ug/ml,.,0.8,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,23-יול-81,10:36,0,14,14.13263889,Days,PD,Efficacy marker,19.368,.,mm,.,.,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,24-יונ-81,07:00,0,12,14.93587952,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,7,VISIT 07,0,0,30-יול-81,07:25,0,21,21,Days,PK,Plasma concentration Z,7.08,.,ug/ml,.,0.8,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,06-אוג-81,07:25,0,28,28,Days,PK,Plasma concentration Z,3.081,.,ug/ml,.,0.8,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,07-אוג-81,13:53,0,28,29.26944444,Days,PD,Efficacy marker,19.429,.,mm,.,.,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,9,VISIT 09,0,0,20-אוג-81,07:25,0,42,42,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,10,VISIT 10,0,0,03-ספט-81,07:27,0,56,56.00138889,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,11,VISIT 11,0,0,18-ספט-81,07:34,0,70,71.00625,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1117,372.3333333,999
.,ZY100101117,Z,Y1,FIH HV Study ,1,0,1,1117,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,12,VISIT 12,0,0,01-אוק-81,07:22,0,84,83.99791667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1117,372.3333333,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,25-יונ-81,07:00,0,-14,-14.04166667,Days,Demographics,Age,75,.,Years,.,.,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,25-יונ-81,07:00,0,-14,-14.04166667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,25-יונ-81,07:00,0,-14,-14.04166667,Days,Demographics,Weight,51.9,.,kg,.,.,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,03-יול-81,07:00,0,0,-6.041666667,Days,Demographics,Weight,50.9,.,kg,.,.,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,04-יול-81,10:55,0,0,-4.878472222,Days,PD,Efficacy marker,22.856,.,mm,.,.,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,25-יונ-81,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,07:45,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,08:00,0.083333333,0,0,Days,Dose,Dose X,76.05,.,mg,.,.,iv,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,10:11,0,0.0833,0.090972222,Days,PK,Plasma concentration Z,135.399,.,ug/ml,.,0.8,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,12:00,0,0.166,0.166666667,Days,PK,Plasma concentration Z,151.8,.,ug/ml,.,0.8,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,4,VISIT 04,1,0,10-יול-81,08:01,0,1,1.000694444,Days,PK,Plasma concentration Z,93.201,.,ug/ml,.,0.8,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,5,VISIT 05,0,0,16-יול-81,08:02,0,7,7.001388889,Days,PK,Plasma concentration Z,24.399,.,ug/ml,.,0.8,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,22-יול-81,08:14,0,14,13.00972222,Days,PK,Plasma concentration Z,13.881,.,ug/ml,.,0.8,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,23-יול-81,11:24,0,14,14.14166667,Days,PD,Efficacy marker,23.759,.,mm,.,.,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,1,Screening,0,1,25-יונ-81,07:00,0,12,14.18024893,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,7,VISIT 07,0,0,30-יול-81,08:02,0,21,21.00138889,Days,PK,Plasma concentration Z,5.019,.,ug/ml,.,0.8,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,06-אוג-81,07:18,0,28,27.97083333,Days,PD,Efficacy marker,24.28,.,mm,.,.,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,06-אוג-81,09:11,0,28,28.04930556,Days,PK,Plasma concentration Z,1.278,.,ug/ml,.,0.8,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,9,VISIT 09,0,0,20-אוג-81,08:00,0,42,42,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,10,VISIT 10,0,0,03-ספט-81,08:00,0,56,56,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,11,VISIT 11,0,0,17-ספט-81,07:36,0,70,69.98333333,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1118,372.6666667,999
.,ZY100101118,Z,Y1,FIH HV Study ,1,0,1,1118,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,12,VISIT 12,0,0,01-אוק-81,08:00,0,84,84,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1118,372.6666667,999
.,ZY100101119,Z,Y1,FIH HV Study ,1,0,1,1119,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,17-יונ-81,07:00,0,-14,-22.06597222,Days,Demographics,Age,76,.,Years,.,.,.,.,.,.,0,1119,373,999
.,ZY100101119,Z,Y1,FIH HV Study ,1,0,1,1119,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,17-יונ-81,07:00,0,-14,-22.06597222,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,0,1119,373,999
.,ZY100101119,Z,Y1,FIH HV Study ,1,0,1,1119,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,17-יונ-81,07:00,0,-14,-22.06597222,Days,Demographics,Weight,69.09,.,kg,.,.,.,.,.,.,0,1119,373,999
.,ZY100101119,Z,Y1,FIH HV Study ,1,0,1,1119,Healthy volunteers,SD IV Placebo,SD IV Placebo,2,Baseline,1,0,01-יול-81,07:00,0,0,-8.065972222,Days,Demographics,Weight,67.8,.,kg,.,.,.,.,.,.,0,1119,373,999
.,ZY100101119,Z,Y1,FIH HV Study ,1,0,1,1119,Healthy volunteers,SD IV Placebo,SD IV Placebo,2,Baseline,1,0,01-יול-81,10:13,0,0,-7.931944444,Days,PD,Efficacy marker,34.916,.,mm,.,.,.,.,.,.,0,1119,373,999
.,ZY100101119,Z,Y1,FIH HV Study ,1,0,1,1119,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,17-יונ-81,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,0,1119,373,999
.,ZY100101119,Z,Y1,FIH HV Study ,1,0,1,1119,Healthy volunteers,SD IV Placebo,SD IV Placebo,3,VISIT 03,1,0,09-יול-81,08:35,0.083333333,0,0,Days,Dose,Dose X,0,.,mg,.,.,iv,.,.,.,0,1119,373,999
.,ZY100101119,Z,Y1,FIH HV Study ,1,0,1,1119,Healthy volunteers,SD IV Placebo,SD IV Placebo,1,Screening,0,1,17-יונ-81,07:00,0,12,13.64903197,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,0,1119,373,999
.,ZY100101119,Z,Y1,FIH HV Study ,1,0,1,1119,Healthy volunteers,SD IV Placebo,SD IV Placebo,6,VISIT 06,0,0,24-יול-81,08:30,0,14,14.99652778,Days,PD,Efficacy marker,35.219,.,mm,.,.,.,.,.,.,0,1119,373,999
.,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,01-יול-81,14:14,0,0,-7.785416667,Days,PD,Efficacy marker,30.687,.,mm,.,.,.,.,.,.,0,1120,373.3333333,999
.,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,01-יול-81,14:14,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,0,1120,373.3333333,999
.,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,08:50,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1120,373.3333333,999
.,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,09:05,0.083333333,0,0,Days,Dose,Dose X,120.15,.,mg,.,.,iv,.,.,.,0,1120,373.3333333,999
.,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,11:16,0,0.0833,0.090972222,Days,PK,Plasma concentration Z,182.001,.,ug/ml,.,0.8,.,.,.,.,0,1120,373.3333333,999
.,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,13:05,0,0.166,0.166666667,Days,PK,Plasma concentration Z,181.401,.,ug/ml,.,0.8,.,.,.,.,0,1120,373.3333333,999
.,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,4,VISIT 04,1,0,10-יול-81,09:05,0,1,1,Days,PK,Plasma concentration Z,112.8,.,ug/ml,.,0.8,.,.,.,.,0,1120,373.3333333,999
.,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,5,VISIT 05,0,0,16-יול-81,09:05,0,7,7,Days,PK,Plasma concentration Z,44.001,.,ug/ml,.,0.8,.,.,.,.,0,1120,373.3333333,999
.,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,08:50,0,12,13.18037126,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,0,1120,373.3333333,999
.,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,23-יול-81,09:05,0,14,14,Days,PK,Plasma concentration Z,21.999,.,ug/ml,.,0.8,.,.,.,.,0,1120,373.3333333,999
.,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,24-יול-81,09:03,0,14,14.99861111,Days,PD,Efficacy marker,31.477,.,mm,.,.,.,.,.,.,0,1120,373.3333333,999
.,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,7,VISIT 07,0,0,30-יול-81,09:05,0,21,21,Days,PK,Plasma concentration Z,9.801,.,ug/ml,.,0.8,.,.,.,.,0,1120,373.3333333,999
.,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,06-אוג-81,09:05,0,28,28,Days,PK,Plasma concentration Z,5.739,.,ug/ml,.,0.8,.,.,.,.,0,1120,373.3333333,999
.,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,07-אוג-81,14:42,0,28,29.23402778,Days,PD,Efficacy marker,31.977,.,mm,.,.,.,.,.,.,0,1120,373.3333333,999
.,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,9,VISIT 09,0,0,20-אוג-81,08:57,0,42,41.99444444,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1120,373.3333333,999
.,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,10,VISIT 10,0,0,03-ספט-81,09:18,0,56,56.00902778,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1120,373.3333333,999
.,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,11,VISIT 11,0,0,17-ספט-81,09:10,0,70,70.00347222,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1120,373.3333333,999
.,ZY100101120,Z,Y1,FIH HV Study ,1,0,1,1120,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,12,VISIT 12,0,0,01-אוק-81,09:05,0,84,84,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1120,373.3333333,999
.,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,03-יול-81,09:15,0,0,-6.017361111,Days,PD,Efficacy marker,27.824,.,mm,.,.,.,.,.,.,0,1121,373.6666667,999
.,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,03-יול-81,09:15,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,0,1121,373.6666667,999
.,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,09:25,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1121,373.6666667,999
.,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,09:40,0.083333333,0,0,Days,Dose,Dose X,110.7,.,mg,.,.,iv,.,.,.,0,1121,373.6666667,999
.,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,12:03,0,0.0833,0.099305556,Days,PK,Plasma concentration Z,196.401,.,ug/ml,.,0.8,.,.,.,.,0,1121,373.6666667,999
.,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,13:40,0,0.166,0.166666667,Days,PK,Plasma concentration Z,210,.,ug/ml,.,0.8,.,.,.,.,0,1121,373.6666667,999
.,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,4,VISIT 04,1,0,10-יול-81,09:43,0,1,1.002083333,Days,PK,Plasma concentration Z,158.199,.,ug/ml,.,0.8,.,.,.,.,0,1121,373.6666667,999
.,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,5,VISIT 05,0,0,16-יול-81,09:40,0,7,7,Days,PK,Plasma concentration Z,32.001,.,ug/ml,.,0.8,.,.,.,.,0,1121,373.6666667,999
.,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,23-יול-81,09:40,0,14,14,Days,PK,Plasma concentration Z,16.659,.,ug/ml,.,0.8,.,.,.,.,0,1121,373.6666667,999
.,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,09-יול-81,09:25,0,12,14.70500064,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,0,1121,373.6666667,999
.,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,24-יול-81,14:05,0,14,15.18402778,Days,PD,Efficacy marker,29.158,.,mm,.,.,.,.,.,.,0,1121,373.6666667,999
.,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,7,VISIT 07,0,0,30-יול-81,09:40,0,21,21,Days,PK,Plasma concentration Z,8.379,.,ug/ml,.,0.8,.,.,.,.,0,1121,373.6666667,999
.,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,06-אוג-81,09:42,0,28,28.00138889,Days,PK,Plasma concentration Z,3.42,.,ug/ml,.,0.8,.,.,.,.,0,1121,373.6666667,999
.,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,07-אוג-81,11:44,0,28,29.08611111,Days,PD,Efficacy marker,29.655,.,mm,.,.,.,.,.,.,0,1121,373.6666667,999
.,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,9,VISIT 09,0,0,20-אוג-81,09:30,0,42,41.99305556,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1121,373.6666667,999
.,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,10,VISIT 10,0,0,03-ספט-81,09:40,0,56,56,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1121,373.6666667,999
.,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,11,VISIT 11,0,0,17-ספט-81,09:36,0,70,69.99722222,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1121,373.6666667,999
.,ZY100101121,Z,Y1,FIH HV Study ,1,0,1,1121,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,12,VISIT 12,0,0,01-אוק-81,09:38,0,84,83.99861111,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1121,373.6666667,999
.,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,30-יול-81,07:39,0,0,-8.972916667,Days,PD,Efficacy marker,24.813,.,mm,.,.,.,.,.,.,0,1122,374,999
.,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,2,Baseline,1,0,30-יול-81,07:39,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,0,1122,374,999
.,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,08-אוג-81,06:25,0,0,-0.024305556,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1122,374,999
.,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,08-אוג-81,07:00,0.083333333,0,0,Days,Dose,Dose X,97.35,.,mg,.,.,iv,.,.,.,0,1122,374,999
.,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,08-אוג-81,09:19,0,0.0833,0.096527778,Days,PK,Plasma concentration Z,189,.,ug/ml,.,0.8,.,.,.,.,0,1122,374,999
.,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,08-אוג-81,11:00,0,0.166,0.166666667,Days,PK,Plasma concentration Z,168.399,.,ug/ml,.,0.8,.,.,.,.,0,1122,374,999
.,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,4,VISIT 04,1,0,09-אוג-81,07:00,0,1,1,Days,PK,Plasma concentration Z,111.399,.,ug/ml,.,0.8,.,.,.,.,0,1122,374,999
.,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,5,VISIT 05,0,0,15-אוג-81,07:00,0,7,7,Days,PK,Plasma concentration Z,28.599,.,ug/ml,.,0.8,.,.,.,.,0,1122,374,999
.,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,22-אוג-81,07:01,0,14,14.00069444,Days,PK,Plasma concentration Z,13.959,.,ug/ml,.,0.8,.,.,.,.,0,1122,374,999
.,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,3,VISIT 03,1,0,08-אוג-81,06:25,0,12,14.00295858,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,0,1122,374,999
.,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,6,VISIT 06,0,0,22-אוג-81,10:09,0,14,14.13125,Days,PD,Efficacy marker,26.545,.,mm,.,.,.,.,.,.,0,1122,374,999
.,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,7,VISIT 07,0,0,29-אוג-81,07:00,0,21,21,Days,PK,Plasma concentration Z,6.9,.,ug/ml,.,0.8,.,.,.,.,0,1122,374,999
.,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,05-ספט-81,07:00,0,28,28,Days,PK,Plasma concentration Z,2.94,.,ug/ml,.,0.8,.,.,.,.,0,1122,374,999
.,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,8,VISIT 08,0,0,05-ספט-81,15:31,0,28,28.35486111,Days,PD,Efficacy marker,25.824,.,mm,.,.,.,.,.,.,0,1122,374,999
.,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,9,VISIT 09,0,0,19-ספט-81,07:00,0,42,42,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1122,374,999
.,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,10,VISIT 10,0,0,03-אוק-81,07:00,0,56,56,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1122,374,999
.,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,11,VISIT 11,0,0,17-אוק-81,07:05,0,70,70.00347222,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1122,374,999
.,ZY100101122,Z,Y1,FIH HV Study ,1,0,1,1122,Healthy volunteers,SD IV 1.5 mg/kg,SD IV 1.5 mg/kg,12,VISIT 12,0,0,31-אוק-81,07:00,0,84,84,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,1122,374,999
.,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,06:44,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,0,4123,1374.333333,999
.,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,06:44,0,0,-0.063194444,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,4123,1374.333333,999
.,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,08:15,0.083333333,0,0,Days,Dose,Dose X,1425,.,mg,.,.,iv,.,.,.,0,4123,1374.333333,999
.,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,10:22,0,0.0833,0.088194444,Days,PK,Plasma concentration Z,1868.001,.,ug/ml,.,0.8,.,.,.,.,0,4123,1374.333333,999
.,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,12:15,0,0.166,0.166666667,Days,PK,Plasma concentration Z,1874.001,.,ug/ml,.,0.8,.,.,.,.,0,4123,1374.333333,999
.,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,24-מאי-81,08:15,0,1,1,Days,PK,Plasma concentration Z,1434,.,ug/ml,.,0.8,.,.,.,.,0,4123,1374.333333,999
.,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,30-מאי-81,08:15,0,7,7,Days,PK,Plasma concentration Z,444,.,ug/ml,.,0.8,.,.,.,.,0,4123,1374.333333,999
.,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,06-יונ-81,08:19,0,14,14.00277778,Days,PK,Plasma concentration Z,296.001,.,ug/ml,.,0.8,.,.,.,.,0,4123,1374.333333,999
.,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,08:15,0,12,14.79061257,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,0,4123,1374.333333,999
.,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,13-יונ-81,08:14,0,21,20.99930556,Days,PK,Plasma concentration Z,222,.,ug/ml,.,0.8,.,.,.,.,0,4123,1374.333333,999
.,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,20-יונ-81,08:15,0,28,28,Days,PK,Plasma concentration Z,173.4,.,ug/ml,.,0.8,.,.,.,.,0,4123,1374.333333,999
.,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,04-יול-81,08:15,0,42,42,Days,PK,Plasma concentration Z,100.599,.,ug/ml,.,0.8,.,.,.,.,0,4123,1374.333333,999
.,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,18-יול-81,08:15,0,56,56,Days,PK,Plasma concentration Z,63,.,ug/ml,.,0.8,.,.,.,.,0,4123,1374.333333,999
.,ZY100404123,Z,Y1,FIH HV Study ,2,0,4,4123,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,01-אוג-81,08:15,0,70,70,Days,PK,Plasma concentration Z,28.2,.,ug/ml,.,0.8,.,.,.,.,0,4123,1374.333333,999
.,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,06:48,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,0,4124,1374.666667,999
.,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,06:48,0,0,-0.0625,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,4124,1374.666667,999
.,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,08:18,0.083333333,0,0,Days,Dose,Dose X,1642.5,.,mg,.,.,iv,.,.,.,0,4124,1374.666667,999
.,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,10:32,0,0.0833,0.093055556,Days,PK,Plasma concentration Z,1716,.,ug/ml,.,0.8,.,.,.,.,0,4124,1374.666667,999
.,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,12:18,0,0.166,0.166666667,Days,PK,Plasma concentration Z,1812,.,ug/ml,.,0.8,.,.,.,.,0,4124,1374.666667,999
.,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,24-מאי-81,08:18,0,1,1,Days,PK,Plasma concentration Z,1404,.,ug/ml,.,0.8,.,.,.,.,0,4124,1374.666667,999
.,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,30-מאי-81,08:18,0,7,7,Days,PK,Plasma concentration Z,453.999,.,ug/ml,.,0.8,.,.,.,.,0,4124,1374.666667,999
.,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,06-יונ-81,08:21,0,14,14.00208333,Days,PK,Plasma concentration Z,288,.,ug/ml,.,0.8,.,.,.,.,0,4124,1374.666667,999
.,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,08:18,0,12,14.554358,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,0,4124,1374.666667,999
.,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,13-יונ-81,08:18,0,21,21,Days,PK,Plasma concentration Z,212.001,.,ug/ml,.,0.8,.,.,.,.,0,4124,1374.666667,999
.,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,20-יונ-81,08:18,0,28,28,Days,PK,Plasma concentration Z,163.599,.,ug/ml,.,0.8,.,.,.,.,0,4124,1374.666667,999
.,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,04-יול-81,08:17,0,42,41.99930556,Days,PK,Plasma concentration Z,88.8,.,ug/ml,.,0.8,.,.,.,.,0,4124,1374.666667,999
.,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,18-יול-81,08:22,0,56,56.00277778,Days,PK,Plasma concentration Z,56.601,.,ug/ml,.,0.8,.,.,.,.,0,4124,1374.666667,999
.,ZY100404124,Z,Y1,FIH HV Study ,2,0,4,4124,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,01-אוג-81,08:18,0,70,70,Days,PK,Plasma concentration Z,26.799,.,ug/ml,.,0.8,.,.,.,.,0,4124,1374.666667,999
.,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,06:51,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,0,4125,1375,999
.,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,06:51,0,0,-0.0625,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,4125,1375,999
.,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,08:21,0.083333333,0,0,Days,Dose,Dose X,1378.5,.,mg,.,.,iv,.,.,.,0,4125,1375,999
.,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,10:24,0,0.0833,0.085416667,Days,PK,Plasma concentration Z,2559.999,.,ug/ml,.,0.8,.,.,.,.,0,4125,1375,999
.,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,12:20,0,0.166,0.165972222,Days,PK,Plasma concentration Z,1767.999,.,ug/ml,.,0.8,.,.,.,.,0,4125,1375,999
.,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,24-מאי-81,08:21,0,1,1,Days,PK,Plasma concentration Z,1161.999,.,ug/ml,.,0.8,.,.,.,.,0,4125,1375,999
.,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,30-מאי-81,08:21,0,7,7,Days,PK,Plasma concentration Z,405.999,.,ug/ml,.,0.8,.,.,.,.,0,4125,1375,999
.,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,06-יונ-81,08:23,0,14,14.00138889,Days,PK,Plasma concentration Z,267.999,.,ug/ml,.,0.8,.,.,.,.,0,4125,1375,999
.,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,08:21,0,12,14.97476981,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,0,4125,1375,999
.,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,13-יונ-81,08:21,0,21,21,Days,PK,Plasma concentration Z,206.001,.,ug/ml,.,0.8,.,.,.,.,0,4125,1375,999
.,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,20-יונ-81,08:21,0,28,28,Days,PK,Plasma concentration Z,156.801,.,ug/ml,.,0.8,.,.,.,.,0,4125,1375,999
.,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,04-יול-81,08:21,0,42,42,Days,PK,Plasma concentration Z,85.401,.,ug/ml,.,0.8,.,.,.,.,0,4125,1375,999
.,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,18-יול-81,08:20,0,56,55.99930556,Days,PK,Plasma concentration Z,51,.,ug/ml,.,0.8,.,.,.,.,0,4125,1375,999
.,ZY100404125,Z,Y1,FIH HV Study ,2,0,4,4125,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,01-אוג-81,08:21,0,70,70,Days,PK,Plasma concentration Z,22.401,.,ug/ml,.,0.8,.,.,.,.,0,4125,1375,999
.,ZY100404126,Z,Y1,FIH HV Study ,2,0,4,4126,Healthy volunteers,SD IV Placebo,SD IV Placebo,3,VISIT 03,1,0,23-מאי-81,08:24,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,0,4126,1375.333333,999
.,ZY100404126,Z,Y1,FIH HV Study ,2,0,4,4126,Healthy volunteers,SD IV Placebo,SD IV Placebo,3,VISIT 03,1,0,23-מאי-81,08:24,0.083333333,0,0,Days,Dose,Dose X,0,.,mg,.,.,iv,.,.,.,0,4126,1375.333333,999
.,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,06:56,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,0,4127,1375.666667,999
.,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,06:56,0,0,-0.063194444,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,4127,1375.666667,999
.,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,08:27,0.083333333,0,0,Days,Dose,Dose X,1437,.,mg,.,.,iv,.,.,.,0,4127,1375.666667,999
.,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,10:26,0,0.0833,0.082638889,Days,PK,Plasma concentration Z,1478.001,.,ug/ml,.,0.8,.,.,.,.,0,4127,1375.666667,999
.,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,12:27,0,0.166,0.166666667,Days,PK,Plasma concentration Z,1500,.,ug/ml,.,0.8,.,.,.,.,0,4127,1375.666667,999
.,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,24-מאי-81,08:27,0,1,1,Days,PK,Plasma concentration Z,1068,.,ug/ml,.,0.8,.,.,.,.,0,4127,1375.666667,999
.,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,30-מאי-81,08:27,0,7,7,Days,PK,Plasma concentration Z,464.001,.,ug/ml,.,0.8,.,.,.,.,0,4127,1375.666667,999
.,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,06-יונ-81,08:28,0,14,14.00069444,Days,PK,Plasma concentration Z,315.999,.,ug/ml,.,0.8,.,.,.,.,0,4127,1375.666667,999
.,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,08:27,0,12,14.6069546,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,0,4127,1375.666667,999
.,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,13-יונ-81,08:27,0,21,21,Days,PK,Plasma concentration Z,231.999,.,ug/ml,.,0.8,.,.,.,.,0,4127,1375.666667,999
.,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,20-יונ-81,08:27,0,28,28,Days,PK,Plasma concentration Z,194.001,.,ug/ml,.,0.8,.,.,.,.,0,4127,1375.666667,999
.,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,04-יול-81,08:27,0,42,42,Days,PK,Plasma concentration Z,110.199,.,ug/ml,.,0.8,.,.,.,.,0,4127,1375.666667,999
.,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,18-יול-81,08:27,0,56,56,Days,PK,Plasma concentration Z,78.201,.,ug/ml,.,0.8,.,.,.,.,0,4127,1375.666667,999
.,ZY100404127,Z,Y1,FIH HV Study ,2,0,4,4127,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,01-אוג-81,08:27,0,70,70,Days,PK,Plasma concentration Z,22.599,.,ug/ml,.,0.8,.,.,.,.,0,4127,1375.666667,999
.,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,0,4128,1376,999
.,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,07:00,0,0,-0.0625,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,4128,1376,999
.,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,08:30,0.083333333,0,0,Days,Dose,Dose X,1714.5,.,mg,.,.,iv,.,.,.,0,4128,1376,999
.,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,10:35,0,0.0833,0.086805556,Days,PK,Plasma concentration Z,1623.999,.,ug/ml,.,0.8,.,.,.,.,0,4128,1376,999
.,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,12:30,0,0.166,0.166666667,Days,PK,Plasma concentration Z,1572,.,ug/ml,.,0.8,.,.,.,.,0,4128,1376,999
.,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,24-מאי-81,08:29,0,1,0.999305556,Days,PK,Plasma concentration Z,1368,.,ug/ml,.,0.8,.,.,.,.,0,4128,1376,999
.,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,30-מאי-81,08:30,0,7,7,Days,PK,Plasma concentration Z,518.001,.,ug/ml,.,0.8,.,.,.,.,0,4128,1376,999
.,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,08:30,0,12,13.7772779,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,0,4128,1376,999
.,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,06-יונ-81,08:30,0,14,14,Days,PK,Plasma concentration Z,255.999,.,ug/ml,.,0.8,.,.,.,.,0,4128,1376,999
.,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,13-יונ-81,08:29,0,21,20.99930556,Days,PK,Plasma concentration Z,174.399,.,ug/ml,.,0.8,.,.,.,.,0,4128,1376,999
.,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,20-יונ-81,08:30,0,28,28,Days,PK,Plasma concentration Z,120,.,ug/ml,.,0.8,.,.,.,.,0,4128,1376,999
.,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,04-יול-81,08:29,0,42,41.99930556,Days,PK,Plasma concentration Z,56.199,.,ug/ml,.,0.8,.,.,.,.,0,4128,1376,999
.,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,18-יול-81,08:29,0,56,55.99930556,Days,PK,Plasma concentration Z,25.401,.,ug/ml,.,0.8,.,.,.,.,0,4128,1376,999
.,ZY100404128,Z,Y1,FIH HV Study ,2,0,4,4128,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,01-אוג-81,08:30,0,70,70,Days,PK,Plasma concentration Z,4.119,.,ug/ml,.,0.8,.,.,.,.,0,4128,1376,999
.,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,07:03,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,0,4129,1376.333333,999
.,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,07:03,0,0,-0.0625,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,0,4129,1376.333333,999
.,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,08:33,0.083333333,0,0,Days,Dose,Dose X,1188,.,mg,.,.,iv,.,.,.,0,4129,1376.333333,999
.,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,10:45,0,0.0833,0.091666667,Days,PK,Plasma concentration Z,1962,.,ug/ml,.,0.8,.,.,.,.,0,4129,1376.333333,999
.,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,12:33,0,0.166,0.166666667,Days,PK,Plasma concentration Z,1940.001,.,ug/ml,.,0.8,.,.,.,.,0,4129,1376.333333,999
.,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,1,0,24-מאי-81,08:33,0,1,1,Days,PK,Plasma concentration Z,1482,.,ug/ml,.,0.8,.,.,.,.,0,4129,1376.333333,999
.,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,30-מאי-81,08:33,0,7,7,Days,PK,Plasma concentration Z,471.999,.,ug/ml,.,0.8,.,.,.,.,0,4129,1376.333333,999
.,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,06-יונ-81,08:33,0,14,14,Days,PK,Plasma concentration Z,288,.,ug/ml,.,0.8,.,.,.,.,0,4129,1376.333333,999
.,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,23-מאי-81,08:33,0,12,14.13730096,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,0,4129,1376.333333,999
.,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,13-יונ-81,08:33,0,21,21,Days,PK,Plasma concentration Z,216,.,ug/ml,.,0.8,.,.,.,.,0,4129,1376.333333,999
.,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,20-יונ-81,08:33,0,28,28,Days,PK,Plasma concentration Z,160.2,.,ug/ml,.,0.8,.,.,.,.,0,4129,1376.333333,999
.,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,04-יול-81,08:33,0,42,42,Days,PK,Plasma concentration Z,98.4,.,ug/ml,.,0.8,.,.,.,.,0,4129,1376.333333,999
.,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,18-יול-81,08:33,0,56,56,Days,PK,Plasma concentration Z,52.8,.,ug/ml,.,0.8,.,.,.,.,0,4129,1376.333333,999
.,ZY100404129,Z,Y1,FIH HV Study ,2,0,4,4129,Healthy volunteers,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,01-אוג-81,08:33,0,70,70,Days,PK,Plasma concentration Z,14.559,.,ug/ml,.,0.8,.,.,.,.,0,4129,1376.333333,999
.,ZY100404130,Z,Y1,FIH HV Study ,2,0,4,4130,Healthy volunteers,SD IV Placebo,SD IV Placebo,3,VISIT 03,1,0,07-יונ-81,08:36,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,0,4130,1376.666667,999
.,ZY100404130,Z,Y1,FIH HV Study ,2,0,4,4130,Healthy volunteers,SD IV Placebo,SD IV Placebo,3,VISIT 03,1,0,07-יונ-81,08:36,0.083333333,0,0,Days,Dose,Dose X,0,.,mg,.,.,iv,.,.,.,0,4130,1376.666667,999
.,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,25-אוק-80,06:30,0,0,-7.111805556,Days,PD,Efficacy marker,21.152,.,mm,.,.,.,.,.,.,1,1066,355.3333333,999
.,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,25-אוק-80,06:30,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,1066,355.3333333,999
.,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,01-נוב-80,09:11,0.083333333,0,0,Days,Dose,Dose X,918,.,mg,.,.,iv,.,.,.,1,1066,355.3333333,999
.,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,01-נוב-80,11:10,0,0.0833,0.082638889,Days,PK,Plasma concentration Z,998.001,.,ug/ml,.,0.8,.,.,.,.,1,1066,355.3333333,999
.,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,01-נוב-80,09:11,0,12,13.25330753,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,1066,355.3333333,999
.,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,17-נוב-80,14:10,0,14,16.20763889,Days,PK,Plasma concentration Z,159.399,.,ug/ml,.,0.8,.,.,.,.,1,1066,355.3333333,999
.,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,30-נוב-80,14:00,0,28,29.20069444,Days,PK,Plasma concentration Z,119.4,.,ug/ml,.,0.8,.,.,.,.,1,1066,355.3333333,999
.,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,13-דצמ-80,13:16,0,42,42.17013889,Days,PK,Plasma concentration Z,42.201,.,ug/ml,.,0.8,.,.,.,.,1,1066,355.3333333,999
.,ZY1000101066,Z,Y10,PoC Study Indication 2,1,0,1,1066,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,21-פבר-81,14:36,0,112,112.2256944,Days,PD,Efficacy marker,22.223,.,mm,.,.,.,.,.,.,1,1066,355.3333333,999
.,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,25-אוק-80,13:48,0,0,-13.81388889,Days,PD,Efficacy marker,23.043,.,mm,.,.,.,.,.,.,1,1067,355.6666667,999
.,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,25-אוק-80,13:48,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,1067,355.6666667,999
.,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,08-נוב-80,09:20,0.083333333,0,0,Days,Dose,Dose X,1311,.,mg,.,.,iv,.,.,.,1,1067,355.6666667,999
.,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,08-נוב-80,11:40,0,0.0833,0.097222222,Days,PK,Plasma concentration Z,1362,.,ug/ml,.,0.8,.,.,.,.,1,1067,355.6666667,999
.,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,08-נוב-80,09:20,0,12,13.88272577,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,1067,355.6666667,999
.,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,23-נוב-80,11:06,0,14,15.07361111,Days,PK,Plasma concentration Z,176.199,.,ug/ml,.,0.8,.,.,.,.,1,1067,355.6666667,999
.,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,07-דצמ-80,15:21,0,28,29.25069444,Days,PK,Plasma concentration Z,100.599,.,ug/ml,.,0.8,.,.,.,.,1,1067,355.6666667,999
.,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,20-דצמ-80,13:05,0,42,42.15625,Days,PK,Plasma concentration Z,57.201,.,ug/ml,.,0.8,.,.,.,.,1,1067,355.6666667,999
.,ZY1000101067,Z,Y10,PoC Study Indication 2,1,0,1,1067,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,27-פבר-81,12:00,0,112,111.1111111,Days,PD,Efficacy marker,22.945,.,mm,.,.,.,.,.,.,1,1067,355.6666667,999
.,ZY1000101068,Z,Y10,PoC Study Indication 2,1,0,1,1068,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,31-אוק-80,06:51,0,0,-2.097222222,Days,PD,Efficacy marker,23.364,.,mm,.,.,.,.,.,.,1,1068,356,999
.,ZY1000101068,Z,Y10,PoC Study Indication 2,1,0,1,1068,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,31-אוק-80,06:51,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,1068,356,999
.,ZY1000101068,Z,Y10,PoC Study Indication 2,1,0,1,1068,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,02-נוב-80,09:11,0.083333333,0,0,Days,Dose,Dose X,0,.,mg,.,.,iv,.,.,.,1,1068,356,999
.,ZY1000101068,Z,Y10,PoC Study Indication 2,1,0,1,1068,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,02-נוב-80,09:11,0,12,14.2449551,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,1068,356,999
.,ZY1000101068,Z,Y10,PoC Study Indication 2,1,0,1,1068,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,19-פבר-81,12:30,0,112,109.1381944,Days,PD,Efficacy marker,23.437,.,mm,.,.,.,.,.,.,1,1068,356,999
.,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,23-אוק-80,15:36,0,0,-14.74722222,Days,PD,Efficacy marker,16.993,.,mm,.,.,.,.,.,.,1,1069,356.3333333,999
.,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,23-אוק-80,15:36,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,1069,356.3333333,999
.,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,07-נוב-80,09:30,0,0,-0.001388889,Days,PK,Plasma concentration Z,0.933,.,ug/ml,.,0.8,.,.,.,.,1,1069,356.3333333,999
.,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,07-נוב-80,09:32,0.083333333,0,0,Days,Dose,Dose X,1156.5,.,mg,.,.,iv,.,.,.,1,1069,356.3333333,999
.,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,07-נוב-80,11:40,0,0.0833,0.088888889,Days,PK,Plasma concentration Z,1826.001,.,ug/ml,.,0.8,.,.,.,.,1,1069,356.3333333,999
.,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,07-נוב-80,09:30,0,12,13.18481706,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,1069,356.3333333,999
.,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,22-נוב-80,09:47,0,14,15.01041667,Days,PK,Plasma concentration Z,258,.,ug/ml,.,0.8,.,.,.,.,1,1069,356.3333333,999
.,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,05-דצמ-80,09:18,0,28,27.99027778,Days,PK,Plasma concentration Z,156.6,.,ug/ml,.,0.8,.,.,.,.,1,1069,356.3333333,999
.,ZY1000101069,Z,Y10,PoC Study Indication 2,1,0,1,1069,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,19-דצמ-80,09:30,0,42,41.99861111,Days,PK,Plasma concentration Z,95.199,.,ug/ml,.,0.8,.,.,.,.,1,1069,356.3333333,999
.,ZY1000101075,Z,Y10,PoC Study Indication 2,1,0,1,1075,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,14-נוב-80,12:16,0,0,-5.895138889,Days,PD,Efficacy marker,25.637,.,mm,.,.,.,.,.,.,1,1075,358.3333333,999
.,ZY1000101075,Z,Y10,PoC Study Indication 2,1,0,1,1075,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,14-נוב-80,12:16,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,1075,358.3333333,999
.,ZY1000101075,Z,Y10,PoC Study Indication 2,1,0,1,1075,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,20-נוב-80,09:45,0.083333333,0,0,Days,Dose,Dose X,0,.,mg,.,.,iv,.,.,.,1,1075,358.3333333,999
.,ZY1000101075,Z,Y10,PoC Study Indication 2,1,0,1,1075,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,20-נוב-80,09:45,0,12,13.44688206,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,1075,358.3333333,999
.,ZY1000101075,Z,Y10,PoC Study Indication 2,1,0,1,1075,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,20-מרץ-81,14:55,0,112,120.2152778,Days,PD,Efficacy marker,24.502,.,mm,.,.,.,.,.,.,1,1075,358.3333333,999
.,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,10-נוב-80,06:38,0,0,-17.10347222,Days,PD,Efficacy marker,36.453,.,mm,.,.,.,.,.,.,1,1076,358.6666667,999
.,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,10-נוב-80,06:38,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,1076,358.6666667,999
.,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,27-נוב-80,09:07,0.083333333,0,0,Days,Dose,Dose X,1759.5,.,mg,.,.,iv,.,.,.,1,1076,358.6666667,999
.,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,27-נוב-80,11:08,0,0.0833,0.084027778,Days,PK,Plasma concentration Z,1460.001,.,ug/ml,.,0.8,.,.,.,.,1,1076,358.6666667,999
.,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,27-נוב-80,09:07,0,12,14.81540151,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,1076,358.6666667,999
.,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,15-דצמ-80,08:26,0,14,17.97152778,Days,PK,Plasma concentration Z,197.001,.,ug/ml,.,0.8,.,.,.,.,1,1076,358.6666667,999
.,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,26-דצמ-80,09:54,0,28,29.03263889,Days,PK,Plasma concentration Z,110.001,.,ug/ml,.,0.8,.,.,.,.,1,1076,358.6666667,999
.,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,12-ינו-81,10:25,0,42,46.05416667,Days,PK,Plasma concentration Z,50.4,.,ug/ml,.,0.8,.,.,.,.,1,1076,358.6666667,999
.,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,26-פבר-81,08:35,0,84,90.97777778,Days,PK,Plasma concentration Z,4.08,.,ug/ml,.,0.8,.,.,.,.,1,1076,358.6666667,999
.,ZY1000101076,Z,Y10,PoC Study Indication 2,1,0,1,1076,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,20-מרץ-81,13:46,0,112,113.19375,Days,PD,Efficacy marker,35.673,.,mm,.,.,.,.,.,.,1,1076,358.6666667,999
.,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,07-נוב-80,07:25,0,0,-22.06597222,Days,PD,Efficacy marker,38.399,.,mm,.,.,.,.,.,.,1,1077,359,999
.,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,07-נוב-80,07:25,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,1077,359,999
.,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-נוב-80,08:59,0,0,-0.000694444,Days,PK,Plasma concentration Z,2.139,.,ug/ml,.,0.8,.,.,.,.,1,1077,359,999
.,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-נוב-80,09:00,0.083333333,0,0,Days,Dose,Dose X,1339.5,.,mg,.,.,iv,.,.,.,1,1077,359,999
.,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-נוב-80,11:01,0,0.0833,0.084027778,Days,PK,Plasma concentration Z,1596,.,ug/ml,.,0.8,.,.,.,.,1,1077,359,999
.,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,29-נוב-80,08:59,0,12,13.43941751,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,1077,359,999
.,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,13-דצמ-80,08:30,0,14,13.97916667,Days,PK,Plasma concentration Z,216,.,ug/ml,.,0.8,.,.,.,.,1,1077,359,999
.,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,27-דצמ-80,09:55,0,28,28.03819444,Days,PK,Plasma concentration Z,124.2,.,ug/ml,.,0.8,.,.,.,.,1,1077,359,999
.,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,10-ינו-81,09:28,0,42,42.01944444,Days,PK,Plasma concentration Z,99.6,.,ug/ml,.,0.8,.,.,.,.,1,1077,359,999
.,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,21-מרץ-81,09:54,0,112,112.0375,Days,PK,Plasma concentration Z,7.74,.,ug/ml,.,0.8,.,.,.,.,1,1077,359,999
.,ZY1000101077,Z,Y10,PoC Study Indication 2,1,0,1,1077,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,21-מרץ-81,14:27,0,112,112.2270833,Days,PD,Efficacy marker,41.392,.,mm,.,.,.,.,.,.,1,1077,359,999
.,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,08-נוב-80,10:29,0,0,-64.94305556,Days,PD,Efficacy marker,21.419,.,mm,.,.,.,.,.,.,1,1078,359.3333333,999
.,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,08-נוב-80,10:29,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,1078,359.3333333,999
.,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,12-ינו-81,09:07,0.083333333,0,0,Days,Dose,Dose X,1420.5,.,mg,.,.,iv,.,.,.,1,1078,359.3333333,999
.,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,12-ינו-81,11:40,0,0.166,0.10625,Days,PK,Plasma concentration Z,1358.001,.,ug/ml,.,0.8,.,.,.,.,1,1078,359.3333333,999
.,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,23-ינו-81,10:27,0,14,11.05555556,Days,PK,Plasma concentration Z,279.999,.,ug/ml,.,0.8,.,.,.,.,1,1078,359.3333333,999
.,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,12-ינו-81,09:07,0,12,14.04701871,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,1078,359.3333333,999
.,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,07-פבר-81,10:00,0,28,26.03680556,Days,PK,Plasma concentration Z,95.199,.,ug/ml,.,0.8,.,.,.,.,1,1078,359.3333333,999
.,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,21-פבר-81,10:10,0,42,40.04375,Days,PK,Plasma concentration Z,53.799,.,ug/ml,.,0.8,.,.,.,.,1,1078,359.3333333,999
.,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,06-אפר-81,11:59,0,84,84.11944444,Days,PK,Plasma concentration Z,6.039,.,ug/ml,.,0.8,.,.,.,.,1,1078,359.3333333,999
.,ZY1000101078,Z,Y10,PoC Study Indication 2,1,0,1,1078,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,10-מאי-81,13:29,0,112,118.1819444,Days,PD,Efficacy marker,24.718,.,mm,.,.,.,.,.,.,1,1078,359.3333333,999
.,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,16-ינו-81,13:02,0,0,-2.821527778,Days,PD,Efficacy marker,19.606,.,mm,.,.,.,.,.,.,1,2079,693,999
.,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,16-ינו-81,13:02,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,2079,693,999
.,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,19-ינו-81,08:44,0,0,-0.000694444,Days,PK,Plasma concentration Z,0.417,.,ug/ml,.,0.8,.,.,.,.,1,2079,693,999
.,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,19-ינו-81,08:45,0.083333333,0,0,Days,Dose,Dose X,871.5,.,mg,.,.,iv,.,.,.,1,2079,693,999
.,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,19-ינו-81,10:55,0,0.0833,0.090277778,Days,PK,Plasma concentration Z,1004.001,.,ug/ml,.,0.8,.,.,.,.,1,2079,693,999
.,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,19-ינו-81,08:44,0,12,14.14273318,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,2079,693,999
.,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,05-פבר-81,10:30,0,14,17.07291667,Days,PK,Plasma concentration Z,264,.,ug/ml,.,0.8,.,.,.,.,1,2079,693,999
.,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,01-מרץ-81,10:00,0,42,41.05208333,Days,PK,Plasma concentration Z,38.799,.,ug/ml,.,0.8,.,.,.,.,1,2079,693,999
.,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,13-אפר-81,10:00,0,84,84.05208333,Days,PK,Plasma concentration Z,0.708,.,ug/ml,.,0.8,.,.,.,.,1,2079,693,999
.,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,08-מאי-81,13:05,0,112,109.1805556,Days,PD,Efficacy marker,20.226,.,mm,.,.,.,.,.,.,1,2079,693,999
.,ZY1000202079,Z,Y10,PoC Study Indication 2,1,0,2,2079,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,09-מאי-81,12:30,0,112,110.15625,Days,PK,Plasma concentration Z,0.405,.,ug/ml,.,0.8,.,.,.,.,1,2079,693,999
.,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,02-נוב-80,15:53,0,0,-4.8,Days,PD,Efficacy marker,26.918,.,mm,.,.,.,.,.,.,1,3070,1023.333333,999
.,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,02-נוב-80,15:53,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,3070,1023.333333,999
.,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,07-נוב-80,11:05,0.083333333,0,0,Days,Dose,Dose X,1449,.,mg,.,.,iv,.,.,.,1,3070,1023.333333,999
.,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,07-נוב-80,14:00,0,0.166,0.121527778,Days,PK,Plasma concentration Z,1413.999,.,ug/ml,.,0.8,.,.,.,.,1,3070,1023.333333,999
.,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,21-נוב-80,06:25,0,14,13.80555556,Days,PK,Plasma concentration Z,199.2,.,ug/ml,.,0.8,.,.,.,.,1,3070,1023.333333,999
.,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,07-נוב-80,11:05,0,12,14.77771161,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,3070,1023.333333,999
.,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,05-דצמ-80,06:33,0,28,27.81111111,Days,PK,Plasma concentration Z,132.6,.,ug/ml,.,0.8,.,.,.,.,1,3070,1023.333333,999
.,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,19-דצמ-80,06:36,0,42,41.81319444,Days,PK,Plasma concentration Z,98.001,.,ug/ml,.,0.8,.,.,.,.,1,3070,1023.333333,999
.,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,13-פבר-81,06:53,0,84,97.825,Days,PK,Plasma concentration Z,9.18,.,ug/ml,.,0.8,.,.,.,.,1,3070,1023.333333,999
.,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,27-פבר-81,06:50,0,112,111.8229167,Days,PK,Plasma concentration Z,3.939,.,ug/ml,.,0.8,.,.,.,.,1,3070,1023.333333,999
.,ZY1000303070,Z,Y10,PoC Study Indication 2,1,0,3,3070,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,27-פבר-81,13:47,0,112,112.1125,Days,PD,Efficacy marker,29.847,.,mm,.,.,.,.,.,.,1,3070,1023.333333,999
.,ZY1000303071,Z,Y10,PoC Study Indication 2,1,0,3,3071,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,09-נוב-80,16:54,0,0,-4.660416667,Days,PD,Efficacy marker,18.569,.,mm,.,.,.,.,.,.,1,3071,1023.666667,999
.,ZY1000303071,Z,Y10,PoC Study Indication 2,1,0,3,3071,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,09-נוב-80,16:54,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,3071,1023.666667,999
.,ZY1000303071,Z,Y10,PoC Study Indication 2,1,0,3,3071,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,14-נוב-80,08:45,0.083333333,0,0,Days,Dose,Dose X,0,.,mg,.,.,iv,.,.,.,1,3071,1023.666667,999
.,ZY1000303071,Z,Y10,PoC Study Indication 2,1,0,3,3071,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,14-נוב-80,08:45,0,12,13.39454185,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,3071,1023.666667,999
.,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,09-נוב-80,11:02,0,0,-4.849305556,Days,PD,Efficacy marker,17.731,.,mm,.,.,.,.,.,.,1,3072,1024,999
.,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,09-נוב-80,11:02,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,3072,1024,999
.,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,14-נוב-80,07:25,0.083333333,0,0,Days,Dose,Dose Z,1231.5,.,mg,.,.,iv,.,.,.,1,3072,1024,999
.,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,14-נוב-80,09:56,0,0.166,0.104861111,Days,PK,Plasma concentration Z,1536,.,ug/ml,.,0.8,.,.,.,.,1,3072,1024,999
.,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,28-נוב-80,10:22,0,14,14.12291667,Days,PK,Plasma concentration Z,171.399,.,ug/ml,.,0.8,.,.,.,.,1,3072,1024,999
.,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,14-נוב-80,07:25,0,12,14.59261935,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,3072,1024,999
.,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,12-דצמ-80,11:04,0,28,28.15208333,Days,PK,Plasma concentration Z,102.6,.,ug/ml,.,0.8,.,.,.,.,1,3072,1024,999
.,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,28-דצמ-80,08:30,0,42,44.04513889,Days,PK,Plasma concentration Z,54.999,.,ug/ml,.,0.8,.,.,.,.,1,3072,1024,999
.,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,13-פבר-81,13:55,0,84,91.27083333,Days,PK,Plasma concentration Z,4.479,.,ug/ml,.,0.8,.,.,.,.,1,3072,1024,999
.,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,28-פבר-81,08:50,0,112,106.0590278,Days,PK,Plasma concentration Z,1.035,.,ug/ml,.,0.8,.,.,.,.,1,3072,1024,999
.,ZY1000303072,Z,Y10,PoC Study Indication 2,1,0,3,3072,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,28-פבר-81,13:39,0,112,106.2597222,Days,PD,Efficacy marker,18.795,.,mm,.,.,.,.,.,.,1,3072,1024,999
.,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,08-נוב-80,16:18,0,0,-4.685416667,Days,PD,Efficacy marker,12.721,.,mm,.,.,.,.,.,.,1,3073,1024.333333,999
.,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,08-נוב-80,16:18,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,3073,1024.333333,999
.,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,13-נוב-80,08:45,0.083333333,0,0,Days,Dose,Dose Z,708,.,mg,.,.,iv,.,.,.,1,3073,1024.333333,999
.,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,13-נוב-80,11:03,0,0.0833,0.095833333,Days,PK,Plasma concentration Z,936,.,ug/ml,.,0.8,.,.,.,.,1,3073,1024.333333,999
.,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,13-נוב-80,08:45,0,12,13.60197996,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,3073,1024.333333,999
.,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,28-נוב-80,08:13,0,14,14.97777778,Days,PK,Plasma concentration Z,135.201,.,ug/ml,.,0.8,.,.,.,.,1,3073,1024.333333,999
.,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,12-דצמ-80,08:44,0,28,28.99930556,Days,PK,Plasma concentration Z,77.799,.,ug/ml,.,0.8,.,.,.,.,1,3073,1024.333333,999
.,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,26-דצמ-80,08:33,0,42,42.99166667,Days,PK,Plasma concentration Z,68.001,.,ug/ml,.,0.8,.,.,.,.,1,3073,1024.333333,999
.,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,14-פבר-81,09:24,0,84,93.02708333,Days,PK,Plasma concentration Z,2.841,.,ug/ml,.,0.8,.,.,.,.,1,3073,1024.333333,999
.,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,01-מרץ-81,08:50,0,112,108.0034722,Days,PK,Plasma concentration Z,0.507,.,ug/ml,.,0.8,.,.,.,.,1,3073,1024.333333,999
.,ZY1000303073,Z,Y10,PoC Study Indication 2,1,0,3,3073,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,01-מרץ-81,16:41,0,112,108.3305556,Days,PD,Efficacy marker,12.549,.,mm,.,.,.,.,.,.,1,3073,1024.333333,999
.,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,08-נוב-80,12:50,0,0,-4.788194444,Days,PD,Efficacy marker,28.574,.,mm,.,.,.,.,.,.,1,3074,1024.666667,999
.,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,08-נוב-80,12:50,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,3074,1024.666667,999
.,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,13-נוב-80,07:45,0.083333333,0,0,Days,Dose,Dose Z,1054.5,.,mg,.,.,iv,.,.,.,1,3074,1024.666667,999
.,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,13-נוב-80,10:08,0,0.0833,0.099305556,Days,PK,Plasma concentration Z,897.999,.,ug/ml,.,0.8,.,.,.,.,1,3074,1024.666667,999
.,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,13-נוב-80,07:45,0,12,13.98078391,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,3074,1024.666667,999
.,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,28-נוב-80,06:18,0,14,14.93958333,Days,PK,Plasma concentration Z,132.6,.,ug/ml,.,0.8,.,.,.,.,1,3074,1024.666667,999
.,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,12-דצמ-80,06:39,0,28,28.95416667,Days,PK,Plasma concentration Z,78.201,.,ug/ml,.,0.8,.,.,.,.,1,3074,1024.666667,999
.,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,26-דצמ-80,06:34,0,42,42.95069444,Days,PK,Plasma concentration Z,100.8,.,ug/ml,.,0.8,.,.,.,.,1,3074,1024.666667,999
.,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,14-פבר-81,07:08,0,84,92.97430556,Days,PK,Plasma concentration Z,2.061,.,ug/ml,.,0.8,.,.,.,.,1,3074,1024.666667,999
.,ZY1000303074,Z,Y10,PoC Study Indication 2,1,0,3,3074,Indication 2,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,01-מרץ-81,15:24,0,112,108.31875,Days,PD,Efficacy marker,29.79,.,mm,.,.,.,.,.,.,1,3074,1024.666667,999
.,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,26-אפר-82,07:22,0,0,-4.986111111,Days,PD,Efficacy marker,34.552,.,mm,.,.,.,.,.,.,1,5001,1667,999
.,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,26-אפר-82,07:22,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,5001,1667,999
.,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,01-מאי-82,07:02,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5001,1667,999
.,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,01-מאי-82,07:02,0,12,13.01067985,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,5001,1667,999
.,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,26-מאי-82,10:39,0,28,25.15069444,Days,PD,Efficacy marker,34.788,.,mm,.,.,.,.,.,.,1,5001,1667,999
.,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,29-מאי-82,07:15,0.083333333,28,28.00902778,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5001,1667,999
.,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,23-יונ-82,14:53,0,56,53.32708333,Days,PD,Efficacy marker,35.752,.,mm,.,.,.,.,.,.,1,5001,1667,999
.,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,26-יונ-82,07:04,0.083333333,56,56.00138889,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5001,1667,999
.,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,19-יול-82,09:47,0,84,79.11458333,Days,PD,Efficacy marker,35.559,.,mm,.,.,.,.,.,.,1,5001,1667,999
.,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,24-יול-82,06:28,0.083333333,84,83.97638889,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5001,1667,999
.,ZY300505001,Z,Y3,Profiling Study 1,1,0,5,5001,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,21-אוג-82,10:17,0,112,112.1354167,Days,PD,Efficacy marker,36.197,.,mm,.,.,.,.,.,.,1,5001,1667,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,27-אפר-82,07:00,0,0,-4.040277778,Days,Demographics,Weight,73,.,kg,.,.,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,28-אפר-82,10:24,0,0,-2.898611111,Days,PD,Efficacy marker,25.804,.,mm,.,.,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,27-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-מאי-82,07:52,0,0,-0.004166667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-מאי-82,07:58,0.083333333,0,0,Days,Dose,Dose Z,368,.,mg,.,.,iv,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-מאי-82,10:09,0,0.0833,0.090972222,Days,PK,Plasma concentration Z,518.001,.,ug/ml,.,0.8,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,28-אפר-82,10:24,0,12,13.71930662,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-מאי-82,11:40,0,28,25.15416667,Days,PD,Efficacy marker,28.266,.,mm,.,.,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-מאי-82,08:00,0,28,28.00138889,Days,PK,Plasma concentration Z,41.001,.,ug/ml,.,0.8,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-מאי-82,08:11,0.083333333,28,28.00902778,Days,Dose,Dose Z,374,.,mg,.,.,iv,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-מאי-82,10:27,0,28,28.10347222,Days,PK,Plasma concentration Z,591.999,.,ug/ml,.,0.8,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,23-יונ-82,08:26,0,56,53.01944444,Days,PD,Efficacy marker,28.692,.,mm,.,.,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,26-יונ-82,07:49,0,56,55.99375,Days,PK,Plasma concentration Z,61.401,.,ug/ml,.,0.8,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,26-יונ-82,08:12,0.083333333,56,56.00972222,Days,Dose,Dose Z,365,.,mg,.,.,iv,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,26-יונ-82,10:24,0,56,56.10138889,Days,PK,Plasma concentration Z,579.999,.,ug/ml,.,0.8,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-יול-82,07:57,0,84,80.99930556,Days,PD,Efficacy marker,28.954,.,mm,.,.,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-יול-82,07:47,0,84,83.99236111,Days,PK,Plasma concentration Z,75.999,.,ug/ml,.,0.8,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-יול-82,08:02,0.083333333,84,84.00277778,Days,Dose,Dose Z,358,.,mg,.,.,iv,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-יול-82,10:14,0,84,84.09444444,Days,PK,Plasma concentration Z,516,.,ug/ml,.,0.8,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-יול-82,12:02,0,84,84.16944444,Days,PK,Plasma concentration Z,564,.,ug/ml,.,0.8,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-יול-82,14:03,0,84,84.25347222,Days,PK,Plasma concentration Z,540,.,ug/ml,.,0.8,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,30-יול-82,12:04,0,91,90.17083333,Days,PK,Plasma concentration Z,242.001,.,ug/ml,.,0.8,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,06-אוג-82,10:44,0,98,97.11527778,Days,PK,Plasma concentration Z,142.401,.,ug/ml,.,0.8,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,21-אוג-82,14:28,0,112,112.2708333,Days,PK,Plasma concentration Z,78.999,.,ug/ml,.,0.8,.,.,.,.,1,5002,1667.333333,999
.,ZY300505002,Z,Y3,Profiling Study 1,1,0,5,5002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,01-ספט-82,10:45,0,112,123.1159722,Days,PD,Efficacy marker,28.343,.,mm,.,.,.,.,.,.,1,5002,1667.333333,999
.,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-אפר-82,07:00,0,-14,-42,Days,Demographics,Age,59,.,Years,.,.,.,.,.,.,1,5003,1667.666667,999
.,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-אפר-82,07:00,0,-14,-42,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5003,1667.666667,999
.,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-אפר-82,07:00,0,-14,-42,Days,Demographics,Weight,69.2,.,kg,.,.,.,.,.,.,1,5003,1667.666667,999
.,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,19-מאי-82,06:45,0,0,-5.010416667,Days,PD,Efficacy marker,35.206,.,mm,.,.,.,.,.,.,1,5003,1667.666667,999
.,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,19-מאי-82,07:00,0,0,-5,Days,Demographics,Weight,70.6,.,kg,.,.,.,.,.,.,1,5003,1667.666667,999
.,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,5003,1667.666667,999
.,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,24-מאי-82,07:00,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5003,1667.666667,999
.,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-אפר-82,07:00,0,12,13.0287305,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,5003,1667.666667,999
.,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,16-יונ-82,19:01,0,28,23.50069444,Days,PD,Efficacy marker,35.109,.,mm,.,.,.,.,.,.,1,5003,1667.666667,999
.,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,21-יונ-82,07:10,0.083333333,28,28.00694444,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5003,1667.666667,999
.,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,14-יול-82,17:02,0,56,51.41805556,Days,PD,Efficacy marker,36.104,.,mm,.,.,.,.,.,.,1,5003,1667.666667,999
.,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,19-יול-82,05:50,0.083333333,56,55.95138889,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5003,1667.666667,999
.,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,13-אוג-82,17:51,0,84,81.45208333,Days,PD,Efficacy marker,36.122,.,mm,.,.,.,.,.,.,1,5003,1667.666667,999
.,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,16-אוג-82,06:15,0.083333333,84,83.96875,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5003,1667.666667,999
.,ZY300505003,Z,Y3,Profiling Study 1,1,0,5,5003,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,25-ספט-82,18:29,0,112,124.4784722,Days,PD,Efficacy marker,35.899,.,mm,.,.,.,.,.,.,1,5003,1667.666667,999
.,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-אפר-82,07:00,0,-14,-42.0125,Days,Demographics,Age,53,.,Years,.,.,.,.,.,.,1,5004,1668,999
.,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-אפר-82,07:00,0,-14,-42.0125,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5004,1668,999
.,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-אפר-82,07:00,0,-14,-42.0125,Days,Demographics,Weight,68.6,.,kg,.,.,.,.,.,.,1,5004,1668,999
.,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,19-מאי-82,07:00,0,0,-5.0125,Days,Demographics,Weight,69.2,.,kg,.,.,.,.,.,.,1,5004,1668,999
.,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,19-מאי-82,19:26,0,0,-4.494444444,Days,PD,Efficacy marker,32.043,.,mm,.,.,.,.,.,.,1,5004,1668,999
.,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,5004,1668,999
.,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,24-מאי-82,07:18,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5004,1668,999
.,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-אפר-82,07:00,0,12,13.56457115,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5004,1668,999
.,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,16-יונ-82,16:58,0,28,23.40277778,Days,PD,Efficacy marker,32.829,.,mm,.,.,.,.,.,.,1,5004,1668,999
.,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,21-יונ-82,07:14,0.083333333,28,27.99722222,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5004,1668,999
.,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,14-יול-82,15:51,0,56,51.35625,Days,PD,Efficacy marker,33.027,.,mm,.,.,.,.,.,.,1,5004,1668,999
.,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,19-יול-82,05:45,0.083333333,56,55.93541667,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5004,1668,999
.,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,11-אוג-82,15:57,0,84,79.36041667,Days,PD,Efficacy marker,33.213,.,mm,.,.,.,.,.,.,1,5004,1668,999
.,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,16-אוג-82,06:05,0.083333333,84,83.94930556,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5004,1668,999
.,ZY300505004,Z,Y3,Profiling Study 1,1,0,5,5004,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,12-ספט-82,17:09,0,112,111.4104167,Days,PD,Efficacy marker,32.038,.,mm,.,.,.,.,.,.,1,5004,1668,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,16-אפר-82,07:00,0,-14,-37.00277778,Days,Demographics,Age,64,.,Years,.,.,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,16-אפר-82,07:00,0,-14,-37.00277778,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,16-אפר-82,07:00,0,-14,-37.00277778,Days,Demographics,Weight,79.8,.,kg,.,.,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-מאי-82,07:00,0,0,-4.002777778,Days,Demographics,Weight,80.1,.,kg,.,.,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-מאי-82,07:41,0,0,-3.974305556,Days,PD,Efficacy marker,24.179,.,mm,.,.,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,16-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,23-מאי-82,06:53,0,0,-0.007638889,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,23-מאי-82,07:04,0.083333333,0,0,Days,Dose,Dose Z,404,.,mg,.,.,iv,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,23-מאי-82,09:18,0,0.0833,0.093055556,Days,PK,Plasma concentration Z,494.001,.,ug/ml,.,0.8,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,16-אפר-82,07:00,0,12,13.57049864,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,16-יונ-82,18:08,0,28,24.46111111,Days,PD,Efficacy marker,26.368,.,mm,.,.,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,20-יונ-82,06:45,0,28,27.98680556,Days,PK,Plasma concentration Z,38.001,.,ug/ml,.,0.8,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,20-יונ-82,07:02,0.083333333,28,27.99861111,Days,Dose,Dose Z,407.5,.,mg,.,.,iv,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,20-יונ-82,09:12,0,28.0833,28.08888889,Days,PK,Plasma concentration Z,518.001,.,ug/ml,.,0.8,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,14-יול-82,14:54,0,56,52.32638889,Days,PD,Efficacy marker,26.887,.,mm,.,.,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,18-יול-82,06:53,0,56,55.99236111,Days,PK,Plasma concentration Z,60.201,.,ug/ml,.,0.8,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,18-יול-82,07:26,0.083333333,56,56.01527778,Days,Dose,Dose Z,407,.,mg,.,.,iv,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,18-יול-82,09:33,0,56.0833,56.10347222,Days,PK,Plasma concentration Z,558,.,ug/ml,.,0.8,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-אוג-82,05:57,0,84,82.95347222,Days,PK,Plasma concentration Z,71.601,.,ug/ml,.,0.8,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-אוג-82,06:12,0.083333333,84,82.96388889,Days,Dose,Dose Z,398.5,.,mg,.,.,iv,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-אוג-82,08:19,0,84.0833,83.05208333,Days,PK,Plasma concentration Z,468,.,ug/ml,.,0.8,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-אוג-82,10:15,0,84.166,83.13263889,Days,PK,Plasma concentration Z,531.999,.,ug/ml,.,0.8,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-אוג-82,12:14,0,84.25,83.21527778,Days,PK,Plasma concentration Z,555.999,.,ug/ml,.,0.8,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,19-אוג-82,07:06,0,91,88.00138889,Days,PK,Plasma concentration Z,237.999,.,ug/ml,.,0.8,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,26-אוג-82,05:45,0,98,94.94513889,Days,PK,Plasma concentration Z,148.401,.,ug/ml,.,0.8,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,27-אוג-82,17:24,0,98,96.43055556,Days,PD,Efficacy marker,27.311,.,mm,.,.,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,12-ספט-82,06:36,0,112,111.9805556,Days,PK,Plasma concentration Z,152.601,.,ug/ml,.,0.8,.,.,.,.,1,5007,1669,999
.,ZY300505007,Z,Y3,Profiling Study 1,1,0,5,5007,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,12-ספט-82,14:22,0,112,112.3041667,Days,PD,Efficacy marker,29.013,.,mm,.,.,.,.,.,.,1,5007,1669,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,-14,-27.04375,Days,Demographics,Age,70,.,Years,.,.,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,-14,-27.04375,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,-14,-27.04375,Days,Demographics,Weight,87.2,.,kg,.,.,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,24-מאי-82,07:00,0,0,-5.04375,Days,Demographics,Weight,87.7,.,kg,.,.,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,26-מאי-82,14:11,0,0,-2.744444444,Days,PD,Efficacy marker,48.98,.,mm,.,.,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-מאי-82,07:49,0,0,-0.009722222,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-מאי-82,08:03,0.083333333,0,0,Days,Dose,Dose Z,443.75,.,mg,.,.,iv,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-מאי-82,10:19,0,0.0833,0.094444444,Days,PK,Plasma concentration Z,417.999,.,ug/ml,.,0.8,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,12,13.40829334,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,23-יונ-82,09:22,0,28,25.05486111,Days,PD,Efficacy marker,51.107,.,mm,.,.,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-יונ-82,07:42,0,28,27.98541667,Days,PK,Plasma concentration Z,29.199,.,ug/ml,.,0.8,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-יונ-82,08:00,0.083333333,28,27.99791667,Days,Dose,Dose Z,439.75,.,mg,.,.,iv,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-יונ-82,10:09,0,28,28.0875,Days,PK,Plasma concentration Z,474,.,ug/ml,.,0.8,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,22-יול-82,13:09,0,56,54.2125,Days,PD,Efficacy marker,50.992,.,mm,.,.,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-יול-82,07:46,0,56,55.98819444,Days,PK,Plasma concentration Z,48.999,.,ug/ml,.,0.8,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-יול-82,08:19,0.083333333,56,56.01111111,Days,Dose,Dose Z,432.5,.,mg,.,.,iv,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-יול-82,10:33,0,56,56.10416667,Days,PK,Plasma concentration Z,417.999,.,ug/ml,.,0.8,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,18-אוג-82,10:24,0,84,81.09791667,Days,PD,Efficacy marker,50.315,.,mm,.,.,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-אוג-82,07:35,0,84,83.98055556,Days,PK,Plasma concentration Z,48.999,.,ug/ml,.,0.8,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-אוג-82,08:02,0.083333333,84,83.99930556,Days,Dose,Dose Z,431,.,mg,.,.,iv,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-אוג-82,10:13,0,84,84.09027778,Days,PK,Plasma concentration Z,422.001,.,ug/ml,.,0.8,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-אוג-82,12:02,0,84,84.16597222,Days,PK,Plasma concentration Z,510,.,ug/ml,.,0.8,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-אוג-82,14:02,0,84,84.24930556,Days,PK,Plasma concentration Z,489.999,.,ug/ml,.,0.8,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,31-אוג-82,13:42,0,91,94.23541667,Days,PK,Plasma concentration Z,116.199,.,ug/ml,.,0.8,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,03-ספט-82,09:39,0,98,97.06666667,Days,PK,Plasma concentration Z,91.2,.,ug/ml,.,0.8,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-ספט-82,09:30,0,112,111.0604167,Days,PK,Plasma concentration Z,61.401,.,ug/ml,.,0.8,.,.,.,.,1,5009,1669.666667,999
.,ZY300505009,Z,Y3,Profiling Study 1,1,0,5,5009,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-ספט-82,16:01,0,112,111.3319444,Days,PD,Efficacy marker,49.761,.,mm,.,.,.,.,.,.,1,5009,1669.666667,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,-14,-27.01319444,Days,Demographics,Age,64,.,Years,.,.,.,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,-14,-27.01319444,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,-14,-27.01319444,Days,Demographics,Weight,82,.,kg,.,.,.,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,24-מאי-82,07:00,0,0,-5.013194444,Days,Demographics,Weight,83.4,.,kg,.,.,.,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,28-מאי-82,11:20,0,0,-0.832638889,Days,PD,Efficacy marker,42.431,.,mm,.,.,.,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-מאי-82,07:04,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-מאי-82,07:19,0.083333333,0,0,Days,Dose,Dose Z,421,.,mg,.,.,iv,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-מאי-82,09:29,0,0.0833,0.090277778,Days,PK,Plasma concentration Z,561.999,.,ug/ml,.,0.8,.,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,12,14.17397942,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-יונ-82,07:57,0,28,23.02638889,Days,PD,Efficacy marker,44.994,.,mm,.,.,.,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-יונ-82,07:03,0,28,27.98888889,Days,PK,Plasma concentration Z,40.599,.,ug/ml,.,0.8,.,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-יונ-82,09:15,0,28,28.08055556,Days,PK,Plasma concentration Z,39.801,.,ug/ml,.,0.8,.,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,21-יול-82,10:11,0,56,53.11944444,Days,PD,Efficacy marker,44.156,.,mm,.,.,.,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,21-יול-82,12:00,0,56,53.19513889,Days,PK,Plasma concentration Z,12.861,.,ug/ml,.,0.8,.,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,18-אוג-82,13:58,0,84,81.27708333,Days,PK,Plasma concentration Z,0.48,.,ug/ml,.,0.8,.,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,18-אוג-82,16:37,0,84,81.3875,Days,PD,Efficacy marker,42.768,.,mm,.,.,.,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,27-אוג-82,10:36,0,91,90.13680556,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,03-ספט-82,10:22,0,98,97.12708333,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-ספט-82,08:26,0,112,111.0465278,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5010,1670,999
.,ZY300505010,Z,Y3,Profiling Study 1,1,0,5,5010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,18-ספט-82,13:15,0,112,112.2472222,Days,PD,Efficacy marker,41.652,.,mm,.,.,.,.,.,.,1,5010,1670,999
.,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,09-מאי-82,07:00,0,-14,-22,Days,Demographics,Age,54,.,Years,.,.,.,.,.,.,1,5012,1670.666667,999
.,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,09-מאי-82,07:00,0,-14,-22,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5012,1670.666667,999
.,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,09-מאי-82,07:00,0,-14,-22,Days,Demographics,Weight,72.4,.,kg,.,.,.,.,.,.,1,5012,1670.666667,999
.,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,26-מאי-82,14:54,0,0,-4.670833333,Days,PD,Efficacy marker,33.302,.,mm,.,.,.,.,.,.,1,5012,1670.666667,999
.,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,29-מאי-82,07:00,0,0,-2,Days,Demographics,Weight,72.2,.,kg,.,.,.,.,.,.,1,5012,1670.666667,999
.,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,09-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,5012,1670.666667,999
.,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,31-מאי-82,07:00,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5012,1670.666667,999
.,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,09-מאי-82,07:00,0,12,13.52547134,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,5012,1670.666667,999
.,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,23-יונ-82,17:52,0,28,23.45277778,Days,PD,Efficacy marker,32.637,.,mm,.,.,.,.,.,.,1,5012,1670.666667,999
.,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,28-יונ-82,07:04,0.083333333,28,28.00277778,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5012,1670.666667,999
.,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,25-יול-82,04:37,0,56,54.90069444,Days,PD,Efficacy marker,34.09,.,mm,.,.,.,.,.,.,1,5012,1670.666667,999
.,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,26-יול-82,06:01,0.083333333,56,55.95902778,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5012,1670.666667,999
.,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,18-אוג-82,17:59,0,84,79.45763889,Days,PD,Efficacy marker,32.994,.,mm,.,.,.,.,.,.,1,5012,1670.666667,999
.,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,23-אוג-82,06:41,0.083333333,84,83.98680556,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5012,1670.666667,999
.,ZY300505012,Z,Y3,Profiling Study 1,1,0,5,5012,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,22-ספט-82,18:54,0,112,114.4958333,Days,PD,Efficacy marker,32.835,.,mm,.,.,.,.,.,.,1,5012,1670.666667,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,23-מאי-82,07:00,0,-14,-42.99791667,Days,Demographics,Age,59,.,Years,.,.,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,23-מאי-82,07:00,0,-14,-42.99791667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,23-מאי-82,07:00,0,-14,-42.99791667,Days,Demographics,Weight,82.3,.,kg,.,.,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,30-יונ-82,16:06,0,0,-4.61875,Days,PD,Efficacy marker,35.276,.,mm,.,.,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,01-יול-82,07:00,0,0,-3.997916667,Days,Demographics,Weight,81.6,.,kg,.,.,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,23-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,05-יול-82,06:22,0,0,-0.024305556,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,05-יול-82,06:57,0.083333333,0,0,Days,Dose,Dose Z,412.5,.,mg,.,.,iv,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,05-יול-82,09:05,0,0.0833,0.088888889,Days,PK,Plasma concentration Z,518.001,.,ug/ml,.,0.8,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,23-מאי-82,07:00,0,12,13.91118109,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,28-יול-82,12:14,0,28,23.22013889,Days,PD,Efficacy marker,37.333,.,mm,.,.,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,31-יול-82,14:56,0,28,26.33263889,Days,PK,Plasma concentration Z,44.001,.,ug/ml,.,0.8,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,31-יול-82,15:19,0.083333333,28,26.34861111,Days,Dose,Dose Z,416,.,mg,.,.,iv,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,31-יול-82,17:25,0,28,26.43611111,Days,PK,Plasma concentration Z,585.999,.,ug/ml,.,0.8,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,25-אוג-82,10:21,0,56,51.14166667,Days,PD,Efficacy marker,37.22,.,mm,.,.,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-אוג-82,05:12,0,56,54.92708333,Days,PK,Plasma concentration Z,56.601,.,ug/ml,.,0.8,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-אוג-82,05:31,0.083333333,56,54.94027778,Days,Dose,Dose Z,419.75,.,mg,.,.,iv,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-אוג-82,07:42,0,56,55.03125,Days,PK,Plasma concentration Z,626.001,.,ug/ml,.,0.8,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,22-ספט-82,10:45,0,84,79.15833333,Days,PD,Efficacy marker,39.112,.,mm,.,.,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,22-ספט-82,13:34,0,84,79.27569444,Days,PK,Plasma concentration Z,72.999,.,ug/ml,.,0.8,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,02-אוק-82,13:05,0,91,89.25555556,Days,PK,Plasma concentration Z,48.201,.,ug/ml,.,0.8,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,13-אוק-82,12:05,0,98,100.2138889,Days,PK,Plasma concentration Z,30.6,.,ug/ml,.,0.8,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,22-אוק-82,15:57,0,112,109.375,Days,PK,Plasma concentration Z,19.419,.,ug/ml,.,0.8,.,.,.,.,1,5014,1671.333333,999
.,ZY300505014,Z,Y3,Profiling Study 1,1,0,5,5014,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,24-אוק-82,15:59,0,112,111.3763889,Days,PD,Efficacy marker,38.497,.,mm,.,.,.,.,.,.,1,5014,1671.333333,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,31-מאי-82,07:00,0,-14,-31.99444444,Days,Demographics,Age,51,.,Years,.,.,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,31-מאי-82,07:00,0,-14,-31.99444444,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,31-מאי-82,07:00,0,-14,-31.99444444,Days,Demographics,Weight,56.6,.,kg,.,.,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,27-יונ-82,07:00,0,0,-4.994444444,Days,Demographics,Weight,56.85,.,kg,.,.,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,27-יונ-82,14:23,0,0,-4.686805556,Days,PD,Efficacy marker,22.644,.,mm,.,.,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,31-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,02-יול-82,06:33,0,0,-0.013194444,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,02-יול-82,06:52,0.083333333,0,0,Days,Dose,Dose Z,287,.,mg,.,.,iv,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,02-יול-82,09:04,0,0.0833,0.091666667,Days,PK,Plasma concentration Z,384,.,ug/ml,.,0.8,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,31-מאי-82,07:00,0,12,13.12347951,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,25-יול-82,03:17,0,28,22.85069444,Days,PD,Efficacy marker,25.449,.,mm,.,.,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-אוג-82,06:24,0,28,29.98055556,Days,PK,Plasma concentration Z,32.4,.,ug/ml,.,0.8,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-אוג-82,06:33,0.083333333,28,29.98680556,Days,Dose,Dose Z,290.5,.,mg,.,.,iv,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-אוג-82,08:42,0,28,30.07638889,Days,PK,Plasma concentration Z,522,.,ug/ml,.,0.8,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,22-אוג-82,15:30,0,56,51.35972222,Days,PD,Efficacy marker,25.793,.,mm,.,.,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,27-אוג-82,07:44,0,56,56.03611111,Days,PK,Plasma concentration Z,62.199,.,ug/ml,.,0.8,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,27-אוג-82,07:55,0.083333333,56,56.04375,Days,Dose,Dose Z,286.5,.,mg,.,.,iv,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,27-אוג-82,10:08,0,56,56.13611111,Days,PK,Plasma concentration Z,482.001,.,ug/ml,.,0.8,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,19-ספט-82,16:26,0,84,79.39861111,Days,PD,Efficacy marker,25.527,.,mm,.,.,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-ספט-82,08:37,0,84,84.07291667,Days,PK,Plasma concentration Z,70.599,.,ug/ml,.,0.8,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,01-אוק-82,09:06,0,91,91.09305556,Days,PK,Plasma concentration Z,57,.,ug/ml,.,0.8,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,08-אוק-82,09:12,0,98,98.09722222,Days,PK,Plasma concentration Z,47.601,.,ug/ml,.,0.8,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,20-אוק-82,12:39,0,112,110.2409722,Days,PK,Plasma concentration Z,28.599,.,ug/ml,.,0.8,.,.,.,.,1,5015,1671.666667,999
.,ZY300505015,Z,Y3,Profiling Study 1,1,0,5,5015,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,22-אוק-82,15:37,0,112,112.3645833,Days,PD,Efficacy marker,25.827,.,mm,.,.,.,.,.,.,1,5015,1671.666667,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-יונ-82,07:00,0,-14,-35.99027778,Days,Demographics,Age,72,.,Years,.,.,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-יונ-82,07:00,0,-14,-35.99027778,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-יונ-82,07:00,0,-14,-35.99027778,Days,Demographics,Weight,71.7,.,kg,.,.,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,03-יול-82,07:00,0,0,-4.990277778,Days,Demographics,Weight,71.9,.,kg,.,.,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,03-יול-82,10:30,0,0,-4.844444444,Days,PD,Efficacy marker,25.944,.,mm,.,.,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-יונ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-יול-82,06:29,0,0,-0.011805556,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-יול-82,06:46,0.083333333,0,0,Days,Dose,Dose Z,357,.,mg,.,.,iv,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-יול-82,08:53,0,0.0833,0.088194444,Days,PK,Plasma concentration Z,447.999,.,ug/ml,.,0.8,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-יונ-82,07:00,0,12,13.61815839,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,31-יול-82,10:23,0,28,23.15069444,Days,PD,Efficacy marker,26.892,.,mm,.,.,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,05-אוג-82,06:45,0,28,27.99930556,Days,PK,Plasma concentration Z,49.8,.,ug/ml,.,0.8,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,05-אוג-82,07:25,0.083333333,28,28.02708333,Days,Dose,Dose Z,354,.,mg,.,.,iv,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,05-אוג-82,09:33,0,28.0833,28.11597222,Days,PK,Plasma concentration Z,555.999,.,ug/ml,.,0.8,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,30-אוג-82,11:34,0,56,53.2,Days,PD,Efficacy marker,27.596,.,mm,.,.,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,02-ספט-82,06:43,0,56,55.99791667,Days,PK,Plasma concentration Z,61.8,.,ug/ml,.,0.8,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,02-ספט-82,07:08,0.083333333,56,56.01527778,Days,Dose,Dose Z,357,.,mg,.,.,iv,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,02-ספט-82,09:16,0,56.0833,56.10416667,Days,PK,Plasma concentration Z,482.001,.,ug/ml,.,0.8,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,30-ספט-82,07:03,0,84,84.01180556,Days,PK,Plasma concentration Z,87.801,.,ug/ml,.,0.8,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,30-ספט-82,07:20,0.083333333,84,84.02361111,Days,Dose,Dose Z,353,.,mg,.,.,iv,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,30-ספט-82,09:33,0,84.0833,84.11597222,Days,PK,Plasma concentration Z,567.999,.,ug/ml,.,0.8,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,30-ספט-82,11:20,0,84.166,84.19027778,Days,PK,Plasma concentration Z,554.001,.,ug/ml,.,0.8,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,30-ספט-82,13:20,0,84.25,84.27361111,Days,PK,Plasma concentration Z,566.001,.,ug/ml,.,0.8,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,08-אוק-82,10:38,0,91,92.16111111,Days,PK,Plasma concentration Z,192.201,.,ug/ml,.,0.8,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,15-אוק-82,09:36,0,98,99.11805556,Days,PK,Plasma concentration Z,132.6,.,ug/ml,.,0.8,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,28-אוק-82,08:16,0,112,112.0625,Days,PK,Plasma concentration Z,94.8,.,ug/ml,.,0.8,.,.,.,.,1,5016,1672,999
.,ZY300505016,Z,Y3,Profiling Study 1,1,0,5,5016,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,28-אוק-82,10:18,0,112,112.1472222,Days,PD,Efficacy marker,27.853,.,mm,.,.,.,.,.,.,1,5016,1672,999
.,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,10-יונ-82,07:00,0,-14,-34.99930556,Days,Demographics,Age,64,.,Years,.,.,.,.,.,.,1,5017,1672.333333,999
.,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,10-יונ-82,07:00,0,-14,-34.99930556,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5017,1672.333333,999
.,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,10-יונ-82,07:00,0,-14,-34.99930556,Days,Demographics,Weight,71.3,.,kg,.,.,.,.,.,.,1,5017,1672.333333,999
.,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,10-יול-82,07:00,0,0,-4.999305556,Days,Demographics,Weight,70.1,.,kg,.,.,.,.,.,.,1,5017,1672.333333,999
.,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,10-יול-82,09:50,0,0,-4.88125,Days,PD,Efficacy marker,30.446,.,mm,.,.,.,.,.,.,1,5017,1672.333333,999
.,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,10-יונ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,5017,1672.333333,999
.,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,15-יול-82,06:59,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5017,1672.333333,999
.,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,10-יונ-82,07:00,0,12,14.08633945,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,5017,1672.333333,999
.,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,07-אוג-82,10:23,0,28,23.14166667,Days,PD,Efficacy marker,30.895,.,mm,.,.,.,.,.,.,1,5017,1672.333333,999
.,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,12-אוג-82,07:44,0.083333333,28,28.03125,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5017,1672.333333,999
.,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,04-ספט-82,10:47,0,56,51.15833333,Days,PD,Efficacy marker,30.802,.,mm,.,.,.,.,.,.,1,5017,1672.333333,999
.,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,09-ספט-82,07:40,0.083333333,56,56.02847222,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5017,1672.333333,999
.,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,02-אוק-82,10:17,0,84,79.1375,Days,PD,Efficacy marker,31.247,.,mm,.,.,.,.,.,.,1,5017,1672.333333,999
.,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,07-אוק-82,07:30,0.083333333,84,84.02152778,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5017,1672.333333,999
.,ZY300505017,Z,Y3,Profiling Study 1,1,0,5,5017,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,04-נוב-82,10:45,0,112,112.1569444,Days,PD,Efficacy marker,31.189,.,mm,.,.,.,.,.,.,1,5017,1672.333333,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-יונ-82,07:00,0,-14,-41.97638889,Days,Demographics,Age,56,.,Years,.,.,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-יונ-82,07:00,0,-14,-41.97638889,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-יונ-82,07:00,0,-14,-41.97638889,Days,Demographics,Weight,91,.,kg,.,.,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,25-יול-82,07:00,0,0,-4.976388889,Days,Demographics,Weight,91.5,.,kg,.,.,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,25-יול-82,09:03,0,0,-4.890972222,Days,PD,Efficacy marker,46.381,.,mm,.,.,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-יונ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,30-יול-82,05:48,0,0,-0.026388889,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,30-יול-82,06:26,0.083333333,0,0,Days,Dose,Dose Z,458,.,mg,.,.,iv,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,30-יול-82,08:39,0,0.0833,0.092361111,Days,PK,Plasma concentration Z,536.001,.,ug/ml,.,0.8,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-יונ-82,07:00,0,12,13.37418718,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,27-אוג-82,06:05,0,28,27.98541667,Days,PK,Plasma concentration Z,30.999,.,ug/ml,.,0.8,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,27-אוג-82,06:36,0.083333333,28,28.00694444,Days,Dose,Dose Z,463,.,mg,.,.,iv,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,27-אוג-82,08:47,0,28,28.09791667,Days,PK,Plasma concentration Z,546,.,ug/ml,.,0.8,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,04-ספט-82,15:25,0,28,36.37430556,Days,PD,Efficacy marker,48.082,.,mm,.,.,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-ספט-82,17:38,0,56,51.46666667,Days,PD,Efficacy marker,48.545,.,mm,.,.,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-ספט-82,06:26,0,56,56,Days,PK,Plasma concentration Z,40.2,.,ug/ml,.,0.8,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-ספט-82,06:40,0.083333333,56,56.00972222,Days,Dose,Dose Z,464.25,.,mg,.,.,iv,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-ספט-82,08:51,0,56,56.10069444,Days,PK,Plasma concentration Z,440.001,.,ug/ml,.,0.8,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,17-אוק-82,16:00,0,84,79.39861111,Days,PD,Efficacy marker,49.831,.,mm,.,.,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,22-אוק-82,06:03,0,84,83.98402778,Days,PK,Plasma concentration Z,57.201,.,ug/ml,.,0.8,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,22-אוק-82,06:30,0.083333333,84,84.00277778,Days,Dose,Dose Z,455,.,mg,.,.,iv,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,22-אוק-82,08:45,0,84,84.09652778,Days,PK,Plasma concentration Z,522,.,ug/ml,.,0.8,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,22-אוק-82,10:30,0,84,84.16944444,Days,PK,Plasma concentration Z,432,.,ug/ml,.,0.8,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,22-אוק-82,12:31,0,84,84.25347222,Days,PK,Plasma concentration Z,498,.,ug/ml,.,0.8,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,29-אוק-82,09:05,0,91,91.11041667,Days,PK,Plasma concentration Z,159.801,.,ug/ml,.,0.8,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,05-נוב-82,08:30,0,98,98.08611111,Days,PK,Plasma concentration Z,121.2,.,ug/ml,.,0.8,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-נוב-82,09:16,0,112,110.1180556,Days,PK,Plasma concentration Z,58.8,.,ug/ml,.,0.8,.,.,.,.,1,5019,1673,999
.,ZY300505019,Z,Y3,Profiling Study 1,1,0,5,5019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,18-נוב-82,10:08,0,112,111.1541667,Days,PD,Efficacy marker,50.9,.,mm,.,.,.,.,.,.,1,5019,1673,999
.,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,21-יונ-82,07:00,0,-14,-34.96041667,Days,Demographics,Age,58,.,Years,.,.,.,.,.,.,1,5020,1673.333333,999
.,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,21-יונ-82,07:00,0,-14,-34.96041667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5020,1673.333333,999
.,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,21-יונ-82,07:00,0,-14,-34.96041667,Days,Demographics,Weight,56.8,.,kg,.,.,.,.,.,.,1,5020,1673.333333,999
.,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,22-יול-82,07:00,0,0,-3.960416667,Days,Demographics,Weight,58,.,kg,.,.,.,.,.,.,1,5020,1673.333333,999
.,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,22-יול-82,10:32,0,0,-3.813194444,Days,PD,Efficacy marker,27.844,.,mm,.,.,.,.,.,.,1,5020,1673.333333,999
.,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,21-יונ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5020,1673.333333,999
.,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,26-יול-82,05:23,0,0,-0.027777778,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5020,1673.333333,999
.,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,26-יול-82,06:03,0.083333333,0,0,Days,Dose,Dose Z,290.5,.,mg,.,.,iv,.,.,.,1,5020,1673.333333,999
.,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,26-יול-82,08:09,0,0.0833,0.0875,Days,PK,Plasma concentration Z,872.001,.,ug/ml,.,0.8,.,.,.,.,1,5020,1673.333333,999
.,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,21-יונ-82,07:00,0,12,14.80718337,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,5020,1673.333333,999
.,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,18-אוג-82,15:54,0,28,23.41041667,Days,PD,Efficacy marker,30.331,.,mm,.,.,.,.,.,.,1,5020,1673.333333,999
.,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-אוג-82,16:03,0,28,26.41666667,Days,PK,Plasma concentration Z,41.601,.,ug/ml,.,0.8,.,.,.,.,1,5020,1673.333333,999
.,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,15-ספט-82,08:37,0,56,51.10694444,Days,PK,Plasma concentration Z,8.979,.,ug/ml,.,0.8,.,.,.,.,1,5020,1673.333333,999
.,ZY300505020,Z,Y3,Profiling Study 1,1,0,5,5020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,15-ספט-82,10:21,0,56,51.17916667,Days,PD,Efficacy marker,31.06,.,mm,.,.,.,.,.,.,1,5020,1673.333333,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-יול-82,07:00,0,-14,-35.97777778,Days,Demographics,Age,74,.,Years,.,.,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-יול-82,07:00,0,-14,-35.97777778,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-יול-82,07:00,0,-14,-35.97777778,Days,Demographics,Weight,77.9,.,kg,.,.,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,18-אוג-82,07:00,0,0,-3.977777778,Days,Demographics,Weight,78.2,.,kg,.,.,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,18-אוג-82,12:57,0,0,-3.729861111,Days,PD,Efficacy marker,35.687,.,mm,.,.,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-יול-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,22-אוג-82,06:07,0,0,-0.014583333,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,22-אוג-82,06:28,0.083333333,0,0,Days,Dose,Dose Z,396,.,mg,.,.,iv,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,22-אוג-82,08:41,0,0.0833,0.092361111,Days,PK,Plasma concentration Z,446.001,.,ug/ml,.,0.8,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-יול-82,07:00,0,12,13.17748228,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,15-ספט-82,15:26,0,28,24.37361111,Days,PD,Efficacy marker,38.397,.,mm,.,.,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,19-ספט-82,05:56,0,28,27.97777778,Days,PK,Plasma concentration Z,40.2,.,ug/ml,.,0.8,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,19-ספט-82,06:30,0.083333333,28,28.00138889,Days,Dose,Dose Z,396.5,.,mg,.,.,iv,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,19-ספט-82,08:43,0,28,28.09375,Days,PK,Plasma concentration Z,488.001,.,ug/ml,.,0.8,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,13-אוק-82,10:26,0,56,52.16527778,Days,PD,Efficacy marker,38.811,.,mm,.,.,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,17-אוק-82,06:11,0,56,55.98819444,Days,PK,Plasma concentration Z,58.2,.,ug/ml,.,0.8,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,17-אוק-82,06:25,0.083333333,56,55.99791667,Days,Dose,Dose Z,403.75,.,mg,.,.,iv,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,17-אוק-82,08:35,0,56,56.08819444,Days,PK,Plasma concentration Z,438,.,ug/ml,.,0.8,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,11-נוב-82,10:12,0,84,81.15555556,Days,PD,Efficacy marker,39.442,.,mm,.,.,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-נוב-82,06:12,0,84,83.98888889,Days,PK,Plasma concentration Z,106.599,.,ug/ml,.,0.8,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-נוב-82,06:25,0.083333333,84,83.99791667,Days,Dose,Dose Z,408.5,.,mg,.,.,iv,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-נוב-82,08:40,0,84,84.09166667,Days,PK,Plasma concentration Z,576,.,ug/ml,.,0.8,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-נוב-82,10:25,0,84,84.16458333,Days,PK,Plasma concentration Z,537.999,.,ug/ml,.,0.8,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-נוב-82,12:25,0,84,84.24791667,Days,PK,Plasma concentration Z,525.999,.,ug/ml,.,0.8,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,19-נוב-82,12:15,0,91,89.24097222,Days,PK,Plasma concentration Z,236.001,.,ug/ml,.,0.8,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,28-נוב-82,07:04,0,98,98.025,Days,PK,Plasma concentration Z,127.599,.,ug/ml,.,0.8,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,09-דצמ-82,14:44,0,112,109.3444444,Days,PD,Efficacy marker,39.048,.,mm,.,.,.,.,.,.,1,5021,1673.666667,999
.,ZY300505021,Z,Y3,Profiling Study 1,1,0,5,5021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,15-דצמ-82,06:47,0,112,115.0131944,Days,PK,Plasma concentration Z,0.474,.,ug/ml,.,0.8,.,.,.,.,1,5021,1673.666667,999
.,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,22-יול-82,07:00,0,-14,-34.975,Days,Demographics,Age,74,.,Years,.,.,.,.,.,.,1,5022,1674,999
.,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,22-יול-82,07:00,0,-14,-34.975,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5022,1674,999
.,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,22-יול-82,07:00,0,-14,-34.975,Days,Demographics,Weight,73.55,.,kg,.,.,.,.,.,.,1,5022,1674,999
.,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-אוג-82,07:00,0,0,-4.975,Days,Demographics,Weight,73.05,.,kg,.,.,.,.,.,.,1,5022,1674,999
.,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-אוג-82,08:07,0,0,-4.928472222,Days,PD,Efficacy marker,27.126,.,mm,.,.,.,.,.,.,1,5022,1674,999
.,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,22-יול-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5022,1674,999
.,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,26-אוג-82,06:24,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5022,1674,999
.,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,22-יול-82,07:00,0,12,14.9037577,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,5022,1674,999
.,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,23-ספט-82,06:33,0.083333333,28,28.00625,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5022,1674,999
.,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,01-אוק-82,16:30,0,28,36.42083333,Days,PD,Efficacy marker,26.562,.,mm,.,.,.,.,.,.,1,5022,1674,999
.,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,21-אוק-82,06:35,0.083333333,56,56.00763889,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5022,1674,999
.,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,01-נוב-82,08:41,0,56,67.09513889,Days,PD,Efficacy marker,28.052,.,mm,.,.,.,.,.,.,1,5022,1674,999
.,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,14-נוב-82,10:32,0,84,80.17222222,Days,PD,Efficacy marker,27.347,.,mm,.,.,.,.,.,.,1,5022,1674,999
.,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,18-נוב-82,06:30,0.083333333,84,84.00416667,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5022,1674,999
.,ZY300505022,Z,Y3,Profiling Study 1,1,0,5,5022,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,15-דצמ-82,10:02,0,112,111.1513889,Days,PD,Efficacy marker,27.011,.,mm,.,.,.,.,.,.,1,5022,1674,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-יול-82,07:00,0,-14,-33.05069444,Days,Demographics,Age,70,.,Years,.,.,.,.,.,.,1,5023,1674.333333,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-יול-82,07:00,0,-14,-33.05069444,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5023,1674.333333,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-יול-82,07:00,0,-14,-33.05069444,Days,Demographics,Weight,84.7,.,kg,.,.,.,.,.,.,1,5023,1674.333333,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,22-אוג-82,07:00,0,0,-5.050694444,Days,Demographics,Weight,84.4,.,kg,.,.,.,.,.,.,1,5023,1674.333333,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,22-אוג-82,10:10,0,0,-4.91875,Days,PD,Efficacy marker,35.643,.,mm,.,.,.,.,.,.,1,5023,1674.333333,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-יול-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,5023,1674.333333,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,27-אוג-82,07:57,0,0,-0.011111111,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5023,1674.333333,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,27-אוג-82,08:13,0.083333333,0,0,Days,Dose,Dose Z,427.5,.,mg,.,.,iv,.,.,.,1,5023,1674.333333,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,27-אוג-82,10:25,0,0.0833,0.091666667,Days,PK,Plasma concentration Z,446.001,.,ug/ml,.,0.8,.,.,.,.,1,5023,1674.333333,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-יול-82,07:00,0,12,13.36616485,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5023,1674.333333,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,19-ספט-82,10:31,0,28,23.09583333,Days,PD,Efficacy marker,37.549,.,mm,.,.,.,.,.,.,1,5023,1674.333333,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,23-ספט-82,14:50,0,28,27.27569444,Days,PK,Plasma concentration Z,29.001,.,ug/ml,.,0.8,.,.,.,.,1,5023,1674.333333,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,17-אוק-82,10:06,0,56,51.07847222,Days,PD,Efficacy marker,37.631,.,mm,.,.,.,.,.,.,1,5023,1674.333333,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,22-אוק-82,13:14,0,56,56.20902778,Days,PK,Plasma concentration Z,4.86,.,ug/ml,.,0.8,.,.,.,.,1,5023,1674.333333,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,17-נוב-82,10:28,0,84,82.09375,Days,PD,Efficacy marker,36.779,.,mm,.,.,.,.,.,.,1,5023,1674.333333,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,17-נוב-82,12:09,0,84,82.16388889,Days,PK,Plasma concentration Z,94.2,.,ug/ml,.,0.8,.,.,.,.,1,5023,1674.333333,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,27-נוב-82,09:57,0,91,92.07222222,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5023,1674.333333,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,03-דצמ-82,09:45,0,98,98.06388889,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5023,1674.333333,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,15-דצמ-82,14:58,0,112,110.28125,Days,PD,Efficacy marker,36.926,.,mm,.,.,.,.,.,.,1,5023,1674.333333,999
.,ZY300505023,Z,Y3,Profiling Study 1,1,0,5,5023,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-דצמ-82,11:54,0,112,112.1534722,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5023,1674.333333,999
.,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-יול-82,07:00,0,-14,-28.98402778,Days,Demographics,Age,57,.,Years,.,.,.,.,.,.,1,5024,1674.666667,999
.,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-יול-82,07:00,0,-14,-28.98402778,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5024,1674.666667,999
.,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-יול-82,07:00,0,-14,-28.98402778,Days,Demographics,Weight,56.9,.,kg,.,.,.,.,.,.,1,5024,1674.666667,999
.,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,18-אוג-82,07:00,0,0,-4.984027778,Days,Demographics,Weight,56.7,.,kg,.,.,.,.,.,.,1,5024,1674.666667,999
.,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,20-אוג-82,19:09,0,0,-2.477777778,Days,PD,Efficacy marker,23.656,.,mm,.,.,.,.,.,.,1,5024,1674.666667,999
.,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-יול-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,5024,1674.666667,999
.,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,23-אוג-82,06:37,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5024,1674.666667,999
.,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-יול-82,07:00,0,12,14.09474257,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,5024,1674.666667,999
.,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,15-ספט-82,18:08,0,28,23.47986111,Days,PD,Efficacy marker,23.49,.,mm,.,.,.,.,.,.,1,5024,1674.666667,999
.,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,20-ספט-82,06:45,0.083333333,28,28.00555556,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5024,1674.666667,999
.,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,13-אוק-82,18:27,0,56,51.49305556,Days,PD,Efficacy marker,24.083,.,mm,.,.,.,.,.,.,1,5024,1674.666667,999
.,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,18-אוק-82,06:13,0.083333333,56,55.98333333,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5024,1674.666667,999
.,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,11-נוב-82,17:54,0,84,80.47013889,Days,PD,Efficacy marker,23.888,.,mm,.,.,.,.,.,.,1,5024,1674.666667,999
.,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,15-נוב-82,06:01,0.083333333,84,83.975,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5024,1674.666667,999
.,ZY300505024,Z,Y3,Profiling Study 1,1,0,5,5024,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,10-דצמ-82,17:38,0,112,109.4590278,Days,PD,Efficacy marker,23.001,.,mm,.,.,.,.,.,.,1,5024,1674.666667,999
.,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-יול-82,07:00,0,-14,-46.0625,Days,Demographics,Age,72,.,Years,.,.,.,.,.,.,1,5025,1675,999
.,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-יול-82,07:00,0,-14,-46.0625,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5025,1675,999
.,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-יול-82,07:00,0,-14,-46.0625,Days,Demographics,Weight,55.2,.,kg,.,.,.,.,.,.,1,5025,1675,999
.,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,08-ספט-82,07:00,0,0,-5.0625,Days,Demographics,Weight,57.7,.,kg,.,.,.,.,.,.,1,5025,1675,999
.,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,08-ספט-82,15:47,0,0,-4.696527778,Days,PD,Efficacy marker,22.119,.,mm,.,.,.,.,.,.,1,5025,1675,999
.,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-יול-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5025,1675,999
.,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,13-ספט-82,08:30,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5025,1675,999
.,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-יול-82,07:00,0,12,13.70309464,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5025,1675,999
.,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,11-אוק-82,09:15,0.083333333,28,28.03125,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5025,1675,999
.,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,17-אוק-82,17:40,0,28,34.38194444,Days,PD,Efficacy marker,22.273,.,mm,.,.,.,.,.,.,1,5025,1675,999
.,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,08-נוב-82,07:25,0.083333333,56,55.95486111,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5025,1675,999
.,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,17-נוב-82,18:18,0,56,65.40833333,Days,PD,Efficacy marker,21.28,.,mm,.,.,.,.,.,.,1,5025,1675,999
.,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,06-דצמ-82,07:35,0.083333333,84,83.96180556,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5025,1675,999
.,ZY300505025,Z,Y3,Profiling Study 1,1,0,5,5025,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,31-דצמ-82,10:01,0,112,109.0631944,Days,PD,Efficacy marker,20.937,.,mm,.,.,.,.,.,.,1,5025,1675,999
.,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-יול-82,07:00,0,-14,-32.00902778,Days,Demographics,Age,73,.,Years,.,.,.,.,.,.,1,5026,1675.333333,999
.,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-יול-82,07:00,0,-14,-32.00902778,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5026,1675.333333,999
.,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-יול-82,07:00,0,-14,-32.00902778,Days,Demographics,Weight,70.9,.,kg,.,.,.,.,.,.,1,5026,1675.333333,999
.,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-אוג-82,07:00,0,0,-5.009027778,Days,Demographics,Weight,70.3,.,kg,.,.,.,.,.,.,1,5026,1675.333333,999
.,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-אוג-82,18:59,0,0,-4.509722222,Days,PD,Efficacy marker,27.182,.,mm,.,.,.,.,.,.,1,5026,1675.333333,999
.,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-יול-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,5026,1675.333333,999
.,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,26-אוג-82,07:13,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5026,1675.333333,999
.,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-יול-82,07:00,0,12,14.47765224,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,5026,1675.333333,999
.,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,18-ספט-82,15:39,0,28,23.35138889,Days,PD,Efficacy marker,27.423,.,mm,.,.,.,.,.,.,1,5026,1675.333333,999
.,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,23-ספט-82,08:10,0.083333333,28,28.03958333,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5026,1675.333333,999
.,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,17-אוק-82,14:03,0,56,52.28472222,Days,PD,Efficacy marker,27.49,.,mm,.,.,.,.,.,.,1,5026,1675.333333,999
.,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,21-אוק-82,09:06,0.083333333,56,56.07847222,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5026,1675.333333,999
.,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,18-נוב-82,08:05,0.083333333,84,84.03611111,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5026,1675.333333,999
.,ZY300505026,Z,Y3,Profiling Study 1,1,0,5,5026,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,16-דצמ-82,10:18,0,112,112.1284722,Days,PD,Efficacy marker,27.609,.,mm,.,.,.,.,.,.,1,5026,1675.333333,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,31-יול-82,07:00,0,-14,-25.98888889,Days,Demographics,Age,70,.,Years,.,.,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,31-יול-82,07:00,0,-14,-25.98888889,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,31-יול-82,07:00,0,-14,-25.98888889,Days,Demographics,Weight,80.8,.,kg,.,.,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,21-אוג-82,07:00,0,0,-4.988888889,Days,Demographics,Weight,83.4,.,kg,.,.,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,21-אוג-82,15:11,0,0,-4.647916667,Days,PD,Efficacy marker,44.362,.,mm,.,.,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,31-יול-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,26-אוג-82,06:31,0,0,-0.009027778,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,26-אוג-82,06:44,0.083333333,0,0,Days,Dose,Dose Z,411.5,.,mg,.,.,iv,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,26-אוג-82,09:00,0,0.0833,0.094444444,Days,PK,Plasma concentration Z,374.001,.,ug/ml,.,0.8,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,31-יול-82,07:00,0,12,14.15539677,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,18-ספט-82,16:25,0,28,23.40347222,Days,PD,Efficacy marker,47.323,.,mm,.,.,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,23-ספט-82,06:16,0,28,27.98055556,Days,PK,Plasma concentration Z,41.4,.,ug/ml,.,0.8,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,23-ספט-82,06:45,0.083333333,28,28.00069444,Days,Dose,Dose Z,418,.,mg,.,.,iv,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,23-ספט-82,09:00,0,28,28.09444444,Days,PK,Plasma concentration Z,687.999,.,ug/ml,.,0.8,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,16-אוק-82,15:31,0,56,51.36597222,Days,PD,Efficacy marker,48.645,.,mm,.,.,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,21-אוק-82,06:20,0,56,55.98333333,Days,PK,Plasma concentration Z,62.001,.,ug/ml,.,0.8,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,21-אוק-82,06:40,0.083333333,56,55.99722222,Days,Dose,Dose Z,421.5,.,mg,.,.,iv,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,21-אוק-82,08:46,0,56,56.08472222,Days,PK,Plasma concentration Z,590.001,.,ug/ml,.,0.8,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,13-נוב-82,14:53,0,84,79.33958333,Days,PD,Efficacy marker,48.546,.,mm,.,.,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,18-נוב-82,06:28,0,84,83.98888889,Days,PK,Plasma concentration Z,74.601,.,ug/ml,.,0.8,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,18-נוב-82,06:40,0.083333333,84,83.99722222,Days,Dose,Dose Z,420.75,.,mg,.,.,iv,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,18-נוב-82,08:54,0,84,84.09027778,Days,PK,Plasma concentration Z,354,.,ug/ml,.,0.8,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,18-נוב-82,10:40,0,84,84.16388889,Days,PK,Plasma concentration Z,588,.,ug/ml,.,0.8,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,18-נוב-82,12:40,0,84,84.24722222,Days,PK,Plasma concentration Z,537.999,.,ug/ml,.,0.8,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,25-נוב-82,08:55,0,91,91.09097222,Days,PK,Plasma concentration Z,170.199,.,ug/ml,.,0.8,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,01-דצמ-82,08:56,0,98,97.09166667,Days,PK,Plasma concentration Z,132.201,.,ug/ml,.,0.8,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,15-דצמ-82,07:33,0,112,111.0340278,Days,PK,Plasma concentration Z,155.001,.,ug/ml,.,0.8,.,.,.,.,1,5027,1675.666667,999
.,ZY300505027,Z,Y3,Profiling Study 1,1,0,5,5027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-דצמ-82,10:06,0,112,113.1402778,Days,PD,Efficacy marker,48.769,.,mm,.,.,.,.,.,.,1,5027,1675.666667,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,28-יול-82,07:00,0,-14,-30.97986111,Days,Demographics,Age,53,.,Years,.,.,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,28-יול-82,07:00,0,-14,-30.97986111,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,28-יול-82,07:00,0,-14,-30.97986111,Days,Demographics,Weight,81.2,.,kg,.,.,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,22-אוג-82,07:00,0,0,-5.979861111,Days,Demographics,Weight,80,.,kg,.,.,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,26-אוג-82,20:12,0,0,-1.429861111,Days,PD,Efficacy marker,42.391,.,mm,.,.,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,28-יול-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,28-אוג-82,06:02,0,0,-0.020138889,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,28-אוג-82,06:31,0.083333333,0,0,Days,Dose,Dose Z,401,.,mg,.,.,iv,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,28-אוג-82,08:46,0,0.0833,0.09375,Days,PK,Plasma concentration Z,486,.,ug/ml,.,0.8,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,28-יול-82,07:00,0,12,14.40884944,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,19-ספט-82,15:27,0,28,22.37222222,Days,PD,Efficacy marker,44.477,.,mm,.,.,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,25-ספט-82,06:15,0,28,27.98888889,Days,PK,Plasma concentration Z,35.4,.,ug/ml,.,0.8,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,25-ספט-82,06:40,0.083333333,28,28.00625,Days,Dose,Dose Z,412.25,.,mg,.,.,iv,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,25-ספט-82,08:51,0,28,28.09722222,Days,PK,Plasma concentration Z,446.001,.,ug/ml,.,0.8,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,20-אוק-82,15:19,0,56,53.36666667,Days,PD,Efficacy marker,45.717,.,mm,.,.,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,23-אוק-82,06:35,0,56,56.00277778,Days,PK,Plasma concentration Z,52.8,.,ug/ml,.,0.8,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,23-אוק-82,07:00,0.083333333,56,56.02013889,Days,Dose,Dose Z,407.5,.,mg,.,.,iv,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,23-אוק-82,09:15,0,56,56.11388889,Days,PK,Plasma concentration Z,225.999,.,ug/ml,.,0.8,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-נוב-82,15:44,0,84,78.38402778,Days,PD,Efficacy marker,45.549,.,mm,.,.,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,20-נוב-82,06:45,0,84,84.00972222,Days,PK,Plasma concentration Z,138.6,.,ug/ml,.,0.8,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,20-נוב-82,07:00,0.083333333,84,84.02013889,Days,Dose,Dose Z,398.5,.,mg,.,.,iv,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,20-נוב-82,09:12,0,84,84.11180556,Days,PK,Plasma concentration Z,410.001,.,ug/ml,.,0.8,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,20-נוב-82,11:00,0,84,84.18680556,Days,PK,Plasma concentration Z,555.999,.,ug/ml,.,0.8,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,20-נוב-82,13:00,0,84,84.27013889,Days,PK,Plasma concentration Z,494.001,.,ug/ml,.,0.8,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,27-נוב-82,09:17,0,91,91.11527778,Days,PK,Plasma concentration Z,193.2,.,ug/ml,.,0.8,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,03-דצמ-82,13:30,0,98,97.29097222,Days,PK,Plasma concentration Z,144.801,.,ug/ml,.,0.8,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-דצמ-82,12:43,0,112,111.2583333,Days,PK,Plasma concentration Z,89.799,.,ug/ml,.,0.8,.,.,.,.,1,5028,1676,999
.,ZY300505028,Z,Y3,Profiling Study 1,1,0,5,5028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,19-דצמ-82,16:15,0,112,113.4055556,Days,PD,Efficacy marker,46.231,.,mm,.,.,.,.,.,.,1,5028,1676,999
.,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,31-יול-82,07:00,0,-14,-49.01388889,Days,Demographics,Age,64,.,Years,.,.,.,.,.,.,1,5029,1676.333333,999
.,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,31-יול-82,07:00,0,-14,-49.01388889,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5029,1676.333333,999
.,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,31-יול-82,07:00,0,-14,-49.01388889,Days,Demographics,Weight,58.9,.,kg,.,.,.,.,.,.,1,5029,1676.333333,999
.,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,15-ספט-82,06:54,0,0,-3.018055556,Days,PD,Efficacy marker,27.893,.,mm,.,.,.,.,.,.,1,5029,1676.333333,999
.,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,15-ספט-82,07:00,0,0,-3.013888889,Days,Demographics,Weight,58.6,.,kg,.,.,.,.,.,.,1,5029,1676.333333,999
.,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,31-יול-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,5029,1676.333333,999
.,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,18-ספט-82,07:20,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5029,1676.333333,999
.,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,31-יול-82,07:00,0,12,13.32184383,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,5029,1676.333333,999
.,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,13-אוק-82,16:22,0,28,25.37638889,Days,PD,Efficacy marker,29.076,.,mm,.,.,.,.,.,.,1,5029,1676.333333,999
.,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,16-אוק-82,08:10,0.083333333,28,28.03472222,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5029,1676.333333,999
.,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,08-נוב-82,07:50,0,56,51.02083333,Days,PD,Efficacy marker,29.042,.,mm,.,.,.,.,.,.,1,5029,1676.333333,999
.,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,13-נוב-82,07:15,0.083333333,56,55.99652778,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5029,1676.333333,999
.,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,11-דצמ-82,07:55,0.083333333,84,84.02430556,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5029,1676.333333,999
.,ZY300505029,Z,Y3,Profiling Study 1,1,0,5,5029,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,05-ינו-83,09:06,0,112,109.0736111,Days,PD,Efficacy marker,29.092,.,mm,.,.,.,.,.,.,1,5029,1676.333333,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,05-אוג-82,07:00,0,-14,-17.99166667,Days,Demographics,Age,58,.,Years,.,.,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,05-אוג-82,07:00,0,-14,-17.99166667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,05-אוג-82,07:00,0,-14,-17.99166667,Days,Demographics,Weight,66.75,.,kg,.,.,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,20-אוג-82,07:00,0,0,-2.991666667,Days,Demographics,Weight,69,.,kg,.,.,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,22-אוג-82,09:32,0,0,-0.886111111,Days,PD,Efficacy marker,38.089,.,mm,.,.,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,05-אוג-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,23-אוג-82,06:12,0,0,-0.025,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,23-אוג-82,06:48,0.083333333,0,0,Days,Dose,Dose Z,341,.,mg,.,.,iv,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,23-אוג-82,09:00,0,0.0833,0.091666667,Days,PK,Plasma concentration Z,381.999,.,ug/ml,.,0.8,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,05-אוג-82,07:00,0,12,13.87792677,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,15-ספט-82,18:52,0,28,23.50277778,Days,PD,Efficacy marker,38.275,.,mm,.,.,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,20-ספט-82,05:38,0,28,27.95138889,Days,PK,Plasma concentration Z,16.899,.,ug/ml,.,0.8,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,20-ספט-82,06:40,0.083333333,28,27.99444444,Days,Dose,Dose Z,343.5,.,mg,.,.,iv,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,20-ספט-82,08:56,0,28,28.08888889,Days,PK,Plasma concentration Z,261.999,.,ug/ml,.,0.8,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,13-אוק-82,06:24,0,56,50.98333333,Days,PD,Efficacy marker,39.207,.,mm,.,.,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,18-אוק-82,05:30,0,56,55.94583333,Days,PK,Plasma concentration Z,52.8,.,ug/ml,.,0.8,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,18-אוק-82,05:58,0.083333333,56,55.96527778,Days,Dose,Dose Z,346,.,mg,.,.,iv,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,18-אוק-82,08:10,0,56,56.05694444,Days,PK,Plasma concentration Z,486,.,ug/ml,.,0.8,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,11-נוב-82,06:41,0,84,79.99513889,Days,PD,Efficacy marker,40.78,.,mm,.,.,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,15-נוב-82,05:44,0,84,83.95555556,Days,PK,Plasma concentration Z,87.801,.,ug/ml,.,0.8,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,15-נוב-82,06:00,0.083333333,84,83.96666667,Days,Dose,Dose Z,351,.,mg,.,.,iv,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,15-נוב-82,08:12,0,84,84.05833333,Days,PK,Plasma concentration Z,492,.,ug/ml,.,0.8,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,15-נוב-82,10:00,0,84,84.13333333,Days,PK,Plasma concentration Z,555.999,.,ug/ml,.,0.8,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,15-נוב-82,12:00,0,84,84.21666667,Days,PK,Plasma concentration Z,512.001,.,ug/ml,.,0.8,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,22-נוב-82,08:49,0,91,91.08402778,Days,PK,Plasma concentration Z,230.001,.,ug/ml,.,0.8,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,27-נוב-82,15:24,0,98,96.35833333,Days,PK,Plasma concentration Z,165.399,.,ug/ml,.,0.8,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,15-דצמ-82,06:16,0,112,113.9777778,Days,PD,Efficacy marker,40.58,.,mm,.,.,.,.,.,.,1,5030,1676.666667,999
.,ZY300505030,Z,Y3,Profiling Study 1,1,0,5,5030,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,15-דצמ-82,07:24,0,112,114.025,Days,PK,Plasma concentration Z,188.799,.,ug/ml,.,0.8,.,.,.,.,1,5030,1676.666667,999
.,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,05-אוג-82,07:00,0,-14,-21.02222222,Days,Demographics,Age,54,.,Years,.,.,.,.,.,.,1,5031,1677,999
.,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,05-אוג-82,07:00,0,-14,-21.02222222,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,5031,1677,999
.,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,05-אוג-82,07:00,0,-14,-21.02222222,Days,Demographics,Weight,94.7,.,kg,.,.,.,.,.,.,1,5031,1677,999
.,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-אוג-82,07:00,0,0,-5.022222222,Days,Demographics,Weight,95.2,.,kg,.,.,.,.,.,.,1,5031,1677,999
.,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-אוג-82,19:48,0,0,-4.488888889,Days,PD,Efficacy marker,48.788,.,mm,.,.,.,.,.,.,1,5031,1677,999
.,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,05-אוג-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5031,1677,999
.,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,26-אוג-82,07:32,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5031,1677,999
.,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,05-אוג-82,07:00,0,12,14.74369675,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,5031,1677,999
.,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,18-ספט-82,10:40,0,28,23.13055556,Days,PD,Efficacy marker,49.47,.,mm,.,.,.,.,.,.,1,5031,1677,999
.,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,23-ספט-82,08:00,0.083333333,28,28.01944444,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5031,1677,999
.,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,16-אוק-82,16:39,0,56,51.37986111,Days,PD,Efficacy marker,49.073,.,mm,.,.,.,.,.,.,1,5031,1677,999
.,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,21-אוק-82,07:55,0.083333333,56,56.01597222,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5031,1677,999
.,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,13-נוב-82,10:56,0,84,79.14166667,Days,PD,Efficacy marker,50.02,.,mm,.,.,.,.,.,.,1,5031,1677,999
.,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,18-נוב-82,07:50,0.083333333,84,84.0125,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5031,1677,999
.,ZY300505031,Z,Y3,Profiling Study 1,1,0,5,5031,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,18-דצמ-82,10:01,0,112,114.1034722,Days,PD,Efficacy marker,49.802,.,mm,.,.,.,.,.,.,1,5031,1677,999
.,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-אוג-82,07:00,0,-14,-28.23611111,Days,Demographics,Age,57,.,Years,.,.,.,.,.,.,1,5032,1677.333333,999
.,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-אוג-82,07:00,0,-14,-28.23611111,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5032,1677.333333,999
.,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-אוג-82,07:00,0,-14,-28.23611111,Days,Demographics,Weight,73.4,.,kg,.,.,.,.,.,.,1,5032,1677.333333,999
.,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,01-ספט-82,07:00,0,0,-8.236111111,Days,Demographics,Weight,74,.,kg,.,.,.,.,.,.,1,5032,1677.333333,999
.,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,06-ספט-82,11:07,0,0,-3.064583333,Days,PD,Efficacy marker,25.292,.,mm,.,.,.,.,.,.,1,5032,1677.333333,999
.,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-אוג-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,5032,1677.333333,999
.,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,09-ספט-82,12:40,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5032,1677.333333,999
.,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,12-אוג-82,07:00,0,12,13.75667676,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,5032,1677.333333,999
.,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,02-אוק-82,15:25,0,28,23.11458333,Days,PD,Efficacy marker,25.183,.,mm,.,.,.,.,.,.,1,5032,1677.333333,999
.,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,07-אוק-82,07:20,0.083333333,28,27.77777778,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5032,1677.333333,999
.,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,04-נוב-82,20:06,0,56,56.30972222,Days,PD,Efficacy marker,24.529,.,mm,.,.,.,.,.,.,1,5032,1677.333333,999
.,ZY300505032,Z,Y3,Profiling Study 1,1,0,5,5032,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,06-נוב-82,07:15,0.083333333,56,57.77430556,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5032,1677.333333,999
.,ZY300505033,Z,Y3,Profiling Study 1,1,0,5,5033,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,08-אוג-82,07:00,0,-14,-24.99861111,Days,Demographics,Age,71,.,Years,.,.,.,.,.,.,1,5033,1677.666667,999
.,ZY300505033,Z,Y3,Profiling Study 1,1,0,5,5033,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,08-אוג-82,07:00,0,-14,-24.99861111,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,5033,1677.666667,999
.,ZY300505033,Z,Y3,Profiling Study 1,1,0,5,5033,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,08-אוג-82,07:00,0,-14,-24.99861111,Days,Demographics,Weight,75.2,.,kg,.,.,.,.,.,.,1,5033,1677.666667,999
.,ZY300505033,Z,Y3,Profiling Study 1,1,0,5,5033,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,28-אוג-82,07:00,0,0,-4.998611111,Days,Demographics,Weight,75.8,.,kg,.,.,.,.,.,.,1,5033,1677.666667,999
.,ZY300505033,Z,Y3,Profiling Study 1,1,0,5,5033,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,28-אוג-82,14:54,0,0,-4.669444444,Days,PD,Efficacy marker,37.964,.,mm,.,.,.,.,.,.,1,5033,1677.666667,999
.,ZY300505033,Z,Y3,Profiling Study 1,1,0,5,5033,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,08-אוג-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,5033,1677.666667,999
.,ZY300505033,Z,Y3,Profiling Study 1,1,0,5,5033,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,02-ספט-82,06:58,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5033,1677.666667,999
.,ZY300505033,Z,Y3,Profiling Study 1,1,0,5,5033,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,08-אוג-82,07:00,0,12,13.06692447,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,5033,1677.666667,999
.,ZY300505033,Z,Y3,Profiling Study 1,1,0,5,5033,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,25-ספט-82,16:30,0,28,23.39722222,Days,PD,Efficacy marker,38.541,.,mm,.,.,.,.,.,.,1,5033,1677.666667,999
.,ZY300505033,Z,Y3,Profiling Study 1,1,0,5,5033,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,30-ספט-82,06:55,0.083333333,28,27.99791667,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5033,1677.666667,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-אוג-82,07:00,0,-14,-36.01736111,Days,Demographics,Age,53,.,Years,.,.,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-אוג-82,07:00,0,-14,-36.01736111,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-אוג-82,07:00,0,-14,-36.01736111,Days,Demographics,Weight,79.9,.,kg,.,.,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,08-ספט-82,17:47,0,0,-4.568055556,Days,PD,Efficacy marker,40.578,.,mm,.,.,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,09-ספט-82,07:00,0,0,-4.017361111,Days,Demographics,Weight,80.1,.,kg,.,.,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-אוג-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,13-ספט-82,07:13,0,0,-0.008333333,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,13-ספט-82,07:25,0.083333333,0,0,Days,Dose,Dose Z,399,.,mg,.,.,iv,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,13-ספט-82,09:38,0,0.0833,0.092361111,Days,PK,Plasma concentration Z,416.001,.,ug/ml,.,0.8,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-אוג-82,07:00,0,12,14.81939749,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,08-אוק-82,17:04,0,28,25.40208333,Days,PD,Efficacy marker,43.147,.,mm,.,.,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,11-אוק-82,07:19,0,28,27.99583333,Days,PK,Plasma concentration Z,48.999,.,ug/ml,.,0.8,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,11-אוק-82,07:39,0.083333333,28,28.00972222,Days,Dose,Dose Z,396.5,.,mg,.,.,iv,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,11-אוק-82,09:51,0,28,28.10138889,Days,PK,Plasma concentration Z,558,.,ug/ml,.,0.8,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,04-נוב-82,17:43,0,56,52.42916667,Days,PD,Efficacy marker,43.105,.,mm,.,.,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,08-נוב-82,06:06,0,56,55.94513889,Days,PK,Plasma concentration Z,78.6,.,ug/ml,.,0.8,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,08-נוב-82,06:38,0.083333333,56,55.96736111,Days,Dose,Dose Z,399,.,mg,.,.,iv,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,08-נוב-82,08:50,0,56,56.05902778,Days,PK,Plasma concentration Z,600,.,ug/ml,.,0.8,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-דצמ-82,06:55,0,84,83.97916667,Days,PK,Plasma concentration Z,108.801,.,ug/ml,.,0.8,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-דצמ-82,07:15,0.083333333,84,83.99305556,Days,Dose,Dose Z,391.5,.,mg,.,.,iv,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-דצמ-82,09:29,0,84,84.08611111,Days,PK,Plasma concentration Z,582,.,ug/ml,.,0.8,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-דצמ-82,11:15,0,84,84.15972222,Days,PK,Plasma concentration Z,579.999,.,ug/ml,.,0.8,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-דצמ-82,13:15,0,84,84.24305556,Days,PK,Plasma concentration Z,602.001,.,ug/ml,.,0.8,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,13-דצמ-82,07:20,0,91,90.99652778,Days,PK,Plasma concentration Z,260.001,.,ug/ml,.,0.8,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,18-דצמ-82,05:57,0,98,95.93888889,Days,PK,Plasma concentration Z,183.801,.,ug/ml,.,0.8,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,03-ינו-83,08:44,0,112,112.0548611,Days,PK,Plasma concentration Z,89.799,.,ug/ml,.,0.8,.,.,.,.,1,5034,1678,999
.,ZY300505034,Z,Y3,Profiling Study 1,1,0,5,5034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,05-ינו-83,12:05,0,112,114.1944444,Days,PD,Efficacy marker,44.554,.,mm,.,.,.,.,.,.,1,5034,1678,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-אוג-82,07:00,0,-14,-23.98958333,Days,Demographics,Age,65,.,Years,.,.,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-אוג-82,07:00,0,-14,-23.98958333,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-אוג-82,07:00,0,-14,-23.98958333,Days,Demographics,Weight,73,.,kg,.,.,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,28-אוג-82,07:00,0,0,-3.989583333,Days,Demographics,Weight,72.6,.,kg,.,.,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,28-אוג-82,12:28,0,0,-3.761805556,Days,PD,Efficacy marker,28.065,.,mm,.,.,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-אוג-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-ספט-82,06:25,0,0,-0.013888889,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-ספט-82,06:45,0.083333333,0,0,Days,Dose,Dose Z,368,.,mg,.,.,iv,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-ספט-82,09:02,0,0.0833,0.095138889,Days,PK,Plasma concentration Z,465.999,.,ug/ml,.,0.8,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-אוג-82,07:00,0,12,13.06937861,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,25-ספט-82,15:12,0,28,24.35208333,Days,PD,Efficacy marker,29.647,.,mm,.,.,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-ספט-82,06:28,0,28,27.98819444,Days,PK,Plasma concentration Z,51,.,ug/ml,.,0.8,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-ספט-82,07:00,0.083333333,28,28.01041667,Days,Dose,Dose Z,372,.,mg,.,.,iv,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-ספט-82,09:13,0,28,28.10277778,Days,PK,Plasma concentration Z,660,.,ug/ml,.,0.8,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,23-אוק-82,15:04,0,56,52.34652778,Days,PD,Efficacy marker,29.953,.,mm,.,.,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,27-אוק-82,07:04,0,56,56.01319444,Days,PK,Plasma concentration Z,60,.,ug/ml,.,0.8,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,27-אוק-82,07:30,0.083333333,56,56.03125,Days,Dose,Dose Z,373.5,.,mg,.,.,iv,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,27-אוק-82,09:39,0,56,56.12083333,Days,PK,Plasma concentration Z,561.999,.,ug/ml,.,0.8,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-נוב-82,06:53,0,84,84.00555556,Days,PK,Plasma concentration Z,102.801,.,ug/ml,.,0.8,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-נוב-82,07:15,0.083333333,84,84.02083333,Days,Dose,Dose Z,374.5,.,mg,.,.,iv,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-נוב-82,09:30,0,84,84.11458333,Days,PK,Plasma concentration Z,537.999,.,ug/ml,.,0.8,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-נוב-82,11:15,0,84,84.1875,Days,PK,Plasma concentration Z,590.001,.,ug/ml,.,0.8,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-נוב-82,13:15,0,84,84.27083333,Days,PK,Plasma concentration Z,570,.,ug/ml,.,0.8,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,01-דצמ-82,12:20,0,91,91.23263889,Days,PK,Plasma concentration Z,255.999,.,ug/ml,.,0.8,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,10-דצמ-82,13:51,0,98,100.2958333,Days,PK,Plasma concentration Z,198.999,.,ug/ml,.,0.8,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,22-דצמ-82,09:30,0,112,112.1145833,Days,PK,Plasma concentration Z,120.999,.,ug/ml,.,0.8,.,.,.,.,1,5035,1678.333333,999
.,ZY300505035,Z,Y3,Profiling Study 1,1,0,5,5035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,25-דצמ-82,13:10,0,112,115.2673611,Days,PD,Efficacy marker,30.905,.,mm,.,.,.,.,.,.,1,5035,1678.333333,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-אוג-82,07:00,0,-14,-35.96805556,Days,Demographics,Age,60,.,Years,.,.,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-אוג-82,07:00,0,-14,-35.96805556,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-אוג-82,07:00,0,-14,-35.96805556,Days,Demographics,Weight,79,.,kg,.,.,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,08-ספט-82,18:39,0,0,-4.482638889,Days,PD,Efficacy marker,31.018,.,mm,.,.,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,09-ספט-82,07:00,0,0,-3.968055556,Days,Demographics,Weight,80.5,.,kg,.,.,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-אוג-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,13-ספט-82,06:00,0,0,-0.009722222,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,13-ספט-82,06:14,0.083333333,0,0,Days,Dose,Dose Z,398.5,.,mg,.,.,iv,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,13-ספט-82,08:25,0,0.0833,0.090972222,Days,PK,Plasma concentration Z,408,.,ug/ml,.,0.8,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,08-אוג-82,07:00,0,12,13.79089233,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-אוק-82,17:44,0,28,23.47916667,Days,PD,Efficacy marker,32.014,.,mm,.,.,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,11-אוק-82,06:20,0,28,28.00416667,Days,PK,Plasma concentration Z,52.401,.,ug/ml,.,0.8,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,11-אוק-82,06:42,0.083333333,28,28.01944444,Days,Dose,Dose Z,400.25,.,mg,.,.,iv,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,11-אוק-82,08:49,0,28,28.10763889,Days,PK,Plasma concentration Z,656.001,.,ug/ml,.,0.8,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-נוב-82,18:49,0,56,51.52430556,Days,PD,Efficacy marker,32.821,.,mm,.,.,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,08-נוב-82,06:02,0,56,55.99166667,Days,PK,Plasma concentration Z,102.399,.,ug/ml,.,0.8,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,08-נוב-82,06:40,0.083333333,56,56.01805556,Days,Dose,Dose Z,395,.,mg,.,.,iv,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,08-נוב-82,08:52,0,56,56.10972222,Days,PK,Plasma concentration Z,570,.,ug/ml,.,0.8,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-דצמ-82,06:20,0,84,84.00416667,Days,PK,Plasma concentration Z,87,.,ug/ml,.,0.8,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-דצמ-82,06:35,0.083333333,84,84.01458333,Days,Dose,Dose Z,396,.,mg,.,.,iv,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-דצמ-82,08:48,0,84,84.10694444,Days,PK,Plasma concentration Z,4179.999,.,ug/ml,.,0.8,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-דצמ-82,10:38,0,84,84.18333333,Days,PK,Plasma concentration Z,582,.,ug/ml,.,0.8,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-דצמ-82,12:35,0,84,84.26458333,Days,PK,Plasma concentration Z,573.999,.,ug/ml,.,0.8,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,13-דצמ-82,07:00,0,91,91.03194444,Days,PK,Plasma concentration Z,243.999,.,ug/ml,.,0.8,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,18-דצמ-82,06:38,0,98,96.01666667,Days,PK,Plasma concentration Z,140.601,.,ug/ml,.,0.8,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,01-ינו-83,16:57,0,112,110.4465278,Days,PD,Efficacy marker,34.19,.,mm,.,.,.,.,.,.,1,5036,1678.666667,999
.,ZY300505036,Z,Y3,Profiling Study 1,1,0,5,5036,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,03-ינו-83,07:15,0,112,112.0423611,Days,PK,Plasma concentration Z,75.6,.,ug/ml,.,0.8,.,.,.,.,1,5036,1678.666667,999
.,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,18-פבר-82,07:00,0,-14,-42,Days,Demographics,Age,66,.,Years,.,.,.,.,.,.,1,7005,2335,999
.,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,18-פבר-82,07:00,0,-14,-42,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,7005,2335,999
.,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,18-פבר-82,07:00,0,-14,-42,Days,Demographics,Weight,76.2,.,kg,.,.,.,.,.,.,1,7005,2335,999
.,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,27-מרץ-82,15:00,0,0,-4.666666667,Days,PD,Efficacy marker,44.078,.,mm,.,.,.,.,.,.,1,7005,2335,999
.,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,31-מרץ-82,07:00,0,0,-1,Days,Demographics,Weight,78.8,.,kg,.,.,.,.,.,.,1,7005,2335,999
.,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,18-פבר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,7005,2335,999
.,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,01-אפר-82,07:00,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7005,2335,999
.,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,18-פבר-82,07:00,0,12,14.8798107,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7005,2335,999
.,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,29-אפר-82,07:00,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7005,2335,999
.,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,30-אפר-82,09:07,0,28,29.08819444,Days,PD,Efficacy marker,44.711,.,mm,.,.,.,.,.,.,1,7005,2335,999
.,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,22-מאי-82,15:26,0,56,51.35138889,Days,PD,Efficacy marker,44.613,.,mm,.,.,.,.,.,.,1,7005,2335,999
.,ZY300707005,Z,Y3,Profiling Study 1,1,0,7,7005,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,27-מאי-82,07:00,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7005,2335,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-פבר-82,07:00,0,-14,-42.00347222,Days,Demographics,Age,67,.,Years,.,.,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-פבר-82,07:00,0,-14,-42.00347222,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-פבר-82,07:00,0,-14,-42.00347222,Days,Demographics,Weight,61.8,.,kg,.,.,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,27-מרץ-82,15:48,0,0,-4.636805556,Days,PD,Efficacy marker,23.053,.,mm,.,.,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,31-מרץ-82,07:00,0,0,-1.003472222,Days,Demographics,Weight,61.7,.,kg,.,.,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-פבר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-אפר-82,06:50,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-אפר-82,07:05,0.083333333,0,0,Days,Dose,Dose Z,306.5,.,mg,.,.,iv,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-אפר-82,09:24,0,0.0833,0.096527778,Days,PK,Plasma concentration Z,554.001,.,ug/ml,.,0.8,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-פבר-82,07:00,0,12,14.53346138,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,24-אפר-82,16:43,0,28,23.40138889,Days,PD,Efficacy marker,24.527,.,mm,.,.,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-אפר-82,06:50,0,28,27.98958333,Days,PK,Plasma concentration Z,37.401,.,ug/ml,.,0.8,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-אפר-82,07:05,0.083333333,28,28,Days,Dose,Dose Z,309.5,.,mg,.,.,iv,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-אפר-82,09:24,0,28,28.09652778,Days,PK,Plasma concentration Z,582,.,ug/ml,.,0.8,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,22-מאי-82,17:06,0,56,51.41736111,Days,PD,Efficacy marker,26.111,.,mm,.,.,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,27-מאי-82,06:50,0,56,55.98958333,Days,PK,Plasma concentration Z,48.801,.,ug/ml,.,0.8,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,27-מאי-82,07:05,0.083333333,56,56,Days,Dose,Dose Z,310,.,mg,.,.,iv,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,27-מאי-82,09:26,0,56,56.09791667,Days,PK,Plasma concentration Z,645.999,.,ug/ml,.,0.8,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,19-יונ-82,15:55,0,84,79.36805556,Days,PD,Efficacy marker,26.637,.,mm,.,.,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-יונ-82,06:50,0,84,83.98958333,Days,PK,Plasma concentration Z,59.001,.,ug/ml,.,0.8,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-יונ-82,07:05,0.083333333,84,84,Days,Dose,Dose Z,308,.,mg,.,.,iv,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-יונ-82,09:05,0,84,84.08333333,Days,PK,Plasma concentration Z,525.999,.,ug/ml,.,0.8,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-יונ-82,11:05,0,84,84.16666667,Days,PK,Plasma concentration Z,678,.,ug/ml,.,0.8,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,24-יונ-82,13:05,0,84,84.25,Days,PK,Plasma concentration Z,638.001,.,ug/ml,.,0.8,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,01-יול-82,07:05,0,91,91,Days,PK,Plasma concentration Z,177.999,.,ug/ml,.,0.8,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,08-יול-82,07:05,0,98,98,Days,PK,Plasma concentration Z,110.601,.,ug/ml,.,0.8,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,21-יול-82,15:31,0,112,111.3513889,Days,PD,Efficacy marker,27.734,.,mm,.,.,.,.,.,.,1,7006,2335.333333,999
.,ZY300707006,Z,Y3,Profiling Study 1,1,0,7,7006,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,22-יול-82,07:05,0,112,112,Days,PK,Plasma concentration Z,74.199,.,ug/ml,.,0.8,.,.,.,.,1,7006,2335.333333,999
.,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,18-פבר-82,07:00,0,-14,-42.00694444,Days,Demographics,Age,59,.,Years,.,.,.,.,.,.,1,7007,2335.666667,999
.,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,18-פבר-82,07:00,0,-14,-42.00694444,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7007,2335.666667,999
.,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,18-פבר-82,07:00,0,-14,-42.00694444,Days,Demographics,Weight,77.6,.,kg,.,.,.,.,.,.,1,7007,2335.666667,999
.,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,27-מרץ-82,16:56,0,0,-4.593055556,Days,PD,Efficacy marker,30.247,.,mm,.,.,.,.,.,.,1,7007,2335.666667,999
.,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,31-מרץ-82,07:00,0,0,-1.006944444,Days,Demographics,Weight,77.4,.,kg,.,.,.,.,.,.,1,7007,2335.666667,999
.,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,18-פבר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,7007,2335.666667,999
.,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,01-אפר-82,07:10,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7007,2335.666667,999
.,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,18-פבר-82,07:00,0,12,13.59619539,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,7007,2335.666667,999
.,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,29-אפר-82,07:10,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7007,2335.666667,999
.,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,03-מאי-82,08:56,0,28,32.07361111,Days,PD,Efficacy marker,30.796,.,mm,.,.,.,.,.,.,1,7007,2335.666667,999
.,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,22-מאי-82,16:44,0,56,51.39861111,Days,PD,Efficacy marker,31.835,.,mm,.,.,.,.,.,.,1,7007,2335.666667,999
.,ZY300707007,Z,Y3,Profiling Study 1,1,0,7,7007,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,27-מאי-82,07:10,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7007,2335.666667,999
.,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-פבר-82,07:00,0,-14,-42.01041667,Days,Demographics,Age,75,.,Years,.,.,.,.,.,.,1,7008,2336,999
.,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-פבר-82,07:00,0,-14,-42.01041667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7008,2336,999
.,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-פבר-82,07:00,0,-14,-42.01041667,Days,Demographics,Weight,72.8,.,kg,.,.,.,.,.,.,1,7008,2336,999
.,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,27-מרץ-82,17:29,0,0,-4.573611111,Days,PD,Efficacy marker,26.459,.,mm,.,.,.,.,.,.,1,7008,2336,999
.,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,31-מרץ-82,07:00,0,0,-1.010416667,Days,Demographics,Weight,75.6,.,kg,.,.,.,.,.,.,1,7008,2336,999
.,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-פבר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,7008,2336,999
.,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-אפר-82,07:00,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,7008,2336,999
.,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-אפר-82,07:15,0.083333333,0,0,Days,Dose,Dose Z,372,.,mg,.,.,iv,.,.,.,1,7008,2336,999
.,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,01-אפר-82,09:39,0,0.166,0.1,Days,PK,Plasma concentration Z,594,.,ug/ml,.,0.8,.,.,.,.,1,7008,2336,999
.,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,18-פבר-82,07:00,0,12,14.29612331,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7008,2336,999
.,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-אפר-82,07:00,0,28,27.98958333,Days,PK,Plasma concentration Z,44.199,.,ug/ml,.,0.8,.,.,.,.,1,7008,2336,999
.,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-אפר-82,07:15,0.083333333,28,28,Days,Dose,Dose Z,383,.,mg,.,.,iv,.,.,.,1,7008,2336,999
.,ZY300707008,Z,Y3,Profiling Study 1,1,0,7,7008,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,29-אפר-82,09:33,0,28,28.09583333,Days,PK,Plasma concentration Z,650.001,.,ug/ml,.,0.8,.,.,.,.,1,7008,2336,999
.,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,19-פבר-82,07:00,0,-14,-43,Days,Demographics,Age,51,.,Years,.,.,.,.,.,.,1,7011,2337,999
.,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,19-פבר-82,07:00,0,-14,-43,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,7011,2337,999
.,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,19-פבר-82,07:00,0,-14,-43,Days,Demographics,Weight,97.8,.,kg,.,.,.,.,.,.,1,7011,2337,999
.,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,01-אפר-82,18:34,0,0,-1.518055556,Days,PD,Efficacy marker,55.36,.,mm,.,.,.,.,.,.,1,7011,2337,999
.,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,02-אפר-82,07:00,0,0,-1,Days,Demographics,Weight,97,.,kg,.,.,.,.,.,.,1,7011,2337,999
.,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,19-פבר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7011,2337,999
.,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,03-אפר-82,07:00,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7011,2337,999
.,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,19-פבר-82,07:00,0,12,14.84878128,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,7011,2337,999
.,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,30-אפר-82,14:49,0,28,27.32569444,Days,PD,Efficacy marker,54.873,.,mm,.,.,.,.,.,.,1,7011,2337,999
.,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,01-מאי-82,07:00,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7011,2337,999
.,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,29-מאי-82,07:00,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7011,2337,999
.,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,31-מאי-82,10:45,0,56,58.15625,Days,PD,Efficacy marker,53.825,.,mm,.,.,.,.,.,.,1,7011,2337,999
.,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,21-יונ-82,08:27,0,84,79.06041667,Days,PD,Efficacy marker,58.472,.,mm,.,.,.,.,.,.,1,7011,2337,999
.,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,26-יונ-82,07:02,0.083333333,84,84.00138889,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7011,2337,999
.,ZY300707011,Z,Y3,Profiling Study 1,1,0,7,7011,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,08-אוג-82,17:43,0,112,127.4465278,Days,PD,Efficacy marker,55.334,.,mm,.,.,.,.,.,.,1,7011,2337,999
.,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-פבר-82,07:00,0,-14,-37.00347222,Days,Demographics,Age,67,.,Years,.,.,.,.,.,.,1,7015,2338.333333,999
.,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-פבר-82,07:00,0,-14,-37.00347222,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7015,2338.333333,999
.,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-פבר-82,07:00,0,-14,-37.00347222,Days,Demographics,Weight,54.9,.,kg,.,.,.,.,.,.,1,7015,2338.333333,999
.,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,29-מרץ-82,10:17,0,0,-4.866666667,Days,PD,Efficacy marker,21.507,.,mm,.,.,.,.,.,.,1,7015,2338.333333,999
.,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,02-אפר-82,07:00,0,0,-1.003472222,Days,Demographics,Weight,55.9,.,kg,.,.,.,.,.,.,1,7015,2338.333333,999
.,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-פבר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,7015,2338.333333,999
.,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,03-אפר-82,07:05,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7015,2338.333333,999
.,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,25-פבר-82,07:00,0,12,13.98055656,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,7015,2338.333333,999
.,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,26-אפר-82,08:32,0,28,23.06041667,Days,PD,Efficacy marker,21.897,.,mm,.,.,.,.,.,.,1,7015,2338.333333,999
.,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,01-מאי-82,07:05,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7015,2338.333333,999
.,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,24-מאי-82,07:18,0,56,51.00902778,Days,PD,Efficacy marker,22.196,.,mm,.,.,.,.,.,.,1,7015,2338.333333,999
.,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,29-מאי-82,07:06,0.083333333,56,56.00069444,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7015,2338.333333,999
.,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,21-יונ-82,08:02,0,84,79.03958333,Days,PD,Efficacy marker,23.221,.,mm,.,.,.,.,.,.,1,7015,2338.333333,999
.,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,26-יונ-82,07:05,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7015,2338.333333,999
.,ZY300707015,Z,Y3,Profiling Study 1,1,0,7,7015,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,23-יול-82,15:32,0,112,111.3520833,Days,PD,Efficacy marker,23.504,.,mm,.,.,.,.,.,.,1,7015,2338.333333,999
.,ZY300707018,Z,Y3,Profiling Study 1,1,0,7,7018,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-פבר-82,07:00,0,-14,-42,Days,Demographics,Age,58,.,Years,.,.,.,.,.,.,1,7018,2339.333333,999
.,ZY300707018,Z,Y3,Profiling Study 1,1,0,7,7018,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-פבר-82,07:00,0,-14,-42,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7018,2339.333333,999
.,ZY300707018,Z,Y3,Profiling Study 1,1,0,7,7018,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-פבר-82,07:00,0,-14,-42,Days,Demographics,Weight,78.6,.,kg,.,.,.,.,.,.,1,7018,2339.333333,999
.,ZY300707018,Z,Y3,Profiling Study 1,1,0,7,7018,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,03-אפר-82,18:12,0,0,-4.533333333,Days,PD,Efficacy marker,32.892,.,mm,.,.,.,.,.,.,1,7018,2339.333333,999
.,ZY300707018,Z,Y3,Profiling Study 1,1,0,7,7018,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,07-אפר-82,07:00,0,0,-1,Days,Demographics,Weight,78.5,.,kg,.,.,.,.,.,.,1,7018,2339.333333,999
.,ZY300707018,Z,Y3,Profiling Study 1,1,0,7,7018,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-פבר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,7018,2339.333333,999
.,ZY300707018,Z,Y3,Profiling Study 1,1,0,7,7018,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-אפר-82,06:45,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,7018,2339.333333,999
.,ZY300707018,Z,Y3,Profiling Study 1,1,0,7,7018,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-אפר-82,07:00,0.083333333,0,0,Days,Dose,Dose Z,397.5,.,mg,.,.,iv,.,.,.,1,7018,2339.333333,999
.,ZY300707018,Z,Y3,Profiling Study 1,1,0,7,7018,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-אפר-82,09:19,0,0.0833,0.096527778,Days,PK,Plasma concentration Z,483.999,.,ug/ml,.,0.8,.,.,.,.,1,7018,2339.333333,999
.,ZY300707018,Z,Y3,Profiling Study 1,1,0,7,7018,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-פבר-82,07:00,0,12,13.96242827,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,7018,2339.333333,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-פבר-82,07:00,0,-14,-42.00347222,Days,Demographics,Age,64,.,Years,.,.,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-פבר-82,07:00,0,-14,-42.00347222,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-פבר-82,07:00,0,-14,-42.00347222,Days,Demographics,Weight,80.2,.,kg,.,.,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,03-אפר-82,18:40,0,0,-4.517361111,Days,PD,Efficacy marker,28.048,.,mm,.,.,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,07-אפר-82,07:00,0,0,-1.003472222,Days,Demographics,Weight,81.9,.,kg,.,.,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-פבר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-אפר-82,06:50,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-אפר-82,07:05,0.083333333,0,0,Days,Dose,Dose Z,410.5,.,mg,.,.,iv,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-אפר-82,09:22,0,0.0833,0.095138889,Days,PK,Plasma concentration Z,597.999,.,ug/ml,.,0.8,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-פבר-82,07:00,0,12,14.57063949,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-מאי-82,15:19,0,28,23.34305556,Days,PD,Efficacy marker,30.802,.,mm,.,.,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-מאי-82,06:50,0,28,27.98958333,Days,PK,Plasma concentration Z,47.199,.,ug/ml,.,0.8,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-מאי-82,07:05,0.083333333,28,28,Days,Dose,Dose Z,414.5,.,mg,.,.,iv,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-מאי-82,09:13,0,28,28.08888889,Days,PK,Plasma concentration Z,600,.,ug/ml,.,0.8,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-מאי-82,14:56,0,56,51.32708333,Days,PD,Efficacy marker,31.284,.,mm,.,.,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-יונ-82,06:50,0,56,55.98958333,Days,PK,Plasma concentration Z,53.601,.,ug/ml,.,0.8,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-יונ-82,07:05,0.083333333,56,56,Days,Dose,Dose Z,414.5,.,mg,.,.,iv,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-יונ-82,09:00,0,56,56.07986111,Days,PK,Plasma concentration Z,687.999,.,ug/ml,.,0.8,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-יונ-82,16:11,0,84,79.37916667,Days,PD,Efficacy marker,31.897,.,mm,.,.,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-יול-82,06:50,0,84,83.98958333,Days,PK,Plasma concentration Z,75,.,ug/ml,.,0.8,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-יול-82,07:05,0.083333333,84,84,Days,Dose,Dose Z,414,.,mg,.,.,iv,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-יול-82,09:16,0,84,84.09097222,Days,PK,Plasma concentration Z,654,.,ug/ml,.,0.8,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-יול-82,11:05,0,84,84.16666667,Days,PK,Plasma concentration Z,672,.,ug/ml,.,0.8,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-יול-82,13:05,0,84,84.25,Days,PK,Plasma concentration Z,614.001,.,ug/ml,.,0.8,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,08-יול-82,07:05,0,91,91,Days,PK,Plasma concentration Z,191.601,.,ug/ml,.,0.8,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,15-יול-82,07:05,0,98,98,Days,PK,Plasma concentration Z,130.2,.,ug/ml,.,0.8,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,28-יול-82,15:50,0,112,111.3645833,Days,PD,Efficacy marker,32.082,.,mm,.,.,.,.,.,.,1,7019,2339.666667,999
.,ZY300707019,Z,Y3,Profiling Study 1,1,0,7,7019,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,29-יול-82,07:05,0,112,112,Days,PK,Plasma concentration Z,84.399,.,ug/ml,.,0.8,.,.,.,.,1,7019,2339.666667,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-פבר-82,07:00,0,-14,-42.10763889,Days,Demographics,Age,70,.,Years,.,.,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-פבר-82,07:00,0,-14,-42.10763889,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-פבר-82,07:00,0,-14,-42.10763889,Days,Demographics,Weight,73.6,.,kg,.,.,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,03-אפר-82,16:31,0,0,-4.711111111,Days,PD,Efficacy marker,39.146,.,mm,.,.,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,07-אפר-82,07:00,0,0,-1.107638889,Days,Demographics,Weight,75,.,kg,.,.,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-פבר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-אפר-82,09:05,0,0,-0.020833333,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-אפר-82,09:35,0.083333333,0,0,Days,Dose,Dose Z,380.5,.,mg,.,.,iv,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-אפר-82,11:48,0,0.0833,0.092361111,Days,PK,Plasma concentration Z,534,.,ug/ml,.,0.8,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,25-פבר-82,07:00,0,12,13.73314153,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-מאי-82,16:52,0,28,23.30347222,Days,PD,Efficacy marker,41.15,.,mm,.,.,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-מאי-82,07:10,0,28,27.89930556,Days,PK,Plasma concentration Z,26.199,.,ug/ml,.,0.8,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-מאי-82,07:20,0.083333333,28,27.90625,Days,Dose,Dose Z,389,.,mg,.,.,iv,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-מאי-82,09:34,0,28,27.99930556,Days,PK,Plasma concentration Z,530.001,.,ug/ml,.,0.8,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-מאי-82,15:03,0,56,51.22777778,Days,PD,Efficacy marker,43.116,.,mm,.,.,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-יונ-82,07:05,0,56,55.89583333,Days,PK,Plasma concentration Z,35.601,.,ug/ml,.,0.8,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-יונ-82,07:20,0.083333333,56,55.90625,Days,Dose,Dose Z,396,.,mg,.,.,iv,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-יונ-82,09:36,0,56,56.00069444,Days,PK,Plasma concentration Z,576,.,ug/ml,.,0.8,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-יונ-82,16:39,0,84,79.29444444,Days,PD,Efficacy marker,44.212,.,mm,.,.,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-יול-82,07:05,0,84,83.89583333,Days,PK,Plasma concentration Z,46.599,.,ug/ml,.,0.8,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-יול-82,07:20,0.083333333,84,83.90625,Days,Dose,Dose Z,395.5,.,mg,.,.,iv,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-יול-82,09:37,0,84,84.00138889,Days,PK,Plasma concentration Z,588,.,ug/ml,.,0.8,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-יול-82,11:20,0,84,84.07291667,Days,PK,Plasma concentration Z,602.001,.,ug/ml,.,0.8,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-יול-82,13:20,0,84,84.15625,Days,PK,Plasma concentration Z,519.999,.,ug/ml,.,0.8,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,08-יול-82,07:20,0,91,90.90625,Days,PK,Plasma concentration Z,151.401,.,ug/ml,.,0.8,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,15-יול-82,07:20,0,98,97.90625,Days,PK,Plasma concentration Z,91.599,.,ug/ml,.,0.8,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,28-יול-82,15:19,0,112,111.2388889,Days,PD,Efficacy marker,43.91,.,mm,.,.,.,.,.,.,1,7021,2340.333333,999
.,ZY300707021,Z,Y3,Profiling Study 1,1,0,7,7021,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,29-יול-82,07:20,0,112,111.90625,Days,PK,Plasma concentration Z,58.2,.,ug/ml,.,0.8,.,.,.,.,1,7021,2340.333333,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,13-מרץ-82,07:00,0,-14,-27,Days,Demographics,Age,60,.,Years,.,.,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,13-מרץ-82,07:00,0,-14,-27,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,13-מרץ-82,07:00,0,-14,-27,Days,Demographics,Weight,71.8,.,kg,.,.,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,04-אפר-82,15:52,0,0,-4.630555556,Days,PD,Efficacy marker,42.368,.,mm,.,.,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,08-אפר-82,07:00,0,0,-1,Days,Demographics,Weight,72.6,.,kg,.,.,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,13-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,09-אפר-82,06:45,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,09-אפר-82,07:00,0.083333333,0,0,Days,Dose,Dose Z,365,.,mg,.,.,iv,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,09-אפר-82,09:14,0,0.0833,0.093055556,Days,PK,Plasma concentration Z,458.001,.,ug/ml,.,0.8,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,13-מרץ-82,07:00,0,12,13.20456407,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,02-מאי-82,15:33,0,28,23.35625,Days,PD,Efficacy marker,44.161,.,mm,.,.,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-מאי-82,06:45,0,28,27.98958333,Days,PK,Plasma concentration Z,32.4,.,ug/ml,.,0.8,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-מאי-82,07:00,0.083333333,28,28,Days,Dose,Dose Z,371.5,.,mg,.,.,iv,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-מאי-82,09:18,0,28,28.09583333,Days,PK,Plasma concentration Z,440.001,.,ug/ml,.,0.8,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,30-מאי-82,15:44,0,56,51.36388889,Days,PD,Efficacy marker,44.998,.,mm,.,.,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,04-יונ-82,06:49,0,56,55.99236111,Days,PK,Plasma concentration Z,45.201,.,ug/ml,.,0.8,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,04-יונ-82,07:00,0.083333333,56,56,Days,Dose,Dose Z,369,.,mg,.,.,iv,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,04-יונ-82,09:14,0,56,56.09305556,Days,PK,Plasma concentration Z,537.999,.,ug/ml,.,0.8,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,27-יונ-82,15:47,0,84,79.36597222,Days,PD,Efficacy marker,45.924,.,mm,.,.,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-יול-82,06:45,0,84,83.98958333,Days,PK,Plasma concentration Z,59.4,.,ug/ml,.,0.8,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-יול-82,07:00,0.083333333,84,84,Days,Dose,Dose Z,364,.,mg,.,.,iv,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-יול-82,09:15,0,84,84.09375,Days,PK,Plasma concentration Z,494.001,.,ug/ml,.,0.8,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-יול-82,11:00,0,84,84.16666667,Days,PK,Plasma concentration Z,495.999,.,ug/ml,.,0.8,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-יול-82,13:00,0,84,84.25,Days,PK,Plasma concentration Z,453.999,.,ug/ml,.,0.8,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,09-יול-82,07:00,0,91,91,Days,PK,Plasma concentration Z,95.001,.,ug/ml,.,0.8,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,16-יול-82,07:00,0,98,98,Days,PK,Plasma concentration Z,103.599,.,ug/ml,.,0.8,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,29-יול-82,17:14,0,112,111.4263889,Days,PD,Efficacy marker,47.218,.,mm,.,.,.,.,.,.,1,7025,2341.666667,999
.,ZY300707025,Z,Y3,Profiling Study 1,1,0,7,7025,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,30-יול-82,07:00,0,112,112,Days,PK,Plasma concentration Z,76.401,.,ug/ml,.,0.8,.,.,.,.,1,7025,2341.666667,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,14-מרץ-82,07:00,0,-14,-25.00694444,Days,Demographics,Age,63,.,Years,.,.,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,14-מרץ-82,07:00,0,-14,-25.00694444,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,14-מרץ-82,07:00,0,-14,-25.00694444,Days,Demographics,Weight,60.1,.,kg,.,.,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,03-אפר-82,19:09,0,0,-4.500694444,Days,PD,Efficacy marker,24.234,.,mm,.,.,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,07-אפר-82,07:00,0,0,-1.006944444,Days,Demographics,Weight,59.7,.,kg,.,.,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,14-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-אפר-82,06:55,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-אפר-82,07:10,0.083333333,0,0,Days,Dose,Dose Z,303,.,mg,.,.,iv,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,08-אפר-82,09:22,0,0.0833,0.091666667,Days,PK,Plasma concentration Z,524.001,.,ug/ml,.,0.8,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,14-מרץ-82,07:00,0,12,13.63352434,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-מאי-82,17:28,0,28,23.42916667,Days,PD,Efficacy marker,24.848,.,mm,.,.,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-מאי-82,06:55,0,28,27.98958333,Days,PK,Plasma concentration Z,39.6,.,ug/ml,.,0.8,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-מאי-82,07:10,0.083333333,28,28,Days,Dose,Dose Z,300.5,.,mg,.,.,iv,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,06-מאי-82,09:23,0,28,28.09236111,Days,PK,Plasma concentration Z,474,.,ug/ml,.,0.8,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-מאי-82,16:05,0,56,51.37152778,Days,PD,Efficacy marker,25.704,.,mm,.,.,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-יונ-82,06:55,0,56,55.98958333,Days,PK,Plasma concentration Z,63.6,.,ug/ml,.,0.8,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-יונ-82,07:10,0.083333333,56,56,Days,Dose,Dose Z,304.5,.,mg,.,.,iv,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,03-יונ-82,09:24,0,56,56.09305556,Days,PK,Plasma concentration Z,570,.,ug/ml,.,0.8,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-יונ-82,15:43,0,84,79.35625,Days,PD,Efficacy marker,26.208,.,mm,.,.,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-יול-82,06:55,0,84,83.98958333,Days,PK,Plasma concentration Z,93.6,.,ug/ml,.,0.8,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-יול-82,07:10,0.083333333,84,84,Days,Dose,Dose Z,304,.,mg,.,.,iv,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-יול-82,09:27,0,84,84.09513889,Days,PK,Plasma concentration Z,590.001,.,ug/ml,.,0.8,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-יול-82,11:10,0,84,84.16666667,Days,PK,Plasma concentration Z,596.001,.,ug/ml,.,0.8,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-יול-82,13:10,0,84,84.25,Days,PK,Plasma concentration Z,483.999,.,ug/ml,.,0.8,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,08-יול-82,07:10,0,91,91,Days,PK,Plasma concentration Z,201.999,.,ug/ml,.,0.8,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,15-יול-82,07:10,0,98,98,Days,PK,Plasma concentration Z,135.801,.,ug/ml,.,0.8,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,28-יול-82,17:24,0,112,111.4263889,Days,PD,Efficacy marker,26.253,.,mm,.,.,.,.,.,.,1,7029,2343,999
.,ZY300707029,Z,Y3,Profiling Study 1,1,0,7,7029,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,29-יול-82,07:10,0,112,112,Days,PK,Plasma concentration Z,78.399,.,ug/ml,.,0.8,.,.,.,.,1,7029,2343,999
.,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,14-מרץ-82,07:00,0,-14,-25.01041667,Days,Demographics,Age,55,.,Years,.,.,.,.,.,.,1,7030,2343.333333,999
.,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,14-מרץ-82,07:00,0,-14,-25.01041667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7030,2343.333333,999
.,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,14-מרץ-82,07:00,0,-14,-25.01041667,Days,Demographics,Weight,72,.,kg,.,.,.,.,.,.,1,7030,2343.333333,999
.,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,03-אפר-82,19:37,0,0,-4.484722222,Days,PD,Efficacy marker,28.049,.,mm,.,.,.,.,.,.,1,7030,2343.333333,999
.,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,07-אפר-82,07:00,0,0,-1.010416667,Days,Demographics,Weight,72.2,.,kg,.,.,.,.,.,.,1,7030,2343.333333,999
.,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,14-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,7030,2343.333333,999
.,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,08-אפר-82,07:15,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7030,2343.333333,999
.,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,14-מרץ-82,07:00,0,12,14.45108171,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,7030,2343.333333,999
.,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,01-מאי-82,18:23,0,28,23.46388889,Days,PD,Efficacy marker,28.244,.,mm,.,.,.,.,.,.,1,7030,2343.333333,999
.,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,06-מאי-82,07:15,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7030,2343.333333,999
.,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,29-מאי-82,17:22,0,56,51.42152778,Days,PD,Efficacy marker,27.725,.,mm,.,.,.,.,.,.,1,7030,2343.333333,999
.,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,03-יונ-82,07:15,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7030,2343.333333,999
.,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,26-יונ-82,17:31,0,84,79.42777778,Days,PD,Efficacy marker,28.35,.,mm,.,.,.,.,.,.,1,7030,2343.333333,999
.,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,01-יול-82,07:15,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7030,2343.333333,999
.,ZY300707030,Z,Y3,Profiling Study 1,1,0,7,7030,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,28-יול-82,15:49,0,112,111.3569444,Days,PD,Efficacy marker,28.764,.,mm,.,.,.,.,.,.,1,7030,2343.333333,999
.,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,14-מרץ-82,07:00,0,-14,-32,Days,Demographics,Age,72,.,Years,.,.,.,.,.,.,1,7033,2344.333333,999
.,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,14-מרץ-82,07:00,0,-14,-32,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,7033,2344.333333,999
.,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,14-מרץ-82,07:00,0,-14,-32,Days,Demographics,Weight,77.6,.,kg,.,.,.,.,.,.,1,7033,2344.333333,999
.,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,10-אפר-82,14:52,0,0,-4.672222222,Days,PD,Efficacy marker,43.842,.,mm,.,.,.,.,.,.,1,7033,2344.333333,999
.,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,14-אפר-82,07:00,0,0,-1,Days,Demographics,Weight,77.6,.,kg,.,.,.,.,.,.,1,7033,2344.333333,999
.,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,14-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,7033,2344.333333,999
.,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,15-אפר-82,07:00,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7033,2344.333333,999
.,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,14-מרץ-82,07:00,0,12,14.00312788,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,7033,2344.333333,999
.,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,08-מאי-82,16:18,0,28,23.3875,Days,PD,Efficacy marker,44.879,.,mm,.,.,.,.,.,.,1,7033,2344.333333,999
.,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,13-מאי-82,07:00,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7033,2344.333333,999
.,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,05-יונ-82,15:10,0,56,51.34027778,Days,PD,Efficacy marker,44.502,.,mm,.,.,.,.,.,.,1,7033,2344.333333,999
.,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,10-יונ-82,07:00,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7033,2344.333333,999
.,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,03-יול-82,15:13,0,84,79.34236111,Days,PD,Efficacy marker,44.474,.,mm,.,.,.,.,.,.,1,7033,2344.333333,999
.,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,08-יול-82,07:03,0.083333333,84,84.00208333,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7033,2344.333333,999
.,ZY300707033,Z,Y3,Profiling Study 1,1,0,7,7033,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,09-אוג-82,14:21,0,112,116.30625,Days,PD,Efficacy marker,43.879,.,mm,.,.,.,.,.,.,1,7033,2344.333333,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-מרץ-82,07:00,0,-14,-29.09375,Days,Demographics,Age,58,.,Years,.,.,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-מרץ-82,07:00,0,-14,-29.09375,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-מרץ-82,07:00,0,-14,-29.09375,Days,Demographics,Weight,75.1,.,kg,.,.,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,10-אפר-82,15:24,0,0,-4.74375,Days,PD,Efficacy marker,37.907,.,mm,.,.,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,14-אפר-82,07:00,0,0,-1.09375,Days,Demographics,Weight,75.2,.,kg,.,.,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,15-אפר-82,08:32,0,0,-0.029861111,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,15-אפר-82,09:15,0.083333333,0,0,Days,Dose,Dose Z,380,.,mg,.,.,iv,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,15-אפר-82,11:26,0,0.0833,0.090972222,Days,PK,Plasma concentration Z,483.999,.,ug/ml,.,0.8,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-מרץ-82,07:00,0,12,13.34296487,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,08-מאי-82,17:21,0,28,23.3375,Days,PD,Efficacy marker,40.012,.,mm,.,.,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,13-מאי-82,07:00,0,28,27.90625,Days,PK,Plasma concentration Z,23.199,.,ug/ml,.,0.8,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,13-מאי-82,07:15,0.083333333,28,27.91666667,Days,Dose,Dose Z,386.5,.,mg,.,.,iv,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,13-מאי-82,09:28,0,28,28.00902778,Days,PK,Plasma concentration Z,564,.,ug/ml,.,0.8,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,05-יונ-82,15:38,0,56,51.26597222,Days,PD,Efficacy marker,41.462,.,mm,.,.,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,10-יונ-82,07:00,0,56,55.90625,Days,PK,Plasma concentration Z,38.4,.,ug/ml,.,0.8,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,10-יונ-82,07:15,0.083333333,56,55.91666667,Days,Dose,Dose Z,385,.,mg,.,.,iv,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,10-יונ-82,09:30,0,56,56.01041667,Days,PK,Plasma concentration Z,518.001,.,ug/ml,.,0.8,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,03-יול-82,15:55,0,84,79.27777778,Days,PD,Efficacy marker,43.362,.,mm,.,.,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-יול-82,07:00,0,84,83.90625,Days,PK,Plasma concentration Z,42.399,.,ug/ml,.,0.8,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-יול-82,07:15,0.083333333,84,83.91666667,Days,Dose,Dose Z,384,.,mg,.,.,iv,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-יול-82,09:31,0,84,84.01111111,Days,PK,Plasma concentration Z,554.001,.,ug/ml,.,0.8,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-יול-82,11:15,0,84,84.08333333,Days,PK,Plasma concentration Z,567.999,.,ug/ml,.,0.8,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-יול-82,13:15,0,84,84.16666667,Days,PK,Plasma concentration Z,537.999,.,ug/ml,.,0.8,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,15-יול-82,07:15,0,91,90.91666667,Days,PK,Plasma concentration Z,153,.,ug/ml,.,0.8,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,22-יול-82,07:15,0,98,97.91666667,Days,PK,Plasma concentration Z,87.801,.,ug/ml,.,0.8,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,05-אוג-82,07:15,0,112,111.9166667,Days,PK,Plasma concentration Z,45.201,.,ug/ml,.,0.8,.,.,.,.,1,7034,2344.666667,999
.,ZY300707034,Z,Y3,Profiling Study 1,1,0,7,7034,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,05-אוג-82,14:46,0,112,112.2298611,Days,PD,Efficacy marker,42.476,.,mm,.,.,.,.,.,.,1,7034,2344.666667,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-מרץ-82,07:00,0,-14,-29.00347222,Days,Demographics,Age,54,.,Years,.,.,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-מרץ-82,07:00,0,-14,-29.00347222,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-מרץ-82,07:00,0,-14,-29.00347222,Days,Demographics,Weight,66.4,.,kg,.,.,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,10-אפר-82,15:53,0,0,-4.633333333,Days,PD,Efficacy marker,19.066,.,mm,.,.,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,14-אפר-82,07:00,0,0,-1.003472222,Days,Demographics,Weight,66.3,.,kg,.,.,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,15-אפר-82,07:05,0.083333333,0,0,Days,Dose,Dose Z,332.5,.,mg,.,.,iv,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,15-אפר-82,07:07,0,0,0.001388889,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,15-אפר-82,09:18,0,0.0833,0.092361111,Days,PK,Plasma concentration Z,603.999,.,ug/ml,.,0.8,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-מרץ-82,07:00,0,12,14.19642015,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,08-מאי-82,18:00,0,28,23.45486111,Days,PD,Efficacy marker,19.517,.,mm,.,.,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,13-מאי-82,06:50,0,28,27.98958333,Days,PK,Plasma concentration Z,37.2,.,ug/ml,.,0.8,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,13-מאי-82,07:05,0.083333333,28,28,Days,Dose,Dose Z,336.5,.,mg,.,.,iv,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,13-מאי-82,09:26,0,28,28.09791667,Days,PK,Plasma concentration Z,639.999,.,ug/ml,.,0.8,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,05-יונ-82,18:18,0,56,51.46736111,Days,PD,Efficacy marker,19.787,.,mm,.,.,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,10-יונ-82,06:53,0,56,55.99166667,Days,PK,Plasma concentration Z,58.8,.,ug/ml,.,0.8,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,10-יונ-82,07:11,0.083333333,56,56.00416667,Days,Dose,Dose Z,333,.,mg,.,.,iv,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,10-יונ-82,09:29,0,56,56.1,Days,PK,Plasma concentration Z,690,.,ug/ml,.,0.8,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,03-יול-82,17:41,0,84,79.44166667,Days,PD,Efficacy marker,19.699,.,mm,.,.,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-יול-82,06:50,0,84,83.98958333,Days,PK,Plasma concentration Z,63.399,.,ug/ml,.,0.8,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-יול-82,07:06,0.083333333,84,84.00069444,Days,Dose,Dose Z,321,.,mg,.,.,iv,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-יול-82,09:23,0,84,84.09583333,Days,PK,Plasma concentration Z,656.001,.,ug/ml,.,0.8,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-יול-82,11:05,0,84,84.16666667,Days,PK,Plasma concentration Z,732,.,ug/ml,.,0.8,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,08-יול-82,13:05,0,84,84.25,Days,PK,Plasma concentration Z,686.001,.,ug/ml,.,0.8,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,18-יול-82,07:52,0,91,94.03263889,Days,PK,Plasma concentration Z,150.399,.,ug/ml,.,0.8,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,22-יול-82,07:05,0,98,98,Days,PK,Plasma concentration Z,160.2,.,ug/ml,.,0.8,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,05-אוג-82,07:25,0,112,112.0138889,Days,PK,Plasma concentration Z,77.001,.,ug/ml,.,0.8,.,.,.,.,1,7035,2345,999
.,ZY300707035,Z,Y3,Profiling Study 1,1,0,7,7035,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,05-אוג-82,16:09,0,112,112.3777778,Days,PD,Efficacy marker,19.748,.,mm,.,.,.,.,.,.,1,7035,2345,999
.,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-מרץ-82,07:00,0,-14,-23.00347222,Days,Demographics,Age,56,.,Years,.,.,.,.,.,.,1,7036,2345.333333,999
.,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-מרץ-82,07:00,0,-14,-23.00347222,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7036,2345.333333,999
.,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-מרץ-82,07:00,0,-14,-23.00347222,Days,Demographics,Weight,53,.,kg,.,.,.,.,.,.,1,7036,2345.333333,999
.,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,04-אפר-82,16:23,0,0,-4.6125,Days,PD,Efficacy marker,24.703,.,mm,.,.,.,.,.,.,1,7036,2345.333333,999
.,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,08-אפר-82,07:00,0,0,-1.003472222,Days,Demographics,Weight,53.8,.,kg,.,.,.,.,.,.,1,7036,2345.333333,999
.,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,7036,2345.333333,999
.,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,09-אפר-82,07:05,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7036,2345.333333,999
.,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-מרץ-82,07:00,0,12,13.18792224,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,7036,2345.333333,999
.,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,02-מאי-82,16:02,0,28,23.37291667,Days,PD,Efficacy marker,24.934,.,mm,.,.,.,.,.,.,1,7036,2345.333333,999
.,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,07-מאי-82,07:05,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7036,2345.333333,999
.,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,03-יונ-82,16:01,0,56,55.37222222,Days,PD,Efficacy marker,25.656,.,mm,.,.,.,.,.,.,1,7036,2345.333333,999
.,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,04-יונ-82,07:05,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7036,2345.333333,999
.,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,27-יונ-82,15:12,0,84,79.33819444,Days,PD,Efficacy marker,25.636,.,mm,.,.,.,.,.,.,1,7036,2345.333333,999
.,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,02-יול-82,07:05,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7036,2345.333333,999
.,ZY300707036,Z,Y3,Profiling Study 1,1,0,7,7036,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,29-יול-82,17:39,0,112,111.4402778,Days,PD,Efficacy marker,26.156,.,mm,.,.,.,.,.,.,1,7036,2345.333333,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-מרץ-82,07:00,0,-14,-23.00694444,Days,Demographics,Age,54,.,Years,.,.,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-מרץ-82,07:00,0,-14,-23.00694444,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-מרץ-82,07:00,0,-14,-23.00694444,Days,Demographics,Weight,60.2,.,kg,.,.,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,04-אפר-82,16:47,0,0,-4.599305556,Days,PD,Efficacy marker,25.115,.,mm,.,.,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,08-אפר-82,07:00,0,0,-1.006944444,Days,Demographics,Weight,59.7,.,kg,.,.,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,09-אפר-82,06:55,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,09-אפר-82,07:10,0.083333333,0,0,Days,Dose,Dose Z,301.5,.,mg,.,.,iv,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,09-אפר-82,09:26,0,0.0833,0.094444444,Days,PK,Plasma concentration Z,495.999,.,ug/ml,.,0.8,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,17-מרץ-82,07:00,0,12,13.10315384,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,02-מאי-82,17:08,0,28,23.41527778,Days,PD,Efficacy marker,28.244,.,mm,.,.,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-מאי-82,06:55,0,28,27.98958333,Days,PK,Plasma concentration Z,31.401,.,ug/ml,.,0.8,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-מאי-82,07:10,0.083333333,28,28,Days,Dose,Dose Z,307.5,.,mg,.,.,iv,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-מאי-82,09:23,0,28,28.09236111,Days,PK,Plasma concentration Z,462,.,ug/ml,.,0.8,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,30-מאי-82,18:05,0,56,51.45486111,Days,PD,Efficacy marker,28.889,.,mm,.,.,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,04-יונ-82,06:57,0,56,55.99097222,Days,PK,Plasma concentration Z,45.6,.,ug/ml,.,0.8,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,04-יונ-82,07:10,0.083333333,56,56,Days,Dose,Dose Z,309,.,mg,.,.,iv,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,04-יונ-82,09:27,0,56,56.09513889,Days,PK,Plasma concentration Z,519.999,.,ug/ml,.,0.8,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,27-יונ-82,16:22,0,84,79.38333333,Days,PD,Efficacy marker,30.74,.,mm,.,.,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-יול-82,06:55,0,84,83.98958333,Days,PK,Plasma concentration Z,51.999,.,ug/ml,.,0.8,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-יול-82,07:10,0.083333333,84,84,Days,Dose,Dose Z,314,.,mg,.,.,iv,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-יול-82,09:24,0,84,84.09305556,Days,PK,Plasma concentration Z,531.999,.,ug/ml,.,0.8,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-יול-82,11:10,0,84,84.16666667,Days,PK,Plasma concentration Z,519.999,.,ug/ml,.,0.8,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-יול-82,13:10,0,84,84.25,Days,PK,Plasma concentration Z,525.999,.,ug/ml,.,0.8,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,09-יול-82,07:10,0,91,91,Days,PK,Plasma concentration Z,155.601,.,ug/ml,.,0.8,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,16-יול-82,07:10,0,98,98,Days,PK,Plasma concentration Z,111,.,ug/ml,.,0.8,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,30-יול-82,07:10,0,112,112,Days,PK,Plasma concentration Z,63.201,.,ug/ml,.,0.8,.,.,.,.,1,7038,2346,999
.,ZY300707038,Z,Y3,Profiling Study 1,1,0,7,7038,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,01-אוג-82,17:29,0,112,114.4298611,Days,PD,Efficacy marker,30.059,.,mm,.,.,.,.,.,.,1,7038,2346,999
.,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-מרץ-82,07:00,0,-14,-23.01041667,Days,Demographics,Age,52,.,Years,.,.,.,.,.,.,1,7039,2346.333333,999
.,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-מרץ-82,07:00,0,-14,-23.01041667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7039,2346.333333,999
.,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-מרץ-82,07:00,0,-14,-23.01041667,Days,Demographics,Weight,63.2,.,kg,.,.,.,.,.,.,1,7039,2346.333333,999
.,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,04-אפר-82,17:21,0,0,-4.579166667,Days,PD,Efficacy marker,26.688,.,mm,.,.,.,.,.,.,1,7039,2346.333333,999
.,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,08-אפר-82,07:00,0,0,-1.010416667,Days,Demographics,Weight,62.8,.,kg,.,.,.,.,.,.,1,7039,2346.333333,999
.,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,7039,2346.333333,999
.,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,09-אפר-82,07:15,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7039,2346.333333,999
.,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-מרץ-82,07:00,0,12,14.63902753,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7039,2346.333333,999
.,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,02-מאי-82,17:48,0,28,23.43958333,Days,PD,Efficacy marker,28.016,.,mm,.,.,.,.,.,.,1,7039,2346.333333,999
.,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,07-מאי-82,07:15,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7039,2346.333333,999
.,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,30-מאי-82,17:39,0,56,51.43333333,Days,PD,Efficacy marker,27.117,.,mm,.,.,.,.,.,.,1,7039,2346.333333,999
.,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,04-יונ-82,07:15,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7039,2346.333333,999
.,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,27-יונ-82,16:58,0,84,79.40486111,Days,PD,Efficacy marker,27.019,.,mm,.,.,.,.,.,.,1,7039,2346.333333,999
.,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,02-יול-82,07:15,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7039,2346.333333,999
.,ZY300707039,Z,Y3,Profiling Study 1,1,0,7,7039,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,29-יול-82,18:52,0,112,111.4840278,Days,PD,Efficacy marker,27.575,.,mm,.,.,.,.,.,.,1,7039,2346.333333,999
.,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-מרץ-82,07:00,0,-14,-29.00694444,Days,Demographics,Age,55,.,Years,.,.,.,.,.,.,1,7040,2346.666667,999
.,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-מרץ-82,07:00,0,-14,-29.00694444,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7040,2346.666667,999
.,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-מרץ-82,07:00,0,-14,-29.00694444,Days,Demographics,Weight,57.8,.,kg,.,.,.,.,.,.,1,7040,2346.666667,999
.,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,10-אפר-82,16:24,0,0,-4.615277778,Days,PD,Efficacy marker,26.422,.,mm,.,.,.,.,.,.,1,7040,2346.666667,999
.,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,14-אפר-82,07:00,0,0,-1.006944444,Days,Demographics,Weight,58.3,.,kg,.,.,.,.,.,.,1,7040,2346.666667,999
.,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7040,2346.666667,999
.,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,15-אפר-82,07:10,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7040,2346.666667,999
.,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-מרץ-82,07:00,0,12,13.34311471,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,7040,2346.666667,999
.,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,08-מאי-82,18:23,0,28,23.46736111,Days,PD,Efficacy marker,27.295,.,mm,.,.,.,.,.,.,1,7040,2346.666667,999
.,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,13-מאי-82,07:10,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7040,2346.666667,999
.,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,05-יונ-82,16:04,0,56,51.37083333,Days,PD,Efficacy marker,26.804,.,mm,.,.,.,.,.,.,1,7040,2346.666667,999
.,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,10-יונ-82,07:10,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7040,2346.666667,999
.,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,03-יול-82,16:39,0,84,79.39513889,Days,PD,Efficacy marker,27.263,.,mm,.,.,.,.,.,.,1,7040,2346.666667,999
.,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,08-יול-82,07:10,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7040,2346.666667,999
.,ZY300707040,Z,Y3,Profiling Study 1,1,0,7,7040,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,05-אוג-82,16:35,0,112,112.3923611,Days,PD,Efficacy marker,28.114,.,mm,.,.,.,.,.,.,1,7040,2346.666667,999
.,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,26-מרץ-82,07:00,0,-14,-21.00694444,Days,Demographics,Age,53,.,Years,.,.,.,.,.,.,1,7044,2348,999
.,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,26-מרץ-82,07:00,0,-14,-21.00694444,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7044,2348,999
.,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,26-מרץ-82,07:00,0,-14,-21.00694444,Days,Demographics,Weight,56.9,.,kg,.,.,.,.,.,.,1,7044,2348,999
.,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,11-אפר-82,17:44,0,0,-4.559722222,Days,PD,Efficacy marker,24.367,.,mm,.,.,.,.,.,.,1,7044,2348,999
.,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,15-אפר-82,07:00,0,0,-1.006944444,Days,Demographics,Weight,57,.,kg,.,.,.,.,.,.,1,7044,2348,999
.,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,26-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,7044,2348,999
.,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,16-אפר-82,07:10,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7044,2348,999
.,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,26-מרץ-82,07:00,0,12,13.66248877,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7044,2348,999
.,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,09-מאי-82,16:02,0,28,23.36944444,Days,PD,Efficacy marker,24.365,.,mm,.,.,.,.,.,.,1,7044,2348,999
.,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,14-מאי-82,07:10,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7044,2348,999
.,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,09-יונ-82,18:52,0,56,54.4875,Days,PD,Efficacy marker,24.332,.,mm,.,.,.,.,.,.,1,7044,2348,999
.,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,11-יונ-82,07:10,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7044,2348,999
.,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,04-יול-82,15:43,0,84,79.35625,Days,PD,Efficacy marker,24.788,.,mm,.,.,.,.,.,.,1,7044,2348,999
.,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,09-יול-82,07:12,0.083333333,84,84.00138889,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7044,2348,999
.,ZY300707044,Z,Y3,Profiling Study 1,1,0,7,7044,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,06-אוג-82,16:36,0,112,112.3930556,Days,PD,Efficacy marker,25.079,.,mm,.,.,.,.,.,.,1,7044,2348,999
.,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,26-מרץ-82,07:00,0,-14,-21,Days,Demographics,Age,54,.,Years,.,.,.,.,.,.,1,7045,2348.333333,999
.,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,26-מרץ-82,07:00,0,-14,-21,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,7045,2348.333333,999
.,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,26-מרץ-82,07:00,0,-14,-21,Days,Demographics,Weight,73.6,.,kg,.,.,.,.,.,.,1,7045,2348.333333,999
.,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,12-אפר-82,07:34,0,0,-3.976388889,Days,PD,Efficacy marker,40,.,mm,.,.,.,.,.,.,1,7045,2348.333333,999
.,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,15-אפר-82,07:00,0,0,-1,Days,Demographics,Weight,73.1,.,kg,.,.,.,.,.,.,1,7045,2348.333333,999
.,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,26-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,7045,2348.333333,999
.,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,16-אפר-82,07:00,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7045,2348.333333,999
.,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,26-מרץ-82,07:00,0,12,14.95364386,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7045,2348.333333,999
.,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,14-מאי-82,07:00,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7045,2348.333333,999
.,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,11-יונ-82,07:00,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7045,2348.333333,999
.,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,19-יונ-82,16:20,0,56,64.38888889,Days,PD,Efficacy marker,42.868,.,mm,.,.,.,.,.,.,1,7045,2348.333333,999
.,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,04-יול-82,16:26,0,84,79.39305556,Days,PD,Efficacy marker,43.273,.,mm,.,.,.,.,.,.,1,7045,2348.333333,999
.,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,09-יול-82,07:00,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7045,2348.333333,999
.,ZY300707045,Z,Y3,Profiling Study 1,1,0,7,7045,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,06-אוג-82,17:02,0,112,112.4180556,Days,PD,Efficacy marker,42.414,.,mm,.,.,.,.,.,.,1,7045,2348.333333,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מרץ-82,07:00,0,-14,-20.01041667,Days,Demographics,Age,54,.,Years,.,.,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מרץ-82,07:00,0,-14,-20.01041667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מרץ-82,07:00,0,-14,-20.01041667,Days,Demographics,Weight,71.1,.,kg,.,.,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,11-אפר-82,19:53,0,0,-4.473611111,Days,PD,Efficacy marker,26.475,.,mm,.,.,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,15-אפר-82,07:00,0,0,-1.010416667,Days,Demographics,Weight,69.5,.,kg,.,.,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,16-אפר-82,07:00,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,16-אפר-82,07:15,0.083333333,0,0,Days,Dose,Dose Z,353.5,.,mg,.,.,iv,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,16-אפר-82,09:31,0,0.0833,0.094444444,Days,PK,Plasma concentration Z,584.001,.,ug/ml,.,0.8,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מרץ-82,07:00,0,12,13.32957782,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,09-מאי-82,17:41,0,28,23.43472222,Days,PD,Efficacy marker,28.667,.,mm,.,.,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,14-מאי-82,07:00,0,28,27.98958333,Days,PK,Plasma concentration Z,33.801,.,ug/ml,.,0.8,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,14-מאי-82,07:15,0.083333333,28,28,Days,Dose,Dose Z,358,.,mg,.,.,iv,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,14-מאי-82,09:28,0,28,28.09236111,Days,PK,Plasma concentration Z,582,.,ug/ml,.,0.8,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,06-יונ-82,18:07,0,56,51.45277778,Days,PD,Efficacy marker,29.85,.,mm,.,.,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,11-יונ-82,07:00,0,56,55.98958333,Days,PK,Plasma concentration Z,48.999,.,ug/ml,.,0.8,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,11-יונ-82,07:15,0.083333333,56,56,Days,Dose,Dose Z,360.5,.,mg,.,.,iv,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,11-יונ-82,09:30,0,56,56.09375,Days,PK,Plasma concentration Z,704.001,.,ug/ml,.,0.8,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,04-יול-82,14:41,0,84,79.30972222,Days,PD,Efficacy marker,31.169,.,mm,.,.,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-יול-82,07:00,0,84,83.98958333,Days,PK,Plasma concentration Z,66.999,.,ug/ml,.,0.8,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-יול-82,07:15,0.083333333,84,84,Days,Dose,Dose Z,366,.,mg,.,.,iv,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-יול-82,09:30,0,84,84.09375,Days,PK,Plasma concentration Z,723.999,.,ug/ml,.,0.8,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-יול-82,11:15,0,84,84.16666667,Days,PK,Plasma concentration Z,734.001,.,ug/ml,.,0.8,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-יול-82,13:15,0,84,84.25,Days,PK,Plasma concentration Z,663.999,.,ug/ml,.,0.8,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,16-יול-82,07:15,0,91,91,Days,PK,Plasma concentration Z,176.199,.,ug/ml,.,0.8,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,23-יול-82,07:15,0,98,98,Days,PK,Plasma concentration Z,132,.,ug/ml,.,0.8,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,06-אוג-82,07:15,0,112,112,Days,PK,Plasma concentration Z,76.8,.,ug/ml,.,0.8,.,.,.,.,1,7046,2348.666667,999
.,ZY300707046,Z,Y3,Profiling Study 1,1,0,7,7046,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,06-אוג-82,15:54,0,112,112.3604167,Days,PD,Efficacy marker,32.973,.,mm,.,.,.,.,.,.,1,7046,2348.666667,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מרץ-82,07:00,0,-14,-21.01388889,Days,Demographics,Age,51,.,Years,.,.,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מרץ-82,07:00,0,-14,-21.01388889,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מרץ-82,07:00,0,-14,-21.01388889,Days,Demographics,Weight,86.8,.,kg,.,.,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,15-אפר-82,07:00,0,0,-2.013888889,Days,Demographics,Weight,84.7,.,kg,.,.,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,15-אפר-82,18:53,0,0,-1.51875,Days,PD,Efficacy marker,32.794,.,mm,.,.,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,17-אפר-82,07:05,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,17-אפר-82,07:20,0.083333333,0,0,Days,Dose,Dose Z,422,.,mg,.,.,iv,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,17-אפר-82,09:33,0,0.0833,0.092361111,Days,PK,Plasma concentration Z,693.999,.,ug/ml,.,0.8,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מרץ-82,07:00,0,12,14.61096544,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,14-מאי-82,07:05,0,28,26.98958333,Days,PK,Plasma concentration Z,45.999,.,ug/ml,.,0.8,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,14-מאי-82,07:20,0.083333333,28,27,Days,Dose,Dose Z,428,.,mg,.,.,iv,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,14-מאי-82,09:40,0,28,27.09722222,Days,PK,Plasma concentration Z,674.001,.,ug/ml,.,0.8,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,11-יונ-82,07:05,0,56,54.98958333,Days,PK,Plasma concentration Z,67.8,.,ug/ml,.,0.8,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,11-יונ-82,07:20,0.083333333,56,55,Days,Dose,Dose Z,435,.,mg,.,.,iv,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,11-יונ-82,09:38,0,56,55.09583333,Days,PK,Plasma concentration Z,675.999,.,ug/ml,.,0.8,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,12-יונ-82,16:46,0,56,56.39305556,Days,PD,Efficacy marker,36.201,.,mm,.,.,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-יול-82,07:20,0,84,83,Days,PK,Plasma concentration Z,89.199,.,ug/ml,.,0.8,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-יול-82,07:23,0.083333333,84,83.00208333,Days,Dose,Dose Z,442.5,.,mg,.,.,iv,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-יול-82,09:37,0,84,83.09513889,Days,PK,Plasma concentration Z,776.001,.,ug/ml,.,0.8,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-יול-82,11:20,0,84,83.16666667,Days,PK,Plasma concentration Z,741.999,.,ug/ml,.,0.8,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-יול-82,13:20,0,84,83.25,Days,PK,Plasma concentration Z,651.999,.,ug/ml,.,0.8,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,10-יול-82,17:37,0,84,84.42847222,Days,PD,Efficacy marker,37.665,.,mm,.,.,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,16-יול-82,07:20,0,91,90,Days,PK,Plasma concentration Z,234,.,ug/ml,.,0.8,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,23-יול-82,07:20,0,98,97,Days,PK,Plasma concentration Z,162.801,.,ug/ml,.,0.8,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,06-אוג-82,07:20,0,112,111,Days,PK,Plasma concentration Z,103.401,.,ug/ml,.,0.8,.,.,.,.,1,7047,2349,999
.,ZY300707047,Z,Y3,Profiling Study 1,1,0,7,7047,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,06-אוג-82,15:13,0,112,111.3284722,Days,PD,Efficacy marker,37.755,.,mm,.,.,.,.,.,.,1,7047,2349,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מרץ-82,07:00,0,-14,-20.00347222,Days,Demographics,Age,53,.,Years,.,.,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מרץ-82,07:00,0,-14,-20.00347222,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מרץ-82,07:00,0,-14,-20.00347222,Days,Demographics,Weight,71,.,kg,.,.,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,11-אפר-82,18:07,0,0,-4.540277778,Days,PD,Efficacy marker,48.387,.,mm,.,.,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,15-אפר-82,07:00,0,0,-1.003472222,Days,Demographics,Weight,70.9,.,kg,.,.,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,16-אפר-82,06:50,0,0,-0.010416667,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,16-אפר-82,07:05,0.083333333,0,0,Days,Dose,Dose Z,353,.,mg,.,.,iv,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,16-אפר-82,09:23,0,0.0833,0.095833333,Days,PK,Plasma concentration Z,434.001,.,ug/ml,.,0.8,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מרץ-82,07:00,0,12,14.5456687,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,09-מאי-82,17:00,0,28,23.41319444,Days,PD,Efficacy marker,51.675,.,mm,.,.,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,14-מאי-82,06:50,0,28,27.98958333,Days,PK,Plasma concentration Z,23.4,.,ug/ml,.,0.8,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,14-מאי-82,07:05,0.083333333,28,28,Days,Dose,Dose Z,359.5,.,mg,.,.,iv,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,14-מאי-82,09:22,0,28,28.09513889,Days,PK,Plasma concentration Z,423.999,.,ug/ml,.,0.8,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,06-יונ-82,17:41,0,56,51.44166667,Days,PD,Efficacy marker,53.187,.,mm,.,.,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,11-יונ-82,06:50,0,56,55.98958333,Days,PK,Plasma concentration Z,36.6,.,ug/ml,.,0.8,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,11-יונ-82,07:05,0.083333333,56,56,Days,Dose,Dose Z,372,.,mg,.,.,iv,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,11-יונ-82,09:21,0,56,56.09444444,Days,PK,Plasma concentration Z,482.001,.,ug/ml,.,0.8,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,04-יול-82,16:03,0,84,79.37361111,Days,PD,Efficacy marker,53.83,.,mm,.,.,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-יול-82,06:50,0,84,83.98958333,Days,PK,Plasma concentration Z,48.999,.,ug/ml,.,0.8,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-יול-82,07:05,0.083333333,84,84,Days,Dose,Dose Z,369,.,mg,.,.,iv,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-יול-82,09:21,0,84,84.09444444,Days,PK,Plasma concentration Z,483.999,.,ug/ml,.,0.8,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-יול-82,11:05,0,84,84.16666667,Days,PK,Plasma concentration Z,480,.,ug/ml,.,0.8,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,09-יול-82,13:05,0,84,84.25,Days,PK,Plasma concentration Z,501.999,.,ug/ml,.,0.8,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,16-יול-82,07:05,0,91,91,Days,PK,Plasma concentration Z,131.199,.,ug/ml,.,0.8,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,23-יול-82,07:25,0,98,98.01388889,Days,PK,Plasma concentration Z,95.199,.,ug/ml,.,0.8,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,06-אוג-82,07:05,0,112,112,Days,PK,Plasma concentration Z,51.999,.,ug/ml,.,0.8,.,.,.,.,1,7048,2349.333333,999
.,ZY300707048,Z,Y3,Profiling Study 1,1,0,7,7048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,09-אוג-82,13:56,0,112,115.2854167,Days,PD,Efficacy marker,53.869,.,mm,.,.,.,.,.,.,1,7048,2349.333333,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,24-אפר-82,07:00,0,-14,-35.01319444,Days,Demographics,Age,54,.,Years,.,.,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,24-אפר-82,07:00,0,-14,-35.01319444,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,24-אפר-82,07:00,0,-14,-35.01319444,Days,Demographics,Weight,70.2,.,kg,.,.,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,24-מאי-82,10:41,0,0,-4.859722222,Days,PD,Efficacy marker,35.292,.,mm,.,.,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,28-מאי-82,07:00,0,0,-1.013194444,Days,Demographics,Weight,69.5,.,kg,.,.,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,24-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-מאי-82,07:00,0,0,-0.013194444,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-מאי-82,07:19,0.083333333,0,0,Days,Dose,Dose Z,348,.,mg,.,.,iv,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-מאי-82,09:33,0,0.0833,0.093055556,Days,PK,Plasma concentration Z,630,.,ug/ml,.,0.8,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,24-אפר-82,07:00,0,12,13.13165091,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-יונ-82,11:27,0,28,23.17222222,Days,PD,Efficacy marker,37.356,.,mm,.,.,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-יונ-82,07:00,0,28,27.98680556,Days,PK,Plasma concentration Z,44.001,.,ug/ml,.,0.8,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-יונ-82,07:15,0.083333333,28,27.99722222,Days,Dose,Dose Z,356,.,mg,.,.,iv,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-יונ-82,09:36,0,28,28.09513889,Days,PK,Plasma concentration Z,560.001,.,ug/ml,.,0.8,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-יול-82,12:30,0,56,51.21597222,Days,PD,Efficacy marker,37.734,.,mm,.,.,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-יול-82,07:00,0,56,55.98680556,Days,PK,Plasma concentration Z,65.601,.,ug/ml,.,0.8,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-יול-82,07:15,0.083333333,56,55.99722222,Days,Dose,Dose Z,356,.,mg,.,.,iv,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-יול-82,09:33,0,56,56.09305556,Days,PK,Plasma concentration Z,636,.,ug/ml,.,0.8,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-אוג-82,10:23,0,84,79.12777778,Days,PD,Efficacy marker,38.638,.,mm,.,.,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-אוג-82,07:00,0,84,83.98680556,Days,PK,Plasma concentration Z,72.801,.,ug/ml,.,0.8,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-אוג-82,07:17,0.083333333,84,83.99861111,Days,Dose,Dose Z,349.5,.,mg,.,.,iv,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-אוג-82,09:36,0,84,84.09513889,Days,PK,Plasma concentration Z,702,.,ug/ml,.,0.8,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-אוג-82,11:15,0,84,84.16388889,Days,PK,Plasma concentration Z,702,.,ug/ml,.,0.8,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-אוג-82,13:15,0,84,84.24722222,Days,PK,Plasma concentration Z,690,.,ug/ml,.,0.8,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,28-אוג-82,07:15,0,91,90.99722222,Days,PK,Plasma concentration Z,230.001,.,ug/ml,.,0.8,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,04-ספט-82,07:15,0,98,97.99722222,Days,PK,Plasma concentration Z,164.199,.,ug/ml,.,0.8,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-ספט-82,12:12,0,112,111.2034722,Days,PD,Efficacy marker,38.423,.,mm,.,.,.,.,.,.,1,7049,2349.666667,999
.,ZY300707049,Z,Y3,Profiling Study 1,1,0,7,7049,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,18-ספט-82,07:15,0,112,111.9972222,Days,PK,Plasma concentration Z,96.801,.,ug/ml,.,0.8,.,.,.,.,1,7049,2349.666667,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,24-אפר-82,07:00,0,-14,-35.01388889,Days,Demographics,Age,58,.,Years,.,.,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,24-אפר-82,07:00,0,-14,-35.01388889,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,24-אפר-82,07:00,0,-14,-35.01388889,Days,Demographics,Weight,72.5,.,kg,.,.,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,24-מאי-82,10:01,0,0,-4.888194444,Days,PD,Efficacy marker,25.225,.,mm,.,.,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,28-מאי-82,07:00,0,0,-1.013888889,Days,Demographics,Weight,73.8,.,kg,.,.,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,24-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-מאי-82,07:11,0,0,-0.00625,Days,PK,Plasma concentration Z,0.483,.,ug/ml,.,0.8,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-מאי-82,07:20,0.083333333,0,0,Days,Dose,Dose Z,368.5,.,mg,.,.,iv,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-מאי-82,09:37,0,0.0833,0.095138889,Days,PK,Plasma concentration Z,609.999,.,ug/ml,.,0.8,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,24-אפר-82,07:00,0,12,13.69267403,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-יונ-82,10:59,0,28,23.15208333,Days,PD,Efficacy marker,25.816,.,mm,.,.,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-יונ-82,07:05,0,28,27.98958333,Days,PK,Plasma concentration Z,27.399,.,ug/ml,.,0.8,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-יונ-82,07:20,0.083333333,28,28,Days,Dose,Dose Z,368.5,.,mg,.,.,iv,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-יונ-82,09:34,0,28,28.09305556,Days,PK,Plasma concentration Z,570,.,ug/ml,.,0.8,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-יול-82,11:41,0,56,51.18125,Days,PD,Efficacy marker,25.423,.,mm,.,.,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-יול-82,07:05,0,56,55.98958333,Days,PK,Plasma concentration Z,39,.,ug/ml,.,0.8,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-יול-82,07:20,0.083333333,56,56,Days,Dose,Dose Z,365.5,.,mg,.,.,iv,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-יול-82,09:37,0,56,56.09513889,Days,PK,Plasma concentration Z,585.999,.,ug/ml,.,0.8,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-אוג-82,11:42,0,84,79.18194444,Days,PD,Efficacy marker,26.107,.,mm,.,.,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-אוג-82,07:05,0,84,83.98958333,Days,PK,Plasma concentration Z,43.599,.,ug/ml,.,0.8,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-אוג-82,07:21,0.083333333,84,84.00069444,Days,Dose,Dose Z,368,.,mg,.,.,iv,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-אוג-82,09:44,0,84,84.1,Days,PK,Plasma concentration Z,600,.,ug/ml,.,0.8,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-אוג-82,11:20,0,84,84.16666667,Days,PK,Plasma concentration Z,572.001,.,ug/ml,.,0.8,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-אוג-82,13:20,0,84,84.25,Days,PK,Plasma concentration Z,561.999,.,ug/ml,.,0.8,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,28-אוג-82,07:20,0,91,91,Days,PK,Plasma concentration Z,165.999,.,ug/ml,.,0.8,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,04-ספט-82,07:29,0,98,98.00625,Days,PK,Plasma concentration Z,91.401,.,ug/ml,.,0.8,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-ספט-82,13:27,0,112,111.2548611,Days,PD,Efficacy marker,25.748,.,mm,.,.,.,.,.,.,1,7050,2350,999
.,ZY300707050,Z,Y3,Profiling Study 1,1,0,7,7050,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,18-ספט-82,07:20,0,112,112,Days,PK,Plasma concentration Z,53.001,.,ug/ml,.,0.8,.,.,.,.,1,7050,2350,999
.,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,24-אפר-82,07:00,0,-14,-35.01736111,Days,Demographics,Age,58,.,Years,.,.,.,.,.,.,1,7051,2350.333333,999
.,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,24-אפר-82,07:00,0,-14,-35.01736111,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7051,2350.333333,999
.,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,24-אפר-82,07:00,0,-14,-35.01736111,Days,Demographics,Weight,60.5,.,kg,.,.,.,.,.,.,1,7051,2350.333333,999
.,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,24-מאי-82,11:33,0,0,-4.827777778,Days,PD,Efficacy marker,22.414,.,mm,.,.,.,.,.,.,1,7051,2350.333333,999
.,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,28-מאי-82,07:00,0,0,-1.017361111,Days,Demographics,Weight,59.9,.,kg,.,.,.,.,.,.,1,7051,2350.333333,999
.,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,24-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7051,2350.333333,999
.,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,29-מאי-82,07:25,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7051,2350.333333,999
.,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,24-אפר-82,07:00,0,12,13.34257691,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,7051,2350.333333,999
.,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,21-יונ-82,11:55,0,28,23.1875,Days,PD,Efficacy marker,22.979,.,mm,.,.,.,.,.,.,1,7051,2350.333333,999
.,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,26-יונ-82,07:25,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7051,2350.333333,999
.,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,19-יול-82,14:40,0,56,51.30208333,Days,PD,Efficacy marker,23.468,.,mm,.,.,.,.,.,.,1,7051,2350.333333,999
.,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,24-יול-82,07:25,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7051,2350.333333,999
.,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,16-אוג-82,12:53,0,84,79.22777778,Days,PD,Efficacy marker,23.752,.,mm,.,.,.,.,.,.,1,7051,2350.333333,999
.,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,21-אוג-82,07:27,0.083333333,84,84.00138889,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7051,2350.333333,999
.,ZY300707051,Z,Y3,Profiling Study 1,1,0,7,7051,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,26-ספט-82,17:10,0,112,120.40625,Days,PD,Efficacy marker,23.843,.,mm,.,.,.,.,.,.,1,7051,2350.333333,999
.,ZY300707055,Z,Y3,Profiling Study 1,1,0,7,7055,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,28-אפר-82,07:00,0,-14,-31.00694444,Days,Demographics,Age,58,.,Years,.,.,.,.,.,.,1,7055,2351.666667,999
.,ZY300707055,Z,Y3,Profiling Study 1,1,0,7,7055,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,28-אפר-82,07:00,0,-14,-31.00694444,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,7055,2351.666667,999
.,ZY300707055,Z,Y3,Profiling Study 1,1,0,7,7055,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,28-אפר-82,07:00,0,-14,-31.00694444,Days,Demographics,Weight,81.1,.,kg,.,.,.,.,.,.,1,7055,2351.666667,999
.,ZY300707055,Z,Y3,Profiling Study 1,1,0,7,7055,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,24-מאי-82,12:02,0,0,-4.797222222,Days,PD,Efficacy marker,48.495,.,mm,.,.,.,.,.,.,1,7055,2351.666667,999
.,ZY300707055,Z,Y3,Profiling Study 1,1,0,7,7055,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,28-מאי-82,07:00,0,0,-1.006944444,Days,Demographics,Weight,79,.,kg,.,.,.,.,.,.,1,7055,2351.666667,999
.,ZY300707055,Z,Y3,Profiling Study 1,1,0,7,7055,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,28-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,7055,2351.666667,999
.,ZY300707055,Z,Y3,Profiling Study 1,1,0,7,7055,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,29-מאי-82,07:10,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7055,2351.666667,999
.,ZY300707055,Z,Y3,Profiling Study 1,1,0,7,7055,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,28-אפר-82,07:00,0,12,14.89845482,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,7055,2351.666667,999
.,ZY300707055,Z,Y3,Profiling Study 1,1,0,7,7055,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,21-יונ-82,10:20,0,28,23.13194444,Days,PD,Efficacy marker,50.02,.,mm,.,.,.,.,.,.,1,7055,2351.666667,999
.,ZY300707055,Z,Y3,Profiling Study 1,1,0,7,7055,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,26-יונ-82,07:10,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7055,2351.666667,999
.,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,-14,-27.02430556,Days,Demographics,Age,62,.,Years,.,.,.,.,.,.,1,7060,2353.333333,999
.,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,-14,-27.02430556,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7060,2353.333333,999
.,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,-14,-27.02430556,Days,Demographics,Weight,57.2,.,kg,.,.,.,.,.,.,1,7060,2353.333333,999
.,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,24-מאי-82,15:08,0,0,-4.685416667,Days,PD,Efficacy marker,26.489,.,mm,.,.,.,.,.,.,1,7060,2353.333333,999
.,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,28-מאי-82,07:00,0,0,-1.024305556,Days,Demographics,Weight,56.3,.,kg,.,.,.,.,.,.,1,7060,2353.333333,999
.,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,7060,2353.333333,999
.,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-מאי-82,07:15,0,0,-0.013888889,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,7060,2353.333333,999
.,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-מאי-82,07:35,0.083333333,0,0,Days,Dose,Dose Z,282,.,mg,.,.,iv,.,.,.,1,7060,2353.333333,999
.,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-מאי-82,09:51,0,0.0833,0.094444444,Days,PK,Plasma concentration Z,500.001,.,ug/ml,.,0.8,.,.,.,.,1,7060,2353.333333,999
.,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,12,13.69986793,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7060,2353.333333,999
.,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-יונ-82,12:22,0,28,23.19930556,Days,PD,Efficacy marker,28.845,.,mm,.,.,.,.,.,.,1,7060,2353.333333,999
.,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-יונ-82,07:15,0,28,27.98611111,Days,PK,Plasma concentration Z,24,.,ug/ml,.,0.8,.,.,.,.,1,7060,2353.333333,999
.,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-יונ-82,07:30,0.083333333,28,27.99652778,Days,Dose,Dose Z,292,.,mg,.,.,iv,.,.,.,1,7060,2353.333333,999
.,ZY300707060,Z,Y3,Profiling Study 1,1,0,7,7060,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-יונ-82,09:48,0,28,28.09236111,Days,PK,Plasma concentration Z,522,.,ug/ml,.,0.8,.,.,.,.,1,7060,2353.333333,999
.,ZY300707062,Z,Y3,Profiling Study 1,1,0,7,7062,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,-14,-27.02916667,Days,Demographics,Age,69,.,Years,.,.,.,.,.,.,1,7062,2354,999
.,ZY300707062,Z,Y3,Profiling Study 1,1,0,7,7062,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,-14,-27.02916667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7062,2354,999
.,ZY300707062,Z,Y3,Profiling Study 1,1,0,7,7062,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,-14,-27.02916667,Days,Demographics,Weight,72.4,.,kg,.,.,.,.,.,.,1,7062,2354,999
.,ZY300707062,Z,Y3,Profiling Study 1,1,0,7,7062,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,24-מאי-82,13:27,0,0,-4.760416667,Days,PD,Efficacy marker,26.583,.,mm,.,.,.,.,.,.,1,7062,2354,999
.,ZY300707062,Z,Y3,Profiling Study 1,1,0,7,7062,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,28-מאי-82,07:00,0,0,-1.029166667,Days,Demographics,Weight,71.4,.,kg,.,.,.,.,.,.,1,7062,2354,999
.,ZY300707062,Z,Y3,Profiling Study 1,1,0,7,7062,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,7062,2354,999
.,ZY300707062,Z,Y3,Profiling Study 1,1,0,7,7062,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-מאי-82,07:20,0,0,-0.015277778,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,7062,2354,999
.,ZY300707062,Z,Y3,Profiling Study 1,1,0,7,7062,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-מאי-82,07:42,0.083333333,0,0,Days,Dose,Dose Z,348.5,.,mg,.,.,iv,.,.,.,1,7062,2354,999
.,ZY300707062,Z,Y3,Profiling Study 1,1,0,7,7062,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,29-מאי-82,09:57,0,0.0833,0.09375,Days,PK,Plasma concentration Z,464.001,.,ug/ml,.,0.8,.,.,.,.,1,7062,2354,999
.,ZY300707062,Z,Y3,Profiling Study 1,1,0,7,7062,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,02-מאי-82,07:00,0,12,13.41519257,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7062,2354,999
.,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,05-מאי-82,07:00,0,-14,-24.03125,Days,Demographics,Age,62,.,Years,.,.,.,.,.,.,1,7065,2355,999
.,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,05-מאי-82,07:00,0,-14,-24.03125,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,7065,2355,999
.,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,05-מאי-82,07:00,0,-14,-24.03125,Days,Demographics,Weight,59.7,.,kg,.,.,.,.,.,.,1,7065,2355,999
.,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,24-מאי-82,12:48,0,0,-4.789583333,Days,PD,Efficacy marker,22.971,.,mm,.,.,.,.,.,.,1,7065,2355,999
.,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,28-מאי-82,07:00,0,0,-1.03125,Days,Demographics,Weight,59.6,.,kg,.,.,.,.,.,.,1,7065,2355,999
.,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,05-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7065,2355,999
.,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,29-מאי-82,07:45,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7065,2355,999
.,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,05-מאי-82,07:00,0,12,13.23646725,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7065,2355,999
.,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,21-יונ-82,13:05,0,28,23.22222222,Days,PD,Efficacy marker,23.794,.,mm,.,.,.,.,.,.,1,7065,2355,999
.,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,26-יונ-82,07:40,0.083333333,28,27.99652778,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7065,2355,999
.,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,19-יול-82,15:17,0,56,51.31388889,Days,PD,Efficacy marker,23.379,.,mm,.,.,.,.,.,.,1,7065,2355,999
.,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,24-יול-82,07:40,0.083333333,56,55.99652778,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7065,2355,999
.,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,16-אוג-82,12:22,0,84,79.19236111,Days,PD,Efficacy marker,24.007,.,mm,.,.,.,.,.,.,1,7065,2355,999
.,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,21-אוג-82,07:40,0.083333333,84,83.99652778,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7065,2355,999
.,ZY300707065,Z,Y3,Profiling Study 1,1,0,7,7065,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,17-ספט-82,14:20,0,112,111.2743056,Days,PD,Efficacy marker,23.363,.,mm,.,.,.,.,.,.,1,7065,2355,999
.,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-אפר-82,07:00,0,-14,-39.04166667,Days,Demographics,Age,55,.,Years,.,.,.,.,.,.,1,8001,2667,999
.,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-אפר-82,07:00,0,-14,-39.04166667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,8001,2667,999
.,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-אפר-82,07:00,0,-14,-39.04166667,Days,Demographics,Weight,57.2,.,kg,.,.,.,.,.,.,1,8001,2667,999
.,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,19-מאי-82,07:00,0,0,-5.041666667,Days,Demographics,Weight,58.5,.,kg,.,.,.,.,.,.,1,8001,2667,999
.,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,19-מאי-82,08:42,0,0,-4.970833333,Days,PD,Efficacy marker,25.257,.,mm,.,.,.,.,.,.,1,8001,2667,999
.,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8001,2667,999
.,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,24-מאי-82,08:00,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8001,2667,999
.,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-אפר-82,07:00,0,12,14.12597845,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,8001,2667,999
.,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,16-יונ-82,08:33,0,28,23.02291667,Days,PD,Efficacy marker,25.474,.,mm,.,.,.,.,.,.,1,8001,2667,999
.,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,21-יונ-82,08:00,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8001,2667,999
.,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,14-יול-82,08:28,0,56,51.01944444,Days,PD,Efficacy marker,25.144,.,mm,.,.,.,.,.,.,1,8001,2667,999
.,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,19-יול-82,09:00,0.083333333,56,56.04166667,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8001,2667,999
.,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,11-אוג-82,08:33,0,84,79.02291667,Days,PD,Efficacy marker,25.39,.,mm,.,.,.,.,.,.,1,8001,2667,999
.,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,16-אוג-82,08:00,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8001,2667,999
.,ZY300808001,Z,Y3,Profiling Study 1,1,0,8,8001,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,15-ספט-82,08:49,0,112,114.0340278,Days,PD,Efficacy marker,24.778,.,mm,.,.,.,.,.,.,1,8001,2667,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,15-אפר-82,07:00,0,-14,-39.04583333,Days,Demographics,Age,55,.,Years,.,.,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,15-אפר-82,07:00,0,-14,-39.04583333,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,15-אפר-82,07:00,0,-14,-39.04583333,Days,Demographics,Weight,71.2,.,kg,.,.,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-מאי-82,07:00,0,0,-5.045833333,Days,Demographics,Weight,72.1,.,kg,.,.,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-מאי-82,12:58,0,0,-4.797222222,Days,PD,Efficacy marker,27.493,.,mm,.,.,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,15-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,24-מאי-82,07:36,0,0,-0.020833333,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,24-מאי-82,08:06,0.083333333,0,0,Days,Dose,Dose Z,360.5,.,mg,.,.,iv,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,24-מאי-82,10:06,0,0.0833,0.083333333,Days,PK,Plasma concentration Z,564,.,ug/ml,.,0.8,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,15-אפר-82,07:00,0,12,14.51161612,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,16-יונ-82,13:01,0,28,23.20486111,Days,PD,Efficacy marker,28.308,.,mm,.,.,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-יונ-82,07:36,0,28,27.97916667,Days,PK,Plasma concentration Z,47.199,.,ug/ml,.,0.8,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-יונ-82,08:05,0.083333333,28,27.99930556,Days,Dose,Dose Z,349.5,.,mg,.,.,iv,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-יונ-82,10:09,0,28,28.08541667,Days,PK,Plasma concentration Z,530.001,.,ug/ml,.,0.8,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,14-יול-82,12:52,0,56,51.19861111,Days,PD,Efficacy marker,28.994,.,mm,.,.,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-יול-82,08:36,0,56,56.02083333,Days,PK,Plasma concentration Z,75,.,ug/ml,.,0.8,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-יול-82,09:06,0.083333333,56,56.04166667,Days,Dose,Dose Z,336.5,.,mg,.,.,iv,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-יול-82,11:11,0,56,56.12847222,Days,PK,Plasma concentration Z,558,.,ug/ml,.,0.8,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,11-אוג-82,13:04,0,84,79.20694444,Days,PD,Efficacy marker,28.973,.,mm,.,.,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-אוג-82,07:36,0,84,83.97916667,Days,PK,Plasma concentration Z,94.401,.,ug/ml,.,0.8,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-אוג-82,08:06,0.083333333,84,84,Days,Dose,Dose Z,326.5,.,mg,.,.,iv,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-אוג-82,10:09,0,84,84.08541667,Days,PK,Plasma concentration Z,549.999,.,ug/ml,.,0.8,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-אוג-82,12:05,0,84,84.16597222,Days,PK,Plasma concentration Z,594,.,ug/ml,.,0.8,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-אוג-82,14:05,0,84,84.24930556,Days,PK,Plasma concentration Z,579.999,.,ug/ml,.,0.8,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,23-אוג-82,08:09,0,91,91.00208333,Days,PK,Plasma concentration Z,183.399,.,ug/ml,.,0.8,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,30-אוג-82,08:05,0,98,97.99930556,Days,PK,Plasma concentration Z,148.8,.,ug/ml,.,0.8,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,15-ספט-82,11:17,0,112,114.1326389,Days,PK,Plasma concentration Z,109.8,.,ug/ml,.,0.8,.,.,.,.,1,8002,2667.333333,999
.,ZY300808002,Z,Y3,Profiling Study 1,1,0,8,8002,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,15-ספט-82,13:01,0,112,114.2048611,Days,PD,Efficacy marker,29.005,.,mm,.,.,.,.,.,.,1,8002,2667.333333,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,15-אפר-82,07:00,0,-14,-39.04375,Days,Demographics,Age,63,.,Years,.,.,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,15-אפר-82,07:00,0,-14,-39.04375,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,15-אפר-82,07:00,0,-14,-39.04375,Days,Demographics,Weight,65.5,.,kg,.,.,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-מאי-82,07:00,0,0,-5.04375,Days,Demographics,Weight,67.8,.,kg,.,.,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-מאי-82,10:05,0,0,-4.915277778,Days,PD,Efficacy marker,35.26,.,mm,.,.,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,15-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,24-מאי-82,07:33,0,0,-0.020833333,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,24-מאי-82,08:03,0.083333333,0,0,Days,Dose,Dose Z,335,.,mg,.,.,iv,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,24-מאי-82,10:11,0,0.0833,0.088888889,Days,PK,Plasma concentration Z,420,.,ug/ml,.,0.8,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,15-אפר-82,07:00,0,12,13.33770128,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,16-יונ-82,10:10,0,28,23.08819444,Days,PD,Efficacy marker,36.384,.,mm,.,.,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-יונ-82,07:32,0,28,27.97847222,Days,PK,Plasma concentration Z,23.4,.,ug/ml,.,0.8,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-יונ-82,08:03,0.083333333,28,28,Days,Dose,Dose Z,337,.,mg,.,.,iv,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,21-יונ-82,10:09,0,28,28.0875,Days,PK,Plasma concentration Z,410.001,.,ug/ml,.,0.8,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,14-יול-82,10:04,0,56,51.08402778,Days,PD,Efficacy marker,36.105,.,mm,.,.,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-יול-82,08:32,0,56,56.02013889,Days,PK,Plasma concentration Z,36.6,.,ug/ml,.,0.8,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-יול-82,09:03,0.083333333,56,56.04166667,Days,Dose,Dose Z,339,.,mg,.,.,iv,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-יול-82,11:06,0,56,56.12708333,Days,PK,Plasma concentration Z,368.001,.,ug/ml,.,0.8,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,11-אוג-82,13:42,0,84,79.23541667,Days,PD,Efficacy marker,38.012,.,mm,.,.,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-אוג-82,07:33,0,84,83.97916667,Days,PK,Plasma concentration Z,43.599,.,ug/ml,.,0.8,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-אוג-82,08:03,0.083333333,84,84,Days,Dose,Dose Z,344.5,.,mg,.,.,iv,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-אוג-82,10:05,0,84,84.08472222,Days,PK,Plasma concentration Z,434.001,.,ug/ml,.,0.8,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-אוג-82,12:02,0,84,84.16597222,Days,PK,Plasma concentration Z,405.999,.,ug/ml,.,0.8,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-אוג-82,14:02,0,84,84.24930556,Days,PK,Plasma concentration Z,408,.,ug/ml,.,0.8,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,23-אוג-82,08:05,0,91,91.00138889,Days,PK,Plasma concentration Z,143.001,.,ug/ml,.,0.8,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,30-אוג-82,08:03,0,98,98,Days,PK,Plasma concentration Z,94.8,.,ug/ml,.,0.8,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,15-ספט-82,08:16,0,112,114.0090278,Days,PK,Plasma concentration Z,57.6,.,ug/ml,.,0.8,.,.,.,.,1,8010,2670,999
.,ZY300808010,Z,Y3,Profiling Study 1,1,0,8,8010,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,23-ספט-82,14:50,0,112,122.2826389,Days,PD,Efficacy marker,40.023,.,mm,.,.,.,.,.,.,1,8010,2670,999
.,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-אפר-82,07:00,0,-14,-67.05,Days,Demographics,Age,63,.,Years,.,.,.,.,.,.,1,8012,2670.666667,999
.,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-אפר-82,07:00,0,-14,-67.05,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,8012,2670.666667,999
.,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-אפר-82,07:00,0,-14,-67.05,Days,Demographics,Weight,52.3,.,kg,.,.,.,.,.,.,1,8012,2670.666667,999
.,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,16-יונ-82,07:00,0,0,-5.05,Days,Demographics,Weight,53.3,.,kg,.,.,.,.,.,.,1,8012,2670.666667,999
.,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,16-יונ-82,11:46,0,0,-4.851388889,Days,PD,Efficacy marker,25.518,.,mm,.,.,.,.,.,.,1,8012,2670.666667,999
.,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8012,2670.666667,999
.,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,21-יונ-82,08:12,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8012,2670.666667,999
.,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-אפר-82,07:00,0,12,13.46050709,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8012,2670.666667,999
.,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,14-יול-82,11:35,0,28,23.14097222,Days,PD,Efficacy marker,24.961,.,mm,.,.,.,.,.,.,1,8012,2670.666667,999
.,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,19-יול-82,09:12,0.083333333,28,28.04166667,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8012,2670.666667,999
.,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,11-אוג-82,11:36,0,56,51.14166667,Days,PD,Efficacy marker,24.525,.,mm,.,.,.,.,.,.,1,8012,2670.666667,999
.,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,16-אוג-82,08:12,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8012,2670.666667,999
.,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,08-ספט-82,11:57,0,84,79.15625,Days,PD,Efficacy marker,25.309,.,mm,.,.,.,.,.,.,1,8012,2670.666667,999
.,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,13-ספט-82,08:12,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8012,2670.666667,999
.,ZY300808012,Z,Y3,Profiling Study 1,1,0,8,8012,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,13-אוק-82,11:32,0,112,114.1388889,Days,PD,Efficacy marker,25.625,.,mm,.,.,.,.,.,.,1,8012,2670.666667,999
.,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-אפר-82,07:00,0,-14,-67.04791667,Days,Demographics,Age,57,.,Years,.,.,.,.,.,.,1,8013,2671,999
.,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-אפר-82,07:00,0,-14,-67.04791667,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,8013,2671,999
.,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-אפר-82,07:00,0,-14,-67.04791667,Days,Demographics,Weight,61.4,.,kg,.,.,.,.,.,.,1,8013,2671,999
.,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,16-יונ-82,07:00,0,0,-5.047916667,Days,Demographics,Weight,60.9,.,kg,.,.,.,.,.,.,1,8013,2671,999
.,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,16-יונ-82,07:08,0,0,-5.042361111,Days,PD,Efficacy marker,42.399,.,mm,.,.,.,.,.,.,1,8013,2671,999
.,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8013,2671,999
.,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,21-יונ-82,08:09,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8013,2671,999
.,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,15-אפר-82,07:00,0,12,13.34024024,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,8013,2671,999
.,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,14-יול-82,07:02,0,28,22.95347222,Days,PD,Efficacy marker,42.918,.,mm,.,.,.,.,.,.,1,8013,2671,999
.,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,19-יול-82,09:09,0.083333333,28,28.04166667,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8013,2671,999
.,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,11-אוג-82,07:34,0,56,50.97569444,Days,PD,Efficacy marker,43.02,.,mm,.,.,.,.,.,.,1,8013,2671,999
.,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,16-אוג-82,08:09,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8013,2671,999
.,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,08-ספט-82,07:10,0,84,78.95902778,Days,PD,Efficacy marker,41.842,.,mm,.,.,.,.,.,.,1,8013,2671,999
.,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,13-ספט-82,08:09,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8013,2671,999
.,ZY300808013,Z,Y3,Profiling Study 1,1,0,8,8013,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,13-אוק-82,12:49,0,112,114.1944444,Days,PD,Efficacy marker,40.973,.,mm,.,.,.,.,.,.,1,8013,2671,999
.,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-אפר-82,07:00,0,-14,-35.08333333,Days,Demographics,Age,69,.,Years,.,.,.,.,.,.,1,8017,2672.333333,999
.,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-אפר-82,07:00,0,-14,-35.08333333,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,8017,2672.333333,999
.,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-אפר-82,07:00,0,-14,-35.08333333,Days,Demographics,Weight,58.9,.,kg,.,.,.,.,.,.,1,8017,2672.333333,999
.,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,29-מאי-82,07:00,0,0,-5.083333333,Days,Demographics,Weight,59,.,kg,.,.,.,.,.,.,1,8017,2672.333333,999
.,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,29-מאי-82,07:08,0,0,-5.077777778,Days,PD,Efficacy marker,25.664,.,mm,.,.,.,.,.,.,1,8017,2672.333333,999
.,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8017,2672.333333,999
.,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,03-יונ-82,09:00,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8017,2672.333333,999
.,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-אפר-82,07:00,0,12,13.454983,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,8017,2672.333333,999
.,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,26-יונ-82,06:55,0,28,22.91319444,Days,PD,Efficacy marker,25.603,.,mm,.,.,.,.,.,.,1,8017,2672.333333,999
.,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,01-יול-82,08:00,0.083333333,28,27.95833333,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8017,2672.333333,999
.,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,24-יול-82,07:10,0,56,50.92361111,Days,PD,Efficacy marker,25.201,.,mm,.,.,.,.,.,.,1,8017,2672.333333,999
.,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,29-יול-82,08:00,0.083333333,56,55.95833333,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8017,2672.333333,999
.,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,22-אוג-82,07:13,0,84,79.92569444,Days,PD,Efficacy marker,25.162,.,mm,.,.,.,.,.,.,1,8017,2672.333333,999
.,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,26-אוג-82,08:00,0.083333333,84,83.95833333,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8017,2672.333333,999
.,ZY300808017,Z,Y3,Profiling Study 1,1,0,8,8017,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,23-ספט-82,07:26,0,112,111.9347222,Days,PD,Efficacy marker,24.711,.,mm,.,.,.,.,.,.,1,8017,2672.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,29-אפר-82,07:00,0,-14,-35.0875,Days,Demographics,Age,67,.,Years,.,.,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,29-אפר-82,07:00,0,-14,-35.0875,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,29-אפר-82,07:00,0,-14,-35.0875,Days,Demographics,Weight,86.6,.,kg,.,.,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,29-מאי-82,07:00,0,0,-5.0875,Days,Demographics,Weight,84.8,.,kg,.,.,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,29-מאי-82,10:03,0,0,-4.960416667,Days,PD,Efficacy marker,43.577,.,mm,.,.,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,29-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,03-יונ-82,07:36,0,0,-0.0625,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,03-יונ-82,09:06,0.083333333,0,0,Days,Dose,Dose Z,427,.,mg,.,.,iv,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,03-יונ-82,11:11,0,0.0833,0.086805556,Days,PK,Plasma concentration Z,504,.,ug/ml,.,0.8,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,29-אפר-82,07:00,0,12,13.06859651,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-יונ-82,10:03,0,28,23.03958333,Days,PD,Efficacy marker,46.519,.,mm,.,.,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-יול-82,07:36,0,28,27.9375,Days,PK,Plasma concentration Z,33.999,.,ug/ml,.,0.8,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-יול-82,08:06,0.083333333,28,27.95833333,Days,Dose,Dose Z,429.5,.,mg,.,.,iv,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-יול-82,10:08,0,28,28.04305556,Days,PK,Plasma concentration Z,444,.,ug/ml,.,0.8,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-יול-82,10:11,0,56,51.04513889,Days,PD,Efficacy marker,48.584,.,mm,.,.,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-יול-82,07:35,0,56,55.93680556,Days,PK,Plasma concentration Z,51.399,.,ug/ml,.,0.8,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-יול-82,08:06,0.083333333,56,55.95833333,Days,Dose,Dose Z,426.5,.,mg,.,.,iv,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-יול-82,10:08,0,56,56.04305556,Days,PK,Plasma concentration Z,582,.,ug/ml,.,0.8,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-אוג-82,10:03,0,84,79.03958333,Days,PD,Efficacy marker,48.031,.,mm,.,.,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-אוג-82,07:35,0,84,83.93680556,Days,PK,Plasma concentration Z,66.201,.,ug/ml,.,0.8,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-אוג-82,08:06,0.083333333,84,83.95833333,Days,Dose,Dose Z,418,.,mg,.,.,iv,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-אוג-82,10:08,0,84,84.04305556,Days,PK,Plasma concentration Z,495.999,.,ug/ml,.,0.8,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-אוג-82,12:05,0,84,84.12430556,Days,PK,Plasma concentration Z,560.001,.,ug/ml,.,0.8,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-אוג-82,14:06,0,84,84.20833333,Days,PK,Plasma concentration Z,489.999,.,ug/ml,.,0.8,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,02-ספט-82,08:06,0,91,90.95833333,Days,PK,Plasma concentration Z,164.199,.,ug/ml,.,0.8,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,09-ספט-82,08:06,0,98,97.95833333,Days,PK,Plasma concentration Z,120.6,.,ug/ml,.,0.8,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,23-ספט-82,08:16,0,112,111.9652778,Days,PK,Plasma concentration Z,75.399,.,ug/ml,.,0.8,.,.,.,.,1,8020,2673.333333,999
.,ZY300808020,Z,Y3,Profiling Study 1,1,0,8,8020,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,23-ספט-82,10:15,0,112,112.0479167,Days,PD,Efficacy marker,47.32,.,mm,.,.,.,.,.,.,1,8020,2673.333333,999
.,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-אפר-82,07:00,0,-14,-35.08541667,Days,Demographics,Age,57,.,Years,.,.,.,.,.,.,1,8023,2674.333333,999
.,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-אפר-82,07:00,0,-14,-35.08541667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,8023,2674.333333,999
.,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-אפר-82,07:00,0,-14,-35.08541667,Days,Demographics,Weight,75.4,.,kg,.,.,.,.,.,.,1,8023,2674.333333,999
.,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,29-מאי-82,07:00,0,0,-5.085416667,Days,Demographics,Weight,76,.,kg,.,.,.,.,.,.,1,8023,2674.333333,999
.,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,29-מאי-82,08:33,0,0,-5.020833333,Days,PD,Efficacy marker,28.354,.,mm,.,.,.,.,.,.,1,8023,2674.333333,999
.,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8023,2674.333333,999
.,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,03-יונ-82,09:03,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8023,2674.333333,999
.,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,29-אפר-82,07:00,0,12,14.44571649,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8023,2674.333333,999
.,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,26-יונ-82,08:29,0,28,22.97638889,Days,PD,Efficacy marker,27.985,.,mm,.,.,.,.,.,.,1,8023,2674.333333,999
.,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,01-יול-82,08:03,0.083333333,28,27.95833333,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8023,2674.333333,999
.,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,24-יול-82,08:40,0,56,50.98402778,Days,PD,Efficacy marker,28.474,.,mm,.,.,.,.,.,.,1,8023,2674.333333,999
.,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,29-יול-82,08:03,0.083333333,56,55.95833333,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8023,2674.333333,999
.,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,21-אוג-82,08:22,0,84,78.97152778,Days,PD,Efficacy marker,28.502,.,mm,.,.,.,.,.,.,1,8023,2674.333333,999
.,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,26-אוג-82,08:03,0.083333333,84,83.95833333,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8023,2674.333333,999
.,ZY300808023,Z,Y3,Profiling Study 1,1,0,8,8023,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,23-ספט-82,08:38,0,112,111.9826389,Days,PD,Efficacy marker,28.993,.,mm,.,.,.,.,.,.,1,8023,2674.333333,999
.,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-28.08958333,Days,Demographics,Age,50,.,Years,.,.,.,.,.,.,1,8026,2675.333333,999
.,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-28.08958333,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,8026,2675.333333,999
.,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-28.08958333,Days,Demographics,Weight,83.2,.,kg,.,.,.,.,.,.,1,8026,2675.333333,999
.,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,29-מאי-82,07:00,0,0,-5.089583333,Days,Demographics,Weight,81.1,.,kg,.,.,.,.,.,.,1,8026,2675.333333,999
.,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,30-מאי-82,15:36,0,0,-3.73125,Days,PD,Efficacy marker,49.802,.,mm,.,.,.,.,.,.,1,8026,2675.333333,999
.,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8026,2675.333333,999
.,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,03-יונ-82,09:09,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8026,2675.333333,999
.,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,12,14.37880322,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8026,2675.333333,999
.,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,26-יונ-82,11:30,0,28,23.09791667,Days,PD,Efficacy marker,52.582,.,mm,.,.,.,.,.,.,1,8026,2675.333333,999
.,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,01-יול-82,08:09,0.083333333,28,27.95833333,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8026,2675.333333,999
.,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,24-יול-82,11:44,0,56,51.10763889,Days,PD,Efficacy marker,52.92,.,mm,.,.,.,.,.,.,1,8026,2675.333333,999
.,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,29-יול-82,08:09,0.083333333,56,55.95833333,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8026,2675.333333,999
.,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,21-אוג-82,11:32,0,84,79.09930556,Days,PD,Efficacy marker,50.672,.,mm,.,.,.,.,.,.,1,8026,2675.333333,999
.,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,26-אוג-82,08:09,0.083333333,84,83.95833333,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8026,2675.333333,999
.,ZY300808026,Z,Y3,Profiling Study 1,1,0,8,8026,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,23-ספט-82,11:50,0,112,112.1118056,Days,PD,Efficacy marker,51.73,.,mm,.,.,.,.,.,.,1,8026,2675.333333,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-39.05,Days,Demographics,Age,52,.,Years,.,.,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-39.05,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-39.05,Days,Demographics,Weight,106.1,.,kg,.,.,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,09-יונ-82,07:00,0,0,-5.05,Days,Demographics,Weight,107.5,.,kg,.,.,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,09-יונ-82,12:56,0,0,-4.802777778,Days,PD,Efficacy marker,51.354,.,mm,.,.,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,14-יונ-82,07:41,0,0,-0.021527778,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,14-יונ-82,08:12,0.083333333,0,0,Days,Dose,Dose Z,538,.,mg,.,.,iv,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,14-יונ-82,10:16,0,0.0833,0.086111111,Days,PK,Plasma concentration Z,528,.,ug/ml,.,0.8,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-מאי-82,07:00,0,12,14.31688856,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-יול-82,13:09,0,28,23.20625,Days,PD,Efficacy marker,53.077,.,mm,.,.,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,12-יול-82,08:42,0,28,28.02083333,Days,PK,Plasma concentration Z,36.201,.,ug/ml,.,0.8,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,12-יול-82,09:12,0.083333333,28,28.04166667,Days,Dose,Dose Z,533.5,.,mg,.,.,iv,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,12-יול-82,11:16,0,28,28.12777778,Days,PK,Plasma concentration Z,501.999,.,ug/ml,.,0.8,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,05-אוג-82,12:59,0,56,52.19930556,Days,PD,Efficacy marker,53.676,.,mm,.,.,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,09-אוג-82,07:42,0,56,55.97916667,Days,PK,Plasma concentration Z,51,.,ug/ml,.,0.8,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,09-אוג-82,08:12,0.083333333,56,56,Days,Dose,Dose Z,530.5,.,mg,.,.,iv,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,09-אוג-82,10:17,0,56,56.08680556,Days,PK,Plasma concentration Z,561.999,.,ug/ml,.,0.8,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-ספט-82,12:58,0,84,79.19861111,Days,PD,Efficacy marker,53.142,.,mm,.,.,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-ספט-82,07:41,0,84,83.97847222,Days,PK,Plasma concentration Z,70.8,.,ug/ml,.,0.8,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-ספט-82,08:12,0.083333333,84,84,Days,Dose,Dose Z,527,.,mg,.,.,iv,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-ספט-82,10:18,0,84,84.0875,Days,PK,Plasma concentration Z,678,.,ug/ml,.,0.8,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-ספט-82,12:12,0,84,84.16666667,Days,PK,Plasma concentration Z,603.999,.,ug/ml,.,0.8,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-ספט-82,14:11,0,84,84.24930556,Days,PK,Plasma concentration Z,555.999,.,ug/ml,.,0.8,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,13-ספט-82,08:11,0,91,90.99930556,Days,PK,Plasma concentration Z,191.601,.,ug/ml,.,0.8,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,20-ספט-82,08:15,0,98,98.00208333,Days,PK,Plasma concentration Z,122.799,.,ug/ml,.,0.8,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,06-אוק-82,11:11,0,112,114.1243056,Days,PK,Plasma concentration Z,79.8,.,ug/ml,.,0.8,.,.,.,.,1,8027,2675.666667,999
.,ZY300808027,Z,Y3,Profiling Study 1,1,0,8,8027,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,06-אוק-82,13:02,0,112,114.2013889,Days,PD,Efficacy marker,54.455,.,mm,.,.,.,.,.,.,1,8027,2675.666667,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-39.04791667,Days,Demographics,Age,52,.,Years,.,.,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-39.04791667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-39.04791667,Days,Demographics,Weight,57.4,.,kg,.,.,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,09-יונ-82,07:00,0,0,-5.047916667,Days,Demographics,Weight,57.2,.,kg,.,.,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,09-יונ-82,11:29,0,0,-4.861111111,Days,PD,Efficacy marker,31.667,.,mm,.,.,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,14-יונ-82,07:39,0,0,-0.020833333,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,14-יונ-82,08:09,0.083333333,0,0,Days,Dose,Dose Z,287,.,mg,.,.,iv,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,14-יונ-82,10:13,0,0.0833,0.086111111,Days,PK,Plasma concentration Z,404.001,.,ug/ml,.,0.8,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-מאי-82,07:00,0,12,14.76337477,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-יול-82,11:28,0,28,23.13819444,Days,PD,Efficacy marker,33.676,.,mm,.,.,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,12-יול-82,08:39,0,28,28.02083333,Days,PK,Plasma concentration Z,32.799,.,ug/ml,.,0.8,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,12-יול-82,09:09,0.083333333,28,28.04166667,Days,Dose,Dose Z,291,.,mg,.,.,iv,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,12-יול-82,11:14,0,28,28.12847222,Days,PK,Plasma concentration Z,465.999,.,ug/ml,.,0.8,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,05-אוג-82,11:29,0,56,52.13888889,Days,PD,Efficacy marker,33.001,.,mm,.,.,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,09-אוג-82,07:38,0,56,55.97847222,Days,PK,Plasma concentration Z,47.199,.,ug/ml,.,0.8,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,09-אוג-82,08:09,0.083333333,56,56,Days,Dose,Dose Z,289,.,mg,.,.,iv,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,09-אוג-82,10:16,0,56,56.08819444,Days,PK,Plasma concentration Z,410.001,.,ug/ml,.,0.8,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,01-ספט-82,11:33,0,84,79.14166667,Days,PD,Efficacy marker,33.857,.,mm,.,.,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-ספט-82,07:38,0,84,83.97847222,Days,PK,Plasma concentration Z,75.6,.,ug/ml,.,0.8,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-ספט-82,08:09,0.083333333,84,84,Days,Dose,Dose Z,292,.,mg,.,.,iv,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-ספט-82,10:14,0,84,84.08680556,Days,PK,Plasma concentration Z,567.999,.,ug/ml,.,0.8,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-ספט-82,12:09,0,84,84.16666667,Days,PK,Plasma concentration Z,477.999,.,ug/ml,.,0.8,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,06-ספט-82,14:09,0,84,84.25,Days,PK,Plasma concentration Z,411.999,.,ug/ml,.,0.8,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,13-ספט-82,08:08,0,91,90.99930556,Days,PK,Plasma concentration Z,147.801,.,ug/ml,.,0.8,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,20-ספט-82,08:12,0,98,98.00208333,Days,PK,Plasma concentration Z,113.001,.,ug/ml,.,0.8,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,06-אוק-82,09:44,0,112,114.0659722,Days,PK,Plasma concentration Z,69.999,.,ug/ml,.,0.8,.,.,.,.,1,8028,2676,999
.,ZY300808028,Z,Y3,Profiling Study 1,1,0,8,8028,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,06-אוק-82,11:34,0,112,114.1423611,Days,PD,Efficacy marker,34.53,.,mm,.,.,.,.,.,.,1,8028,2676,999
.,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-39.04166667,Days,Demographics,Age,57,.,Years,.,.,.,.,.,.,1,8029,2676.333333,999
.,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-39.04166667,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,8029,2676.333333,999
.,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-39.04166667,Days,Demographics,Weight,99.9,.,kg,.,.,.,.,.,.,1,8029,2676.333333,999
.,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,09-יונ-82,07:00,0,0,-5.041666667,Days,Demographics,Weight,100,.,kg,.,.,.,.,.,.,1,8029,2676.333333,999
.,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,09-יונ-82,07:48,0,0,-5.008333333,Days,PD,Efficacy marker,58.087,.,mm,.,.,.,.,.,.,1,8029,2676.333333,999
.,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8029,2676.333333,999
.,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,14-יונ-82,08:00,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8029,2676.333333,999
.,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,12,14.51429813,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8029,2676.333333,999
.,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,07-יול-82,07:07,0,28,22.96319444,Days,PD,Efficacy marker,59.743,.,mm,.,.,.,.,.,.,1,8029,2676.333333,999
.,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,12-יול-82,09:00,0.083333333,28,28.04166667,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8029,2676.333333,999
.,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,05-אוג-82,07:06,0,56,51.9625,Days,PD,Efficacy marker,60.388,.,mm,.,.,.,.,.,.,1,8029,2676.333333,999
.,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,09-אוג-82,08:00,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8029,2676.333333,999
.,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,01-ספט-82,07:12,0,84,78.96666667,Days,PD,Efficacy marker,59.342,.,mm,.,.,.,.,.,.,1,8029,2676.333333,999
.,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,06-ספט-82,08:00,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8029,2676.333333,999
.,ZY300808029,Z,Y3,Profiling Study 1,1,0,8,8029,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,06-אוק-82,07:01,0,112,113.9590278,Days,PD,Efficacy marker,58.891,.,mm,.,.,.,.,.,.,1,8029,2676.333333,999
.,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-39.04375,Days,Demographics,Age,57,.,Years,.,.,.,.,.,.,1,8034,2678,999
.,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-39.04375,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,8034,2678,999
.,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-39.04375,Days,Demographics,Weight,79.7,.,kg,.,.,.,.,.,.,1,8034,2678,999
.,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,09-יונ-82,07:00,0,0,-5.04375,Days,Demographics,Weight,79.8,.,kg,.,.,.,.,.,.,1,8034,2678,999
.,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,09-יונ-82,08:36,0,0,-4.977083333,Days,PD,Efficacy marker,44.835,.,mm,.,.,.,.,.,.,1,8034,2678,999
.,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8034,2678,999
.,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,14-יונ-82,08:03,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8034,2678,999
.,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,12,13.78759146,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,8034,2678,999
.,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,07-יול-82,08:28,0,28,23.01736111,Days,PD,Efficacy marker,44.769,.,mm,.,.,.,.,.,.,1,8034,2678,999
.,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,12-יול-82,09:03,0.083333333,28,28.04166667,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8034,2678,999
.,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,05-אוג-82,08:24,0,56,52.01458333,Days,PD,Efficacy marker,44.099,.,mm,.,.,.,.,.,.,1,8034,2678,999
.,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,09-אוג-82,08:03,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8034,2678,999
.,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,01-ספט-82,08:33,0,84,79.02083333,Days,PD,Efficacy marker,44.829,.,mm,.,.,.,.,.,.,1,8034,2678,999
.,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,06-ספט-82,08:03,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8034,2678,999
.,ZY300808034,Z,Y3,Profiling Study 1,1,0,8,8034,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,06-אוק-82,08:28,0,112,114.0173611,Days,PD,Efficacy marker,45.577,.,mm,.,.,.,.,.,.,1,8034,2678,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-28.09166667,Days,Demographics,Age,59,.,Years,.,.,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-28.09166667,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-28.09166667,Days,Demographics,Weight,76.9,.,kg,.,.,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,29-מאי-82,07:00,0,0,-5.091666667,Days,Demographics,Weight,75.2,.,kg,.,.,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,29-מאי-82,13:05,0,0,-4.838194444,Days,PD,Efficacy marker,41.081,.,mm,.,.,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,03-יונ-82,07:42,0,0,-0.0625,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,03-יונ-82,09:12,0.083333333,0,0,Days,Dose,Dose Z,369,.,mg,.,.,iv,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,03-יונ-82,11:15,0,0.0833,0.085416667,Days,PK,Plasma concentration Z,578.001,.,ug/ml,.,0.8,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,06-מאי-82,07:00,0,12,14.53018104,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,26-יונ-82,13:00,0,28,23.15833333,Days,PD,Efficacy marker,42.152,.,mm,.,.,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-יול-82,07:42,0,28,27.9375,Days,PK,Plasma concentration Z,40.2,.,ug/ml,.,0.8,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-יול-82,08:12,0.083333333,28,27.95833333,Days,Dose,Dose Z,374,.,mg,.,.,iv,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,01-יול-82,10:18,0,28,28.04583333,Days,PK,Plasma concentration Z,600,.,ug/ml,.,0.8,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,24-יול-82,13:25,0,56,51.17569444,Days,PD,Efficacy marker,43.731,.,mm,.,.,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-יול-82,07:41,0,56,55.93680556,Days,PK,Plasma concentration Z,56.601,.,ug/ml,.,0.8,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-יול-82,08:12,0.083333333,56,55.95833333,Days,Dose,Dose Z,372,.,mg,.,.,iv,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,29-יול-82,10:15,0,56,56.04375,Days,PK,Plasma concentration Z,542.001,.,ug/ml,.,0.8,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,21-אוג-82,13:01,0,84,79.15902778,Days,PD,Efficacy marker,43.435,.,mm,.,.,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-אוג-82,07:41,0,84,83.93680556,Days,PK,Plasma concentration Z,80.799,.,ug/ml,.,0.8,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-אוג-82,08:12,0.083333333,84,83.95833333,Days,Dose,Dose Z,366,.,mg,.,.,iv,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-אוג-82,10:18,0,84,84.04583333,Days,PK,Plasma concentration Z,636,.,ug/ml,.,0.8,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-אוג-82,12:11,0,84,84.12430556,Days,PK,Plasma concentration Z,548.001,.,ug/ml,.,0.8,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,26-אוג-82,14:12,0,84,84.20833333,Days,PK,Plasma concentration Z,507.999,.,ug/ml,.,0.8,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,8,VISIT 08,0,0,02-ספט-82,08:12,0,91,90.95833333,Days,PK,Plasma concentration Z,150.399,.,ug/ml,.,0.8,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,9,VISIT 09,0,0,08-ספט-82,08:38,0,98,96.97638889,Days,PK,Plasma concentration Z,122.4,.,ug/ml,.,0.8,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,23-ספט-82,11:43,0,112,112.1048611,Days,PK,Plasma concentration Z,72.399,.,ug/ml,.,0.8,.,.,.,.,1,8037,2679,999
.,ZY300808037,Z,Y3,Profiling Study 1,1,0,8,8037,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,23-ספט-82,13:19,0,112,112.1715278,Days,PD,Efficacy marker,44.085,.,mm,.,.,.,.,.,.,1,8037,2679,999
.,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-39.04583333,Days,Demographics,Age,55,.,Years,.,.,.,.,.,.,1,8039,2679.666667,999
.,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-39.04583333,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,8039,2679.666667,999
.,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,-14,-39.04583333,Days,Demographics,Weight,77.9,.,kg,.,.,.,.,.,.,1,8039,2679.666667,999
.,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,09-יונ-82,07:00,0,0,-5.045833333,Days,Demographics,Weight,79,.,kg,.,.,.,.,.,.,1,8039,2679.666667,999
.,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,09-יונ-82,10:04,0,0,-4.918055556,Days,PD,Efficacy marker,30.847,.,mm,.,.,.,.,.,.,1,8039,2679.666667,999
.,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8039,2679.666667,999
.,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,14-יונ-82,08:06,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8039,2679.666667,999
.,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,06-מאי-82,07:00,0,12,13.10031092,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,8039,2679.666667,999
.,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,07-יול-82,10:22,0,28,23.09444444,Days,PD,Efficacy marker,31.189,.,mm,.,.,.,.,.,.,1,8039,2679.666667,999
.,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,12-יול-82,09:06,0.083333333,28,28.04166667,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8039,2679.666667,999
.,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,05-אוג-82,09:52,0,56,52.07361111,Days,PD,Efficacy marker,31.117,.,mm,.,.,.,.,.,.,1,8039,2679.666667,999
.,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,09-אוג-82,08:06,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8039,2679.666667,999
.,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,01-ספט-82,09:59,0,84,79.07847222,Days,PD,Efficacy marker,31.206,.,mm,.,.,.,.,.,.,1,8039,2679.666667,999
.,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,06-ספט-82,08:06,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8039,2679.666667,999
.,ZY300808039,Z,Y3,Profiling Study 1,1,0,8,8039,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,06-אוק-82,10:02,0,112,114.0805556,Days,PD,Efficacy marker,31.521,.,mm,.,.,.,.,.,.,1,8039,2679.666667,999
.,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,20-מאי-82,07:00,0,-14,-35.04375,Days,Demographics,Age,59,.,Years,.,.,.,.,.,.,1,8041,2680.333333,999
.,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,20-מאי-82,07:00,0,-14,-35.04375,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,8041,2680.333333,999
.,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,20-מאי-82,07:00,0,-14,-35.04375,Days,Demographics,Weight,84.5,.,kg,.,.,.,.,.,.,1,8041,2680.333333,999
.,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,19-יונ-82,07:00,0,0,-5.04375,Days,Demographics,Weight,82.5,.,kg,.,.,.,.,.,.,1,8041,2680.333333,999
.,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,19-יונ-82,08:45,0,0,-4.970833333,Days,PD,Efficacy marker,39.849,.,mm,.,.,.,.,.,.,1,8041,2680.333333,999
.,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,20-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,8041,2680.333333,999
.,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,24-יונ-82,08:03,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8041,2680.333333,999
.,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,20-מאי-82,07:00,0,12,14.5973583,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8041,2680.333333,999
.,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,17-יול-82,08:43,0,28,23.02777778,Days,PD,Efficacy marker,39.243,.,mm,.,.,.,.,.,.,1,8041,2680.333333,999
.,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,22-יול-82,08:03,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8041,2680.333333,999
.,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,14-אוג-82,08:44,0,56,51.02847222,Days,PD,Efficacy marker,40.025,.,mm,.,.,.,.,.,.,1,8041,2680.333333,999
.,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,19-אוג-82,08:03,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8041,2680.333333,999
.,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,12-ספט-82,08:55,0,84,80.03611111,Days,PD,Efficacy marker,39.675,.,mm,.,.,.,.,.,.,1,8041,2680.333333,999
.,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,16-ספט-82,08:03,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8041,2680.333333,999
.,ZY300808041,Z,Y3,Profiling Study 1,1,0,8,8041,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,14-אוק-82,08:38,0,112,112.0243056,Days,PD,Efficacy marker,40.756,.,mm,.,.,.,.,.,.,1,8041,2680.333333,999
.,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,20-מאי-82,07:00,0,-14,-35.04166667,Days,Demographics,Age,50,.,Years,.,.,.,.,.,.,1,8042,2680.666667,999
.,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,20-מאי-82,07:00,0,-14,-35.04166667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,8042,2680.666667,999
.,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,20-מאי-82,07:00,0,-14,-35.04166667,Days,Demographics,Weight,75.7,.,kg,.,.,.,.,.,.,1,8042,2680.666667,999
.,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-יונ-82,07:00,0,0,-5.041666667,Days,Demographics,Weight,77.7,.,kg,.,.,.,.,.,.,1,8042,2680.666667,999
.,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-יונ-82,07:08,0,0,-5.036111111,Days,PD,Efficacy marker,35.532,.,mm,.,.,.,.,.,.,1,8042,2680.666667,999
.,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,20-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8042,2680.666667,999
.,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,24-יונ-82,08:00,0.083333333,0,0,Days,Dose,Dose Z,387.5,.,mg,.,.,iv,.,.,.,1,8042,2680.666667,999
.,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,20-מאי-82,07:00,0,12,14.48493757,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,8042,2680.666667,999
.,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,17-יול-82,07:05,0,28,22.96180556,Days,PD,Efficacy marker,37.335,.,mm,.,.,.,.,.,.,1,8042,2680.666667,999
.,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,22-יול-82,08:00,0.083333333,28,28,Days,Dose,Dose Z,393,.,mg,.,.,iv,.,.,.,1,8042,2680.666667,999
.,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,14-אוג-82,07:01,0,56,50.95902778,Days,PD,Efficacy marker,38.617,.,mm,.,.,.,.,.,.,1,8042,2680.666667,999
.,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-אוג-82,08:00,0.083333333,56,56,Days,Dose,Dose Z,401.5,.,mg,.,.,iv,.,.,.,1,8042,2680.666667,999
.,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,12-ספט-82,07:07,0,84,79.96319444,Days,PD,Efficacy marker,38.023,.,mm,.,.,.,.,.,.,1,8042,2680.666667,999
.,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-ספט-82,08:00,0.083333333,84,84,Days,Dose,Dose Z,392.5,.,mg,.,.,iv,.,.,.,1,8042,2680.666667,999
.,ZY300808042,Z,Y3,Profiling Study 1,1,0,8,8042,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,14-אוק-82,06:51,0,112,111.9520833,Days,PD,Efficacy marker,37.549,.,mm,.,.,.,.,.,.,1,8042,2680.666667,999
.,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,20-מאי-82,07:00,0,-14,-35.04791667,Days,Demographics,Age,68,.,Years,.,.,.,.,.,.,1,8043,2681,999
.,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,20-מאי-82,07:00,0,-14,-35.04791667,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,8043,2681,999
.,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,20-מאי-82,07:00,0,-14,-35.04791667,Days,Demographics,Weight,75.7,.,kg,.,.,.,.,.,.,1,8043,2681,999
.,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,19-יונ-82,07:00,0,0,-5.047916667,Days,Demographics,Weight,73.2,.,kg,.,.,.,.,.,.,1,8043,2681,999
.,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,23-יונ-82,15:41,0,0,-0.686111111,Days,PD,Efficacy marker,36.566,.,mm,.,.,.,.,.,.,1,8043,2681,999
.,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,20-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8043,2681,999
.,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,24-יונ-82,08:09,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8043,2681,999
.,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,20-מאי-82,07:00,0,12,14.20622809,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8043,2681,999
.,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,17-יול-82,12:59,0,28,23.20138889,Days,PD,Efficacy marker,34.976,.,mm,.,.,.,.,.,.,1,8043,2681,999
.,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,22-יול-82,08:09,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8043,2681,999
.,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,19-אוג-82,08:09,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8043,2681,999
.,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,03-ספט-82,08:22,0,56,71.00902778,Days,PD,Efficacy marker,34.847,.,mm,.,.,.,.,.,.,1,8043,2681,999
.,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,16-ספט-82,08:09,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8043,2681,999
.,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,22-ספט-82,18:02,0,84,90.41180556,Days,PD,Efficacy marker,34.805,.,mm,.,.,.,.,.,.,1,8043,2681,999
.,ZY300808043,Z,Y3,Profiling Study 1,1,0,8,8043,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,14-אוק-82,13:00,0,112,112.2020833,Days,PD,Efficacy marker,35.792,.,mm,.,.,.,.,.,.,1,8043,2681,999
.,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,20-מאי-82,07:00,0,-14,-35.04583333,Days,Demographics,Age,51,.,Years,.,.,.,.,.,.,1,8045,2681.666667,999
.,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,20-מאי-82,07:00,0,-14,-35.04583333,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,8045,2681.666667,999
.,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,20-מאי-82,07:00,0,-14,-35.04583333,Days,Demographics,Weight,95.3,.,kg,.,.,.,.,.,.,1,8045,2681.666667,999
.,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-יונ-82,07:00,0,0,-5.045833333,Days,Demographics,Weight,95.2,.,kg,.,.,.,.,.,.,1,8045,2681.666667,999
.,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,19-יונ-82,09:55,0,0,-4.924305556,Days,PD,Efficacy marker,54.17,.,mm,.,.,.,.,.,.,1,8045,2681.666667,999
.,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,20-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8045,2681.666667,999
.,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,24-יונ-82,08:06,0.083333333,0,0,Days,Dose,Dose Z,485,.,mg,.,.,iv,.,.,.,1,8045,2681.666667,999
.,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,20-מאי-82,07:00,0,12,13.37565012,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8045,2681.666667,999
.,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,17-יול-82,10:03,0,28,23.08125,Days,PD,Efficacy marker,55.516,.,mm,.,.,.,.,.,.,1,8045,2681.666667,999
.,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,22-יול-82,08:06,0.083333333,28,28,Days,Dose,Dose Z,493.5,.,mg,.,.,iv,.,.,.,1,8045,2681.666667,999
.,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,14-אוג-82,10:00,0,56,51.07916667,Days,PD,Efficacy marker,56.436,.,mm,.,.,.,.,.,.,1,8045,2681.666667,999
.,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,19-אוג-82,08:06,0.083333333,56,56,Days,Dose,Dose Z,495.5,.,mg,.,.,iv,.,.,.,1,8045,2681.666667,999
.,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,12-ספט-82,10:09,0,84,80.08541667,Days,PD,Efficacy marker,57.564,.,mm,.,.,.,.,.,.,1,8045,2681.666667,999
.,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,16-ספט-82,08:06,0.083333333,84,84,Days,Dose,Dose Z,486,.,mg,.,.,iv,.,.,.,1,8045,2681.666667,999
.,ZY300808045,Z,Y3,Profiling Study 1,1,0,8,8045,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,14-אוק-82,10:15,0,112,112.0895833,Days,PD,Efficacy marker,60.41,.,mm,.,.,.,.,.,.,1,8045,2681.666667,999
.,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מאי-82,07:00,0,-14,-39.04166667,Days,Demographics,Age,59,.,Years,.,.,.,.,.,.,1,8048,2682.666667,999
.,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מאי-82,07:00,0,-14,-39.04166667,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,8048,2682.666667,999
.,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מאי-82,07:00,0,-14,-39.04166667,Days,Demographics,Weight,69.9,.,kg,.,.,.,.,.,.,1,8048,2682.666667,999
.,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,30-יונ-82,07:00,0,0,-5.041666667,Days,Demographics,Weight,70.4,.,kg,.,.,.,.,.,.,1,8048,2682.666667,999
.,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,30-יונ-82,08:48,0,0,-4.966666667,Days,PD,Efficacy marker,43.953,.,mm,.,.,.,.,.,.,1,8048,2682.666667,999
.,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,8048,2682.666667,999
.,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,05-יול-82,08:00,0.083333333,0,0,Days,Dose,Dose Z,354.5,.,mg,.,.,iv,.,.,.,1,8048,2682.666667,999
.,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-מאי-82,07:00,0,12,13.70041827,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,8048,2682.666667,999
.,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,28-יול-82,08:27,0,28,23.01875,Days,PD,Efficacy marker,46.346,.,mm,.,.,.,.,.,.,1,8048,2682.666667,999
.,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,02-אוג-82,08:00,0.083333333,28,28,Days,Dose,Dose Z,344,.,mg,.,.,iv,.,.,.,1,8048,2682.666667,999
.,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,25-אוג-82,08:30,0,56,51.02083333,Days,PD,Efficacy marker,45.963,.,mm,.,.,.,.,.,.,1,8048,2682.666667,999
.,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,30-אוג-82,08:00,0.083333333,56,56,Days,Dose,Dose Z,340.5,.,mg,.,.,iv,.,.,.,1,8048,2682.666667,999
.,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,22-ספט-82,08:40,0,84,79.02777778,Days,PD,Efficacy marker,46.117,.,mm,.,.,.,.,.,.,1,8048,2682.666667,999
.,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,27-ספט-82,08:00,0.083333333,84,84,Days,Dose,Dose Z,342,.,mg,.,.,iv,.,.,.,1,8048,2682.666667,999
.,ZY300808048,Z,Y3,Profiling Study 1,1,0,8,8048,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,27-אוק-82,08:40,0,112,114.0277778,Days,PD,Efficacy marker,47.1,.,mm,.,.,.,.,.,.,1,8048,2682.666667,999
.,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-מאי-82,07:00,0,-14,-39.04375,Days,Demographics,Age,69,.,Years,.,.,.,.,.,.,1,8052,2684,999
.,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-מאי-82,07:00,0,-14,-39.04375,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,8052,2684,999
.,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-מאי-82,07:00,0,-14,-39.04375,Days,Demographics,Weight,86.4,.,kg,.,.,.,.,.,.,1,8052,2684,999
.,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,30-יונ-82,07:00,0,0,-5.04375,Days,Demographics,Weight,87.3,.,kg,.,.,.,.,.,.,1,8052,2684,999
.,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,30-יונ-82,09:56,0,0,-4.921527778,Days,PD,Efficacy marker,41.563,.,mm,.,.,.,.,.,.,1,8052,2684,999
.,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,8052,2684,999
.,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,05-יול-82,08:03,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8052,2684,999
.,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-מאי-82,07:00,0,12,13.73730429,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,8052,2684,999
.,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,28-יול-82,10:05,0,28,23.08472222,Days,PD,Efficacy marker,39.331,.,mm,.,.,.,.,.,.,1,8052,2684,999
.,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,02-אוג-82,08:03,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8052,2684,999
.,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,25-אוג-82,09:54,0,56,51.07708333,Days,PD,Efficacy marker,40.588,.,mm,.,.,.,.,.,.,1,8052,2684,999
.,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,30-אוג-82,08:03,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8052,2684,999
.,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,22-ספט-82,10:18,0,84,79.09375,Days,PD,Efficacy marker,40.293,.,mm,.,.,.,.,.,.,1,8052,2684,999
.,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,27-ספט-82,08:03,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8052,2684,999
.,ZY300808052,Z,Y3,Profiling Study 1,1,0,8,8052,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,27-אוק-82,10:03,0,112,114.0833333,Days,PD,Efficacy marker,40.507,.,mm,.,.,.,.,.,.,1,8052,2684,999
.,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-יונ-82,07:00,0,-14,-24.04583333,Days,Demographics,Age,50,.,Years,.,.,.,.,.,.,1,8053,2684.333333,999
.,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-יונ-82,07:00,0,-14,-24.04583333,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,8053,2684.333333,999
.,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-יונ-82,07:00,0,-14,-24.04583333,Days,Demographics,Weight,82.1,.,kg,.,.,.,.,.,.,1,8053,2684.333333,999
.,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,30-יונ-82,07:00,0,0,-5.045833333,Days,Demographics,Weight,82.3,.,kg,.,.,.,.,.,.,1,8053,2684.333333,999
.,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,30-יונ-82,11:22,0,0,-4.863888889,Days,PD,Efficacy marker,55.053,.,mm,.,.,.,.,.,.,1,8053,2684.333333,999
.,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-יונ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8053,2684.333333,999
.,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,05-יול-82,08:06,0.083333333,0,0,Days,Dose,Dose Z,414.5,.,mg,.,.,iv,.,.,.,1,8053,2684.333333,999
.,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-יונ-82,07:00,0,12,13.90412156,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,8053,2684.333333,999
.,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,28-יול-82,11:32,0,28,23.14305556,Days,PD,Efficacy marker,57.838,.,mm,.,.,.,.,.,.,1,8053,2684.333333,999
.,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,02-אוג-82,08:06,0.083333333,28,28,Days,Dose,Dose Z,415,.,mg,.,.,iv,.,.,.,1,8053,2684.333333,999
.,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,25-אוג-82,11:18,0,56,51.13333333,Days,PD,Efficacy marker,57.828,.,mm,.,.,.,.,.,.,1,8053,2684.333333,999
.,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,30-אוג-82,08:06,0.083333333,56,56,Days,Dose,Dose Z,410.5,.,mg,.,.,iv,.,.,.,1,8053,2684.333333,999
.,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,22-ספט-82,11:51,0,84,79.15625,Days,PD,Efficacy marker,59.375,.,mm,.,.,.,.,.,.,1,8053,2684.333333,999
.,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,27-ספט-82,08:06,0.083333333,84,84,Days,Dose,Dose Z,413.5,.,mg,.,.,iv,.,.,.,1,8053,2684.333333,999
.,ZY300808053,Z,Y3,Profiling Study 1,1,0,8,8053,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,27-אוק-82,11:24,0,112,114.1375,Days,PD,Efficacy marker,58.831,.,mm,.,.,.,.,.,.,1,8053,2684.333333,999
.,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,11-יונ-82,07:00,0,-14,-24.04791667,Days,Demographics,Age,57,.,Years,.,.,.,.,.,.,1,8054,2684.666667,999
.,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,11-יונ-82,07:00,0,-14,-24.04791667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,8054,2684.666667,999
.,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,11-יונ-82,07:00,0,-14,-24.04791667,Days,Demographics,Weight,52,.,kg,.,.,.,.,.,.,1,8054,2684.666667,999
.,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,30-יונ-82,07:00,0,0,-5.047916667,Days,Demographics,Weight,51.7,.,kg,.,.,.,.,.,.,1,8054,2684.666667,999
.,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,30-יונ-82,13:03,0,0,-4.795833333,Days,PD,Efficacy marker,31.874,.,mm,.,.,.,.,.,.,1,8054,2684.666667,999
.,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,11-יונ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8054,2684.666667,999
.,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,05-יול-82,08:09,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8054,2684.666667,999
.,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,11-יונ-82,07:00,0,12,14.28873463,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8054,2684.666667,999
.,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,28-יול-82,12:58,0,28,23.20069444,Days,PD,Efficacy marker,33.01,.,mm,.,.,.,.,.,.,1,8054,2684.666667,999
.,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,02-אוג-82,08:09,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8054,2684.666667,999
.,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,25-אוג-82,13:03,0,56,51.20416667,Days,PD,Efficacy marker,33.542,.,mm,.,.,.,.,.,.,1,8054,2684.666667,999
.,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,30-אוג-82,08:09,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8054,2684.666667,999
.,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,22-ספט-82,14:04,0,84,79.24652778,Days,PD,Efficacy marker,32.902,.,mm,.,.,.,.,.,.,1,8054,2684.666667,999
.,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,27-ספט-82,08:09,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8054,2684.666667,999
.,ZY300808054,Z,Y3,Profiling Study 1,1,0,8,8054,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,27-אוק-82,13:03,0,112,114.2041667,Days,PD,Efficacy marker,32.102,.,mm,.,.,.,.,.,.,1,8054,2684.666667,999
.,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-יונ-82,07:00,0,-14,-34.04375,Days,Demographics,Age,58,.,Years,.,.,.,.,.,.,1,8056,2685.333333,999
.,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-יונ-82,07:00,0,-14,-34.04375,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,8056,2685.333333,999
.,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-יונ-82,07:00,0,-14,-34.04375,Days,Demographics,Weight,86.1,.,kg,.,.,.,.,.,.,1,8056,2685.333333,999
.,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,10-יול-82,07:00,0,0,-5.04375,Days,Demographics,Weight,85.1,.,kg,.,.,.,.,.,.,1,8056,2685.333333,999
.,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,10-יול-82,08:31,0,0,-4.980555556,Days,PD,Efficacy marker,50.812,.,mm,.,.,.,.,.,.,1,8056,2685.333333,999
.,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-יונ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,8056,2685.333333,999
.,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,15-יול-82,08:03,0.083333333,0,0,Days,Dose,Dose Z,424,.,mg,.,.,iv,.,.,.,1,8056,2685.333333,999
.,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-יונ-82,07:00,0,12,13.89411283,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8056,2685.333333,999
.,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-אוג-82,08:43,0,28,23.02777778,Days,PD,Efficacy marker,53.023,.,mm,.,.,.,.,.,.,1,8056,2685.333333,999
.,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,12-אוג-82,08:03,0.083333333,28,28,Days,Dose,Dose Z,432,.,mg,.,.,iv,.,.,.,1,8056,2685.333333,999
.,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,05-ספט-82,17:46,0,56,52.40486111,Days,PD,Efficacy marker,52.745,.,mm,.,.,.,.,.,.,1,8056,2685.333333,999
.,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,09-ספט-82,08:03,0.083333333,56,56,Days,Dose,Dose Z,430,.,mg,.,.,iv,.,.,.,1,8056,2685.333333,999
.,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-אוק-82,08:31,0,84,79.01944444,Days,PD,Efficacy marker,53.747,.,mm,.,.,.,.,.,.,1,8056,2685.333333,999
.,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,07-אוק-82,08:03,0.083333333,84,84,Days,Dose,Dose Z,434.5,.,mg,.,.,iv,.,.,.,1,8056,2685.333333,999
.,ZY300808056,Z,Y3,Profiling Study 1,1,0,8,8056,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,04-נוב-82,09:07,0,112,112.0444444,Days,PD,Efficacy marker,52.702,.,mm,.,.,.,.,.,.,1,8056,2685.333333,999
.,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,11-יונ-82,07:00,0,-14,-34.04166667,Days,Demographics,Age,72,.,Years,.,.,.,.,.,.,1,8057,2685.666667,999
.,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,11-יונ-82,07:00,0,-14,-34.04166667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,8057,2685.666667,999
.,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,11-יונ-82,07:00,0,-14,-34.04166667,Days,Demographics,Weight,54.3,.,kg,.,.,.,.,.,.,1,8057,2685.666667,999
.,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,10-יול-82,06:56,0,0,-5.044444444,Days,PD,Efficacy marker,23.67,.,mm,.,.,.,.,.,.,1,8057,2685.666667,999
.,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,10-יול-82,07:00,0,0,-5.041666667,Days,Demographics,Weight,54.3,.,kg,.,.,.,.,.,.,1,8057,2685.666667,999
.,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,11-יונ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,8057,2685.666667,999
.,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,15-יול-82,08:00,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8057,2685.666667,999
.,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,11-יונ-82,07:00,0,12,13.13285829,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8057,2685.666667,999
.,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,07-אוג-82,06:58,0,28,22.95694444,Days,PD,Efficacy marker,23.097,.,mm,.,.,.,.,.,.,1,8057,2685.666667,999
.,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,12-אוג-82,08:00,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8057,2685.666667,999
.,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,04-ספט-82,07:04,0,56,50.96111111,Days,PD,Efficacy marker,23.666,.,mm,.,.,.,.,.,.,1,8057,2685.666667,999
.,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,09-ספט-82,08:00,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8057,2685.666667,999
.,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,02-אוק-82,07:21,0,84,78.97291667,Days,PD,Efficacy marker,23.638,.,mm,.,.,.,.,.,.,1,8057,2685.666667,999
.,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,07-אוק-82,08:00,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8057,2685.666667,999
.,ZY300808057,Z,Y3,Profiling Study 1,1,0,8,8057,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,04-נוב-82,07:09,0,112,111.9645833,Days,PD,Efficacy marker,22.66,.,mm,.,.,.,.,.,.,1,8057,2685.666667,999
.,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-יונ-82,07:00,0,-14,-34.04583333,Days,Demographics,Age,65,.,Years,.,.,.,.,.,.,1,8058,2686,999
.,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-יונ-82,07:00,0,-14,-34.04583333,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,8058,2686,999
.,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-יונ-82,07:00,0,-14,-34.04583333,Days,Demographics,Weight,70.8,.,kg,.,.,.,.,.,.,1,8058,2686,999
.,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,10-יול-82,07:00,0,0,-5.045833333,Days,Demographics,Weight,72.6,.,kg,.,.,.,.,.,.,1,8058,2686,999
.,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,10-יול-82,09:57,0,0,-4.922916667,Days,PD,Efficacy marker,33.935,.,mm,.,.,.,.,.,.,1,8058,2686,999
.,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-יונ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8058,2686,999
.,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,15-יול-82,08:06,0.083333333,0,0,Days,Dose,Dose Z,352.5,.,mg,.,.,iv,.,.,.,1,8058,2686,999
.,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,11-יונ-82,07:00,0,12,13.0901041,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8058,2686,999
.,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,07-אוג-82,10:05,0,28,23.08263889,Days,PD,Efficacy marker,35.112,.,mm,.,.,.,.,.,.,1,8058,2686,999
.,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,12-אוג-82,08:06,0.083333333,28,28,Days,Dose,Dose Z,361.5,.,mg,.,.,iv,.,.,.,1,8058,2686,999
.,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,04-ספט-82,10:23,0,56,51.09513889,Days,PD,Efficacy marker,35.538,.,mm,.,.,.,.,.,.,1,8058,2686,999
.,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,09-ספט-82,08:06,0.083333333,56,56,Days,Dose,Dose Z,353,.,mg,.,.,iv,.,.,.,1,8058,2686,999
.,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,02-אוק-82,10:03,0,84,79.08125,Days,PD,Efficacy marker,36.011,.,mm,.,.,.,.,.,.,1,8058,2686,999
.,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,07-אוק-82,08:06,0.083333333,84,84,Days,Dose,Dose Z,352.5,.,mg,.,.,iv,.,.,.,1,8058,2686,999
.,ZY300808058,Z,Y3,Profiling Study 1,1,0,8,8058,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-נוב-82,18:43,0,112,125.4423611,Days,PD,Efficacy marker,36.104,.,mm,.,.,.,.,.,.,1,8058,2686,999
.,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-יונ-82,07:00,0,-14,-28.04791667,Days,Demographics,Age,61,.,Years,.,.,.,.,.,.,1,8059,2686.333333,999
.,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-יונ-82,07:00,0,-14,-28.04791667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,8059,2686.333333,999
.,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-יונ-82,07:00,0,-14,-28.04791667,Days,Demographics,Weight,66.9,.,kg,.,.,.,.,.,.,1,8059,2686.333333,999
.,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,10-יול-82,07:00,0,0,-5.047916667,Days,Demographics,Weight,66.3,.,kg,.,.,.,.,.,.,1,8059,2686.333333,999
.,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,10-יול-82,11:33,0,0,-4.858333333,Days,PD,Efficacy marker,27.463,.,mm,.,.,.,.,.,.,1,8059,2686.333333,999
.,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-יונ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8059,2686.333333,999
.,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,15-יול-82,08:09,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8059,2686.333333,999
.,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,17-יונ-82,07:00,0,12,13.03309698,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8059,2686.333333,999
.,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,07-אוג-82,11:36,0,28,23.14375,Days,PD,Efficacy marker,28.294,.,mm,.,.,.,.,.,.,1,8059,2686.333333,999
.,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,12-אוג-82,08:09,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8059,2686.333333,999
.,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,04-ספט-82,11:52,0,56,51.15486111,Days,PD,Efficacy marker,28.44,.,mm,.,.,.,.,.,.,1,8059,2686.333333,999
.,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,09-ספט-82,08:09,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8059,2686.333333,999
.,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,02-אוק-82,11:47,0,84,79.15138889,Days,PD,Efficacy marker,28.956,.,mm,.,.,.,.,.,.,1,8059,2686.333333,999
.,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,07-אוק-82,08:09,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8059,2686.333333,999
.,ZY300808059,Z,Y3,Profiling Study 1,1,0,8,8059,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,04-נוב-82,11:35,0,112,112.1430556,Days,PD,Efficacy marker,28.473,.,mm,.,.,.,.,.,.,1,8059,2686.333333,999
.,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-יונ-82,07:00,0,-14,-29.04583333,Days,Demographics,Age,65,.,Years,.,.,.,.,.,.,1,8060,2686.666667,999
.,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-יונ-82,07:00,0,-14,-29.04583333,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,8060,2686.666667,999
.,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-יונ-82,07:00,0,-14,-29.04583333,Days,Demographics,Weight,77.2,.,kg,.,.,.,.,.,.,1,8060,2686.666667,999
.,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-יול-82,07:00,0,0,-5.045833333,Days,Demographics,Weight,78.3,.,kg,.,.,.,.,.,.,1,8060,2686.666667,999
.,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,23-יול-82,09:14,0,0,-2.952777778,Days,PD,Efficacy marker,41.363,.,mm,.,.,.,.,.,.,1,8060,2686.666667,999
.,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-יונ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,8060,2686.666667,999
.,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,26-יול-82,08:06,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8060,2686.666667,999
.,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-יונ-82,07:00,0,12,14.21826936,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8060,2686.666667,999
.,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,18-אוג-82,10:19,0,28,23.09236111,Days,PD,Efficacy marker,40.208,.,mm,.,.,.,.,.,.,1,8060,2686.666667,999
.,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,23-אוג-82,08:06,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8060,2686.666667,999
.,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,16-ספט-82,10:01,0,56,52.07986111,Days,PD,Efficacy marker,39.837,.,mm,.,.,.,.,.,.,1,8060,2686.666667,999
.,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,20-ספט-82,08:06,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8060,2686.666667,999
.,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,13-אוק-82,09:15,0,84,79.04791667,Days,PD,Efficacy marker,37.799,.,mm,.,.,.,.,.,.,1,8060,2686.666667,999
.,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,18-אוק-82,08:06,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8060,2686.666667,999
.,ZY300808060,Z,Y3,Profiling Study 1,1,0,8,8060,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,17-נוב-82,10:01,0,112,114.0798611,Days,PD,Efficacy marker,39.238,.,mm,.,.,.,.,.,.,1,8060,2686.666667,999
.,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-יונ-82,07:00,0,-14,-29.04791667,Days,Demographics,Age,61,.,Years,.,.,.,.,.,.,1,8061,2687,999
.,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-יונ-82,07:00,0,-14,-29.04791667,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,8061,2687,999
.,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-יונ-82,07:00,0,-14,-29.04791667,Days,Demographics,Weight,85.3,.,kg,.,.,.,.,.,.,1,8061,2687,999
.,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-יול-82,07:00,0,0,-5.047916667,Days,Demographics,Weight,85.1,.,kg,.,.,.,.,.,.,1,8061,2687,999
.,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,23-יול-82,15:49,0,0,-2.680555556,Days,PD,Efficacy marker,50.484,.,mm,.,.,.,.,.,.,1,8061,2687,999
.,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-יונ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8061,2687,999
.,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,26-יול-82,08:09,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8061,2687,999
.,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-יונ-82,07:00,0,12,13.51952482,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8061,2687,999
.,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,18-אוג-82,11:53,0,28,23.15555556,Days,PD,Efficacy marker,52.129,.,mm,.,.,.,.,.,.,1,8061,2687,999
.,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,23-אוג-82,08:09,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8061,2687,999
.,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,16-ספט-82,11:52,0,56,52.15486111,Days,PD,Efficacy marker,50.84,.,mm,.,.,.,.,.,.,1,8061,2687,999
.,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,20-ספט-82,08:09,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8061,2687,999
.,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,13-אוק-82,10:47,0,84,79.10972222,Days,PD,Efficacy marker,51.254,.,mm,.,.,.,.,.,.,1,8061,2687,999
.,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,18-אוק-82,08:09,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8061,2687,999
.,ZY300808061,Z,Y3,Profiling Study 1,1,0,8,8061,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,17-נוב-82,11:41,0,112,114.1472222,Days,PD,Efficacy marker,50.987,.,mm,.,.,.,.,.,.,1,8061,2687,999
.,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-יונ-82,07:00,0,-14,-29.04375,Days,Demographics,Age,69,.,Years,.,.,.,.,.,.,1,8063,2687.666667,999
.,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-יונ-82,07:00,0,-14,-29.04375,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,8063,2687.666667,999
.,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-יונ-82,07:00,0,-14,-29.04375,Days,Demographics,Weight,85.4,.,kg,.,.,.,.,.,.,1,8063,2687.666667,999
.,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-יול-82,07:00,0,0,-5.04375,Days,Demographics,Weight,89.1,.,kg,.,.,.,.,.,.,1,8063,2687.666667,999
.,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,3,VISIT 03,1,0,21-יול-82,09:27,0,0,-4.941666667,Days,PD,Efficacy marker,48.372,.,mm,.,.,.,.,.,.,1,8063,2687.666667,999
.,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-יונ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8063,2687.666667,999
.,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,4,VISIT 04,1,0,26-יול-82,08:03,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8063,2687.666667,999
.,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,1,SCREENING,0,1,27-יונ-82,07:00,0,12,14.51457973,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,8063,2687.666667,999
.,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,18-אוג-82,09:08,0,28,23.04513889,Days,PD,Efficacy marker,48.337,.,mm,.,.,.,.,.,.,1,8063,2687.666667,999
.,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,5,VISIT 05,0,0,23-אוג-82,08:03,0.083333333,28,28,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8063,2687.666667,999
.,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,16-ספט-82,08:24,0,56,52.01458333,Days,PD,Efficacy marker,47.543,.,mm,.,.,.,.,.,.,1,8063,2687.666667,999
.,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,6,VISIT 06,0,0,20-ספט-82,08:03,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8063,2687.666667,999
.,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,14-אוק-82,11:32,0,84,80.14513889,Days,PD,Efficacy marker,48.835,.,mm,.,.,.,.,.,.,1,8063,2687.666667,999
.,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,7,VISIT 07,0,0,18-אוק-82,08:03,0.083333333,84,84,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8063,2687.666667,999
.,ZY300808063,Z,Y3,Profiling Study 1,1,0,8,8063,Healthy volunteers,MD IV Placebo,MD IV Placebo,10,VISIT 10,0,0,17-נוב-82,08:32,0,112,114.0201389,Days,PD,Efficacy marker,49.957,.,mm,.,.,.,.,.,.,1,8063,2687.666667,999
.,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-יונ-82,07:00,0,-14,-29.04166667,Days,Demographics,Age,52,.,Years,.,.,.,.,.,.,1,8064,2688,999
.,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-יונ-82,07:00,0,-14,-29.04166667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,8064,2688,999
.,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-יונ-82,07:00,0,-14,-29.04166667,Days,Demographics,Weight,69.6,.,kg,.,.,.,.,.,.,1,8064,2688,999
.,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,21-יול-82,07:00,0,0,-5.041666667,Days,Demographics,Weight,70.8,.,kg,.,.,.,.,.,.,1,8064,2688,999
.,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,3,VISIT 03,1,0,21-יול-82,08:41,0,0,-4.971527778,Days,PD,Efficacy marker,33.414,.,mm,.,.,.,.,.,.,1,8064,2688,999
.,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-יונ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,8064,2688,999
.,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,4,VISIT 04,1,0,26-יול-82,08:00,0.083333333,0,0,Days,Dose,Dose Z,347,.,mg,.,.,iv,.,.,.,1,8064,2688,999
.,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,1,SCREENING,0,1,27-יונ-82,07:00,0,12,13.51609865,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8064,2688,999
.,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,18-אוג-82,06:58,0,28,22.95694444,Days,PD,Efficacy marker,35.229,.,mm,.,.,.,.,.,.,1,8064,2688,999
.,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,5,VISIT 05,0,0,23-אוג-82,08:00,0.083333333,28,28,Days,Dose,Dose Z,357,.,mg,.,.,iv,.,.,.,1,8064,2688,999
.,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,17-ספט-82,07:01,0,56,52.95902778,Days,PD,Efficacy marker,36.601,.,mm,.,.,.,.,.,.,1,8064,2688,999
.,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,6,VISIT 06,0,0,20-ספט-82,08:00,0.083333333,56,56,Days,Dose,Dose Z,357.5,.,mg,.,.,iv,.,.,.,1,8064,2688,999
.,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,14-אוק-82,13:45,0,84,80.23958333,Days,PD,Efficacy marker,37.061,.,mm,.,.,.,.,.,.,1,8064,2688,999
.,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,7,VISIT 07,0,0,18-אוק-82,08:00,0.083333333,84,84,Days,Dose,Dose Z,357,.,mg,.,.,iv,.,.,.,1,8064,2688,999
.,ZY300808064,Z,Y3,Profiling Study 1,1,0,8,8064,Healthy volunteers,MD IV 5mg/kg,MD IV 5mg/kg,10,VISIT 10,0,0,17-נוב-82,07:04,0,112,113.9611111,Days,PD,Efficacy marker,37.767,.,mm,.,.,.,.,.,.,1,8064,2688,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,24-אפר-81,07:00,0,-14,-22.11527778,Days,Demographics,Age,75,.,Years,.,.,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,24-אפר-81,07:00,0,-14,-22.11527778,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,24-אפר-81,07:00,0,-14,-22.11527778,Days,Demographics,Weight,70.9,.,kg,.,.,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,04-מאי-81,11:55,0,0,-11.91041667,Days,PD,Efficacy marker,38.138,.,mm,.,.,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,09-מאי-81,07:00,0,0,-7.115277778,Days,Demographics,Weight,70.3,.,kg,.,.,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,16-מאי-81,07:00,0,0,-0.115277778,Days,Demographics,Weight,70.5,.,kg,.,.,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,24-אפר-81,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,16-מאי-81,09:46,0.083333333,0,0,Days,Dose,Dose Z,1057.5,.,mg,.,.,iv,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,16-מאי-81,11:58,0,0.0833,0.091666667,Days,PK,Plasma concentration Z,1458,.,ug/ml,.,0.8,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,16-מאי-81,15:46,0,0.25,0.25,Days,PK,Plasma concentration Z,1322.001,.,ug/ml,.,0.8,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,23-מאי-81,08:08,0,7,6.931944444,Days,PK,Plasma concentration Z,344.001,.,ug/ml,.,0.8,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,24-אפר-81,07:00,0,12,14.13764058,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,31-מאי-81,08:51,0,14,14.96180556,Days,PK,Plasma concentration Z,207.999,.,ug/ml,.,0.8,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,03-יונ-81,09:32,0,14,17.99027778,Days,PD,Efficacy marker,39.388,.,mm,.,.,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,13-יונ-81,09:45,0,28,27.99930556,Days,PK,Plasma concentration Z,122.199,.,ug/ml,.,0.8,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,14-יונ-81,09:49,0,28,29.00208333,Days,PD,Efficacy marker,39.189,.,mm,.,.,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,27-יונ-81,09:50,0,42,42.00277778,Days,PK,Plasma concentration Z,61.8,.,ug/ml,.,0.8,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,10-יול-81,09:24,0,56,54.98472222,Days,PK,Plasma concentration Z,46.2,.,ug/ml,.,0.8,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,11-יול-81,09:39,0,56,55.99513889,Days,PD,Efficacy marker,39.326,.,mm,.,.,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,25-יול-81,08:50,0,70,69.96111111,Days,PK,Plasma concentration Z,25.401,.,ug/ml,.,0.8,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,07-אוג-81,08:00,0,84,82.92638889,Days,PK,Plasma concentration Z,13.959,.,ug/ml,.,0.8,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,04-ספט-81,08:18,0,112,110.9388889,Days,PK,Plasma concentration Z,1.719,.,ug/ml,.,0.8,.,.,.,.,1,5067,1689,999
.,ZY800505067,Z,Y8,PoC Study Indication 1,1,0,5,5067,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,04-ספט-81,12:22,0,112,111.1083333,Days,PD,Efficacy marker,38.424,.,mm,.,.,.,.,.,.,1,5067,1689,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,26-יונ-81,07:00,0,-14,-14.98333333,Days,Demographics,Age,80,.,Years,.,.,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,26-יונ-81,07:00,0,-14,-14.98333333,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,26-יונ-81,07:00,0,-14,-14.98333333,Days,Demographics,Weight,77.3,.,kg,.,.,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,03-יול-81,07:00,0,0,-7.983333333,Days,Demographics,Weight,78.6,.,kg,.,.,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,04-יול-81,10:25,0,0,-6.840972222,Days,PD,Efficacy marker,38.908,.,mm,.,.,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,26-יונ-81,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-יול-81,06:05,0,0,-0.021527778,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-יול-81,06:36,0.083333333,0,0,Days,Dose,Dose Z,1179,.,mg,.,.,iv,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-יול-81,07:00,0,0,0.016666667,Days,Demographics,Weight,78.6,.,kg,.,.,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-יול-81,09:28,0,0.166,0.119444444,Days,PK,Plasma concentration Z,1227.999,.,ug/ml,.,0.8,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-יול-81,12:30,0,0.25,0.245833333,Days,PK,Plasma concentration Z,1226.001,.,ug/ml,.,0.8,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,18-יול-81,07:25,0,7,7.034027778,Days,PK,Plasma concentration Z,288,.,ug/ml,.,0.8,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,25-יול-81,07:18,0,14,14.02916667,Days,PK,Plasma concentration Z,173.199,.,ug/ml,.,0.8,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,26-יונ-81,07:00,0,12,14.05231134,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,25-יול-81,13:35,0,14,14.29097222,Days,PD,Efficacy marker,39.075,.,mm,.,.,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,08-אוג-81,08:27,0,28,28.07708333,Days,PK,Plasma concentration Z,95.799,.,ug/ml,.,0.8,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,09-אוג-81,12:14,0,28,29.23472222,Days,PD,Efficacy marker,39.711,.,mm,.,.,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,22-אוג-81,07:14,0,42,42.02638889,Days,PK,Plasma concentration Z,50.001,.,ug/ml,.,0.8,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,05-ספט-81,08:41,0,56,56.08680556,Days,PK,Plasma concentration Z,31.8,.,ug/ml,.,0.8,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,05-ספט-81,13:50,0,56,56.30138889,Days,PD,Efficacy marker,39.191,.,mm,.,.,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,20-ספט-81,08:16,0,70,71.06944444,Days,PK,Plasma concentration Z,17.079,.,ug/ml,.,0.8,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,04-אוק-81,07:41,0,84,85.04513889,Days,PK,Plasma concentration Z,7.941,.,ug/ml,.,0.8,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,31-אוק-81,08:01,0,112,112.0590278,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5070,1690,999
.,ZY800505070,Z,Y8,PoC Study Indication 1,1,0,5,5070,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,12-נוב-81,14:27,0,112,124.3270833,Days,PD,Efficacy marker,38.914,.,mm,.,.,.,.,.,.,1,5070,1690,999
.,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,04-יול-81,07:00,0,0,-7.020833333,Days,Demographics,Weight,66.4,.,kg,.,.,.,.,.,.,1,5071,1690.333333,999
.,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,05-יול-81,11:49,0,0,-5.820138889,Days,PD,Efficacy marker,22.899,.,mm,.,.,.,.,.,.,1,5071,1690.333333,999
.,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,04-יול-81,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,5071,1690.333333,999
.,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,11-יול-81,07:00,0,0,-0.020833333,Days,Demographics,Weight,65,.,kg,.,.,.,.,.,.,1,5071,1690.333333,999
.,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,11-יול-81,07:30,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5071,1690.333333,999
.,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,05-יול-81,11:49,0,12,13.71255697,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,5071,1690.333333,999
.,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,25-יול-81,12:35,0,14,14.21180556,Days,PD,Efficacy marker,22.639,.,mm,.,.,.,.,.,.,1,5071,1690.333333,999
.,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,09-אוג-81,10:04,0,28,29.10694444,Days,PD,Efficacy marker,22.829,.,mm,.,.,.,.,.,.,1,5071,1690.333333,999
.,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,06-ספט-81,12:25,0,56,57.20486111,Days,PD,Efficacy marker,22.212,.,mm,.,.,.,.,.,.,1,5071,1690.333333,999
.,ZY800505071,Z,Y8,PoC Study Indication 1,1,0,5,5071,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,06-נוב-81,10:27,0,112,118.1229167,Days,PD,Efficacy marker,22.093,.,mm,.,.,.,.,.,.,1,5071,1690.333333,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,28-יונ-81,07:00,0,-14,-13.0625,Days,Demographics,Age,68,.,Years,.,.,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,28-יונ-81,07:00,0,-14,-13.0625,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,28-יונ-81,07:00,0,-14,-13.0625,Days,Demographics,Weight,70,.,kg,.,.,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,04-יול-81,11:40,0,0,-6.868055556,Days,PD,Efficacy marker,33.268,.,mm,.,.,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,05-יול-81,07:00,0,0,-6.0625,Days,Demographics,Weight,68.6,.,kg,.,.,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,28-יונ-81,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-יול-81,07:00,0,0,-0.0625,Days,Demographics,Weight,66.4,.,kg,.,.,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-יול-81,07:58,0,0,-0.022222222,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-יול-81,08:30,0.083333333,0,0,Days,Dose,Dose Z,996,.,mg,.,.,iv,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-יול-81,11:04,0,0.166,0.106944444,Days,PK,Plasma concentration Z,1545.999,.,ug/ml,.,0.8,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-יול-81,14:34,0,0.25,0.252777778,Days,PK,Plasma concentration Z,1452,.,ug/ml,.,0.8,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,18-יול-81,10:20,0,7,7.076388889,Days,PK,Plasma concentration Z,368.001,.,ug/ml,.,0.8,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,28-יונ-81,07:00,0,12,14.86063743,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,14-אוג-81,10:45,0,28,34.09375,Days,PK,Plasma concentration Z,96.399,.,ug/ml,.,0.8,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,14-אוג-81,15:48,0,28,34.30416667,Days,PD,Efficacy marker,34.854,.,mm,.,.,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,22-אוג-81,10:49,0,42,42.09652778,Days,PK,Plasma concentration Z,79.8,.,ug/ml,.,0.8,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,05-ספט-81,11:20,0,56,56.11805556,Days,PK,Plasma concentration Z,56.799,.,ug/ml,.,0.8,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,05-ספט-81,14:25,0,56,56.24652778,Days,PD,Efficacy marker,35.094,.,mm,.,.,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,20-ספט-81,09:52,0,70,71.05694444,Days,PK,Plasma concentration Z,26.601,.,ug/ml,.,0.8,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,03-אוק-81,09:18,0,84,84.03333333,Days,PK,Plasma concentration Z,17.88,.,ug/ml,.,0.8,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,31-אוק-81,10:40,0,112,112.0902778,Days,PK,Plasma concentration Z,2.361,.,ug/ml,.,0.8,.,.,.,.,1,5072,1690.666667,999
.,ZY800505072,Z,Y8,PoC Study Indication 1,1,0,5,5072,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,31-אוק-81,12:47,0,112,112.1784722,Days,PD,Efficacy marker,34.222,.,mm,.,.,.,.,.,.,1,5072,1690.666667,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,09-אוק-81,07:00,0,-14,-15.05277778,Days,Demographics,Age,68,.,Years,.,.,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,09-אוק-81,07:00,0,-14,-15.05277778,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,09-אוק-81,07:00,0,-14,-15.05277778,Days,Demographics,Weight,63.4,.,kg,.,.,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,17-אוק-81,07:00,0,0,-7.052777778,Days,Demographics,Weight,63,.,kg,.,.,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,17-אוק-81,13:45,0,0,-6.771527778,Days,PD,Efficacy marker,23.956,.,mm,.,.,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,09-אוק-81,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,24-אוק-81,07:00,0,0,-0.052777778,Days,Demographics,Weight,62.7,.,kg,.,.,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,24-אוק-81,07:05,0,0,-0.049305556,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,24-אוק-81,08:16,0.083333333,0,0,Days,Dose,Dose Z,940.5,.,mg,.,.,iv,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,24-אוק-81,10:34,0,0.0833,0.095833333,Days,PK,Plasma concentration Z,1394.001,.,ug/ml,.,0.8,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,24-אוק-81,14:16,0,0.25,0.25,Days,PK,Plasma concentration Z,1656,.,ug/ml,.,0.8,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,31-אוק-81,09:16,0,7,7.041666667,Days,PK,Plasma concentration Z,351.999,.,ug/ml,.,0.8,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,09-אוק-81,07:00,0,12,13.59219159,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,07-נוב-81,08:13,0,14,13.99791667,Days,PK,Plasma concentration Z,234,.,ug/ml,.,0.8,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,08-נוב-81,15:03,0,14,15.28263889,Days,PD,Efficacy marker,25.014,.,mm,.,.,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,21-נוב-81,08:57,0,28,28.02847222,Days,PK,Plasma concentration Z,87.399,.,ug/ml,.,0.8,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,21-נוב-81,12:13,0,28,28.16458333,Days,PD,Efficacy marker,26.037,.,mm,.,.,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,05-דצמ-81,08:18,0,42,42.00138889,Days,PK,Plasma concentration Z,58.599,.,ug/ml,.,0.8,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,19-דצמ-81,08:29,0,56,56.00902778,Days,PK,Plasma concentration Z,27.201,.,ug/ml,.,0.8,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,26-דצמ-81,11:04,0,56,63.11666667,Days,PD,Efficacy marker,25.916,.,mm,.,.,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,02-ינו-82,07:35,0,70,69.97152778,Days,PK,Plasma concentration Z,10.959,.,ug/ml,.,0.8,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,16-ינו-82,07:46,0,84,83.97916667,Days,PK,Plasma concentration Z,3.081,.,ug/ml,.,0.8,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,13-פבר-82,09:06,0,112,112.0347222,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,5077,1692.333333,999
.,ZY800505077,Z,Y8,PoC Study Indication 1,1,0,5,5077,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,13-פבר-82,12:10,0,112,112.1625,Days,PD,Efficacy marker,25.608,.,mm,.,.,.,.,.,.,1,5077,1692.333333,999
.,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,24-דצמ-81,07:00,0,-14,-15.02638889,Days,Demographics,Age,65,.,Years,.,.,.,.,.,.,1,5078,1692.666667,999
.,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,24-דצמ-81,07:00,0,-14,-15.02638889,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,5078,1692.666667,999
.,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,24-דצמ-81,07:00,0,-14,-15.02638889,Days,Demographics,Weight,75.9,.,kg,.,.,.,.,.,.,1,5078,1692.666667,999
.,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,02-ינו-82,07:00,0,0,-6.026388889,Days,Demographics,Weight,76.3,.,kg,.,.,.,.,.,.,1,5078,1692.666667,999
.,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,02-ינו-82,12:04,0,0,-5.815277778,Days,PD,Efficacy marker,40.263,.,mm,.,.,.,.,.,.,1,5078,1692.666667,999
.,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,24-דצמ-81,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,5078,1692.666667,999
.,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,08-ינו-82,07:00,0,0,-0.026388889,Days,Demographics,Weight,75.9,.,kg,.,.,.,.,.,.,1,5078,1692.666667,999
.,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,08-ינו-82,07:38,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,5078,1692.666667,999
.,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,24-דצמ-81,07:00,0,12,13.26741081,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,5078,1692.666667,999
.,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,23-ינו-82,09:05,0,14,15.06041667,Days,PD,Efficacy marker,39.447,.,mm,.,.,.,.,.,.,1,5078,1692.666667,999
.,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,05-פבר-82,06:20,0,28,27.94583333,Days,PD,Efficacy marker,40.276,.,mm,.,.,.,.,.,.,1,5078,1692.666667,999
.,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,05-מרץ-82,11:18,0,56,56.15277778,Days,PD,Efficacy marker,40.103,.,mm,.,.,.,.,.,.,1,5078,1692.666667,999
.,ZY800505078,Z,Y8,PoC Study Indication 1,1,0,5,5078,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,30-אפר-82,10:40,0,112,112.1263889,Days,PD,Efficacy marker,40.488,.,mm,.,.,.,.,.,.,1,5078,1692.666667,999
.,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,27-אוג-81,07:00,0,-14,-27.02430556,Days,Demographics,Age,74,.,Years,.,.,.,.,.,.,1,6073,2024.333333,999
.,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,27-אוג-81,07:00,0,-14,-27.02430556,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,6073,2024.333333,999
.,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,27-אוג-81,07:00,0,-14,-27.02430556,Days,Demographics,Weight,66.4,.,kg,.,.,.,.,.,.,1,6073,2024.333333,999
.,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,13-ספט-81,07:00,0,0,-10.02430556,Days,Demographics,Weight,66.8,.,kg,.,.,.,.,.,.,1,6073,2024.333333,999
.,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,19-ספט-81,13:32,0,0,-3.752083333,Days,PD,Efficacy marker,32.401,.,mm,.,.,.,.,.,.,1,6073,2024.333333,999
.,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,27-אוג-81,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,6073,2024.333333,999
.,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,23-ספט-81,07:00,0,0,-0.024305556,Days,Demographics,Weight,66.8,.,kg,.,.,.,.,.,.,1,6073,2024.333333,999
.,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,23-ספט-81,07:35,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,6073,2024.333333,999
.,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,27-אוג-81,07:00,0,12,13.09904762,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,6073,2024.333333,999
.,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,07-אוק-81,12:49,0,14,14.21805556,Days,PD,Efficacy marker,33.085,.,mm,.,.,.,.,.,.,1,6073,2024.333333,999
.,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,18-נוב-81,14:08,0,56,56.27291667,Days,PD,Efficacy marker,32.756,.,mm,.,.,.,.,.,.,1,6073,2024.333333,999
.,ZY800606073,Z,Y8,PoC Study Indication 1,1,0,6,6073,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,13-ינו-82,12:19,0,112,112.1972222,Days,PD,Efficacy marker,33.53,.,mm,.,.,.,.,.,.,1,6073,2024.333333,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-ספט-81,07:00,0,-14,-26,Days,Demographics,Age,65,.,Years,.,.,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-ספט-81,07:00,0,-14,-26,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-ספט-81,07:00,0,-14,-26,Days,Demographics,Weight,91.81,.,kg,.,.,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,17-ספט-81,07:00,0,0,-13,Days,Demographics,Weight,91.36,.,kg,.,.,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,19-ספט-81,14:05,0,0,-10.70486111,Days,PD,Efficacy marker,37.516,.,mm,.,.,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-ספט-81,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-ספט-81,06:55,0,0,-0.003472222,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-ספט-81,07:00,0.083333333,0,0,Days,Dose,Dose Z,1370.4,.,mg,.,.,iv,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-ספט-81,07:00,0,0,0,Days,Demographics,Weight,91.36,.,kg,.,.,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-ספט-81,08:50,0,0.0833,0.076388889,Days,PK,Plasma concentration Z,1476,.,ug/ml,.,0.8,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-ספט-81,12:55,0,0.25,0.246527778,Days,PK,Plasma concentration Z,1352.001,.,ug/ml,.,0.8,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,07-אוק-81,07:28,0,7,7.019444444,Days,PK,Plasma concentration Z,356.001,.,ug/ml,.,0.8,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,14-אוק-81,07:35,0,14,14.02430556,Days,PK,Plasma concentration Z,213.999,.,ug/ml,.,0.8,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-ספט-81,07:00,0,12,14.17235114,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,28-אוק-81,09:05,0,28,28.08680556,Days,PK,Plasma concentration Z,90.399,.,ug/ml,.,0.8,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,28-אוק-81,13:06,0,28,28.25416667,Days,PD,Efficacy marker,38.991,.,mm,.,.,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,12-נוב-81,07:30,0,42,43.02083333,Days,PK,Plasma concentration Z,42,.,ug/ml,.,0.8,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,25-נוב-81,06:12,0,56,55.96666667,Days,PK,Plasma concentration Z,24.999,.,ug/ml,.,0.8,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,25-נוב-81,13:22,0,56,56.26527778,Days,PD,Efficacy marker,38.99,.,mm,.,.,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,09-דצמ-81,07:16,0,70,70.01111111,Days,PK,Plasma concentration Z,11.679,.,ug/ml,.,0.8,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,23-דצמ-81,07:39,0,84,84.02708333,Days,PK,Plasma concentration Z,3.939,.,ug/ml,.,0.8,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,20-ינו-82,07:27,0,112,112.01875,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,6075,2025,999
.,ZY800606075,Z,Y8,PoC Study Indication 1,1,0,6,6075,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,20-ינו-82,13:02,0,112,112.2513889,Days,PD,Efficacy marker,38.135,.,mm,.,.,.,.,.,.,1,6075,2025,999
.,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,03-ספט-81,07:00,0,-14,-27.02083333,Days,Demographics,Age,72,.,Years,.,.,.,.,.,.,1,6076,2025.333333,999
.,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,03-ספט-81,07:00,0,-14,-27.02083333,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,6076,2025.333333,999
.,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,03-ספט-81,07:00,0,-14,-27.02083333,Days,Demographics,Weight,81.36,.,kg,.,.,.,.,.,.,1,6076,2025.333333,999
.,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,12-ספט-81,07:00,0,0,-18.02083333,Days,Demographics,Weight,80.45,.,kg,.,.,.,.,.,.,1,6076,2025.333333,999
.,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,16-ספט-81,13:53,0,0,-13.73402778,Days,PD,Efficacy marker,23.076,.,mm,.,.,.,.,.,.,1,6076,2025.333333,999
.,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,03-ספט-81,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,6076,2025.333333,999
.,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,30-ספט-81,07:00,0,0,-0.020833333,Days,Demographics,Weight,80.45,.,kg,.,.,.,.,.,.,1,6076,2025.333333,999
.,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,30-ספט-81,07:30,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,6076,2025.333333,999
.,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,03-ספט-81,07:00,0,12,13.03815201,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,6076,2025.333333,999
.,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,14-אוק-81,14:08,0,14,14.27638889,Days,PD,Efficacy marker,22.683,.,mm,.,.,.,.,.,.,1,6076,2025.333333,999
.,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,28-אוק-81,13:48,0,28,28.2625,Days,PD,Efficacy marker,23.269,.,mm,.,.,.,.,.,.,1,6076,2025.333333,999
.,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,25-נוב-81,13:45,0,56,56.26041667,Days,PD,Efficacy marker,23.465,.,mm,.,.,.,.,.,.,1,6076,2025.333333,999
.,ZY800606076,Z,Y8,PoC Study Indication 1,1,0,6,6076,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,20-ינו-82,12:35,0,112,112.2118056,Days,PD,Efficacy marker,24.19,.,mm,.,.,.,.,.,.,1,6076,2025.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,15-ינו-82,07:00,0,-14,-26.98958333,Days,Demographics,Age,65,.,Years,.,.,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,15-ינו-82,07:00,0,-14,-26.98958333,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,15-ינו-82,07:00,0,-14,-26.98958333,Days,Demographics,Weight,67.7,.,kg,.,.,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,04-פבר-82,12:25,0,0,-6.763888889,Days,PD,Efficacy marker,26.035,.,mm,.,.,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,15-ינו-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-פבר-82,06:44,0,0,-0.000694444,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-פבר-82,06:45,0.083333333,0,0,Days,Dose,Dose Z,1015.8,.,mg,.,.,iv,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-פבר-82,07:00,0,0,0.010416667,Days,Demographics,Weight,67.72,.,kg,.,.,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-פבר-82,08:46,0,0.0833,0.084027778,Days,PK,Plasma concentration Z,1094.001,.,ug/ml,.,0.8,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,11-פבר-82,12:45,0,0.25,0.25,Days,PK,Plasma concentration Z,1230,.,ug/ml,.,0.8,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,18-פבר-82,07:42,0,7,7.039583333,Days,PK,Plasma concentration Z,336,.,ug/ml,.,0.8,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,25-פבר-82,09:12,0,14,14.10208333,Days,PK,Plasma concentration Z,264,.,ug/ml,.,0.8,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,25-פבר-82,12:53,0,14,14.25555556,Days,PD,Efficacy marker,27.461,.,mm,.,.,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,15-ינו-82,07:00,0,12,14.87279328,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,13-מרץ-82,09:02,0,28,30.09513889,Days,PK,Plasma concentration Z,135.201,.,ug/ml,.,0.8,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,25-מרץ-82,07:35,0,42,42.03472222,Days,PK,Plasma concentration Z,83.199,.,ug/ml,.,0.8,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,08-אפר-82,07:23,0,56,56.02638889,Days,PK,Plasma concentration Z,68.199,.,ug/ml,.,0.8,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,08-אפר-82,12:45,0,56,56.25,Days,PD,Efficacy marker,30.128,.,mm,.,.,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,22-אפר-82,07:36,0,70,70.03541667,Days,PK,Plasma concentration Z,45.201,.,ug/ml,.,0.8,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,06-מאי-82,08:05,0,84,84.05555556,Days,PK,Plasma concentration Z,26.601,.,ug/ml,.,0.8,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,02-יונ-82,07:42,0,112,111.0395833,Days,PK,Plasma concentration Z,5.001,.,ug/ml,.,0.8,.,.,.,.,1,6079,2026.333333,999
.,ZY800606079,Z,Y8,PoC Study Indication 1,1,0,6,6079,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,03-יונ-82,13:02,0,112,112.2618056,Days,PD,Efficacy marker,30.468,.,mm,.,.,.,.,.,.,1,6079,2026.333333,999
.,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,07-מאי-82,07:00,0,-14,-28.22916667,Days,Demographics,Age,70,.,Years,.,.,.,.,.,.,1,6094,2031.333333,999
.,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,07-מאי-82,07:00,0,-14,-28.22916667,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,6094,2031.333333,999
.,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,07-מאי-82,07:00,0,-14,-28.22916667,Days,Demographics,Weight,100,.,kg,.,.,.,.,.,.,1,6094,2031.333333,999
.,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,28-מאי-82,07:00,0,0,-7.229166667,Days,Demographics,Weight,100,.,kg,.,.,.,.,.,.,1,6094,2031.333333,999
.,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,28-מאי-82,12:39,0,0,-6.99375,Days,PD,Efficacy marker,43.465,.,mm,.,.,.,.,.,.,1,6094,2031.333333,999
.,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,04-יונ-82,07:00,0,0,-0.229166667,Days,Demographics,Weight,100,.,kg,.,.,.,.,.,.,1,6094,2031.333333,999
.,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,07-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,6094,2031.333333,999
.,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,04-יונ-82,12:30,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,6094,2031.333333,999
.,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,18-יונ-82,12:46,0,14,14.01111111,Days,PD,Efficacy marker,43.888,.,mm,.,.,.,.,.,.,1,6094,2031.333333,999
.,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,07-מאי-82,07:00,0,12,14.45951436,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,6094,2031.333333,999
.,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,02-יול-82,11:09,0,28,27.94375,Days,PD,Efficacy marker,43.951,.,mm,.,.,.,.,.,.,1,6094,2031.333333,999
.,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,30-יול-82,06:47,0.083333333,56,55.76180556,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,6094,2031.333333,999
.,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,30-יול-82,12:26,0,56,55.99722222,Days,PD,Efficacy marker,43.806,.,mm,.,.,.,.,.,.,1,6094,2031.333333,999
.,ZY800606094,Z,Y8,PoC Study Indication 1,1,0,6,6094,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,24-ספט-82,12:33,0,112,112.0020833,Days,PD,Efficacy marker,42.806,.,mm,.,.,.,.,.,.,1,6094,2031.333333,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,08-מאי-82,07:00,0,-14,-26,Days,Demographics,Age,69,.,Years,.,.,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,08-מאי-82,07:00,0,-14,-26,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,08-מאי-82,07:00,0,-14,-26,Days,Demographics,Weight,73.63,.,kg,.,.,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,22-מאי-82,07:00,0,0,-12,Days,Demographics,Weight,73.18,.,kg,.,.,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,02-יונ-82,12:25,0,0,-0.774305556,Days,PD,Efficacy marker,26.207,.,mm,.,.,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,08-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,03-יונ-82,06:50,0,0,-0.006944444,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,03-יונ-82,07:00,0.083333333,0,0,Days,Dose,Dose Z,1097.7,.,mg,.,.,iv,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,03-יונ-82,07:00,0,0,0,Days,Demographics,Weight,73.18,.,kg,.,.,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,03-יונ-82,08:55,0,0.0833,0.079861111,Days,PK,Plasma concentration Z,1569.999,.,ug/ml,.,0.8,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,03-יונ-82,13:00,0,0.25,0.25,Days,PK,Plasma concentration Z,1806,.,ug/ml,.,0.8,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,4,VISIT 04,0,0,10-יונ-82,07:30,0,7,7.020833333,Days,PK,Plasma concentration Z,477.999,.,ug/ml,.,0.8,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,08-מאי-82,07:00,0,12,13.52848296,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,17-יונ-82,07:23,0,14,14.01597222,Days,PK,Plasma concentration Z,314.001,.,ug/ml,.,0.8,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,18-יונ-82,11:02,0,14,15.16805556,Days,PD,Efficacy marker,27.825,.,mm,.,.,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,08-יול-82,08:30,0,28,35.0625,Days,PK,Plasma concentration Z,137.199,.,ug/ml,.,0.8,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,10-יול-82,12:40,0,28,37.23611111,Days,PD,Efficacy marker,27.841,.,mm,.,.,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,7,VISIT 07,0,0,15-יול-82,07:30,0,42,42.02083333,Days,PK,Plasma concentration Z,121.401,.,ug/ml,.,0.8,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,29-יול-82,12:01,0,56,56.20902778,Days,PD,Efficacy marker,28.518,.,mm,.,.,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,30-יול-82,06:35,0,56,56.98263889,Days,PK,Plasma concentration Z,74.001,.,ug/ml,.,0.8,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,30-יול-82,06:45,0.083333333,56,56.98958333,Days,Dose,Dose Z,1104.45,.,mg,.,.,iv,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,30-יול-82,08:50,0,56,57.07638889,Days,PK,Plasma concentration Z,2120.001,.,ug/ml,.,0.8,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,9,VISIT 09,0,0,12-אוג-82,07:27,0,70,70.01875,Days,PK,Plasma concentration Z,380.001,.,ug/ml,.,0.8,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,10,VISIT 10,0,0,26-אוג-82,08:15,0,84,84.05208333,Days,PK,Plasma concentration Z,243.999,.,ug/ml,.,0.8,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,23-ספט-82,06:25,0,112,111.9756944,Days,PK,Plasma concentration Z,110.001,.,ug/ml,.,0.8,.,.,.,.,1,6095,2031.666667,999
.,ZY800606095,Z,Y8,PoC Study Indication 1,1,0,6,6095,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,23-ספט-82,12:32,0,112,112.2305556,Days,PD,Efficacy marker,28.432,.,mm,.,.,.,.,.,.,1,6095,2031.666667,999
.,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,08-מאי-82,07:00,0,-14,-32.125,Days,Demographics,Age,74,.,Years,.,.,.,.,.,.,1,6096,2032,999
.,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,08-מאי-82,07:00,0,-14,-32.125,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,6096,2032,999
.,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,08-מאי-82,07:00,0,-14,-32.125,Days,Demographics,Weight,76.81,.,kg,.,.,.,.,.,.,1,6096,2032,999
.,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,04-יונ-82,07:00,0,0,-5.125,Days,Demographics,Weight,76.81,.,kg,.,.,.,.,.,.,1,6096,2032,999
.,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,04-יונ-82,12:50,0,0,-4.881944444,Days,PD,Efficacy marker,20.58,.,mm,.,.,.,.,.,.,1,6096,2032,999
.,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,09-יונ-82,07:00,0,0,-0.125,Days,Demographics,Weight,76.59,.,kg,.,.,.,.,.,.,1,6096,2032,999
.,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,08-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,6096,2032,999
.,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,09-יונ-82,10:00,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,6096,2032,999
.,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,08-מאי-82,07:00,0,12,13.86466398,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,6096,2032,999
.,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,24-יונ-82,11:41,0,14,15.07013889,Days,PD,Efficacy marker,20.131,.,mm,.,.,.,.,.,.,1,6096,2032,999
.,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,07-יול-82,12:53,0,28,28.12013889,Days,PD,Efficacy marker,20.691,.,mm,.,.,.,.,.,.,1,6096,2032,999
.,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,05-אוג-82,07:55,0.083333333,56,56.91319444,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,6096,2032,999
.,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,06-אוג-82,12:34,0,56,58.10694444,Days,PD,Efficacy marker,20.908,.,mm,.,.,.,.,.,.,1,6096,2032,999
.,ZY800606096,Z,Y8,PoC Study Indication 1,1,0,6,6096,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,29-ספט-82,13:02,0,112,112.1263889,Days,PD,Efficacy marker,20.83,.,mm,.,.,.,.,.,.,1,6096,2032,999
.,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,18-יול-82,07:00,0,-14,-26.99305556,Days,Demographics,Age,65,.,Years,.,.,.,.,.,.,1,6104,2034.666667,999
.,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,18-יול-82,07:00,0,-14,-26.99305556,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,6104,2034.666667,999
.,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,18-יול-82,07:00,0,-14,-26.99305556,Days,Demographics,Weight,61.81,.,kg,.,.,.,.,.,.,1,6104,2034.666667,999
.,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,07-אוג-82,07:00,0,0,-6.993055556,Days,Demographics,Weight,62.27,.,kg,.,.,.,.,.,.,1,6104,2034.666667,999
.,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,07-אוג-82,13:20,0,0,-6.729166667,Days,PD,Efficacy marker,24.185,.,mm,.,.,.,.,.,.,1,6104,2034.666667,999
.,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,18-יול-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,6104,2034.666667,999
.,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,14-אוג-82,06:50,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,6104,2034.666667,999
.,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,14-אוג-82,07:00,0,0,0.006944444,Days,Demographics,Weight,62.27,.,kg,.,.,.,.,.,.,1,6104,2034.666667,999
.,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,18-יול-82,07:00,0,12,13.85750866,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,6104,2034.666667,999
.,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,28-אוג-82,13:06,0,14,14.26111111,Days,PD,Efficacy marker,23.097,.,mm,.,.,.,.,.,.,1,6104,2034.666667,999
.,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,10-ספט-82,13:16,0,28,27.26805556,Days,PD,Efficacy marker,25.62,.,mm,.,.,.,.,.,.,1,6104,2034.666667,999
.,ZY800606104,Z,Y8,PoC Study Indication 1,1,0,6,6104,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,09-אוק-82,07:00,0.083333333,56,56.00694444,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,6104,2034.666667,999
.,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,12-יונ-81,07:00,0,-14,-22.04513889,Days,Demographics,Age,77,.,Years,.,.,.,.,.,.,1,7068,2356,999
.,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,12-יונ-81,07:00,0,-14,-22.04513889,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,7068,2356,999
.,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,12-יונ-81,07:00,0,-14,-22.04513889,Days,Demographics,Weight,63,.,kg,.,.,.,.,.,.,1,7068,2356,999
.,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,19-יונ-81,11:49,0,0,-14.84444444,Days,PD,Efficacy marker,32.149,.,mm,.,.,.,.,.,.,1,7068,2356,999
.,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,21-יונ-81,07:00,0,0,-13.04513889,Days,Demographics,Weight,63,.,kg,.,.,.,.,.,.,1,7068,2356,999
.,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,12-יונ-81,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,7068,2356,999
.,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,04-יול-81,07:00,0,0,-0.045138889,Days,Demographics,Weight,63,.,kg,.,.,.,.,.,.,1,7068,2356,999
.,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,04-יול-81,08:05,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7068,2356,999
.,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,17-יול-81,11:49,0,14,13.15555556,Days,PD,Efficacy marker,30.937,.,mm,.,.,.,.,.,.,1,7068,2356,999
.,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,12-יונ-81,07:00,0,12,13.97948157,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7068,2356,999
.,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,31-יול-81,12:45,0,28,27.19444444,Days,PD,Efficacy marker,29.129,.,mm,.,.,.,.,.,.,1,7068,2356,999
.,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,28-אוג-81,11:48,0,56,55.15486111,Days,PD,Efficacy marker,28.854,.,mm,.,.,.,.,.,.,1,7068,2356,999
.,ZY800707068,Z,Y8,PoC Study Indication 1,1,0,7,7068,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,23-אוק-81,10:54,0,112,111.1173611,Days,PD,Efficacy marker,26.897,.,mm,.,.,.,.,.,.,1,7068,2356,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,20-יונ-81,07:00,0,-14,-14.04861111,Days,Demographics,Age,71,.,Years,.,.,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,20-יונ-81,07:00,0,-14,-14.04861111,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,20-יונ-81,07:00,0,-14,-14.04861111,Days,Demographics,Weight,72,.,kg,.,.,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,20-יונ-81,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-יול-81,07:00,0,0,-0.048611111,Days,Demographics,Weight,76,.,kg,.,.,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-יול-81,07:53,0,0,-0.011805556,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-יול-81,08:10,0.083333333,0,0,Days,Dose,Dose Z,1140,.,mg,.,.,iv,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,19-יונ-81,12:58,0,0,0,Days,PD,Efficacy marker,39.898,.,mm,.,.,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-יול-81,10:06,0,0.0833,0.080555556,Days,PK,Plasma concentration Z,1112.001,.,ug/ml,.,0.8,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-יול-81,14:10,0,0.25,0.25,Days,PK,Plasma concentration Z,1128,.,ug/ml,.,0.8,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,10-יול-81,08:15,0,7,6.003472222,Days,PK,Plasma concentration Z,342,.,ug/ml,.,0.8,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,17-יול-81,08:18,0,14,13.00555556,Days,PK,Plasma concentration Z,234,.,ug/ml,.,0.8,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,17-יול-81,11:19,0,14,13.13125,Days,PD,Efficacy marker,41.965,.,mm,.,.,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,20-יונ-81,07:00,0,12,13.83145242,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,31-יול-81,07:00,0,28,26.95138889,Days,PK,Plasma concentration Z,117.6,.,ug/ml,.,0.8,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,31-יול-81,13:19,0,28,27.21458333,Days,PD,Efficacy marker,42.835,.,mm,.,.,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,14-אוג-81,07:50,0,42,40.98611111,Days,PK,Plasma concentration Z,55.2,.,ug/ml,.,0.8,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,28-אוג-81,08:00,0,56,54.99305556,Days,PK,Plasma concentration Z,35.601,.,ug/ml,.,0.8,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,28-אוג-81,12:46,0,56,55.19166667,Days,PD,Efficacy marker,41.47,.,mm,.,.,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,12-ספט-81,08:27,0,70,70.01180556,Days,PK,Plasma concentration Z,18.159,.,ug/ml,.,0.8,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,25-ספט-81,08:43,0,84,83.02291667,Days,PK,Plasma concentration Z,9.321,.,ug/ml,.,0.8,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,23-אוק-81,07:25,0,112,110.96875,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,7069,2356.333333,999
.,ZY800707069,Z,Y8,PoC Study Indication 1,1,0,7,7069,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,11,VISIT 11,0,0,23-אוק-81,11:27,0,112,111.1368056,Days,PD,Efficacy marker,41.031,.,mm,.,.,.,.,.,.,1,7069,2356.333333,999
.,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,28-אוג-81,07:00,0,-14,-21.96875,Days,Demographics,Age,65,.,Years,.,.,.,.,.,.,1,7074,2358,999
.,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,28-אוג-81,07:00,0,-14,-21.96875,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,7074,2358,999
.,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,28-אוג-81,07:00,0,-14,-21.96875,Days,Demographics,Weight,91.5,.,kg,.,.,.,.,.,.,1,7074,2358,999
.,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,12-ספט-81,07:00,0,0,-6.96875,Days,Demographics,Weight,93,.,kg,.,.,.,.,.,.,1,7074,2358,999
.,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,17-ספט-81,13:23,0,0,-1.702777778,Days,PD,Efficacy marker,45.246,.,mm,.,.,.,.,.,.,1,7074,2358,999
.,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,28-אוג-81,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,7074,2358,999
.,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,19-ספט-81,06:15,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,7074,2358,999
.,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,19-ספט-81,07:00,0,0,0.03125,Days,Demographics,Weight,91.5,.,kg,.,.,.,.,.,.,1,7074,2358,999
.,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,02-אוק-81,15:10,0,14,13.37152778,Days,PD,Efficacy marker,46.934,.,mm,.,.,.,.,.,.,1,7074,2358,999
.,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,28-אוג-81,07:00,0,12,14.78477838,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,7074,2358,999
.,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,16-אוק-81,13:51,0,28,27.31666667,Days,PD,Efficacy marker,47.862,.,mm,.,.,.,.,.,.,1,7074,2358,999
.,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,03-דצמ-81,15:14,0,56,75.37430556,Days,PD,Efficacy marker,47.9,.,mm,.,.,.,.,.,.,1,7074,2358,999
.,ZY800707074,Z,Y8,PoC Study Indication 1,1,0,7,7074,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,08-ינו-82,14:56,0,112,111.3618056,Days,PD,Efficacy marker,46.304,.,mm,.,.,.,.,.,.,1,7074,2358,999
.,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,28-אפר-82,07:00,0,-14,-24.01527778,Days,Demographics,Age,76,.,Years,.,.,.,.,.,.,1,8093,2697.666667,999
.,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,28-אפר-82,07:00,0,-14,-24.01527778,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,8093,2697.666667,999
.,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,28-אפר-82,07:00,0,-14,-24.01527778,Days,Demographics,Weight,72,.,kg,.,.,.,.,.,.,1,8093,2697.666667,999
.,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,15-מאי-82,09:21,0,0,-6.917361111,Days,PD,Efficacy marker,26.611,.,mm,.,.,.,.,.,.,1,8093,2697.666667,999
.,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,20-מאי-82,07:00,0,0,-2.015277778,Days,Demographics,Weight,72,.,kg,.,.,.,.,.,.,1,8093,2697.666667,999
.,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,28-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8093,2697.666667,999
.,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,22-מאי-82,07:00,0,0,-0.015277778,Days,Demographics,Weight,72,.,kg,.,.,.,.,.,.,1,8093,2697.666667,999
.,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,22-מאי-82,07:22,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8093,2697.666667,999
.,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,28-אפר-82,07:00,0,12,13.07085783,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,8093,2697.666667,999
.,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,05-יונ-82,09:36,0,14,14.09305556,Days,PD,Efficacy marker,25.605,.,mm,.,.,.,.,.,.,1,8093,2697.666667,999
.,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,20-יונ-82,07:32,0,28,29.00694444,Days,PD,Efficacy marker,25.485,.,mm,.,.,.,.,.,.,1,8093,2697.666667,999
.,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,16-יול-82,09:42,0,56,55.09722222,Days,PD,Efficacy marker,26.912,.,mm,.,.,.,.,.,.,1,8093,2697.666667,999
.,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,17-יול-82,07:10,0.083333333,56,55.99166667,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8093,2697.666667,999
.,ZY800808093,Z,Y8,PoC Study Indication 1,1,0,8,8093,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,09-ספט-82,09:27,0,112,110.0868056,Days,PD,Efficacy marker,27.451,.,mm,.,.,.,.,.,.,1,8093,2697.666667,999
.,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,10-אפר-82,07:00,0,-14,-60,Days,Demographics,Age,73,.,Years,.,.,.,.,.,.,1,8099,2699.666667,999
.,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,10-אפר-82,07:00,0,-14,-60,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,8099,2699.666667,999
.,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,10-אפר-82,07:00,0,-14,-60,Days,Demographics,Weight,66.8,.,kg,.,.,.,.,.,.,1,8099,2699.666667,999
.,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,09-מאי-82,08:58,0,0,-30.91805556,Days,PD,Efficacy marker,26.434,.,mm,.,.,.,.,.,.,1,8099,2699.666667,999
.,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,28-מאי-82,07:00,0,0,-12,Days,Demographics,Weight,68,.,kg,.,.,.,.,.,.,1,8099,2699.666667,999
.,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,10-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,8099,2699.666667,999
.,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,09-יונ-82,07:00,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8099,2699.666667,999
.,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,09-יונ-82,07:00,0,0,0,Days,Demographics,Weight,67,.,kg,.,.,.,.,.,.,1,8099,2699.666667,999
.,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,23-יונ-82,09:56,0,14,14.12222222,Days,PD,Efficacy marker,25.978,.,mm,.,.,.,.,.,.,1,8099,2699.666667,999
.,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,10-אפר-82,07:00,0,12,14.17530405,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,8099,2699.666667,999
.,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,07-יול-82,09:08,0,28,28.08888889,Days,PD,Efficacy marker,27.553,.,mm,.,.,.,.,.,.,1,8099,2699.666667,999
.,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,05-אוג-82,07:15,0.083333333,56,57.01041667,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,8099,2699.666667,999
.,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,06-אוג-82,09:10,0,56,58.09027778,Days,PD,Efficacy marker,27.163,.,mm,.,.,.,.,.,.,1,8099,2699.666667,999
.,ZY800808099,Z,Y8,PoC Study Indication 1,1,0,8,8099,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,30-ספט-82,09:56,0,112,113.1222222,Days,PD,Efficacy marker,27.483,.,mm,.,.,.,.,.,.,1,8099,2699.666667,999
.,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,20-מרץ-82,07:00,0,-14,-29.00138889,Days,Demographics,Age,76,.,Years,.,.,.,.,.,.,1,9080,3026.666667,999
.,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,20-מרץ-82,07:00,0,-14,-29.00138889,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,9080,3026.666667,999
.,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,20-מרץ-82,07:00,0,-14,-29.00138889,Days,Demographics,Weight,71.8,.,kg,.,.,.,.,.,.,1,9080,3026.666667,999
.,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,11-אפר-82,07:00,0,0,-7.001388889,Days,Demographics,Weight,71.3,.,kg,.,.,.,.,.,.,1,9080,3026.666667,999
.,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,16-אפר-82,15:07,0,0,-1.663194444,Days,PD,Efficacy marker,21.921,.,mm,.,.,.,.,.,.,1,9080,3026.666667,999
.,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,20-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,9080,3026.666667,999
.,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,18-אפר-82,07:00,0,0,-0.001388889,Days,Demographics,Weight,71.8,.,kg,.,.,.,.,.,.,1,9080,3026.666667,999
.,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,18-אפר-82,07:02,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,9080,3026.666667,999
.,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,02-מאי-82,18:37,0,14,14.48263889,Days,PD,Efficacy marker,22.528,.,mm,.,.,.,.,.,.,1,9080,3026.666667,999
.,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,20-מרץ-82,07:00,0,12,14.67298268,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,9080,3026.666667,999
.,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,17-מאי-82,12:27,0,28,29.22569444,Days,PD,Efficacy marker,22.235,.,mm,.,.,.,.,.,.,1,9080,3026.666667,999
.,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,13-יונ-82,07:02,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,9080,3026.666667,999
.,ZY800909080,Z,Y8,PoC Study Indication 1,1,0,9,9080,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,13-יונ-82,15:05,0,56,56.33541667,Days,PD,Efficacy marker,22.255,.,mm,.,.,.,.,.,.,1,9080,3026.666667,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,20-מרץ-82,07:00,0,-14,-29.00694444,Days,Demographics,Age,86,.,Years,.,.,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,20-מרץ-82,07:00,0,-14,-29.00694444,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,20-מרץ-82,07:00,0,-14,-29.00694444,Days,Demographics,Weight,76.2,.,kg,.,.,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,01-אפר-82,17:20,0,0,-16.57638889,Days,PD,Efficacy marker,30.239,.,mm,.,.,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,11-אפר-82,07:00,0,0,-7.006944444,Days,Demographics,Weight,74.5,.,kg,.,.,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,20-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,18-אפר-82,07:00,0,0,-0.006944444,Days,Demographics,Weight,75.2,.,kg,.,.,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,18-אפר-82,07:07,0,0,-0.002083333,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,18-אפר-82,07:10,0.083333333,0,0,Days,Dose,Dose Z,1128,.,mg,.,.,iv,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,18-אפר-82,09:10,0,0.0833,0.083333333,Days,PK,Plasma concentration Z,1292.001,.,ug/ml,.,0.8,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,18-אפר-82,13:10,0,0.25,0.25,Days,PK,Plasma concentration Z,1293.999,.,ug/ml,.,0.8,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,4,VISIT 04,0,0,25-אפר-82,07:10,0,7,7,Days,PK,Plasma concentration Z,351.999,.,ug/ml,.,0.8,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,20-מרץ-82,07:00,0,12,13.61806125,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,02-מאי-82,07:10,0,14,14,Days,PK,Plasma concentration Z,246,.,ug/ml,.,0.8,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,02-מאי-82,19:28,0,14,14.5125,Days,PD,Efficacy marker,32.49,.,mm,.,.,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,16-מאי-82,07:10,0,28,28,Days,PK,Plasma concentration Z,127.8,.,ug/ml,.,0.8,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,17-מאי-82,11:47,0,28,29.19236111,Days,PD,Efficacy marker,32.998,.,mm,.,.,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,7,VISIT 07,0,0,30-מאי-82,07:10,0,42,42,Days,PK,Plasma concentration Z,90.999,.,ug/ml,.,0.8,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,13-יונ-82,07:10,0.083333333,56,56,Days,Dose,Dose Z,1093.5,.,mg,.,.,iv,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,13-יונ-82,16:14,0,56,56.37777778,Days,PD,Efficacy marker,33.783,.,mm,.,.,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,9,VISIT 09,0,0,27-יונ-82,07:10,0,70,70,Days,PK,Plasma concentration Z,266.001,.,ug/ml,.,0.8,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,10,VISIT 10,0,0,11-יול-82,08:30,0,84,84.05555556,Days,PK,Plasma concentration Z,160.599,.,ug/ml,.,0.8,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,08-אוג-82,07:10,0,112,112,Days,PK,Plasma concentration Z,51.6,.,ug/ml,.,0.8,.,.,.,.,1,9081,3027,999
.,ZY800909081,Z,Y8,PoC Study Indication 1,1,0,9,9081,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,08-אוג-82,14:52,0,112,112.3208333,Days,PD,Efficacy marker,33.733,.,mm,.,.,.,.,.,.,1,9081,3027,999
.,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,24-מרץ-82,07:00,0,-14,-25.02083333,Days,Demographics,Age,73,.,Years,.,.,.,.,.,.,1,9082,3027.333333,999
.,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,24-מרץ-82,07:00,0,-14,-25.02083333,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,9082,3027.333333,999
.,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,24-מרץ-82,07:00,0,-14,-25.02083333,Days,Demographics,Weight,63.5,.,kg,.,.,.,.,.,.,1,9082,3027.333333,999
.,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,01-אפר-82,17:50,0,0,-16.56944444,Days,PD,Efficacy marker,21.425,.,mm,.,.,.,.,.,.,1,9082,3027.333333,999
.,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,11-אפר-82,07:00,0,0,-7.020833333,Days,Demographics,Weight,63,.,kg,.,.,.,.,.,.,1,9082,3027.333333,999
.,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,24-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,9082,3027.333333,999
.,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,18-אפר-82,07:00,0,0,-0.020833333,Days,Demographics,Weight,62.8,.,kg,.,.,.,.,.,.,1,9082,3027.333333,999
.,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,18-אפר-82,07:30,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,9082,3027.333333,999
.,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,02-מאי-82,20:05,0,14,14.52430556,Days,PD,Efficacy marker,21.63,.,mm,.,.,.,.,.,.,1,9082,3027.333333,999
.,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,24-מרץ-82,07:00,0,12,14.54827961,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,9082,3027.333333,999
.,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,17-מאי-82,11:14,0,28,29.15555556,Days,PD,Efficacy marker,21.451,.,mm,.,.,.,.,.,.,1,9082,3027.333333,999
.,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,13-יונ-82,07:30,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,9082,3027.333333,999
.,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,13-יונ-82,17:08,0,56,56.40138889,Days,PD,Efficacy marker,21.467,.,mm,.,.,.,.,.,.,1,9082,3027.333333,999
.,ZY800909082,Z,Y8,PoC Study Indication 1,1,0,9,9082,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,08-אוג-82,15:33,0,112,112.3354167,Days,PD,Efficacy marker,22.852,.,mm,.,.,.,.,.,.,1,9082,3027.333333,999
.,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,14-מרץ-82,07:00,0,-14,-41.97916667,Days,Demographics,Age,83,.,Years,.,.,.,.,.,.,1,9083,3027.666667,999
.,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,14-מרץ-82,07:00,0,-14,-41.97916667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,9083,3027.666667,999
.,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,14-מרץ-82,07:00,0,-14,-41.97916667,Days,Demographics,Weight,66.2,.,kg,.,.,.,.,.,.,1,9083,3027.666667,999
.,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,27-מרץ-82,19:13,0,0,-28.47013889,Days,PD,Efficacy marker,21.372,.,mm,.,.,.,.,.,.,1,9083,3027.666667,999
.,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,16-אפר-82,07:00,0,0,-8.979166667,Days,Demographics,Weight,67.8,.,kg,.,.,.,.,.,.,1,9083,3027.666667,999
.,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,14-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,9083,3027.666667,999
.,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,25-אפר-82,06:30,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,9083,3027.666667,999
.,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,25-אפר-82,07:00,0,0,0.020833333,Days,Demographics,Weight,65.7,.,kg,.,.,.,.,.,.,1,9083,3027.666667,999
.,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,14-מרץ-82,07:00,0,12,14.51270473,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,9083,3027.666667,999
.,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,12-מאי-82,14:06,0,14,17.31666667,Days,PD,Efficacy marker,21.095,.,mm,.,.,.,.,.,.,1,9083,3027.666667,999
.,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,23-מאי-82,15:46,0,28,28.38611111,Days,PD,Efficacy marker,21.026,.,mm,.,.,.,.,.,.,1,9083,3027.666667,999
.,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,20-יונ-82,06:30,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,9083,3027.666667,999
.,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,20-יונ-82,15:19,0,56,56.36736111,Days,PD,Efficacy marker,21.097,.,mm,.,.,.,.,.,.,1,9083,3027.666667,999
.,ZY800909083,Z,Y8,PoC Study Indication 1,1,0,9,9083,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,28-אוג-82,16:00,0,112,125.3958333,Days,PD,Efficacy marker,21.25,.,mm,.,.,.,.,.,.,1,9083,3027.666667,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,14-מרץ-82,07:00,0,-14,-41.98611111,Days,Demographics,Age,83,.,Years,.,.,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,14-מרץ-82,07:00,0,-14,-41.98611111,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,14-מרץ-82,07:00,0,-14,-41.98611111,Days,Demographics,Weight,55.7,.,kg,.,.,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,27-מרץ-82,18:43,0,0,-28.49791667,Days,PD,Efficacy marker,18.249,.,mm,.,.,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,16-אפר-82,07:00,0,0,-8.986111111,Days,Demographics,Weight,56,.,kg,.,.,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,14-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,25-אפר-82,06:37,0,0,-0.002083333,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,25-אפר-82,06:40,0.083333333,0,0,Days,Dose,Dose Z,834,.,mg,.,.,iv,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,25-אפר-82,07:00,0,0,0.013888889,Days,Demographics,Weight,55.6,.,kg,.,.,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,25-אפר-82,08:50,0,0.0833,0.090277778,Days,PK,Plasma concentration Z,1773.999,.,ug/ml,.,0.8,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,25-אפר-82,12:40,0,0.25,0.25,Days,PK,Plasma concentration Z,1538.001,.,ug/ml,.,0.8,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,4,VISIT 04,0,0,02-מאי-82,06:40,0,7,7,Days,PK,Plasma concentration Z,294,.,ug/ml,.,0.8,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,14-מרץ-82,07:00,0,12,13.57034705,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,09-מאי-82,06:40,0,14,14,Days,PK,Plasma concentration Z,178.2,.,ug/ml,.,0.8,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,12-מאי-82,15:16,0,14,17.35833333,Days,PD,Efficacy marker,18.858,.,mm,.,.,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,23-מאי-82,06:40,0,28,28,Days,PK,Plasma concentration Z,90.6,.,ug/ml,.,0.8,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,23-מאי-82,15:12,0,28,28.35555556,Days,PD,Efficacy marker,18.709,.,mm,.,.,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,7,VISIT 07,0,0,06-יונ-82,06:40,0,42,42,Days,PK,Plasma concentration Z,49.2,.,ug/ml,.,0.8,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,20-יונ-82,06:37,0,56,55.99791667,Days,PK,Plasma concentration Z,33.399,.,ug/ml,.,0.8,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,20-יונ-82,06:43,0.083333333,56,56.00208333,Days,Dose,Dose Z,831,.,mg,.,.,iv,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,20-יונ-82,08:52,0,56,56.09166667,Days,PK,Plasma concentration Z,1706.001,.,ug/ml,.,0.8,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,20-יונ-82,14:45,0,56,56.33680556,Days,PD,Efficacy marker,19.799,.,mm,.,.,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,9,VISIT 09,0,0,04-יול-82,06:40,0,70,70,Days,PK,Plasma concentration Z,222,.,ug/ml,.,0.8,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,10,VISIT 10,0,0,18-יול-82,06:40,0,84,84,Days,PK,Plasma concentration Z,124.401,.,ug/ml,.,0.8,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,15-אוג-82,06:52,0,112,112.0083333,Days,PK,Plasma concentration Z,46.599,.,ug/ml,.,0.8,.,.,.,.,1,9084,3028,999
.,ZY800909084,Z,Y8,PoC Study Indication 1,1,0,9,9084,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,15-אוג-82,15:49,0,112,112.38125,Days,PD,Efficacy marker,19.986,.,mm,.,.,.,.,.,.,1,9084,3028,999
.,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,27-מרץ-82,07:00,0,-14,-28.99305556,Days,Demographics,Age,69,.,Years,.,.,.,.,.,.,1,9085,3028.333333,999
.,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,27-מרץ-82,07:00,0,-14,-28.99305556,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,9085,3028.333333,999
.,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,27-מרץ-82,07:00,0,-14,-28.99305556,Days,Demographics,Weight,61.8,.,kg,.,.,.,.,.,.,1,9085,3028.333333,999
.,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,17-אפר-82,15:50,0,0,-7.625,Days,PD,Efficacy marker,28.59,.,mm,.,.,.,.,.,.,1,9085,3028.333333,999
.,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,18-אפר-82,07:00,0,0,-6.993055556,Days,Demographics,Weight,61.8,.,kg,.,.,.,.,.,.,1,9085,3028.333333,999
.,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,27-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,9085,3028.333333,999
.,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,25-אפר-82,06:47,0,0,-0.002083333,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,9085,3028.333333,999
.,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,25-אפר-82,06:50,0.083333333,0,0,Days,Dose,Dose Z,811.5,.,mg,.,.,iv,.,.,.,1,9085,3028.333333,999
.,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,25-אפר-82,07:00,0,0,0.006944444,Days,Demographics,Weight,54.1,.,kg,.,.,.,.,.,.,1,9085,3028.333333,999
.,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,25-אפר-82,09:00,0,0.0833,0.090277778,Days,PK,Plasma concentration Z,1059.999,.,ug/ml,.,0.8,.,.,.,.,1,9085,3028.333333,999
.,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,25-אפר-82,12:50,0,0.25,0.25,Days,PK,Plasma concentration Z,920.001,.,ug/ml,.,0.8,.,.,.,.,1,9085,3028.333333,999
.,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,02-מאי-82,06:50,0,7,7,Days,PK,Plasma concentration Z,236.001,.,ug/ml,.,0.8,.,.,.,.,1,9085,3028.333333,999
.,ZY800909085,Z,Y8,PoC Study Indication 1,1,0,9,9085,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,27-מרץ-82,07:00,0,12,13.43594379,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,9085,3028.333333,999
.,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,31-מרץ-82,07:00,0,-14,-29.97916667,Days,Demographics,Age,73,.,Years,.,.,.,.,.,.,1,9086,3028.666667,999
.,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,31-מרץ-82,07:00,0,-14,-29.97916667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,9086,3028.666667,999
.,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,31-מרץ-82,07:00,0,-14,-29.97916667,Days,Demographics,Weight,63.6,.,kg,.,.,.,.,.,.,1,9086,3028.666667,999
.,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,22-אפר-82,19:38,0,0,-7.452777778,Days,PD,Efficacy marker,21.298,.,mm,.,.,.,.,.,.,1,9086,3028.666667,999
.,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,23-אפר-82,07:00,0,0,-6.979166667,Days,Demographics,Weight,66.5,.,kg,.,.,.,.,.,.,1,9086,3028.666667,999
.,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,31-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,9086,3028.666667,999
.,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,30-אפר-82,06:30,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,9086,3028.666667,999
.,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,30-אפר-82,07:00,0,0,0.020833333,Days,Demographics,Weight,65.3,.,kg,.,.,.,.,.,.,1,9086,3028.666667,999
.,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,31-מרץ-82,07:00,0,12,14.19628525,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,9086,3028.666667,999
.,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,17-מאי-82,13:56,0,14,17.30972222,Days,PD,Efficacy marker,20.98,.,mm,.,.,.,.,.,.,1,9086,3028.666667,999
.,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,31-מאי-82,10:12,0,28,31.15416667,Days,PD,Efficacy marker,20.807,.,mm,.,.,.,.,.,.,1,9086,3028.666667,999
.,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,25-יונ-82,06:30,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,9086,3028.666667,999
.,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,14-יול-82,18:14,0,56,75.48888889,Days,PD,Efficacy marker,21.159,.,mm,.,.,.,.,.,.,1,9086,3028.666667,999
.,ZY800909086,Z,Y8,PoC Study Indication 1,1,0,9,9086,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,20-אוג-82,18:13,0,112,112.4881944,Days,PD,Efficacy marker,20.6,.,mm,.,.,.,.,.,.,1,9086,3028.666667,999
.,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-אפר-82,07:00,0,-14,-25.98611111,Days,Demographics,Age,73,.,Years,.,.,.,.,.,.,1,9087,3029,999
.,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-אפר-82,07:00,0,-14,-25.98611111,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,9087,3029,999
.,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-אפר-82,07:00,0,-14,-25.98611111,Days,Demographics,Weight,74.5,.,kg,.,.,.,.,.,.,1,9087,3029,999
.,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,22-אפר-82,19:08,0,0,-7.480555556,Days,PD,Efficacy marker,23.409,.,mm,.,.,.,.,.,.,1,9087,3029,999
.,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,23-אפר-82,07:00,0,0,-6.986111111,Days,Demographics,Weight,76.2,.,kg,.,.,.,.,.,.,1,9087,3029,999
.,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,9087,3029,999
.,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-אפר-82,06:37,0,0,-0.002083333,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,9087,3029,999
.,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-אפר-82,06:40,0.083333333,0,0,Days,Dose,Dose Z,1128,.,mg,.,.,iv,.,.,.,1,9087,3029,999
.,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-אפר-82,07:00,0,0,0.013888889,Days,Demographics,Weight,75.2,.,kg,.,.,.,.,.,.,1,9087,3029,999
.,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-אפר-82,08:47,0,0.0833,0.088194444,Days,PK,Plasma concentration Z,1670.001,.,ug/ml,.,0.8,.,.,.,.,1,9087,3029,999
.,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,30-אפר-82,12:40,0,0.25,0.25,Days,PK,Plasma concentration Z,1580.001,.,ug/ml,.,0.8,.,.,.,.,1,9087,3029,999
.,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,07-מאי-82,06:40,0,7,7,Days,PK,Plasma concentration Z,480,.,ug/ml,.,0.8,.,.,.,.,1,9087,3029,999
.,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,04-אפר-82,07:00,0,12,13.63572747,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,9087,3029,999
.,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,14-מאי-82,06:40,0,14,14,Days,PK,Plasma concentration Z,290.001,.,ug/ml,.,0.8,.,.,.,.,1,9087,3029,999
.,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,17-מאי-82,14:28,0,14,17.325,Days,PD,Efficacy marker,24.046,.,mm,.,.,.,.,.,.,1,9087,3029,999
.,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,28-מאי-82,06:40,0,28,28,Days,PK,Plasma concentration Z,120.999,.,ug/ml,.,0.8,.,.,.,.,1,9087,3029,999
.,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,03-יונ-82,18:14,0,28,34.48194444,Days,PD,Efficacy marker,24.647,.,mm,.,.,.,.,.,.,1,9087,3029,999
.,ZY800909087,Z,Y8,PoC Study Indication 1,1,0,9,9087,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,11-יונ-82,06:40,0,42,42,Days,PK,Plasma concentration Z,71.799,.,ug/ml,.,0.8,.,.,.,.,1,9087,3029,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,27-מרץ-82,07:00,0,-14,-45.97916667,Days,Demographics,Age,67,.,Years,.,.,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,27-מרץ-82,07:00,0,-14,-45.97916667,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,27-מרץ-82,07:00,0,-14,-45.97916667,Days,Demographics,Weight,61.4,.,kg,.,.,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,16-אפר-82,19:27,0,0,-25.46041667,Days,PD,Efficacy marker,33.27,.,mm,.,.,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,05-מאי-82,07:00,0,0,-6.979166667,Days,Demographics,Weight,62.5,.,kg,.,.,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,27-מרץ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,12-מאי-82,06:27,0,0,-0.002083333,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,12-מאי-82,06:30,0.083333333,0,0,Days,Dose,Dose Z,924,.,mg,.,.,iv,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,12-מאי-82,07:00,0,0,0.020833333,Days,Demographics,Weight,61.6,.,kg,.,.,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,12-מאי-82,08:45,0,0.0833,0.09375,Days,PK,Plasma concentration Z,1647.999,.,ug/ml,.,0.8,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,12-מאי-82,12:30,0,0.25,0.25,Days,PK,Plasma concentration Z,1287.999,.,ug/ml,.,0.8,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,4,VISIT 04,0,0,19-מאי-82,06:30,0,7,7,Days,PK,Plasma concentration Z,326.001,.,ug/ml,.,0.8,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,27-מרץ-82,07:00,0,12,13.49471444,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,26-מאי-82,06:30,0,14,14,Days,PK,Plasma concentration Z,183.399,.,ug/ml,.,0.8,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,27-מאי-82,15:52,0,14,15.39027778,Days,PD,Efficacy marker,35.482,.,mm,.,.,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,09-יונ-82,06:30,0,28,28,Days,PK,Plasma concentration Z,113.799,.,ug/ml,.,0.8,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,09-יונ-82,17:27,0,28,28.45625,Days,PD,Efficacy marker,35.171,.,mm,.,.,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,7,VISIT 07,0,0,23-יונ-82,06:30,0,42,42,Days,PK,Plasma concentration Z,55.401,.,ug/ml,.,0.8,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,07-יול-82,06:27,0,56,55.99791667,Days,PK,Plasma concentration Z,30,.,ug/ml,.,0.8,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,07-יול-82,06:30,0.083333333,56,56,Days,Dose,Dose Z,954,.,mg,.,.,iv,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,07-יול-82,08:40,0,56,56.09027778,Days,PK,Plasma concentration Z,1347.999,.,ug/ml,.,0.8,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,07-יול-82,16:16,0,56,56.40694444,Days,PD,Efficacy marker,36.697,.,mm,.,.,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,9,VISIT 09,0,0,21-יול-82,06:30,0,70,70,Days,PK,Plasma concentration Z,237.999,.,ug/ml,.,0.8,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,10,VISIT 10,0,0,04-אוג-82,06:30,0,84,84,Days,PK,Plasma concentration Z,121.401,.,ug/ml,.,0.8,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,01-ספט-82,06:30,0,112,112,Days,PK,Plasma concentration Z,37.599,.,ug/ml,.,0.8,.,.,.,.,1,9088,3029.333333,999
.,ZY800909088,Z,Y8,PoC Study Indication 1,1,0,9,9088,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,03-ספט-82,16:05,0,112,114.3993056,Days,PD,Efficacy marker,36.341,.,mm,.,.,.,.,.,.,1,9088,3029.333333,999
.,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,23-אפר-82,07:00,0,-14,-19.03194444,Days,Demographics,Age,72,.,Years,.,.,.,.,.,.,1,9089,3029.666667,999
.,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,23-אפר-82,07:00,0,-14,-19.03194444,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,9089,3029.666667,999
.,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,23-אפר-82,07:00,0,-14,-19.03194444,Days,Demographics,Weight,78.9,.,kg,.,.,.,.,.,.,1,9089,3029.666667,999
.,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,03-מאי-82,13:24,0,0,-8.765277778,Days,PD,Efficacy marker,27.88,.,mm,.,.,.,.,.,.,1,9089,3029.666667,999
.,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,05-מאי-82,07:00,0,0,-7.031944444,Days,Demographics,Weight,79.8,.,kg,.,.,.,.,.,.,1,9089,3029.666667,999
.,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,23-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,9089,3029.666667,999
.,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,12-מאי-82,07:00,0,0,-0.031944444,Days,Demographics,Weight,78.5,.,kg,.,.,.,.,.,.,1,9089,3029.666667,999
.,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,12-מאי-82,07:46,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,9089,3029.666667,999
.,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,23-אפר-82,07:00,0,12,13.84612595,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,9089,3029.666667,999
.,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,27-מאי-82,16:26,0,14,15.36111111,Days,PD,Efficacy marker,27.115,.,mm,.,.,.,.,.,.,1,9089,3029.666667,999
.,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,17-יונ-82,17:49,0,28,36.41875,Days,PD,Efficacy marker,28.059,.,mm,.,.,.,.,.,.,1,9089,3029.666667,999
.,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,07-יול-82,07:46,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,9089,3029.666667,999
.,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,17-יול-82,16:48,0,56,66.37638889,Days,PD,Efficacy marker,28.491,.,mm,.,.,.,.,.,.,1,9089,3029.666667,999
.,ZY800909089,Z,Y8,PoC Study Indication 1,1,0,9,9089,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,01-ספט-82,16:59,0,112,112.3840278,Days,PD,Efficacy marker,28.134,.,mm,.,.,.,.,.,.,1,9089,3029.666667,999
.,ZY800909090,Z,Y8,PoC Study Indication 1,1,0,9,9090,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,04-אפר-82,07:00,0,-14,-38.00763889,Days,Demographics,Age,77,.,Years,.,.,.,.,.,.,1,9090,3030,999
.,ZY800909090,Z,Y8,PoC Study Indication 1,1,0,9,9090,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,04-אפר-82,07:00,0,-14,-38.00763889,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,9090,3030,999
.,ZY800909090,Z,Y8,PoC Study Indication 1,1,0,9,9090,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,04-אפר-82,07:00,0,-14,-38.00763889,Days,Demographics,Weight,55.1,.,kg,.,.,.,.,.,.,1,9090,3030,999
.,ZY800909090,Z,Y8,PoC Study Indication 1,1,0,9,9090,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,30-אפר-82,13:35,0,0,-11.73333333,Days,PD,Efficacy marker,32.081,.,mm,.,.,.,.,.,.,1,9090,3030,999
.,ZY800909090,Z,Y8,PoC Study Indication 1,1,0,9,9090,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,05-מאי-82,07:00,0,0,-7.007638889,Days,Demographics,Weight,55.4,.,kg,.,.,.,.,.,.,1,9090,3030,999
.,ZY800909090,Z,Y8,PoC Study Indication 1,1,0,9,9090,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,04-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,9090,3030,999
.,ZY800909090,Z,Y8,PoC Study Indication 1,1,0,9,9090,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,12-מאי-82,07:00,0,0,-0.007638889,Days,Demographics,Weight,56.5,.,kg,.,.,.,.,.,.,1,9090,3030,999
.,ZY800909090,Z,Y8,PoC Study Indication 1,1,0,9,9090,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,12-מאי-82,07:11,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,9090,3030,999
.,ZY800909090,Z,Y8,PoC Study Indication 1,1,0,9,9090,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,04-אפר-82,07:00,0,12,13.70858293,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,9090,3030,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,23-אפר-82,07:00,0,-14,-22.98055556,Days,Demographics,Age,67,.,Years,.,.,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,23-אפר-82,07:00,0,-14,-22.98055556,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,23-אפר-82,07:00,0,-14,-22.98055556,Days,Demographics,Weight,47.7,.,kg,.,.,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,09-מאי-82,07:00,0,0,-6.980555556,Days,Demographics,Weight,47.5,.,kg,.,.,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,13-מאי-82,09:26,0,0,-2.879166667,Days,PD,Efficacy marker,22.654,.,mm,.,.,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,23-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,16-מאי-82,06:27,0,0,-0.003472222,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,16-מאי-82,06:32,0.083333333,0,0,Days,Dose,Dose Z,666,.,mg,.,.,iv,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,16-מאי-82,07:00,0,0,0.019444444,Days,Demographics,Weight,44.4,.,kg,.,.,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,16-מאי-82,08:49,0,0.0833,0.095138889,Days,PK,Plasma concentration Z,1022.001,.,ug/ml,.,0.8,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,16-מאי-82,12:49,0,0.25,0.261805556,Days,PK,Plasma concentration Z,1184.001,.,ug/ml,.,0.8,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,4,VISIT 04,0,0,23-מאי-82,06:32,0,7,7,Days,PK,Plasma concentration Z,290.001,.,ug/ml,.,0.8,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,23-אפר-82,07:00,0,12,13.69696607,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,30-מאי-82,06:32,0,14,14,Days,PK,Plasma concentration Z,174.801,.,ug/ml,.,0.8,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,04-יונ-82,18:48,0,14,19.51111111,Days,PD,Efficacy marker,23.646,.,mm,.,.,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,13-יונ-82,06:32,0,28,28,Days,PK,Plasma concentration Z,89.601,.,ug/ml,.,0.8,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,13-יונ-82,17:33,0,28,28.45902778,Days,PD,Efficacy marker,24.001,.,mm,.,.,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,7,VISIT 07,0,0,27-יונ-82,06:32,0,42,42,Days,PK,Plasma concentration Z,51.201,.,ug/ml,.,0.8,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,11-יול-82,06:29,0,56,55.99791667,Days,PK,Plasma concentration Z,39.801,.,ug/ml,.,0.8,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,11-יול-82,06:32,0.083333333,56,56,Days,Dose,Dose Z,705,.,mg,.,.,iv,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,11-יול-82,08:39,0,56,56.08819444,Days,PK,Plasma concentration Z,1298.001,.,ug/ml,.,0.8,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,11-יול-82,15:09,0,56,56.35902778,Days,PD,Efficacy marker,25.229,.,mm,.,.,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,9,VISIT 09,0,0,25-יול-82,06:33,0,70,70.00069444,Days,PK,Plasma concentration Z,204,.,ug/ml,.,0.8,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,10,VISIT 10,0,0,07-אוג-82,06:32,0,84,83,Days,PK,Plasma concentration Z,144.201,.,ug/ml,.,0.8,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,05-ספט-82,06:35,0,112,112.0020833,Days,PK,Plasma concentration Z,44.001,.,ug/ml,.,0.8,.,.,.,.,1,9091,3030.333333,999
.,ZY800909091,Z,Y8,PoC Study Indication 1,1,0,9,9091,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,05-ספט-82,15:42,0,112,112.3819444,Days,PD,Efficacy marker,26.645,.,mm,.,.,.,.,.,.,1,9091,3030.333333,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,23-אפר-82,07:00,0,-14,-32.97916667,Days,Demographics,Age,65,.,Years,.,.,.,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,23-אפר-82,07:00,0,-14,-32.97916667,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,23-אפר-82,07:00,0,-14,-32.97916667,Days,Demographics,Weight,81.8,.,kg,.,.,.,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,19-מאי-82,19:05,0,0,-6.475694444,Days,PD,Efficacy marker,38.463,.,mm,.,.,.,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,23-אפר-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,26-מאי-82,06:27,0,0,-0.002083333,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,26-מאי-82,06:30,0.083333333,0,0,Days,Dose,Dose Z,1245,.,mg,.,.,iv,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,26-מאי-82,07:00,0,0,0.020833333,Days,Demographics,Weight,83,.,kg,.,.,.,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,26-מאי-82,08:43,0,0.0833,0.092361111,Days,PK,Plasma concentration Z,1599.999,.,ug/ml,.,0.8,.,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,26-מאי-82,12:30,0,0.25,0.25,Days,PK,Plasma concentration Z,1371.999,.,ug/ml,.,0.8,.,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,4,VISIT 04,0,0,02-יונ-82,06:30,0,7,7,Days,PK,Plasma concentration Z,344.001,.,ug/ml,.,0.8,.,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,09-יונ-82,06:30,0,14,14,Days,PK,Plasma concentration Z,243.999,.,ug/ml,.,0.8,.,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,23-אפר-82,07:00,0,12,14.99301183,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,23-יונ-82,06:30,0,28,28,Days,PK,Plasma concentration Z,129.801,.,ug/ml,.,0.8,.,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,7,VISIT 07,0,0,07-יול-82,06:30,0,42,42,Days,PK,Plasma concentration Z,76.8,.,ug/ml,.,0.8,.,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,21-יול-82,06:27,0,56,55.99791667,Days,PK,Plasma concentration Z,47.001,.,ug/ml,.,0.8,.,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,21-יול-82,06:30,0.083333333,56,56,Days,Dose,Dose Z,1264.5,.,mg,.,.,iv,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,21-יול-82,16:24,0,56,56.4125,Days,PD,Efficacy marker,41.578,.,mm,.,.,.,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,9,VISIT 09,0,0,04-אוג-82,06:30,0,70,70,Days,PK,Plasma concentration Z,306,.,ug/ml,.,0.8,.,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,10,VISIT 10,0,0,18-אוג-82,06:34,0,84,84.00277778,Days,PK,Plasma concentration Z,162.399,.,ug/ml,.,0.8,.,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,15-ספט-82,06:30,0,112,112,Days,PK,Plasma concentration Z,56.601,.,ug/ml,.,0.8,.,.,.,.,1,9092,3030.666667,999
.,ZY800909092,Z,Y8,PoC Study Indication 1,1,0,9,9092,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,15-ספט-82,14:53,0,112,112.3493056,Days,PD,Efficacy marker,42.371,.,mm,.,.,.,.,.,.,1,9092,3030.666667,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,12-מאי-82,07:00,0,-14,-22.98055556,Days,Demographics,Age,78,.,Years,.,.,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,12-מאי-82,07:00,0,-14,-22.98055556,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,12-מאי-82,07:00,0,-14,-22.98055556,Days,Demographics,Weight,50,.,kg,.,.,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,28-מאי-82,07:00,0,0,-6.980555556,Days,Demographics,Weight,51,.,kg,.,.,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,31-מאי-82,12:13,0,0,-3.763194444,Days,PD,Efficacy marker,21.118,.,mm,.,.,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,12-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,04-יונ-82,06:27,0,0,-0.003472222,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,04-יונ-82,06:32,0.083333333,0,0,Days,Dose,Dose Z,772.5,.,mg,.,.,iv,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,04-יונ-82,07:00,0,0,0.019444444,Days,Demographics,Weight,51.5,.,kg,.,.,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,04-יונ-82,08:53,0,0.0833,0.097916667,Days,PK,Plasma concentration Z,1062,.,ug/ml,.,0.8,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,04-יונ-82,12:32,0,0.25,0.25,Days,PK,Plasma concentration Z,822,.,ug/ml,.,0.8,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,4,VISIT 04,0,0,11-יונ-82,06:32,0,7,7,Days,PK,Plasma concentration Z,218.001,.,ug/ml,.,0.8,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,12-מאי-82,07:00,0,12,13.42058732,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,18-יונ-82,06:32,0,14,14,Days,PK,Plasma concentration Z,136.2,.,ug/ml,.,0.8,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,18-יונ-82,15:05,0,14,14.35625,Days,PD,Efficacy marker,22.721,.,mm,.,.,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,02-יול-82,06:32,0,28,28,Days,PK,Plasma concentration Z,69.6,.,ug/ml,.,0.8,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,02-יול-82,15:03,0,28,28.35486111,Days,PD,Efficacy marker,22.267,.,mm,.,.,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,7,VISIT 07,0,0,16-יול-82,06:32,0,42,42,Days,PK,Plasma concentration Z,46.2,.,ug/ml,.,0.8,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,29-יול-82,18:04,0,56,55.48055556,Days,PD,Efficacy marker,22.87,.,mm,.,.,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,30-יול-82,06:26,0,56,55.99583333,Days,PK,Plasma concentration Z,22.599,.,ug/ml,.,0.8,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,30-יול-82,06:32,0.083333333,56,56,Days,Dose,Dose Z,781.5,.,mg,.,.,iv,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,30-יול-82,08:38,0,56,56.0875,Days,PK,Plasma concentration Z,1190.001,.,ug/ml,.,0.8,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,9,VISIT 09,0,0,13-אוג-82,06:32,0,70,70,Days,PK,Plasma concentration Z,146.601,.,ug/ml,.,0.8,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,10,VISIT 10,0,0,27-אוג-82,06:32,0,84,84,Days,PK,Plasma concentration Z,105.999,.,ug/ml,.,0.8,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,24-ספט-82,06:32,0,112,112,Days,PK,Plasma concentration Z,36,.,ug/ml,.,0.8,.,.,.,.,1,9097,3032.333333,999
.,ZY800909097,Z,Y8,PoC Study Indication 1,1,0,9,9097,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,24-ספט-82,12:36,0,112,112.2527778,Days,PD,Efficacy marker,22.457,.,mm,.,.,.,.,.,.,1,9097,3032.333333,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,13-מאי-82,07:00,0,-14,-21.98611111,Days,Demographics,Age,65,.,Years,.,.,.,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,13-מאי-82,07:00,0,-14,-21.98611111,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,13-מאי-82,07:00,0,-14,-21.98611111,Days,Demographics,Weight,77.3,.,kg,.,.,.,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,28-מאי-82,07:00,0,0,-6.986111111,Days,Demographics,Weight,76.8,.,kg,.,.,.,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,2,Baseline,1,0,28-מאי-82,15:04,0,0,-6.65,Days,PD,Efficacy marker,36.208,.,mm,.,.,.,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,13-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-יונ-82,06:37,0,0,-0.002083333,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-יונ-82,06:40,0.083333333,0,0,Days,Dose,Dose Z,1165.5,.,mg,.,.,iv,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-יונ-82,07:00,0,0,0.013888889,Days,Demographics,Weight,77.7,.,kg,.,.,.,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-יונ-82,09:57,0,0.166,0.136805556,Days,PK,Plasma concentration Z,1272,.,ug/ml,.,0.8,.,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,3,VISIT 03,1,0,04-יונ-82,12:40,0,0.25,0.25,Days,PK,Plasma concentration Z,1164,.,ug/ml,.,0.8,.,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,4,VISIT 04,0,0,11-יונ-82,06:40,0,7,7,Days,PK,Plasma concentration Z,278.001,.,ug/ml,.,0.8,.,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,1,Screening,0,1,13-מאי-82,07:00,0,12,13.29590863,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,18-יונ-82,06:40,0,14,14,Days,PK,Plasma concentration Z,150.399,.,ug/ml,.,0.8,.,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,5,VISIT 05,0,0,18-יונ-82,15:59,0,14,14.38819444,Days,PD,Efficacy marker,38.259,.,mm,.,.,.,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,02-יול-82,06:40,0,28,28,Days,PK,Plasma concentration Z,84.801,.,ug/ml,.,0.8,.,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,6,VISIT 06,0,0,02-יול-82,15:33,0,28,28.37013889,Days,PD,Efficacy marker,38.743,.,mm,.,.,.,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,7,VISIT 07,0,0,16-יול-82,06:40,0,42,42,Days,PK,Plasma concentration Z,66.399,.,ug/ml,.,0.8,.,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,8,VISIT 08,0,0,29-יול-82,15:31,0,56,55.36875,Days,PD,Efficacy marker,40.038,.,mm,.,.,.,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,9,VISIT 09,0,0,13-אוג-82,06:40,0,70,70,Days,PK,Plasma concentration Z,14.679,.,ug/ml,.,0.8,.,.,.,.,1,9098,3032.666667,999
.,ZY800909098,Z,Y8,PoC Study Indication 1,1,0,9,9098,Indication 1,SD IV 15 mg/kg,SD IV 15 mg/kg,10,VISIT 10,0,0,27-אוג-82,06:40,0,84,84,Days,PK,Plasma concentration Z,9.321,.,ug/ml,.,0.8,.,.,.,.,1,9098,3032.666667,999
.,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,20-מאי-82,07:00,0,-14,-28.98125,Days,Demographics,Age,73,.,Years,.,.,.,.,.,.,1,9100,3033.333333,999
.,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,20-מאי-82,07:00,0,-14,-28.98125,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,9100,3033.333333,999
.,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,20-מאי-82,07:00,0,-14,-28.98125,Days,Demographics,Weight,72.7,.,kg,.,.,.,.,.,.,1,9100,3033.333333,999
.,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,11-יונ-82,07:00,0,0,-6.98125,Days,Demographics,Weight,74.4,.,kg,.,.,.,.,.,.,1,9100,3033.333333,999
.,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,14-יונ-82,13:54,0,0,-3.69375,Days,PD,Efficacy marker,25.381,.,mm,.,.,.,.,.,.,1,9100,3033.333333,999
.,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,20-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,9100,3033.333333,999
.,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,18-יונ-82,06:33,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,9100,3033.333333,999
.,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,18-יונ-82,07:00,0,0,0.01875,Days,Demographics,Weight,73,.,kg,.,.,.,.,.,.,1,9100,3033.333333,999
.,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,02-יול-82,16:02,0,14,14.39513889,Days,PD,Efficacy marker,26.404,.,mm,.,.,.,.,.,.,1,9100,3033.333333,999
.,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,20-מאי-82,07:00,0,12,14.53360374,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,9100,3033.333333,999
.,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,16-יול-82,16:04,0,28,28.39652778,Days,PD,Efficacy marker,25.725,.,mm,.,.,.,.,.,.,1,9100,3033.333333,999
.,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,13-אוג-82,06:33,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,9100,3033.333333,999
.,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,22-ספט-82,15:56,0,56,96.39097222,Days,PD,Efficacy marker,26.187,.,mm,.,.,.,.,.,.,1,9100,3033.333333,999
.,ZY800909100,Z,Y8,PoC Study Indication 1,1,0,9,9100,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,23-אוק-82,16:33,0,112,127.4166667,Days,PD,Efficacy marker,25.814,.,mm,.,.,.,.,.,.,1,9100,3033.333333,999
.,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,22-מאי-82,07:00,0,-14,-32.97916667,Days,Demographics,Age,75,.,Years,.,.,.,.,.,.,1,9101,3033.666667,999
.,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,22-מאי-82,07:00,0,-14,-32.97916667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,9101,3033.666667,999
.,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,22-מאי-82,07:00,0,-14,-32.97916667,Days,Demographics,Weight,68.2,.,kg,.,.,.,.,.,.,1,9101,3033.666667,999
.,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,11-יונ-82,07:00,0,0,-12.97916667,Days,Demographics,Weight,69.5,.,kg,.,.,.,.,.,.,1,9101,3033.666667,999
.,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,14-יונ-82,13:00,0,0,-9.729166667,Days,PD,Efficacy marker,24.199,.,mm,.,.,.,.,.,.,1,9101,3033.666667,999
.,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,22-מאי-82,07:00,0,0,-0.08,Days,Vital signs,Health status,1,unwell,-,.,.,.,.,.,.,1,9101,3033.666667,999
.,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,24-יונ-82,06:30,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,9101,3033.666667,999
.,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,24-יונ-82,07:00,0,0,0.020833333,Days,Demographics,Weight,69,.,kg,.,.,.,.,.,.,1,9101,3033.666667,999
.,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,22-מאי-82,07:00,0,12,14.18177238,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,9101,3033.666667,999
.,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,08-יול-82,14:51,0,14,14.34791667,Days,PD,Efficacy marker,24.467,.,mm,.,.,.,.,.,.,1,9101,3033.666667,999
.,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,22-יול-82,16:18,0,28,28.40833333,Days,PD,Efficacy marker,23.91,.,mm,.,.,.,.,.,.,1,9101,3033.666667,999
.,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,18-אוג-82,15:44,0,56,55.38472222,Days,PD,Efficacy marker,23.794,.,mm,.,.,.,.,.,.,1,9101,3033.666667,999
.,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,19-אוג-82,06:50,0.083333333,56,56.01388889,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,9101,3033.666667,999
.,ZY800909101,Z,Y8,PoC Study Indication 1,1,0,9,9101,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,29-אוק-82,15:14,0,112,127.3638889,Days,PD,Efficacy marker,24.094,.,mm,.,.,.,.,.,.,1,9101,3033.666667,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,05-יונ-82,07:00,0,-14,-18.98611111,Days,Demographics,Age,73,.,Years,.,.,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,05-יונ-82,07:00,0,-14,-18.98611111,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,05-יונ-82,07:00,0,-14,-18.98611111,Days,Demographics,Weight,72.7,.,kg,.,.,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,17-יונ-82,07:00,0,0,-6.986111111,Days,Demographics,Weight,72.7,.,kg,.,.,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,18-יונ-82,15:31,0,0,-5.63125,Days,PD,Efficacy marker,32.987,.,mm,.,.,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,05-יונ-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,24-יונ-82,06:37,0,0,-0.002083333,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,24-יונ-82,06:40,0.083333333,0,0,Days,Dose,Dose Z,1095,.,mg,.,.,iv,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,24-יונ-82,07:00,0,0,0.013888889,Days,Demographics,Weight,73,.,kg,.,.,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,24-יונ-82,08:51,0,0.0833,0.090972222,Days,PK,Plasma concentration Z,1404,.,ug/ml,.,0.8,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,24-יונ-82,12:40,0,0.25,0.25,Days,PK,Plasma concentration Z,1302,.,ug/ml,.,0.8,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,4,VISIT 04,0,0,01-יול-82,06:40,0,7,7,Days,PK,Plasma concentration Z,318,.,ug/ml,.,0.8,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,05-יונ-82,07:00,0,12,13.66551831,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,08-יול-82,07:05,0,14,14.01736111,Days,PK,Plasma concentration Z,162.999,.,ug/ml,.,0.8,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,17-יול-82,17:16,0,14,23.44166667,Days,PD,Efficacy marker,35.692,.,mm,.,.,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,22-יול-82,06:40,0,28,28,Days,PK,Plasma concentration Z,86.199,.,ug/ml,.,0.8,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,22-יול-82,15:49,0,28,28.38125,Days,PD,Efficacy marker,36.362,.,mm,.,.,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,7,VISIT 07,0,0,05-אוג-82,06:40,0,42,42,Days,PK,Plasma concentration Z,53.001,.,ug/ml,.,0.8,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,18-אוג-82,16:49,0,56,55.42291667,Days,PD,Efficacy marker,36.365,.,mm,.,.,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,19-אוג-82,06:34,0,56,55.99583333,Days,PK,Plasma concentration Z,25.8,.,ug/ml,.,0.8,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,19-אוג-82,06:40,0.083333333,56,56,Days,Dose,Dose Z,1123.5,.,mg,.,.,iv,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,19-אוג-82,08:46,0,56,56.0875,Days,PK,Plasma concentration Z,2000.001,.,ug/ml,.,0.8,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,9,VISIT 09,0,0,02-ספט-82,06:40,0,70,70,Days,PK,Plasma concentration Z,201.999,.,ug/ml,.,0.8,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,10,VISIT 10,0,0,16-ספט-82,06:44,0,84,84.00277778,Days,PK,Plasma concentration Z,107.001,.,ug/ml,.,0.8,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,14-אוק-82,06:40,0,112,112,Days,PK,Plasma concentration Z,40.401,.,ug/ml,.,0.8,.,.,.,.,1,9102,3034,999
.,ZY800909102,Z,Y8,PoC Study Indication 1,1,0,9,9102,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,23-אוק-82,14:25,0,112,121.3229167,Days,PD,Efficacy marker,36.839,.,mm,.,.,.,.,.,.,1,9102,3034,999
.,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,07-יול-82,07:00,0,-14,-36.98611111,Days,Demographics,Age,74,.,Years,.,.,.,.,.,.,1,9103,3034.333333,999
.,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,07-יול-82,07:00,0,-14,-36.98611111,Days,Demographics,Gender,1,Male,.,.,.,.,.,.,.,1,9103,3034.333333,999
.,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,07-יול-82,07:00,0,-14,-36.98611111,Days,Demographics,Weight,72.7,.,kg,.,.,.,.,.,.,1,9103,3034.333333,999
.,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,30-יול-82,16:08,0,0,-13.60555556,Days,PD,Efficacy marker,31.715,.,mm,.,.,.,.,.,.,1,9103,3034.333333,999
.,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,06-אוג-82,07:00,0,0,-6.986111111,Days,Demographics,Weight,72.5,.,kg,.,.,.,.,.,.,1,9103,3034.333333,999
.,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,07-יול-82,07:00,0,0,-0.08,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,9103,3034.333333,999
.,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,13-אוג-82,06:40,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,9103,3034.333333,999
.,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,13-אוג-82,07:00,0,0,0.013888889,Days,Demographics,Weight,72.2,.,kg,.,.,.,.,.,.,1,9103,3034.333333,999
.,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,07-יול-82,07:00,0,12,13.99024941,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,9103,3034.333333,999
.,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,27-אוג-82,15:15,0,14,14.35763889,Days,PD,Efficacy marker,32.466,.,mm,.,.,.,.,.,.,1,9103,3034.333333,999
.,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,10-ספט-82,15:24,0,28,28.36388889,Days,PD,Efficacy marker,32.032,.,mm,.,.,.,.,.,.,1,9103,3034.333333,999
.,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,07-אוק-82,15:38,0,56,55.37361111,Days,PD,Efficacy marker,32.192,.,mm,.,.,.,.,.,.,1,9103,3034.333333,999
.,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,08-אוק-82,09:00,0.083333333,56,56.09722222,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,9103,3034.333333,999
.,ZY800909103,Z,Y8,PoC Study Indication 1,1,0,9,9103,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,11,VISIT 11,0,0,02-דצמ-82,12:43,0,112,111.2520833,Days,PD,Efficacy marker,32.973,.,mm,.,.,.,.,.,.,1,9103,3034.333333,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,28-יול-82,07:00,0,-14,-23.98611111,Days,Demographics,Age,73,.,Years,.,.,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,28-יול-82,07:00,0,-14,-23.98611111,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,28-יול-82,07:00,0,-14,-23.98611111,Days,Demographics,Weight,65.9,.,kg,.,.,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,2,Baseline,1,0,09-אוג-82,12:46,0,0,-11.74583333,Days,PD,Efficacy marker,23.673,.,mm,.,.,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,28-יול-82,07:00,0,0,-0.08,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,21-אוג-82,06:37,0,0,-0.002083333,Days,PK,Plasma concentration Z,0,.,ug/ml,.,0.8,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,21-אוג-82,06:40,0.083333333,0,0,Days,Dose,Dose Z,1023,.,mg,.,.,iv,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,21-אוג-82,07:00,0,0,0.013888889,Days,Demographics,Weight,68.2,.,kg,.,.,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,21-אוג-82,08:46,0,0.0833,0.0875,Days,PK,Plasma concentration Z,1320,.,ug/ml,.,0.8,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,3,VISIT 03,1,0,21-אוג-82,12:40,0,0.25,0.25,Days,PK,Plasma concentration Z,1362,.,ug/ml,.,0.8,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,4,VISIT 04,0,0,28-אוג-82,06:40,0,7,7,Days,PK,Plasma concentration Z,338.001,.,ug/ml,.,0.8,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,04-ספט-82,06:40,0,14,14,Days,PK,Plasma concentration Z,234,.,ug/ml,.,0.8,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,1,Screening,0,1,28-יול-82,07:00,0,12,14.03894004,Days,Vital signs,Health status,3,good,-,.,.,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,5,VISIT 05,0,0,04-ספט-82,15:34,0,14,14.37083333,Days,PD,Efficacy marker,24.49,.,mm,.,.,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,18-ספט-82,06:40,0,28,28,Days,PK,Plasma concentration Z,126.399,.,ug/ml,.,0.8,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,7,VISIT 07,0,0,02-אוק-82,07:43,0,42,42.04375,Days,PK,Plasma concentration Z,60.6,.,ug/ml,.,0.8,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,6,VISIT 06,0,0,02-אוק-82,16:45,0,42,42.42013889,Days,PD,Efficacy marker,25.145,.,mm,.,.,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,15-אוק-82,15:41,0,56,55.37569444,Days,PD,Efficacy marker,25.372,.,mm,.,.,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,16-אוק-82,06:37,0,56,55.99791667,Days,PK,Plasma concentration Z,21.201,.,ug/ml,.,0.8,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,16-אוק-82,06:41,0.083333333,56,56.00069444,Days,Dose,Dose Z,1029,.,mg,.,.,iv,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,8,VISIT 08,0,0,16-אוק-82,09:00,0,56.0833,56.09722222,Days,PK,Plasma concentration Z,1826.001,.,ug/ml,.,0.8,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,9,VISIT 09,0,0,30-אוק-82,06:40,0,70,70,Days,PK,Plasma concentration Z,213.999,.,ug/ml,.,0.8,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,10,VISIT 10,0,0,13-נוב-82,06:45,0,84,84.00347222,Days,PK,Plasma concentration Z,116.001,.,ug/ml,.,0.8,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,11-דצמ-82,06:40,0,112,112,Days,PK,Plasma concentration Z,25.2,.,ug/ml,.,0.8,.,.,.,.,1,9105,3035,999
.,ZY800909105,Z,Y8,PoC Study Indication 1,1,0,9,9105,Indication 1,MD IV 15mg/kg,MD IV 15mg/kg,11,VISIT 11,0,0,11-דצמ-82,15:50,0,112,112.3819444,Days,PD,Efficacy marker,25.296,.,mm,.,.,.,.,.,.,1,9105,3035,999
.,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,29-אוג-82,07:00,0,-14,-26.97916667,Days,Demographics,Age,66,.,Years,.,.,.,.,.,.,1,9106,3035.333333,999
.,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,29-אוג-82,07:00,0,-14,-26.97916667,Days,Demographics,Gender,2,Female,.,.,.,.,.,.,.,1,9106,3035.333333,999
.,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,29-אוג-82,07:00,0,-14,-26.97916667,Days,Demographics,Weight,65.5,.,kg,.,.,.,.,.,.,1,9106,3035.333333,999
.,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,16-ספט-82,17:49,0,0,-8.528472222,Days,PD,Efficacy marker,25.637,.,mm,.,.,.,.,.,.,1,9106,3035.333333,999
.,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,2,Baseline,1,0,18-ספט-82,07:00,0,0,-6.979166667,Days,Demographics,Weight,65.1,.,kg,.,.,.,.,.,.,1,9106,3035.333333,999
.,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,29-אוג-82,07:00,0,0,-0.08,Days,Vital signs,Health status,2,bad,-,.,.,.,.,.,.,1,9106,3035.333333,999
.,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,25-ספט-82,06:30,0.083333333,0,0,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,9106,3035.333333,999
.,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,3,VISIT 03,1,0,25-ספט-82,07:00,0,0,0.020833333,Days,Demographics,Weight,64,.,kg,.,.,.,.,.,.,1,9106,3035.333333,999
.,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,1,Screening,0,1,29-אוג-82,07:00,0,12,13.78005803,Days,Vital signs,Health status,4,excellent,-,.,.,.,.,.,.,1,9106,3035.333333,999
.,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,5,VISIT 05,0,0,09-אוק-82,15:58,0,14,14.39444444,Days,PD,Efficacy marker,26.024,.,mm,.,.,.,.,.,.,1,9106,3035.333333,999
.,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,6,VISIT 06,0,0,06-נוב-82,17:07,0,28,42.44236111,Days,PD,Efficacy marker,25.393,.,mm,.,.,.,.,.,.,1,9106,3035.333333,999
.,ZY800909106,Z,Y8,PoC Study Indication 1,1,0,9,9106,Indication 1,SD or MD IV Placebo,SD or MD IV Placebo,8,VISIT 08,0,0,20-נוב-82,06:30,0.083333333,56,56,Days,Dose,Dose Z,0,.,mg,.,.,iv,.,.,.,1,9106,3035.333333,999
